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Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders amongst 
women, estimated to affect one out of 10 women. Symptoms include infertility, obesity, 
alopecia, acne, hirsutism and menstrual irregularities. Women with the syndrome are also more 
likely to experience co-morbid physical and psychological conditions such as diabetes, heart 
disease, endometrial cancer and also depression and anxiety. PCOS has also been found to have 
a negative impact on quality of life.  
This thesis aimed to further understanding, and improve quality of life of women with 
PCOS in the UK. To achieve this, the thesis aimed to investigate and identify how women with 
PCOS in the UK perceive and define their quality of life and to further understanding of the day-
to-day experience of living with PCOS. Moreover, in order to measure quality of life, it aimed to 
develop and validate a UK disease-specific quality of life measure for women with PCOS. It also 
aimed to identify, develop and test a pilot intervention to increase quality of life in women with 
PCOS. To achieve these aims a mixed-methods approach was taken employing a variety of data 
generation and collection methods including: photovoice, online Skype™ interviews; 
LimeSurvey and Qualtrics. 
The findings of this thesis emphasise that PCOS has a negative impact on quality of life; 
encompassing psychological, social, environmental, and physical domains of quality of life. 
Women with PCOS who experienced the symptoms of infertility, hirsutism, weight, alopecia, 
skin discolouration, skin tags and mood swings had significantly lower scores of overall quality 
of life than those women who did not experience the symptoms. In addition, those women with 
PCOS who had a diagnosis of anxiety and/or depression had reduced quality of life.  
The dissemination of these findings will enable health care professionals to better 
understand the experience of living with PCOS and its impact on quality of life. Moreover, this 
thesis identifies many areas for future research which will enable a better understanding of the 
impact of PCOS on quality of life. Finally, this thesis makes recommendations for clinical 
practice which include improvement of support from health care professionals for women with 
PCOS in order to help them better manage their symptoms, and therefore improve their overall 
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Chapter One -Polycystic Ovary Syndrome: An introduction. 
 
1.1 Introduction 
This chapter introduces Polycystic Ovary Syndrome (PCOS) and details the symptoms, 
treatments and diagnostic definitions of PCOS. It then discusses PCOS as a long-term condition 
and women’s health. Coping in long-term conditions is detailed with a focus on management of 
long-term conditions. Next, quality of life is discussed in order to set a context for a following 
discussion of what is currently known about the impact of PCOS on quality of life. This chapter 
then concludes with the overarching, and specific aims of this thesis.  
 
1.2 Long-term Conditions 
Radley (2004) suggests that when diagnosed with long-term illness, a person changes from being 
healthy, to living with long-term illness in a world of health. Almost half of the UK population 
has reported having a long-standing illness (46.6%) with some of the most common long-term 
conditions in the UK being hypertension, asthma and depression (ONS, 2015). The Department 
of Health (DOH, 2015) state that in England alone, more than 15 million people have a long-
term condition. It is also suggested that the number of individuals with multiple long-term 
conditions is set to rise to 2.9 million in 2018 (DOH, 2012). Moreover, the cost of care for 
people with long-term conditions in England accounts for 70% of the monies spent on health and 
social care (DOH, 2015), suggesting that long-term conditions are a large cost to the economy. 
As such, research exploring long-term, or long-term conditions, is necessary to help further 
understanding of long-term conditions and their impact.  
 
De Ridder (2004) defines long-term illness as a disorder which persists for an extended period of 
time which is incurable. Moreover, she suggests that most long-term conditions get progressively 
worse over time. Similarly, Forshaw (2002) suggests that long-term illness is not something that 
can be easily cured but is a long lasting, and often permanent condition which becomes part of a 
person’s life. Holman and Lorig (1992) argue that there are many components to long-term 
illness and these can interact to worsen, or to lessen, the illness effect. They suggest that whilst 
there may be biological differences in long-term illness, the illness components and their 
interactions have similarities (Holman & Lorig, 1992). However, not all long-term conditions are 
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the same; some may be life threatening such as cancer or heart disease, and others are considered 
not to be, such as psoriasis (Radley, 2004). 
 
It is of note that within the literature the term chronic conditions and long-term conditions are 
often used interchangeably (e.g., Barlow, Singh, Bayer & Curry, 2007). However, the UK 
Government (DOH, 2015) and the UK National Health Service (NHS; 2016) both utilise the 
terminology, long-term condition. As such, this thesis shall refer to long-term conditions 
throughout. 
 
1.3 Polycystic Ovary Syndrome 
PCOS is a long-term condition which manifests across the lifespan (Teede, Deeks & Moran, 
2010). It was first defined in 1935 by Stein and Leventhal as Stein-Leventhal syndrome and is 
considered as the most common endocrine disorder amongst women of reproductive age (Franks, 
1995; McGowan, 2011) affecting approximately 6.5% of women (Asuncion et al., 2000; Azziz et 
al., 2004). The pathogenesis of PCOS is poorly understood (Goodarzi & Azziz, 2006; Ong, 
Theodoru & Ledger, 2006). Indeed, Franks, McCarthy and Hardy (2006) suggest that although 
the aetiology of PCOS remains uncertain, there is increasing evidence for a genetic basis: they 
propose that the genesis of the syndrome may be during early development, perhaps in utero. 
However, de Melo et al. (2015) report that whilst PCOS might have its origin in utero, 
interaction between genetic and environmental factors is crucial for its appearance.  
 
1.3.1 Symptoms  
Symptoms of PCOS, or Polycystic Ovarian Syndrome, can include insulin resistance, obesity 
(Goudas & Dumesic, 1997), acne (Coffey, Bano & Mason, 2006) hair loss and infertility 
(Elsenbruch et al., 2003). Specifically, women with PCOS may experience anovulatory infertility 
which is infertility due to lack of ovulation (Franks, Stark & Hardy, 2008). PCOS is the most 
common cause of anovulatory infertility in women (Balen & Rutherford, 2007; Gorry, White & 
Franks, 2006). In addition, women with PCOS can experience hirsutism, which can occur as a 
result of hyperandrogenism (excess levels of androgens; Oláh, 2004) and is defined in women as 





Treatment of PCOS has developed over the years but as the cause of PCOS is not clearly 
defined, the treatment of PCOS is symptomatic (Rosenfield, 2008). Common treatments include 
the oral contraceptive pill (Teede, Hutchinson, Zoungas & Meyer, 2006), metformin (Herriot, 
Whitcroft & Jeanes, 2008; La Marca, Artensio, Stabile & Volpe, 2005) and clomiphene citrate 
(Hill, 2003). Lifestyle changes, including weight loss and dietary changes, are also commonly 
prescribed and advised for women with PCOS (Ehrmann, 2002; Harris-Glocker, Davidson, 
Kochman, Guzick & Hoeger, 2010; Hart & Norman, 2006; Norman, Davies, Lord  & Moran, 
2002; Pasquali, Gambineri, & Pagotto, 2006; Teede et al., 2006; Thomson et al., 2010). The 
focus, therefore, has been on treating symptoms, with less literature exploring the experience of 
living with these symptoms and their impact on quality of life.  
 
1.3.3 Diagnostic Definition 
The definition of PCOS has been disputed since its conception in 1935 (Stein & Leventhal) and 
debate over an accepted definition is still rife. Consequently, comparative research on PCOS has 
been hampered by the absence of a consensus on the definition of PCOS (Ong et al., 2006). 
There are currently three widely used PCOS diagnostic criteria. The 1990 National Institute of 
Health (NIH) criteria (cf. NIH, 2012), which requires only the presence of chronic anovulation 
and clinical or biochemical signs of hyperandrogenism (excess levels of androgens), and not 
polycystic ovaries. The Androgen Excess Society (AES) criteria suggests that the NIH criteria 
should be accepted, however, with modifications whereby women with oligoamenorrhea (light 
or infrequent menstrual cycles) and polycystic ovaries, but no hyperandogenism should not be 
considered to have PCOS (Azziz et al., 2006). The final diagnostic criteria are the 2003 
Rotterdam Criteria (2004) which require two of the following three symptoms: oligo and/or 
anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries. The 
Rotterdam criteria, therefore, recognise four phenotypes of PCOS (Norman, Dewailly, Legro & 
Hickey, 2007): Severe PCOS (all diagnostic criteria met), Hyperandrogenism and anovulation, 
Ovulatory PCOS (polycystic ovaries and hyperandrogenism) and Mild PCOS (anovulation and 
polycystic ovaries). The Rotterdam criteria are therefore more inclusive than the NIH or AES 




In 1960, Roberts and Haines claimed that PCOS was not a well-defined entity. More than 40 
years later it was suggested that the need for a universal diagnostic criteria remained to be 
implemented by researchers and health care professionals (Brady, Mousa & Mousa, 2009). 
Indeed, Amato, Galluzzo, Finocchiaro, Criscimanna and Giordano (2008) conducted a 
retrospective study on patients suspected of PCOS (N=204) and a control group (N=34) in the 
authors’ outpatient clinic to assess whether the application of the three diagnostic criteria 
differentially characterised women with PCOS. They found that the prevalence of PCOS in the 
women according to the NIH criteria was 51%, 83% according to the Rotterdam criteria and 71% 
according to the AES. Correspondingly, in 2013 a NIH panel recommended that diagnosis of 
PCOS should be made according to the ‘broad, inclusionary Rotterdam criteria’, however, to 
date research still predominately fails to detail the diagnostic criteria used to diagnose 
participants with PCOS. Moreover, there is no way of ensuring that clinicians implement the 
Rotterdam Criteria (2004) as the primary diagnostic criteria. As such, there remains a lack of 
consistency in diagnostic criteria utilised in practice, and reported in research (Lujan, Chizen & 
Pierson, 2008). Therefore, in order to be broad and inclusive, the inclusion criteria for this thesis 
will be a sample of women with a self-reported diagnosis of PCOS; with no exclusions on the 
basis of the criteria by which they were diagnosed.  
 
1.4 PCOS as a long-term condition 
Marks et al. (2005) suggest long-term conditions are usually characterised by depression, 
anxiety, fatigue, pain, and limits on normal day-to-day activities. Similarly, the DOH (2015) 
suggest that long-term conditions can impact all aspects of an individual’s life from their ability 
to work, to their social relationships. PCOS embodies many of these characteristics including an 
impact on the individual’s ability to take part in normal day-to-day activities (Brady et al., 2009) 
and fatigue (Dokras, 2012). Women with PCOS are also likely to experience depression and 
anxiety which can be characteristic of long-term conditions (Marks et al., 2005). Indeed, women 
with PCOS experience increased levels of anxiety and depression in comparison to women 
without PCOS (Deeks, Gibson-Helm, Paul & Teede, 2011). In a sample of 448 women with 
PCOS, Benson et al. (2009) found that 34% demonstrated elevated levels of anxiety and 20.5% 
demonstrated elevated levels of depression when measured with the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983). They also suggested that co-morbid 
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anxiety and depression is common in women with PCOS. Similarly, Kerchner, Lester, Stuart and 
Dokras (2009) found a 35% prevalence rate of depression in women with PCOS and only 10% in 
controls. However, it has been suggested that the psychological implications of PCOS are easily 
underestimated and have been largely ignored (McCook, Reame & Thatcher, 2005). 
 
Women with PCOS are also likely to experience other comorbid conditions including 
cardiovascular disease, type two diabetes mellitus and endometrial cancer (Chittenden, Fullerton, 
Maheshwari & Bhattacharya, 2009; Fearnley et al., 2010; Navaratnarajah, Pillay & Hardiman, 
2008). Gottschau, Kjaer, Jensen, Munk and Mellemkjaer (2015) whilst supporting findings of an 
increased risk of endometrial cancer in PCOS, also suggested that women with PCOS were at 
increased risk of kidney, colon and brain cancers.  
 
1.5 Women’s Health 
Women can experience long-term conditions which are gender specific, including: endometriosis 
and cancers, including breast cancer and carrying of the BRCA gene (NHS, 2014; Ogden, 2012). 
Similarly to PCOS, experiencing endometriosis and carrying of the BRCA 1 or 2 gene can both 
impact women and their fertility (Facchin et al., 2015; Donnelly et al., 2013). They have also 
been found to have a negative impact on quality of life (Finch & Narod, 2011; Friedl et al., 
2015). Women may also experience issues concerning fertility including miscarriages, infertility 
and menopause (Ogden) which also impair quality of life in women (Chachamovich et al., 2010).  
 
Endometriosis is a condition which affects women of reproductive age which has been shown to 
reduce quality of life in those women that experience it (Facchin et al., 2015; Friedl et al., 2015). 
Women with endometriosis have also been found to experience depression and anxiety in 
addition to their endometriosis (Friedl et al., 2015; Sepulcri & Amaral, 2009). Symptoms of 
endometriosis can include infertility or subfertility (Mavrelos & Saridogan, 2015). There is no 
cure for endometriosis and treatment is symptomatic, often treatment is in response to fertility 
issues, however the condition can improve over time in some cases (NHS, 2015). As such 
endometriosis is similar to PCOS as there is no known cure, it impacts women of reproductive 
age, treatment is symptomatic and can include similar treatments (for example, the oral 
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contraceptive pill). In addition, women with endometriosis can experience a negative impact on 
their fertility, as can women with PCOS.  
 
Women are also at risk of carrying the BRCA 1 or 2 gene mutation which increases the carrier’s 
risk of developing breast or ovarian cancer during their lifetime, more so than women in the 
general population (Donnelly et al., 2013; Smith, Hanson, Mineau & Buys, 2012). Whilst 
carrying the BRCA gene may not considered a long-term condition in the way that PCOS and 
Endometriosis are, carrying the gene can have an impact on an individual’s fertility, including 
their family planning (Donnelly et al.; Friedman & Kramer, 2005; Werner-Lin, 2010). Women 
who carry the BRCA genes must make a decision with regards to their family planning as 
pregnancy is associated with an increased risk of developing cancer (Friedman & Kramer, 2005) 
and it is also possible that any child may inherit the gene (Werner-Lin, 2008). Certainly, Werner-
Lin (2008) found that women with the gene felt a ‘sense of urgency’ (p.428) to have children 
before preventative surgeries, or disease progression, remove this option for them. Other 
participants in Werner-Lin’s study faced a decision of whether or not to have children and risk 
passing the gene on to them. There are, therefore, similarities with PCOS whereby women with 
the BRCA gene may experience sub- and infertility.  
 
The NHS define someone as infertile if they have never conceived a child in the past and they 
have difficulty conceiving (2014). As detailed, women with PCOS may experience problems 
with regards to their fertility (Legro et al., 2007). In addition, women with endometriosis 
(Facchin et al., 2015) and women who have undergone chemotherapy for treatment of cancer 
(Bedoschi, Navarro & Oktay, 2016) may also experience infertility. Whilst men can also 
experience infertility either due to biological causes or due to the experience as part of a couple 
(NHS, 2014), the ability to carry a child during pregnancy is unique to women. Greil, Slauson-
Blevins and McQuillan (2010) suggest that infertility is associated with psychological distress 
due to the individual’s inability to meet a desired social goal (that of having children). Moreover, 
infertility has been found to have a negative impact on quality of life particularly for women, 





1.6 Coping in long-term conditions 
To date there is little research which explores coping in women with PCOS. Carron and Alvero 
(2014) report that women with PCOS who were experiencing psychological distress were more 
likely to use maladaptive coping strategies. Moreover, Özenli et al. (2009) found that women 
with PCOS in Turkey were more likely to use passive, emotion-focused coping strategies in 
comparison to controls. As such, the research which is available suggests that women with PCOS 
may use maladaptive coping strategies, which are associated with decreased quality of life in 
women with PCOS (Benson et al., 2010). 
 
Friedman (2002) suggests that there are several types of coping that people use when faced with 
a long-term illness. The first coping technique involves denying or minimising the seriousness of 
the condition, this is colloquially known as a defence mechanism. The second coping technique 
Friedman suggests is information seeking whereby an individual gathers information about a 
condition in order to gain a sense of control. Thirdly, Friedman suggests that support or requests 
for reassurance form a coping technique, whereby individuals gain comfort from others. Goal 
setting and visualisation of possible outcomes form the fourth and fifth techniques employed by 
people with a long-term condition. Finally, Friedman suggests that people search for meaning as 
a coping technique. Radley (2004), similarly, details two types of coping mechanisms: emotion-
based coping, an attempt to minimise the emotional impact of a condition through the adoption 
of a specific attitude, and problem-based coping whereby an individual tries to do something 
about any difficulties they experience, therefore controlling them. De Ridder (2004) suggests that 
controllability of a disease is a key factor influencing how individuals experience long-term 
conditions. For example some conditions, such as diabetes, are controllable by self-care routines 
(such as using diet and medication), thus increasing perceived control. However, De Ridder 
argues that self-care routines may impose a burden on the individuals, due to the responsibility to 
take care of their illness; their daily lives are filled with performing tasks related to illness 
management. Alternatively, individuals may experience uncontrollable diseases, such as multiple 
sclerosis, which could result in feelings of helplessness (Fournier, de Ridder & Bensing, 2002). 
Interestingly, Helgeson (1992) suggests that perceived control is a stronger predictor of 




Clark et al. (1991) define self-management as the “day to day tasks an individual must undertake 
to control or reduce the impact of disease on physical health status” (p.5). Research suggests that 
in long-term illness, the responsibility for the day-to-day management of a condition may 
gradually shift from the health care professionals to the individual (Barlow, Wright, Sheasby, 
Turner & Hainsworth, 2002). Clark et al. propose that successful self-management of long-term 
conditions requires the individual to have a sufficient amount of knowledge of the condition and 
performance of the activities needed for condition management to maintain adequate 
psychosocial functioning. In managing PCOS, research suggests that women with PCOS often 
feel frustrated with the information provided by their health care professional and as such, use 
alternative sources of information to increase their knowledge of PCOS (Crete & Adamshick, 
2011; Snyder, 2006; Weiss & Bulmer, 2011). 
 
Leventhal, Brisette and Leventhal (2003) suggest that the procedures used by an individual to 
control ongoing illness threats range from the use of dietary supplements, prescribed medications 
or over the counter medications and prescribed treatments, as well as treatments suggested by 
friends and acquaintances over the internet. Similarly, women with PCOS attempt to control 
their symptoms, through use of hair removal methods (Kitzinger & Willmott. 2002; Snyder, 
2006), self-treatment methods (Crete & Adamshick, 2011) and adjustments to diet and physical 
activity (Weiss & Bulmer, 2011). They have also been evidenced to use the internet for treatment 
related advice (Holbrey & Coulson, 2013). 
 
Clark et al. (1991) suggest that individuals with long-term illness also have to cope with the 
psychosocial problems generated by their long-term disease and must, therefore, manage their 
daily living according to their financial and social conditions. Similarly, Holroyd and Creer 
(1986) suggest that self-management means having, or being able to obtain, the skills and 
resources necessary to best accommodate to the long-term condition. However, Barlow et al. 
(2002) claim that there is no ‘gold standard’ definition of self-management and propose that self-
management refers to the “individuals ability to manage the symptoms, treatment, physical and 
psychosocial consequences and lifestyle changes inherent in living with long-term conditions” 
(p.178). Both definitions, however, refer to how an individual manages their life, and consequent 




Barlow et al. (2002) suggest that efficacious self-management encompasses the individual’s 
ability to monitor their condition and to influence the cognitive, behavioural and emotional 
responses necessary to maintain a satisfactory quality of life: therefore, a dynamic and 
continuous process of self-regulation is established. Clark, Gong and Kaciroti (2014) similarly 
state that to be self-regulating one must be observant and make judgements based on that 
observation. They suggest that management strategies must evolve from the person’s 
observations, judgements and reactions whilst considering the internal and external factors. 
However, as the intensity of long-term disease can fluctuate between periods of greater and 
lesser severity and on a day-to-day basis (Holman & Lorig, 1992) this may make self-regulation 
difficult for individuals with long-term conditions. In addition, if a treatment has a negative or 
adverse impact on the individual, then an additional problem may be created (Horman & Lorig, 
1992). This is similar to PCOS, whereby the condition and its management may change over 
time (Sheehan, 2004).  
 
Self-regulation theory proposes that individuals will use strategies based on their understanding 
of the experience, therefore as their perceptions of their condition change, so too will their 
management strategies (Petrie, Broadbent & Meechan, 2003). Indeed, there are many models of 
self-regulation (Carver & Scheier, 2000; Lazarus & Folkman, 1987; Leventhal et al., 1984), 
however they all interpret self-regulation as a systematic process (Cameron & Leventhal, 2003). 
Clark et al. (2014) propose a model of disease management where self-regulation is considered 
key to achieving the individual’s goal. This model involves management strategies whereby the 
individual aims to keep the condition under control. Clark et al. (2011) also suggest that their 
model of disease management is based on the idea that through self-regulatory processes 
individuals learn the strategies they use to manage their condition. 
 
The Common Sense Model of self-regulation (Leventhal et al., 1984), also known as Leventhal’s 
self-regulatory model of illness cognition and behaviour (Cameron & Moss-Morris, 2004) is one 
such model which can be applied to health and illness specifically. Leventhal’s self-regulatory 
model of illness behaviour suggests that people deal with their illness symptoms in the same way 
as they would other problems, and so attempt to solve the problem and return to normality 
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(Ogden, 2012). There are three key stages in Leventhal’s model, these include: interpretation, 
coping and appraisal. Within the interpretation stage, there are five dimensions of illness 
representation which need to be interpreted by the individual: identity (the illness label or 
diagnosis), cause (the factors believed to have caused the illness), timeline (expected duration of 
illness), consequences (effects of the illness: physical, social and psychological) and control/cure 
(the extent to which the illness can be cured or controlled) (Cameron & Moss-Morris, 2004). 
These three stages, interpretation, coping and appraisal, inter-relate in a dynamic way, 
consequently maintaining normality, or in other words regulating the self (Ogden).  
 
Barlow et al. (2002) suggest that self-management approaches are made up of several 
components including: information, drug and symptom management, management of 
psychological consequences of the long-term condition, life style, social support and 
communication; although these categories are not mutually exclusive. In addition, they argue that 
disease specific management approaches focus on medication and symptom management and, 
whilst there are many similarities between self-management approaches across long-term 
conditions, there are also differences. Similarly, Holman and Lorig (1992) suggest that there are 
seven areas of skill needed for an individual to manage their conditions, including: minimising or 
overcoming physical debility, establishing realistic expectations and responses to the variations 
of the illness, interpreting and managing symptoms, learning how to judge the effects of 
medications and manage their use, becoming adept at problem solving, communicating with 
health care professionals and using community resources.  
 
Self-management may be a means of bridging the gap between patients’ needs and the capacity 
of health services to meet those needs (Barlow et al., 2002). However, there is a need for health 
professionals to be trained to ensure that patients self-management abilities are maintained and 
fostered in clinical settings (Barlow et al., 2002). Clark et al. (2011) suggest that the day-to-day 
manager of disease is the patient who undertakes the actions with the guidance of the clinician. 
They further propose that self-management strategies comprise of the individual’s means to keep 
the disease and its effects under control and that these strategies may be consistent, or not 
consistent, with the clinician’s recommendations. Similarly, Holman and Lorig (1992) propose 
that it is the role of the individual with the condition to engage in maximum feasible self-
11 
 
management, whilst it is the healthcare professional’s role to develop and facilitate the 
individual’s self-management and to provide expert knowledge. In long-term conditions, the 
patient often becomes the most knowledgeable person concerning the consequences of the 
disease. Therefore, appropriate management of long-term disease requires the development of a 
partnership between the health care professional and the individual (Holman & Lorig, 1992).  
 
Whilst there is some evidence that women with PCOS utilise self-management and self-
regulation strategies (Bates & Legro, 2013; Deeks, Gibson-Helm, Paul & Teede, 2011; Kitzinger 
& Willmott, 2002; Percy, Gibbs, Potter & Boardman, 2009; Snyder, 2006), there is little research 
exploring how women with PCOS experience this management and their condition on a day-to-
day basis, or how it impacts on their quality of life.  
 
1.7 Quality of Life 
Health-related quality of life of patients with long-term conditions is frequently impaired 
(Sprangers et al., 2000). De Ridder (2004) suggests that long-term illness has the ability to 
induce changes in an individual’s life which can, consequently, have negative effects on their 
quality of life. Accordingly, there is an expansive literature exploring health-related quality of 
life in individuals with long-term conditions, including: breast cancer (Ganz et al., 2002), chronic 
heart failure (Beladinelli, Georgiou, Cianci & Purcaro, 1999), Cushing’s disease (Heald et al., 
2004; van Aken et al., 2005), chronic obstructive pulmonary disease (Gore, Brothy & 
Greenstone, 2000; Seemungal et al., 1998), inflammatory bowel disease (Simrén et al., 2002), 
Celiac disease (van Koppen et al., 2009) and endometriosis (Nnoaham et al., 2011; Simoens et 
al., 2012).   
 
Research has shown that PCOS is related to poor quality of life (Elsenbruch et al., 2003; 
McCook et al., 2005; Hahn et al., 2005) and it is therefore important to consider quality of life in 
relation to long-term conditions and to PCOS specifically. Recent research exploring coping, 
quality of life and PCOS suggests that coping strategies correlate with quality of life in women 
with PCOS (Kolahi et al. 2015). Strategies that relate to better quality of life include cognitive 
(acceptance), problem solving (actively dealing with the problem), social support and emotional 
strategies (seeking social and emotional support). In addition, Benson et al. (2010) found that in 
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women with PCOS; passive, or maladaptive coping, was associated with greater anxiety, 
depression and reduced quality of life. Indeed, Banyard (1997) proposes that the aim for any 
treatment for long-term illness is to improve the patient’s quality of life.  
 
1.7.1 Defining Quality of Life 
What determines quality of life has been considered in scientific investigation for many years 
(Power, Bullinger, Harper & the WHOQOL group, 1999). Power et al. suggest that quality of life 
as a concept came at a time when classic medical endpoints, such as mortality and morbidity, 
were criticised for failing to adequately represent potential outcomes of medical interventions. 
The World Health Organization (WHO) define quality of life as “an individual’s perception of 
their position in life in the context of the culture and value systems in which they live, and in 
relation to their goals, expectations, standards and concerns. It is a broad ranging concept 
affected in a complex way by the person’s physical health, psychological state, level of 
independence, social relationships, their relationship to the salient features of their environment 
and their spiritual, religious and personal beliefs” (WHOQOL Group, 1994, p.1). 
 
The WHOQOL group specify that there are six domains of quality of life (see WHOQOL Group, 
1994, p.4), including: physical health (energy and fatigue, pain and discomfort, sleep and rest); 
psychological health (bodily image and appearance, negative feelings, positive feelings, self-
esteem and thinking, learning, memory and concentration); level of independence (mobility, 
activities of daily living, dependence on medical substances and aids, work capacity); social 
relationships (personal relationships, social support and sexual activity); environment (financial 
resources, freedom, physical safety and security, health and social care, home environment, 
opportunities for acquiring new information and skills; participation in and opportunities for 
recreation, physical environment and transport); and spirituality/religion/personal beliefs. 
Fallowfield (1990) defined quality of life as having four dimensions: psychological (mood, 
emotional distress, adjustment to illness), social (relationships, social and leisure activities), 
occupational (paid and unpaid work) and physical (mobility, pain, sleep and appetite), reflecting 




Orley, Saxena and Herrman (1998) suggest that the emphasis within the WHOQOL definition is 
the subjective nature of quality of life and the need to explore aspects of life that the individual 
considers to have an impact on their quality of life. Moreover, they suggest that quality of life is 
an internal, subjective experience coloured by the individual’s personality, expectations, early 
experiences and mental state. Skevington (2002) similarly suggests that quality of life is about 
the meaning people derive from the important aspects of their life. Quality of life, therefore, is 
dependent on the person’s perceptions of what is important and their subjective experience. 
 
Health-related quality of life has been proposed as a related construct and sub-domain of quality 
of life (Learmonth, Alwick, McAuley & Motl, 2015). Power et al. (1999) propose that the 
concept of health-related quality of life is a patient-perceived multidimensional construct. 
Moreover, Muldoon, Barger, Flory and Manuck (1998) suggest that health-related quality of life 
moves beyond manifestations of a condition to the impact of the condition on everyday life. 
Indeed, Bowling (1995, 2001) suggests that health is one of the most important areas of quality 
of life nominated by individuals and therefore, health-related quality of life should be included as 
a dimension within quality of life. However, Bowling (2001) reports that quality of life is often 
referred to as health-related quality of life in research.  
 
Health-related quality of life is defined by Testa and Simonson (1996) as the physical, 
psychological and social domains of health that are influenced by a person’s experiences, beliefs, 
expectations and perceptions. More recently, Carr, Gibson and Robinson (2001, p.1240) defined 
health-related quality of life as “those aspects of an individual’s subjective experience that relate 
both directly and indirectly to health, disease, disability and impairment”. Moreover, they 
suggest that quality of life is a broad concept concerned with whether disease or impairment 
limits a person’s ability to fulfil a normal role. Quality of life, therefore, appears to be an 
assortment of interactive and subjective domains (Lawton, 1991). As such, whilst there are many 
differing definitions of quality of life there are arguably similarities within the underlying 
constructs, including; the individual’s perspective, their goals and expectations, their 




Despite this number of broadly similar definitions, Fayers and Machin (2007) suggest that 
quality of life is a poorly defined term. Moreover, they suggest that quality of life can mean 
different things to different people. As such, health-related quality of life, whilst still being a 
loose definition, can include factors such as; general health, physical symptoms, physical and 
emotional functioning and social well-being. Consequently, this thesis utilises a broad definition 
of quality of life which encompasses the physical, psychological and social domains of health 
that are influenced by a person’s experiences, beliefs, expectations and perceptions (Testa & 
Simonson, 1996; WHOQOL Group, 1994) and also considers the symptoms and side effects of 
the disease that may affect quality of life (Fayers & Machin).  
 
1.7.2 Measuring Quality of Life 
Rapley (2003) suggests that there is variability in the definition of quality of life, however, they 
maintain that quality of life is a multi-dimensional construct. Bowling (2001) similarly suggests 
that quality of life is a vague, but multidimensional concept which incorporates all aspects of an 
individual’s life.  As such, measures of quality of life should include a number of dimensions and 
include several concepts (Fayers & Machin, 2001). 
 
There are various ways of measuring quality of life including; asking the patient or using 
standardised quality of life assessment instruments, which can be both disease-specific and 
generic (Fayers & Machin, 2007). In 1994 The WHOQOL group developed the WHOQOL-100 
scale, an international health-related, multi-dimensional quality of life measure. The core 
domains include a physical and a psychology domain, in addition to: level of independence, 
social relationships and environment. An additional culture specific domain, 
spirituality/religion/personal beliefs, was included for those cultures and countries where it was 
felt appropriate, such as Thailand (WHOQOL Group, 1994). This is in line with suggestions by 
Fayers and Machin (2001) that most instruments intended for health status include at least some 
items that focus on physical, emotional and social functioning. Similarly, Muldoon et al. (1998) 
suggest that quality of life questionnaires generally embody quality of life as an individual’s 




Further development of the WHOQOL-100 scale led to the validation of a reduced item version 
called the WHOQOL- BREF (Skevington, Lofty & O’Connell, 2004). This scale identified 
similar domains of physical health, psychological issues, social relationships and environment. 
Cruz, Camey, Fleck and Polyanczyk (2009) however, argue that the WHOQOL-BREF measures 
overall quality of life as it encompasses other factors (such as, environment, employment and 
spirituality) outside of health-related quality of life. Power et al. (1999) similarly suggest that the 
WHOQOL-100 encompasses a broader view of quality of life than many other quality of life 
measures, citing the inclusion of the social relationships and environment domains.  
 
Whilst generic quality of life measures allow for scores to be compared between different 
population groups, they fail to focus on issues of particular concern for individuals with various 
conditions or diseases (Fayers & Machin, 2007). Generic health-related quality of life 
instruments, therefore, may not be responsive to a change for individual diseases (El-Serag, 
Olden & Bjorkman, 2002). Osborne, Bindemann, Noble and Reed (2014) found that there were 
differences between perceived importance of areas of quality of life for healthy individuals 
compared to those with long-term illness, whereby, healthy participants noted relationships and 
family as more important to quality of life and participants with a long-term condition noted 
pain, fatigue and sleep as more important. Similarly, Arnold et al. (2004), when comparing 
quality of life domains across a variety of long-term conditions, suggest that there are differences 
between different groups of individuals with long-term conditions and healthy individuals on 
physical, social and psychological functioning.  
 
El-Serag et al. (2002) suggest that disease-specific measures are designed to detect changes in 
health-related quality of life that may not be targeted by generic instruments. Bowling (2001) 
proposes that disease-specific measures should aim to be more clinically and socially significant 
in relation to specific conditions and also be able to discriminate more finely between patients’ 
levels of severity of the condition and be more sensitive to any clinical outcomes. Certainly, 
McGee (2004) suggests that the drive behind the development of disease-specific instruments is 
to focus on the most salient aspects of quality of life for individuals with a specific health 
condition. Moreover, they state that a quality of life measure should be developed to be sensitive 
to change in aspects of life believed to be most affected by the condition concerned and its 
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treatment. This suggests that a disease-specific quality of life measure may be representative of, 
and better able to detect change in, quality of life for women with PCOS. 
 
Currently, there is only one disease-specific quality of life measure for women with PCOS, the 
PCOS Questionnaire, otherwise known as the PCOSQ (Cronin et al., 1998). The PCOSQ is a 26-
item quality of life questionnaire for use with women with PCOS, developed with a clinical 
sample of US women with PCOS (Cronin et al.). Referred to as a measure of symptom-bother by 
some (Malik-Aslam et al., 2010), several limitations of the PCOSQ have been identified 
including poor content validity (Malik-Aslam et al.) and inappropriate development techniques, 
according to relevant literature (DeVellis, 2012). In addition, the inclusion criteria for the 
PCOSQ development excluded some women with PCOS, as diagnosed by the Rotterdam 2003 
criteria, and was developed using women with PCOS who were currently seeking help from a 
healthcare professional within the US healthcare system (see Chapter Two and Five for more 
information). As such, in order to measure the impact of PCOS on quality of life for women in 
the UK the development of a disease specific questionnaire is necessary to measure and address 
issues experienced by individuals with different symptom profiles, according to the Rotterdam 
2003 criteria that may not be present in other conditions.  
 
1.7.3 PCOS and Quality of Life 
A literature search was conducted to locate published studies exploring PCOS and quality of life. 
The search strategy included two main approaches: electronic searches of computerised 
databases including PsychArticles, PsychInfo, PubMed, Science Direct, EBSCO and Google 
Scholar; and also a search of citations in papers identified by the electronic search. The search 
was completed using keywords such as: ‘PCOS’, ‘Polycystic Ovary Syndrome’, ‘Quality of 
Life’, ‘Health-Related Quality of Life’ and ‘QoL’. The search revealed 41 papers which explore 
PCOS and quality of life using quantitative methods. Eight of these were medical or lifestyle 
interventions, eight were reviews, two explored the experiences of adolescents with PCOS, six 
were concerned with scale development and validity testing (discussed in Chapter Five) and two 
focused on the symptom of infertility. The remaining 15 quantitative papers are described in 
detail in Table 1.1. Overall, PCOS has been shown to have large negative effects on health 
related quality of life (Cinar et al., 2011; Coffey et al., 2006; Hahn et al., 2005).
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Table 1.1  
A review of quantitative studies exploring quality of life in women with PCOS. 
Study Aim Participants Setting Outcome Measures Findings 
Elsenbru
ch et al. 
(2003) 
To investigate 
the impact of 
PCOS on Health-
related quality of 
life and sexuality 
100 women 
- 50 women with PCOS 
diagnosed according to 
1990 NIH criteria 
- 50 age matched healthy 
women  
-  excluded for other 
conditions 
Clinical, Germany 
- Outpatient clinic of 
the division of 
Endocrinology, 
Department of 
Medicine at the 







- FLZ (questions on 
life satisfaction) 
Health-related quality 
of life measured with 
SF-36 revealed 
significant decreased 
scores for physical 
role function, bodily 
pain, vitality, social 
function, emotional 
role function in 
patients with PCOS 











quality of life. 
128 Women 
- Did not specify diagnostic 
criteria but detailed 
diagnostic tests 








- Clinical assessment 






of life concern was 
weight followed in 
descending order by 
menstrual problems, 
infertility, emotions 
















- 120 women with PCOS 
(diagnosed with 1990 NIH 
criteria) 
- Excluded for other 
conditions 
- 50 controls from historical 
data  
- Normative data from 
German population 
Clinical, Germany 




- SF-36 (German) 
- SCL-90-R (German) 




reductions in quality 
of life in comparison 
to control data. BMI 
and hirsutism scores, 
but not acne, were 
associated with 
physical aspects of 









with PCOS have 
poorer health-
related quality of 
life than women 





22 women with PCOS 
- Diagnosed if had 
polycystic ovaries, 
menstrual irregularities 
and/or clinical or 
biochemical evidence of 
hyperandrogenism 
- 96 controls - women 
attending the Family 
Planning Clinic (women 
with PCOS or PCOS type 
Clinical, UK 
- Gynecological and 
Endocrinology 





- PCOSQ (modified 
version with 
reference to PCOS 
removed for control 
group) 
PCOS has a negative 
impact on 
psychological health-
related quality of life 
even when compared 
to other serious 
health conditions 
(asthma, epilepsy, 
diabetes, back pain, 
arthritis and coronary 
heart disease).  
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symptoms were not 
excluded from control 
group) 
- Data about other illnesses 
obtained from Oxford 





To assess quality 
of life in a large 
sample of 
women with and 
without PCOS 
1359 women (range reported) 
- Up to 424 women with 
self-reported diagnosis of 
PCOS 
- Up to 935 healthy women  
- Four groups  
- Women with PCOS taking 
Anti-Androgens (AA) 
- Women with PCOS not 
taking AA 
- Healthy women taking AA 
- Healthy women not taking 
AA 
Online, not UK 
specific 
 
- PCOSQ (modified to 
include an acne 
subscale) 
- SDS 
Women with PCOS 
had lower quality of 
life on all seven 





















To study quality 











173 women  
- with PCOS diagnosed with 
the NIH criteria 
- Population norm data 
- Excluded for other long-
term conditions 
Clinical, Australia 
- Women’s health 





Diabetes clinic at 
Sir Charles 





Impaired quality of 
life and increased 
prevalence of 
psychology 








quality of life of 




171 women  
- 42 South Asian with PCOS 
- 129 Caucasian with PCOS 
- Did not specify diagnostic 
criteria but detailed 
diagnostic tests 
- Normative data from 




outpatient clinics of 
two university 
teaching hospitals 





of life scores were 
lower than normative 
data for both groups. 
There was no 
difference in health-





















146 women with PCOS 
- Rotterdam 2003 criteria 
- 170 age matched controls 
recruited from community 
screening  
Field & Clinical, Sri 
Lanka 
- Data were collected 
by a team of field 
investigators & 
female physicians 
- Households located 
and women 
approached 
- Only participants 
who attended local 




- WHOQOL BREF 
validated for Sri 
Lankans 
- GHQ30 





related quality of life 












- 86 women with PCOS 
diagnosed according to 
Rotterdam 2003 criteria 
- Excluded for other 
physical conditions 
Clinical, Turkey 






- SF-36  
- BDI 
- BAI 
The most affecting 
factors for quality of 
life among women 
were irregular 



















on quality of life. 
200 women 
- Diagnosed according to the 
Rotterdam 2003 criteria 
Inclusion criteria: 
- 15 to 40 years old 
- Married, Iranian 
- Not having another cause 
for infertility (male factor) 
Clinical, Iran 
- Two private 
gynecology clinic 
in Kashan, Iran 
- MPCOSQ Most common 
health-related quality 




by hirsutism, weight, 














300 women with PCOS, 
divided into three groups: 
- Hyperandrogenism (HA) & 
PCO morphology 
- Menstrual dysfunction and 
PCO morphology 
- Menstrual dysfunction and 
HA and/or PCO 
- Clinical, Iran 







In patients with 
different phenotypes 
of PCOS, the effects 
of mediating 
variables on health-
related quality of life 







To determine the 
most significant 
predictors of the 
health-related 
quality of life in 
patients with 
PCOS 







Highest effect of 
PCOS symptoms on 
health-related quality 
of life impairment 
was exerted by self-







To assess sexual 
function and 
quality of life in 
women with 
PCOS. 
-56 women with PCOS 
diagnosis according to 
Rotterdam 2003 criteria. 
- 102 control women with 
regular menstrual cycles 
- excluded women with other 
long-term conditions, those 
taking anti-depressants and 
those pregnant. 
Clinical, Brazil 




- WHOQOL BREF 
Women with PCOS 





correlated to the 
worsening of quality 
of life but not sexual 
function. 
Khomam
i et al. 
(2015) 
To assess the 
impact of various 
clinical features 
of PCOS on 
796 women diagnosed with 
PCOS according to Rotterdam 
2003 criteria. Aged 15-49. 
- Excluded if diagnosed with 
other conditions 
Clinical, Iran 
- Referred by 
gynecologists to 
the Reproductive 
- PCOSQ (translated) Hirsutism had 
strongest impact on 
health-related quality 












quality of life in 
women with 
PCOS.  
Women with PCOS between 
ages 18-45 years. 
India - PCOSQ In both married and 
unmarried females, 
most affected domain 




Key- BAI: Beck Anxiety Inventory (Steer & Beck, 1997); BDI: Beck Depression Inventory (Beck, Ward, Mendelson, Mock & Erbaugh, 1961); 
BIC: Body Image Concern Inventory (Littleton, Axsom & Pury, 2005); FLZ: Fragebogen Zur Lebenszufriedenheit (Henrich & Herschbach, 2000); 
GHQ-28 (Goldberg & Hillier, 1979); FSFI: Female Sexual Function Inventory (Rosen et al., 2000); GHQ-30: (Sumathipala & Murray, 2000); 
HRQoL: Health-related quality of life; LSAS: Liebowitz’s Social Anxiety Scale (Liebowitz, 1987); MPCOSQL: Modified PCOSQ (Bazarganipour 
et al., 2013c) PCOSQ (Cronin et al., 1998); PIQ: Patient Information Questionnaire; QoL: Quality of Life;RSES: Rosenberg’s Self Esteem Scale 
(Rosenberg, 1965); SCL-90-R: The Symptom Checklist (Schmitz et al., 2000); SF-36: Short Form (Ware & Sherbourne, 1992); WHOQOL BREF 
(Kumarapeli, Seneviratne & Wijeyaratne, 2006); WHR: Weight/Height Ratio; SDS: Zung Self-Rating Depression Scale (Zung, 1965). 




The studies detailed in Table 1.1 explore the impact of PCOS on quality of life: the earliest study 
to explore this found that women with PCOS reported that the condition negatively affected 
various aspects of their life, including family life, professional activities, leisure activities and 
physical fitness (Elsenbruch et al. 2003). Barnard et al. (2007), Ching, Burke and Stuckey (2007) 
and Jones et al. (2010) all report that women with PCOS have an impaired quality of life in 
comparison to control groups and/or normative data. McCook et al. (2005) identified that the 
symptom of weight was the highest health-related quality of life concern for women with PCOS, 
with hirsutism symptoms being the lowest related concern. Hahn et al. (2005) also found that 
obesity was significantly correlated with quality of life and, they reported that the symptom of 
hirsutism reduced quality of life. Recently, Benetti-Pinto Ferreira, Antunes Jr. and Yela (2015) 
reported that the domain of body weight, as measured by the PCOSQ, was correlated to worse 
quality of life in women with PCOS in Brazil, followed by infertility. 
 
Açmaz et al. (2013) also reported that the most important factors for quality of life among 
women with PCOS in Turkey, were irregular menstrual cycle and hirsutism. This is supported by 
Bazarganipour et al. (2013a) who found that for women with PCOS in Iran, the domains of 
menstrual irregularities and infertility were the most common quality of life concern, followed 
by hirsutism, weight, emotion and acne. Khomami et al. (2015), however, found that for their 
sample of women with PCOS from Iran, hirsutism had the strongest impact on quality of life.  
Therefore, whilst it is evident that the condition of PCOS and its associated symptoms have a 
negative impact on quality of life in women with PCOS across Asia, South America, the USA, 
Australia and Europe, the extent to which the different clinical manifestations of the condition 
impact quality of life differs. Research is needed, therefore, to explore how the symptoms of 
PCOS, for women in the UK, are associated with their quality of life.  
 
It is clear from Table 1.1 that the majority of papers exploring quality of life in adult women 
with PCOS are conducted in a clinical setting (13/15). Of the fifteen studies, only two studies 
were conducted in the UK and both of these studies were conducted in a clinical setting. This 
suggests that women with PCOS in the UK, who are no longer a part of the healthcare system, 




Across the studies detailed in Table 1.1 the number of women with PCOS who participated was 
relatively small, with the largest sample in the UK being 424 participants (Barnard et al. 2007). 
Khomami et al. (2015) did have a larger sample size of 796 women with PCOS, however, all 
other quality of life studies from Iran used a smaller sample size (n<300). Caution is warranted, 
however, when interpreting the studies detailed by Bazarganipour et al. (2013a, 2013b, 2014) as 
there are many similarities between the study samples which suggest that the sample/data used in 
each study may be the same (sample size, recruitment strategy, inclusion/exclusion criteria). 
Moreover, whilst eight studies detailed the diagnostic criteria used to diagnose PCOS (three 
using the 1990 NIH criteria and five using the 2003 Rotterdam criteria), three studies reported 
only diagnostic tests run to establish PCOS (and no specific diagnostic criteria), one study used 
self-report data and the remaining three studies did not detail the criteria used. This supports the 
suggestion that comparative research on PCOS has been disadvantaged by the lack of a 
consensus definition of PCOS (Ong et al., 2006).  
 
Eight of the 15 studies detailed in Table 1.1 state that they exclude women with other conditions, 
both long-term conditions and other physical conditions. However, Women with PCOS often 
experience one or more co-morbid conditions including; type 2 diabetes and impaired glucose 
tolerance (Legro, Kunselman, Dodson, & Dunaif, 1999; Vrbikova & Hainer, 2009) and thyroid 
disorders (Janssen, Mehlmauer, Hahn, Öffner & Gärtner, 2004; Kachuei, Jafari, Kachuei & 
Keshteli, 2012; Nisar et al., 2012; Sinha et al., 2013). Women with PCOS also experience 
elevated risk factors for developing cardiovascular disease compared to matched controls (de 
Groot, Dekkers, Romijn, Dieben & Helmerhorst, 2011; Milman & Dokras, 2014; Talbott et al., 
1995). Research also suggests that women with PCOS are at an increased risk of developing 
endometrial cancer (Gottschau, Kjaer, Jensen, Munk & Mellemkjaer, 2015; Milman & Dokras; 
Haoula, Salman & Atiomo, 2012; Shafiee et al., 2014).  
 
In addition to physical co-morbidities, women with PCOS are also more likely to experience 
psychological co-morbidities, including anxiety and depression (Deeks, Gibson-Helm & Teede, 
2010; Esler, Travers, Guttikonda, Dixon & Lewis, 2007; Månsson et al., 2008; Rasgon et al., 
2003; Rassi et al., 2010). Lipton, Sherr, Elford, Rustin and Clayton (2006) found that in a sample 
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of women with PCOS over 74% had clinical levels of anxiety, over 30% had clinical levels of 
depression and just over 29% of women had clinical levels of both depression and anxiety. It is 
clear that women with PCOS are more likely to experience co-morbid conditions, both physical 
and psychological. As these papers do not specify if co-morbidities were included or excluded 
there are, therefore, only two published papers in the UK (Barnard et al., 2007; Coffey et al., 
2006) and four studies outside of the UK (Bazarganipour et al., 2013a, 2013b, 2014; Riddhi & 
Prajakta, 2015) that explore quality of life for women with PCOS without excluding for common 
co-morbidities. As such, there is a need for research which explores the impact of PCOS, which 
is inclusive of any presenting co-morbid conditions, on quality of life.  
 
Nine of the fifteen studies explored the impact of PCOS on quality of life in comparison to a 
control group or population norms. Of those nine, eight reported that women with PCOS 
experienced a decreased quality of life in comparison to controls in both psychological and 
physical domains. The remaining study reported that women with PCOS reported reduced 
quality of life in the self-assessment of health domain (of the WHOQOL-BREF) but not others, 
in comparison to controls. Moreover, seven of the studies (Açmaz et al., 2013; Barnard et al., 
2007; Bazarganipour et al., 2013a, 2014; Hahn et al., 2005; Khomami et al., 2015; McCook et 
al., 2005) detailed the impact of specific PCOS symptoms on quality of life, suggesting that 
hirsutism, BMI and menstrual irregularities were associated with a negative impact on quality of 
life.  
 
Recent research exploring quality of life in women with PCOS has been published from Iran 
(Banaganipour et al., 2013; Khomami, Tehrani, Hasemi, Farahmand & Azizi, 2015), India 
(Riddhi & Prajakta, 2015) and Brazil (Benetti-Pinto et al. 2015). Like the other studies detailed 
above (Açmaz et al., 2013; Barnard et al., 2007, Hahn et al., 2005; McCook et al., 2005), these 
studies focus on the impact of specific symptoms of PCOS, such as body weight, infertility, 
hirsutism and irregular menstruation, on quality of life rather than investigating overall quality of 
life. Similarly to those studies detailed above, the research found that symptoms such as fertility, 
irregular menstruation, hirsutism and BMI had the strongest impact on quality of life in women 
with PCOS. This suggests that PCOS can have a negative impact on quality of life, and that the 
impact of this condition and its symptoms on quality of life can vary across countries. As such, 
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whilst there is a growing body of research which details the quantitative impact of PCOS on 
quality of life, there is little research which explores the impact of PCOS and its symptoms on 
quality of life, from the perspective of women with PCOS in the UK. 
 
1.8 PCOS and Qualitative Research  
The literature search detailed above (in Section 1.7.2) also revealed three papers (Amiri et al., 
2014; Taghavi et al., 2015; Washington, 2008) which have explored the impact of PCOS on 
quality of life qualitatively. The paper by Washington (2008) details quality of life as pertaining 
to daily activities, self-esteem and employment experiences. This suggests that not all domains 
of quality of life (Testa & Simonson, 1996; The WHOQOL Group, 1994), including the social, 
physical and psychological domains, were explored in their study. The other two papers (Amiri 
et al.; Taghavi et al.) were published within the last two years. Therefore, in order to gain a better 
understanding of the experience of PCOS and how it was perceived by women with the 
condition, an additional literature search, using the same databases, was performed. This search 
used keywords such as: ‘PCOS’, ‘Polycystic Ovary Syndrome’, ‘Qualitative’ and ‘Experience’. 
It revealed 12 studies which explored PCOS using qualitative methods. Two of these were 
unpolished doctoral dissertations (Castillo, 2008; Washington, 2005) and two studies explored 
support for women with PCOS (Holbrey & Coulson, 2013; Percy et al., 2009). The remaining 
eight studies, their methods and findings, are detailed in Table 1.2.  
 
Overall, the papers detailed in Table 1.2 suggest that PCOS can have a negative impact on 
women with the condition. The first qualitative study exploring the experience of the condition 
found that women with PCOS felt stigmatised due to their condition and its symptoms (Kitzinger 
& Willmott, 2002). Similarly, Snyder (2006) and Weiss and Bulmer (2011) both suggest that 
women with PCOS identified themselves as different to other women and that participants were 
negatively impacted by the condition. Indeed, Washington (2008) reports that women with 
PCOS are negatively affected by the condition and this impact was due to symptoms 
experienced. Crete and Adamshick (2011) found that women with PCOS aimed to manage their 
condition in such a way, that they could achieve a high quality of life. Whilst there is little 
qualitative research exploring the impact of PCOS on quality of life directly, the studies 
discussed demonstrate that PCOS can have a negative impact on women with the condition. 
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Moreover, these studies demonstrate the utility of qualitative approaches for gaining 
understanding about the experience of living with PCOS.  
 
Of the qualitative studies discussed in Table 1.2, only one study was conducted with participants 
from the UK (Kitzinger & Willmott, 2002). This study also analysed data using a feminist 
perspective which suggests that analysis was not data led but led by a pre-existing theoretical 
framework, which may not be a complete reflection of the data. Moreover, three studies explored 
the experiences of women with PCOS with a confirmed diagnosis, recruited through a clinical 
setting (Crete & Adamshick, 2011; Synder, 2006; Taghavi et al., 2015). As two of these studies 
are from the USA, the experiences reported by participants may not be applicable for women in 
the UK due to the differences in healthcare systems. The most recent qualitative research (Amiri 
et al., 2013, 2014; Taghavi et al., 2015) is based on an Iranian population and it is possible that 
the participant’s perception of quality of life could be influenced by their spiritual, religious and 
personal beliefs (WHOQOL Group, 1994). As Taghavi et al. state, for many women in Iran it is 
forbidden for menstruating women to perform some religious acts such as prayer. In addition, in 
Islam and Judaism it is forbidden for a man to have intercourse with his wife during 
menstruation (Taghavi et al.). As such, the findings of this body of research may not be 
applicable for women outside of Iran, or in the UK where spiritual, religious and personal beliefs 















To explore women’s 
experiences of PCOS, 
from a feminist 
perspective, and 
investigate how women 
with PCOS negotiate 
their identities as women. 
UK 30 women with PCOS 
- Self-reported 
diagnosis 
- Recruited via 
Verity (a UK 
PCOS charity) 
- 21 - 42 yrs. old 
- Semi Structured 
Interviews 
- Thematic Analysis  
PCOS is a stigmatising 
condition. Women reported 
feelings of being ‘freakish, 




To uncover the meaning 
of living with PCOS 
USA 12 women with PCOS 





- 21 – 48 yrs. old 
- Interviews  
- Thematic Analysis 
PCOS is a syndrome that 





To gain an understanding 
of the impact of PCOS on 
women’s quality of life 
(daily activities, self-
esteem and employment 
experiences) 
USA 10 women with PCOS 
- Self-reported 
diagnosis 
- Recruited from 
online support 
groups 
- 25 – 39 yrs. old 
- Informal conversation 
interview approach 
followed by a modified 
standardised structured 
interview approach 
- Thematic Analysis  
 
Employment and activities 
of daily living were 
reported to have a moderate 
negative impact due to 
symptoms such as pain, 
fatigue and mood swings. 
Table 1.2  












To describe the lived 
experience of women 
with PCOS in the 
management of their 
disorder and the meaning 
of that experience for 
them.  











Women with PCOS face 
many challenges in 
managing their disorder and 
desire to gain control, 




To explore the 
psychosocial effects of 
living with PCOS through 
the experiences of young 
women diagnosed with 
the endocrine disorder. 
USA 12 women with PCOS 
- Required to have a 
clinical diagnosis 
- Recruited from 
College campuses 
- 18 – 23 yrs. old  
- Interviews 
- Used a coding analysis 
based in phenomenology 
- Constant comparative 
method 
Participants in this study 
faced numerous physical, 
social and emotional 
challenges on a daily basis.  
Amiri et al. 
(2013) 
To study the life 
experiences and concerns 
women with PCOS have.  
Iran 20 Iranian women 
with PCOS 
- 18 to 39 years old 
- Interviews 
- Deductive and inductive 
content analysis 
Health care professionals 
working with PCOS 
patients should consider 
providing peer support 
groups.  
Amiri et al. 
(2014).  
To clarify the dimensions 
and components of 
quality of life in Iranian 
women with PCOS 
Iran 23 Iranian women 
with PCOS 





- Qualitative content 
analysis 
The most important factors 
affecting quality of life in 











- 18 – 40 yrs old 
- Excluded if had 
any co-morbid 
conditions 




To generate an in-depth 
understanding of Health-
related quality of life in 
Iranian women with 
PCOS. 
Iran 20 Iranian women 
with PCOS 
- outpatient clinics 






- Married, 21-34 
years old 
- Not taking any 
medications 
- Interviews 
- Thematic Analysis 
- Qualitative Content 
Analysis 
Women report substantial 
effects of PCOS on their 
quality of life. It is 
necessary to take a holistic 
approach to patient care 




The studies in Table 1.2 detailed a phenomenological, thematic or content analysis approach 
to data analysis. However, it is unclear from the papers exactly how these analyses were 
completed. Each of the thematic analysis papers reported slightly different steps of the 
analytical process (Kitzinger & Willmott, 2002; Snyder, 2006; Washington, 2008), with only 
the Taghavi et al. (2015) paper detailing the guidelines of Braun and Clarke (2006). Thematic 
analysis was, until 2006, a ‘poorly demarcated, rarely-acknowledged’ method of data analysis 
(Braun & Clarke, p. 4). However, since Braun and Clarke’s publication of specific guidelines 
for conducting a thematic analysis, qualitative researchers can now utilise appropriate 
vocabulary and conduct a similar methodical analysis. There is a need therefore, for 
qualitative research which explores the experience of PCOS, which clearly details the 
analytical procedure undertaken.  
 
In the first qualitative study exploring PCOS, Kitzinger and Willmott (2002) recommended 
that further qualitative research exploring how women experience PCOS was ‘desperately 
needed’ (p.359), in order to give a voice to women with PCOS. Moreira and Azevedo (2006) 
later stated that qualitative approaches could contribute significantly to understanding the 
psychological impact of PCOS and therefore suggested that qualitative methods should be 
incorporated into future PCOS studies. However, a decade on from Moreira and Azevedo’s 
statement, the available qualitative research is still limited to less than 10 published papers 
(Amiri et al., 2013, 2014; Crete & Adamshick, 2011; Kitzinger & Willmott, 2002; Synder, 
2006; Taghavi et al., 2015; Washington, 2008, Weiss & Bulmer, 2011), with only one paper 
exploring experiences of women with PCOS in the UK. As such, the field of PCOS research 
is still overwhelmingly dominated by quantitative, and largely medicalised research, whereby 
the experience of the condition is missing (Bazarganipour et al., 2015; Ma et al., 2013). 
Therefore, in order to gain an understanding of the perspective of women with PCOS, with 
regards to their quality of life and experience of the condition, more qualitative research is 
necessary (Kitzinger & Willmott, 2002; Ma et al., 2013; Moreira & Azevedo, 2006; Taghavi 
et al., 2015).  
 
1.9 Summary 
PCOS is a long-term condition characterised by symptoms including alopecia, infertility 
(Elsenbruch et al., 2003), acne (Coffey et al., 2006), obesity (Goudas & Dumesic, 1997), 
hirsutism (Oláh, 2004) and menstrual irregularities (Hahn et al., 2005). To date there have 
been eight published papers which explore PCOS from a qualitative perspective (Amiri et al., 
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2013, 2014; Crete & Adamshick, 2011; Kitzinger & Willmott, 2002; Snyder, 2006; Taghavi 
et al., 2015; Washington, 2008; Weiss & Bulmer, 2011). However, none of these has 
explored the experience of women with PCOS in the UK outside of a feminist framework 
(see Kitzinger & Willmott, 2002), nor have they explored quality of life from a qualitative 
perspective. As such, there remains a need to gain an understanding of the experience of 
PCOS for women in the UK and also the impact of PCOS on quality of life from the 
perceptive of women with the condition.  
 
It is clear that there is a lack of consensus over a ‘gold standard’ definition of quality of life 
(Bowling, 2001; Rapley, 2003). However, domains which are commonly associated with 
quality of life include physical and psychological domains, social domains and environmental 
domains (Fayers & Machin, 2007; Testa & Simonson, 1996; WHOQOL Group, 1994). 
Moreover, quality of life concerns the individual’s perspective, their goals and their 
expectations (Carr et al., 2001; Testa & Simonson, 1996). Indeed, Fayers & Machin suggest 
that quality of life is poorly defined and has different meanings to different individuals. 
Therefore, it is necessary to explore how women with PCOS in the UK perceive and define 
their quality of life.  
 
Women with PCOS are also likely to live with co-morbid conditions such as cardiovascular 
disease (Sirmans, Parish, Blake & Wang, 2014) and diabetes (Legro et al., 1999; Shorakee, 
Joham & Teede, 2015). In addition, women with PCOS are more likely to experience 
depression and anxiety (Deeks, Gibson-Helm & Teede, 2010; Rasgon et al., 2003). Whilst 
there is a growing body of quantitative research that explores incidences of co-morbid 
conditions in women with PCOS (Annagür et al., 2015; Betheas & Nestler, 2008; Dokras, 
2012; Rasgon et al., 2003), there has yet to be research that qualitatively explores how 
women with PCOS experience and manage their condition on a day-to-day basis, and any 
presenting co-morbid conditions. Therefore, qualitative research is also needed to further 
understand how women with PCOS live with the condition, and any co-morbid acute or long-
term conditions. 
 
This chapter also presented research which explored quality of life from a quantitative 
perspective. However, it was identified that the existing PCOS quality of life measure, the 
PCOSQ (Cronin et al., 1998), was seen more as a measure of symptom-bother (Malik-Aslam 
et al., 2010) than a quality of life measure and was subject to several developmental issues 
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(see Chapter Two and Five for more detail). As such, there is a need for a UK, disease-
specific, quality of life measure for women with PCOS which focuses on the most salient 
aspects of quality of life for those women (McGee, 2004). Therefore, it encompasses the 
physical, psychological and social domains of health that are influenced by a person’s 
experiences, beliefs, expectations and perceptions (Testa & Simonson, 1996).   
 
Finally, this chapter detailed that treatment of PCOS is symptomatic (Rosenfield, 2008) with 
medical treatments and medications such as the oral contraceptive pill and metformin, 
commonly prescribed (Herriot et al., 2008; Teede et al., 2006). Alternatively, women with 
PCOS undertake lifestyle changes, such as diet and exercise, in order to help them manage 
their symptoms (Harris-Glocker et al., 2010; Hart & Norman, 2006). However, there are few 
non-medical treatment or intervention options available for women with PCOS that aim to 
improve quality of life. As such, an intervention which aims to improve quality of life in 
women with PCOS is needed.  
 
1.10 Research Aims 
The overarching objective of this thesis is to further understanding, and improve quality of 
life of women with PCOS in the UK. As such, this research aims: 
1. To investigate and identify how women with PCOS in the UK perceive and define 
their quality of life; 
2. to further understanding of the impact of PCOS on quality of life of women in the UK 
from their perspective; 
3. to explore and gain an understanding of how women with PCOS in the UK live with 
and perceive their condition, and any co-morbid conditions, on a daily basis;  
4. to develop a scale which will enable measurement of quality of life in women with 
PCOS in the UK, as defined by them, which is inclusive of all aspects of quality of 
life that may impact women with PCOS; 
5. to test the validity and the reliability of a PCOS quality of life scale for women in the 
UK according to current scale development guidelines; 
6. to investigate the prevalence of symptoms in women with PCOS in the UK and their 
association with quality of life; 
7. and to identify, develop and test an intervention aimed at increasing quality of life in 




Chapter Two -Methodology 
 
In order to answer the research aims presented in the previous chapter, consideration needs to 
be given to how this can be best achieved. This chapter first reiterates the aims of this thesis, 
and then discusses how each of these aims will be addressed. This includes a discussion of the 
ontological and epistemological approach taken, the benefits of a mixed methods approach, 
and an introduction to the data collection and generation methods that will be utilised. In 
addition, it will discuss the issues with measuring quality of life in women with PCOS 
currently, and how to overcome these, and also how quality of life can be improved in women 
with PCOS. Finally, it will reflect on issues associated with using an online sample. 
 
2.1 Introduction 
In order to further understand, measure and improve quality of life in women with PCOS it is 
necessary first to identify how women with PCOS perceive and define their own quality of life 
and to explore the impact of PCOS on quality of life from the perception of women with the 
condition. Moreover, it is essential to investigate how women with PCOS live with, and 
perceive, their condition and any co-morbid conditions on a day-to-day basis. It is also 
necessary to create an item pool for scale development purposes, in order to create a measure 
that represents how women with PCOS perceive and understand their own quality of life; and 
finally, to identify, develop and test a suitable intervention to improve quality of life in women 
with PCOS.  
 
In order to achieve the aims of this thesis a mixed methods approach is necessary. Exploration 
of quality of life may be best investigated through the use of qualitative methodology. 
However, to address the latter research aims, including the development and testing of a new 
PCOS quality of life scale and the development and testing of an intervention aimed at 
increasing quality of life in women with PCOS, a quantitative approach will be needed. Indeed, 
Rohleder and Lyons (2015) suggest that research in psychology can benefit from drawing on a 
variety of sources of data in order to better understand a phenomenon. As such, a mixed 






2.2 Ontology and Epistemology 
In research, the method of data collection, method of analysis, and theoretical framework 
should be aligned in order to produce research which can meet the research aims (Braun & 
Clarke, 2006; Chamberlain, 2015). As such, the researcher’s theoretical perspective: ontology 
and epistemology, need to be considered. Ontology has been defined as the assumptions a 
researcher makes about the nature of the world and the phenomena in it, whereas, epistemology 
is concerned with the assumptions a researcher makes about how we can investigate the 
phenomena (Chamberlain, 2015; Coyle, 2016). Within ontology, there are two overarching 
ontological positions, realism and relativism (O’Reilly & Kiyimba, 2015). Realism is the idea 
that there is a reality that exists independently of an individual’s beliefs or understandings of a 
phenomena (O’Reilly & Kiyimba, 2015), whereas relativism assumes that reality is dependent 
on the way we come to know it (Coyle, 2016). A realist approach hopes to generate knowledge 
that captures and reflects what is happening in the real world (Willig, 2013). Indeed, Willig 
(2013) suggests that a realist will position the researcher as someone who uses research skills 
to investigate phenomena and uncover evidence, rather than the researcher being an individual 
who constructs the findings. Furthermore, Willig (2013) suggests that a realist approach 
assumes that there are processes of a psychological nature which exist and can be identified. 
This thesis fits within a realist ontology, in that the research is undertaken with an assumption 
that reality is not dependent on how we come to know it, but that it exists independently to an 
individual’s beliefs. 
 
Positions within a realist ontology can vary from the ‘naïve’ realist, there is a direct relationship 
between what the researcher sees and what is going on, to the ‘critical’ realist (Willig, 2013). 
The critical realist “admits an inherent subjectivity in the production of knowledge” (Madill, 
Jordan & Shirley, 2000, p.3) or, as Willig (2013) defines it, a critical realist approach does not 
assume that data is a direct reflection of what is going on in the world, but that the data needs 
to be interpreted in order to further our understanding of the phenomena. Coyle (2016) defines 
critical realism as a reality that ‘exits independent of the observer’ (p.15) but claims that reality 
cannot be known with certainty. Similarly, Clarke, Braun & Hayfield (2015a) suggest that 
‘reality is ‘out there’’ (p.224) but that access to this reality is always mediated by socio-cultural 
meanings, and the researcher’s interpretation. They further suggest that an individual’s world 
provides access to their particular version of reality and that the researcher produces an 
interpretation of this reality. Willig (2013) similarly suggests that when conducting qualitative 
research, a critical realist may find it necessary to ‘dig deeper’ and interpret the participant’s 
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data to enable them to find any underlying factors that are beyond the participant’s knowledge. 
Critical realism, therefore, ‘admits an inherent subjectivity in the production of knowledge’ 
(Madill, Jordan & Shirley, 2000, p.3). A critical realist researcher, therefore, assumes that the 
data is the participant’s version of reality and, as such, there are different perspectives of reality 
(Maxwell, 2012). However, these may be mediated or interpreted in order to uncover factors 
which are unknown to the participant.  
 
Chamberlain (2015) suggests that it is difficult to discuss ontology and epistemology separately 
because they are ‘inevitably intertwined’ as you cannot discuss one, without the other (p.15). 
Similarly, Coyle (2016) suggests that discussions often slip between the two. These terms, or 
references to them, are often used interchangeably within the literature, for example, Willig 
(2013) refers to realism as an epistemology, whereas Coyle (2016) refers to realism as an 
ontology. Furthermore, it is argued, that unlike other ontological perspectives, critical realism 
encompasses both ontology and epistemology (Bergin, Wells & Owen, 2008). That is, critical 
realism assumes that a researcher can make assumptions about the world (that there is a reality 
- ontology) and how a researcher can investigate this (it is necessary to interpret this reality – 
epistemology) (Maxwell, 2012). Bergin et al. (2008) suggest that it is this combination of 
ontology and epistemology that differentiates critical realism from other theoretical positions. 
As such, the research for this thesis was conducted within a critical realist approach which 
suggests that reality exists independently to what can be observed, but it cannot be known, 
from the perspective of the researcher, with certainty (Coyle, 2016). 
 
2.3 Mixed Methods Research 
The combination of qualitative and quantitative methods is known as mixed methods research 
(Lyons, 2016). It has been suggested that critical realism supports a range of research 
methods (Bergin, Wells & Owen, 2008). Indeed, Healy and Perry (2000) suggest that within 
a critical realist framework, both qualitative and quantitative research is appropriate. Krauss 
(2005) similarly suggests that within critical realism, the divide between quantitative and 
qualitative research is replaced with ‘an approach that is considered appropriate given the 
research topic of interest’ (p.762). Consequently, within a critical realist approach, the 
methods of data collection and analysis should be guided by the research aim; whereby, the 
most effective methods to answer the research question may be a combination of both 




Pragmatism is a similar approach to critical realism, in that it proposes research methods 
should be guided by the research aim (Johnson & Onwuegbuzie, 2004). Feilzer (2010) 
suggests that the most important question in pragmatism is whether the research conducted 
has helped the researcher to find out what they want to know (Hanson, 2006). O’Reilly & 
Kiyimba (2015) suggest that pragmatism focuses on the compatibility of combining 
qualitative and quantitative methods, rather than on the differences of epistemologies. 
Certainly, it is suggested that a pragmatic approach enables researchers to be flexible in the 
investigative techniques they employ (Onwuegbuzie & Leech, 2005).  
 
Creswell (2003) argues that for mixed methods researchers, pragmatism opens the door to 
different forms of data collection and analysis in mixed methods studies. Indeed, it is 
suggested that pragmatic researchers are in a better position to use qualitative research to 
inform quantitative research and vice versa (Onwuegbuzie & Leech, 2005). Within mixed 
methods research qualitative approaches are often used in the preparatory stages of 
quantitative research (McEvoy & Richards, 2006). Creswell (2003) describes the mixed 
methods process as sequential, whereby the researcher expands on findings of one method, 
with another method. Within this thesis, this is exemplified through the use of qualitative 
methods to explore how women with PCOS define quality of life, and the consequential use 
of these qualitative findings in the scale development process. This use of qualitative data to 
inform scale development items is common practice in scale development (DeVellis, 2012; 
Kelly, Jenkinson & Ziebland, 2013; Streiner & Norman, 2008) and has been employed in 
quality of life scales for other health conditions such as diabetes (Bradley et al., 1999), stroke 
(Williams, Weinberger, Harris, Clark & Biller, 1999) and endometriosis (Jones et al., 2001).  
 
Mixed methods research has been defined as describing “study designs that employ 
quantitative and qualitative methods in one or more phases of research that investigates the 
same underlying phenomena” (Vroman, 2015, p. 301). This is similar to the definition 
provided by Johnson et al. (2007) who suggest that mixed methods is “the type of research in 
which a researcher…combines elements of qualitative and quantitative research approaches 
for the broad purposes of breadth and depth of understanding” (p. 123). Furthermore, Johnson 
et al. suggest that mixed methods can form a single study, or a programme of research 
whereby both qualitative and quantitative methods are used across a set of studies which are 




Denscombe (2008) suggests that mixed methods approaches have been previously used to 
allow for a more complete picture of the data to be produced and as a way of developing 
analysis and building on initial findings. Utilisation of a mixed methodology can potentially 
lead to a richer understanding of a phenomenon than does a single approach (Yardley & Bishop, 
2008). Indeed, Dures et al. (2013) suggest that the use of mixed methods research in health 
psychology yields conceptually informative and clinically relevant research data. Similarly, 
Rohleder and Lyons (2015) suggest that both qualitative and quantitative methods are needed 
to ensure full understanding of psychological phenomena. As such, qualitative research does 
not need to be set in opposition to quantitative research as qualitative research often asks 
different but complementary questions (Rohleder & Lyons, 2015). Indeed, Vroman (2015) 
suggests that mixed methods offer researchers multiple perspectives on what is important and 
relevant when seeking answers to health related research questions.  
 
Moreira and Azevedo (2006) recommend that qualitative approaches should be utilised, in 
order to further understanding of the psychological impact of a health condition, in addition to 
traditional quantitative approaches. As such, in order to investigate the research aims of this 
thesis, it is evident that a mixed methods approach, which utilises both qualitative and 
quantitative approaches, would be beneficial to further understanding of PCOS and its impact 
on quality of life. The research within this thesis will be conducted within a critical realist 
approach. It is recognised, however, that through using mixed methods to answer the 
overarching research aim (to further understanding and improve quality of life in women with 
PCOS in the UK), there is also a pragmatic element to the methods used throughout the thesis.   
 
2.4 Qualitative Research 
Smith (2015) suggests that qualitative research is concerned with exploring, describing and 
interpreting the personal experiences of individuals. Within qualitative research there are 
different approaches to research and research methods that are based on different theoretical 
assumptions (Lyons, 2016). Consequently, Chamberlain (2015) proposes that method, 
methodology, theoretical perspective and epistemology are all elements which should be 
aligned in order to produce coherent research. Similarly, Braun and Clarke (2006) 
recommend that, within research, the theoretical framework and methods need to match the 
research aims. Therefore, in order to answer the research aims outlined in Chapter One, the 
ontological and epistemological position and the method of data collection and analysis, were 




There are two types of qualitative research, little q and big Q (Kiddler & Fine, 1987; Willig, 
2013). Big Q refers to qualitative research which rejects the possibility of discovering universal 
meaning but also highlights the role of the researcher as active in the research process (Clarke, 
Braun & Hayfield, 2015). Small q research (Kiddler & Fine, 1987) refers to qualitative research 
which is structured, categorises and quantifies qualitative data systematically (Coyle, 2016). 
As such, the qualitative research detailed in this thesis fits within the Big Q type of qualitative 
research. 
 
Clarke et al. (2015) suggest that ‘fit’ is important in qualitative research and that all the 
elements of research design should be conceptually compatible. The method of analysis, 
therefore, needs to be compatible with a critical realist perspective: one such method is thematic 
analysis (Braun & Clarke, 2006; Clarke, Braun & Hayfield, 2015). In thematic analysis the 
researcher takes an active role in theme selection and development (Braun & Clarke, 2006). 
As such, in accordance with critical realism, the researcher interprets the participant’s version 
of reality (Clarke et al., 2015). Therefore the qualitative studies in this thesis utilised a thematic 
analysis approach within a critical realist framework. 
 
2.4.1 Thematic Analysis 
Thematic analysis can, and has been, described as a Big Q approach (Clarke, Braun & Hayfield, 
2015; Coyle, 2016). Braun, Clarke and Terry (2015) suggest that thematic analysis is an 
excellent tool for qualitative research in health psychology. It is a method which enables the 
researcher to identify and interpret themes in qualitative data (Clarke & Braun, 2016). Thematic 
analysis began to appear in the 1960s and 70s (Clarke & Braun, 2016; Clarke, Braun & 
Hayfield, 2015), however, it has often been used interchangeably with the term ‘content 
analysis’ (Braun, Clarke & Terry, 2015; Clarke & Braun, 2016; Clarke et al., 2015). However 
thematic analysis has now become a widely used method in psychology (Clarke et al., 2015) 
and there are now systematic guidelines in place for researchers to follow, most notably, those 
of Braun and Clarke (2006).  
 
Clarke and Braun (2016) suggest that thematic analysis can be used to answer the majority of 
research aims that may be of interest to qualitative researchers. It can be used to address a large 
range of qualitative research questions and to analyse most types of qualitative data generated 
by both large and small, homogeneous and heterogeneous samples (Braun et al., 2015a, 2015b). 
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Finlay and Gough (2003) suggest that thematic analysis is a fluid, yet systematic process which 
requires an engaged and reflexive researcher. Similarly, Braun and Clarke (2006) suggest that 
thematic analysis is a flexible method of analysis which may provide a rich and detailed 
account of the data. 
 
A good fit between the research aim, theoretical assumptions and approach to thematic analysis 
is key when undertaking qualitative research using thematic analysis (Braun, Clarke & Terry, 
2015). Clarke and Braun (2016) suggest that there are three questions that a researcher should 
seek to answer before beginning a thematic analysis, these are: What is the researcher’s 
theoretical framework? Is the data to be analysed inductively or deductively? And is the data 
to be analysed for semantic or latent meanings? The following provides an answer to each of 
these questions respectively. 
 
What is the researcher’s theoretical framework? Thematic analysis is a method, rather than a 
methodology (Clarke & Braun, 2016). It specifies only the analytical procedures which are 
focused on theme development (Braun, Clarke & Terry, 2015; Braun, Clarke & Hayfield, 
2015a). As such, thematic analysis can be applied flexibly within any of the epistemological 
frameworks which underpin qualitative research, including realism (Braun & Clarke, 2014; 
Clarke & Braun, 2016). Braun and Clarke (2006) suggest that thematic analysis is a method 
‘which works both to reflect reality, and to unpick or unravel the surface of ‘reality’’ (p.9). As 
such, the analysis used in this thesis was within a critical realist framework which allowed for 
the analysis to be grounded within the perspective of the participants whilst allowing for an 
interpretative analysis (Clarke et al., 2015; Terry, 2016).  
 
Is the data to be analysed inductively or deductively? Thematic analysis can be inductive or 
deductive (Braun & Clarke, 2006). Deductive thematic analysis refers to viewing the data 
through a theoretical lens (Braun et al. 2015a). Inductive thematic analysis, however, refers to 
an analysis which is grounded in the data; it aims to stay as close as possible to the meanings 
in the data (Braun et al.). Inductive analysis allows for the themes developed to be derived from 
the data rather than a pre-existing coding frame or researcher preconceptions (Braun & Clarke, 
2006). Clarke and Braun (2016) suggest that realist and inductive approaches often cluster 
together. As such, in order to explore how participants define their quality of life, and how they 
experience PCOS, an inductive thematic analysis approach was taken. This allowed the 
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findings of the thematic analysis to be grounded in the participant’s data, rather than according 
to any pre-conceptual framework.  
 
Is the data to be analysed for semantic or latent meanings? This refers to the level of the 
thematic analysis: a semantic analysis explores the surface meanings of the data and then 
provides an interpretation of their broader meanings and implications (Braun & Clarke, 2006). 
A latent analysis, however, would seek to identify underlying concepts (Braun & Clarke). 
Braun and Clarke (2006) suggest that different combinations of semantic or latent themes are 
compatible with a range of different epistemological positions; for example, realist, inductive 
and semantic approaches often cluster together (Clarke & Braun, 2016). In line with a critical 
realist epistemology, therefore, a semantic thematic analysis was conducted as it allows the 
analysis to stay close to the participants data (Clarke & Braun, 2016) but there is a level of 
interpretation by the researcher (Braun & Clarke, 2006). However, it is recognised that within 
a thematic analysis there is often a combination of elements of both semantic and latent analysis 
(Braun, Clarke & Terry, 2015). 
 
The thematic analysis used in this thesis was undertaken according to the guidelines of Braun 
and Clarke (2006) as they provide an accessible, systematic and rigorous approach to theme 
development (Howitt, 2010). To conduct a thematic analysis, Braun and Clarke (2006) 
recommend six phases that the researcher needs to follow. These include: familiarising oneself 
with the data, generating initial codes, searching for and then reviewing themes, defining and 
naming themes and finally producing a report.  
 
2.4.2 Reflexivity 
Reflexivity is a key feature of qualitative research, this refers to acknowledgement of the role 
the researcher’s theoretical commitments, personal understandings and personal experiences 
have in their analysis (Coyle, 2016). Willig (2013) similarly suggests that reflexivity requires 
the researcher to be aware of their influence on the analysis and the research process. She states 
that reflexivity involves ‘reflecting upon the ways in which our own values, experiences, 
interests, beliefs, political commitments, wider aims in life and social identities’ have shaped 
the research process (Willig, 2013, p.10). Larkin (2015) defines reflexivity as an explicit 
consideration of the ways in which a researcher can influence the data. The researcher needs 
to consider the ways that they can influence the data in order to be reflexive (Larkin, 2015). 
Therefore, this section will explicitly consider the impact the researcher could have had on the 
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data and the ways in which their own personal experiences and understandings can impact the 
analytical process (Coyle, 2016).  
 
The remainder of this section, therefore, shall be written in first person. Arguably, the most 
important aspect for reflection is that I was diagnosed with PCOS almost a decade ago. This 
has the potential to impact the interpretation of the data through consideration of my own 
experiences of living with the condition. However, as I was diagnosed when I was still 
relatively young, I have been able to manage my condition through lifestyle changes. As a 
result I experience very few symptoms, the ones I do experience are limited to hypoglycaemia. 
Consequently, whilst I have to be aware of my blood sugar levels, it seldom bothers me or 
requires me to take any action outside of my normal day-to-day activities. The experiences of 
many of my participants, therefore, are largely different from mine, allowing my interpretation 
to be grounded in the participants experience, rather than my own experiences or assumptions. 
To further ensure that my analyses were grounded in the participants’ experiences and 
perceptions, I had regular discussions with my supervision team to discuss the findings of the 
analysis.  
 
2.5 Methods of Data Generation 
As mentioned, the method of data generation, or collection, needs to fit within the 
epistemological assumptions of the research and research aims (Lyons, 2015). As such, the 
methods of data collection and data generation are considered and discussed with relation to 
their ‘fit’ to the other elements of research design and specifically, the research aims (Clarke 
et al., 2015).  
 
2.5.1 Photovoice  
The WHOQOL Group (1994) define quality of life “as an individual’s perception of their 
position in life in the context of culture and value systems in which they live” (p.3). Similarly, 
Bowling (2001) suggests that quality of life may mean different things to different individuals. 
Therefore, in order to identify how women with PCOS perceive their quality of life, it is first 
necessary for the individual to define their quality of life in relation to their own cultural and 
value systems. As such, it is important to utilise a data collection method which allows the 
participant to generate their data free of the researchers input, in order to reflect the participant’s 
perception of quality of life rather than one which is led by the researcher or previous 
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definitions. One method which can allow the participants to produce data with little 
interference from the researcher is photovoice.  
 
Photovoice is a process whereby individuals can use photographs to capture their everyday 
experience of health (Topcu, 2015). Photovoice puts cameras in the hands of the participants 
allowing them to record their experience (Wang & Burris, 1997). Originally developed as a 
community-based participatory method (Catalani & Minkler, 2010), photovoice has since been 
used in many smaller, specific health populations such as long-term mental illness (Thompson 
et al., 2008), alcohol and drug education (Sharma, 2010), chronic pain (Baker & Wang, 2006), 
Alzheimer’s disease (Wiersma, 2011) and food allergy (Valentine & Knibb, 2011). 
Specifically, Wang (1999) suggests that photovoice may offer unique contributions to women’s 
health as it allows women to control the process in order to ‘express, reflect and communicate 
their everyday lives’ (p.186). Similarly, McIntrye (2003) suggests that through photovoice, 
women have the opportunity to express themselves in their own images, words and reflections. 
Utilising photovoice as a data collection technique could help to gain an understanding of the 
impact PCOS can have on quality of life, and their daily lives, from the perception of women 
with the condition.  
 
To complete data collection through the photovoice method, participants were given cameras 
and a notebook and asked to photograph anything they felt had an impact on their quality of 
life. Participants were also asked to write a diary entry in the notebook to give the picture 
context, a method that has been used in previous research (Valentine & Knibb, 2011). As 
photovoice allows the participants to photograph and detail their reality, which is then 
interpreted by the researcher (through thematic analysis), it is compatible within a critical 
realist framework (Braun & Clarke, 2006; Coyle, 2016).  
 
2.5.2 Focus Groups 
Focus groups are increasingly used in qualitative health psychology research (Willig, 2013). 
Willig defines focus groups as a ‘group interview’ whereby the interaction amongst 
participants is used as a source of data. Braun and Clarke (2013) suggest that focus groups 
provide naturalistic data encourages participants to talk about the research topic in a ‘real’ way. 
Moreover, Braun and Clarke suggest that focus groups can be used as an exploratory took to 
begin to research under-researched areas. Similarly, Willig suggests that methods of data 
collection, such as focus groups and interviews, can be used in combination to explore a 
46 
 
phenomenon. As such, focus groups would provide natural data about the perceptions of living 
with PCOS, and any co-morbid conditions, on a day-to-day basis. This data could then be used 
to inform interviews (see section 2.5.3 below) which would allow access to in-depth data 
around the participant’s experiences (Bauer, Yang & Austin, 2004; Lynn, Barbour & Kitzinger, 
1999; Morgan, 1996). Lambert and Loiselle (2007) similarly used focus groups to generate 
initial data and then individual interviews to generate individual, contextualised accounts of 
the topic under study. However, as detailed in Chapter Four, participants were unable to take 
part in the focus group aspect of data collection and as such qualitative data was only generated 
and collected via photovoice and interviews. 
 
2.5.3 Interviews 
Semi-structured interviews are widely used in qualitative research as they are compatible with 
a variety of analysis methods (Lyons, 2015; Willig, 2013), including thematic analysis (Braun 
& Clarke, 2006; O’Reilly & Kiyimba, 2015). Interviews also allow researchers to gain detailed 
information about the topic being investigated (Lyons, 2015). Consequently, utilising 
interviews as a data collection method will add to the findings of the photovoice study, and 
participant’s perceptions of the impact of PCOS on their daily lives can be explored in more 
depth.  
 
As women with PCOS are often socially isolated (Benson et al., 2009; Kitzinger & Willmott, 
2002; Moreira & Azevedo, 2006) it is necessary to utilise data collection methods which are 
accessible to them. Lyons (2015) suggests that new technologies, such as the internet, offer 
novel ways to collect data. Furthermore, Lyons (2015) suggests that online interviews allow 
access to participants who may otherwise not take part in the study and allows a greater reach 
of participants than traditional face-to-face methods. Similarly, Salmons (2016) suggests that 
online methods may provide access to socially isolated populations. As such, data collection 
through interviews in this thesis utilised real-time synchronous online chat software known as 
Skype™ (Hewson, Vogel & Laurent, 2016) to conduct one-to-one interviews with participants. 
Hanna (2012) suggests that Skype™ can allow for the same benefits as those one would receive 
when conducting face-to-face interviews. In addition, Hewson et al. (2016) suggest that visual 
anonymity in online interviews can improve levels of candour and reduce inhibitions. As 
Skype™ allows the individual to choose whether they use a camera or not; the participants 
were able to choose whether they wished to display this visual image. As such, participants 




2.6 Measuring Quality of Life 
In order to answer the overarching research aim of this thesis, to further understanding and 
improve quality of life for women with PCOS, it is necessary to use a quality of life measure 
for women with PCOS. Bowling (2001) suggests that quality of life is a multidimensional 
concept that should incorporate all aspects of an individual’s life and that a disease specific 
scale should be used when disease related factors need to be assessed. Currently, there is only 
one disease specific quality of life measure for women with PCOS; the PCOSQ (Cronin et al., 
1998). 
 
2.6.1 The PCOSQ 
The PCOSQ (Cronin et al., 1998) was the first health-related quality of life measure for women 
with PCOS. It contains 26-items within five domains: emotions, body hair, weight, infertility 
and menstrual problems. Items include ‘during the past two weeks, how much of the time have 
you felt easily tired?’ and ‘during the past two weeks, how much of the time have you had 
trouble dealing with your weight?’. It was developed by clinicians in the USA who specialise 
in women’s health, obstetrics and endocrinology and used a patient sample to develop items 
(n=10) and perform analyses on the measure (n=100).  
 
Pesudovs, Burr, Harley and Elliott (2007) suggest that patient reported outcome measures are 
an integral part of research focused on outcomes and that health-related quality of life is an 
important aspect when assessing the impact of a disease. In addition, they provide quality 
assessment criteria to assess existing outcome measures, and the development of measures. 
Pseudovs et al. (2007) argue that, according to the quality assessment tool for evaluation of 
health status questionnaires, a measure developed on a non-comparable target population is 
unlikely to include relevant content. In the case of the PCOSQ, this was developed on a clinical 
US sample of patients with only two of the four possible symptom profiles of PCOS. As such, 
Pseuodvs et al. would argue that it is unlikely to be relevant to all patients with PCOS because 
population subsets have been omitted from the development process. 
 
Pseudovs et al. (2007) suggest that whilst many measures purport that they measure quality of 
life; they fail to include the range of dimensions which impact quality of life including 
emotional and vocational attributes. Pseudovs et al. call this ‘construct under representation’ 
(p.665); and, whilst the PCOSQ purports to be a measure of quality of life, it does not measure 
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all dimensions of quality of life previously identified (Fayers & Machin, 2007; Testa & 
Simonson, 1996; WHOQOL Group, 1994) and, is described by the developers as a measure 
which intends to ‘examine disease-related dysfunction’ in women with PCOS (p.1976). The 
WHOQOL Group (1994) identify several domains that should be included in a health related 
quality of life scale including: physical, psychological, level of independence, social 
relationships and environment. Others suggest that quality of life includes physical, emotional 
and social functioning domains (Fayers & Machin, 2001; Testa & Simonson, 1996). The 
PCOSQ (Cronin et al., 1998) features five domains, four of which are symptom based (body 
hair, weight, infertility, menstrual problems), the other being an emotion domain. As such, the 
PCOSQ fails to discuss any wider domains such as the suggested social domains.  
 
Malik-Aslam, Reaney and Speight (2010) suggest the PCOSQ would be better conceptualised 
as a measure of symptom bother and psychological well-being rather than a measure of quality 
of life: arguing that a comprehensive measure of the impact of PCOS on quality of life needs 
to include all the relevant elements of life that can be affected by PCOS. Similarly, Bowling 
(2014) suggests that researchers often use the term quality of life to refer to health status, adding 
that this lack of clarity has led to the use of outcome measures which fail to match the aims of 
a study.   
 
Streiner and Norman (2008) suggest that when conducting research which aims to measure a 
psychological construct and the construct is either new, or existing measures overlook a key 
aspect of the construct, then a new instrument should be developed. Similarly, DeVellis (2012) 
proposes that when addressing a research aim that requires measurement of a phenomenon, if 
existing tools are inappropriate for the research aim, then a new tool should be developed. As 
there are several conceptual and developmental issues with the PCOSQ, with regards to 
construct validity, sample population, sample size and item development techniques (which are 
discussed in the next section of this chapter and in-depth in Chapter Five) a new quality of life 
measure for women with PCOS in the UK needed to be developed in order to effectively meet 
the research aim of this thesis. 
 
2.6.2 Scale Development  
DeVellis (2012) provides a set of eight guidelines that can be used in developing measurement 
scales. These include: determining clearly what it is you want to measure; generating an item 
pool; determining the format for measurement; having the initial item pool reviewed by 
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experts; considering the inclusion of validation items; administering items to a development 
sample; evaluating the items; and optimising the scale length. Similarly, Streiner and Norman 
(2008) recommend scale developers follow similar guidelines, including: devising and 
selecting the items, administering the measure, testing for reliability and testing for validity. 
Coaley (2010) also recommends that scale developers: set clear aims, define the attribute to be 
measured, write a plan, write items, select items and administer the items to a trial sample, 
assess validity and reliability and prepare final documentation for participants. Kline (2000a) 
also recommends that to develop a psychometric scale; items are developed, administered to a 
pool of participants and analysed using factor analysis. As such, in accordance with the 
recommended guidance (Coaley, 2010; DeVellis, 2012; Kline, 2000a, Streiner & Norman, 
2008); to develop a new PCOS quality of life scale for women with PCOS in the UK, the 
following steps were adhered to: generate an item pool; determine the format for measurement; 
have the initial item pool reviewed by experts; administer items to a development sample; 
evaluate the items, administer and evaluate the revised item pool; test for reliability and; test 
for validity.  
 
2.6.2.1 Generating an item pool  
DeVellis (2012) recommends that when generating an item pool, each item should reflect the 
latent variable, in this case quality of life. Furthermore, Streiner and Norman (2008) suggest 
that measurements of quality of life are dependent upon their definition which may vary from 
person to person. In addition, they suggest that patients or potential participants are excellent 
sources of items and that these viewpoints can be gained from qualitative research. Therefore, 
the item pool for the new scale was generated using the qualitative findings of this thesis 
(Chapter Three and Four), which discuss how women with PCOS perceive and understand 
quality of life, and the previous literature in the area. Items were developed according to the 
guidelines presented by DeVellis, these include, reviewing the initial item pool for: lengthy 
items, reading difficulty, multiple negatives, double barrelled items, ambiguous references and 
adjective forms. A large item pool was developed and the ‘best’ items chosen through methods 
of analysis (Coaley, 2010).  
 
Whilst the PCOSQ (Cronin et al., 1998) did conduct interviews with patients in order to 
develop a pool of items, these were limited to the authors own clinical patients. In addition, the 
authors only conducted a review of the clinical literature and at the time of development of the 
PCOSQ (1998) there were no qualitative papers available exploring PCOS (the first qualitative 
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paper was published by Kitzinger & Willmott in 2002). Moreover, Cronin et al. used a narrow 
diagnostic criteria which excluded two phenotypes of women with PCOS as recognised by the 
current Rotterdam 2003 criteria (2004). This suggests that the PCOSQ was developed on a 
limited, non-representative clinical sample which ignores the experiences of those women who 
have been discharged from the healthcare system or who present with a phenotype that differs 
from those included in the development interviews. The work presented in this thesis aims to 
overcome these limitations. 
 
2.6.2.2 Determining the format for measurement 
The format of response options for items in a scale should be developed simultaneously to the 
item themselves (DeVellis, 2012). Aiken and Groth-Marnat (2006) suggest that there are two 
main categories of response format used in scale development: selected-response format (the 
participant is forced to choose a response from those given, also known as forced choice) and 
constructed response format (the participant creates a response). A common item format is a 
Likert, or rating scale; in a Likert scale the item is presented as a declarative sentence which 
reflects the underlying variable, and followed by response options that indicate degrees of 
endorsement of the item (Coaley, 2010; DeVellis). Coaley (2010) suggests that this response 
format allows individuals to respond more flexibly and more precisely than other response 
formats. The time frame of responses also needs to be considered and DeVellis recommends 
that developers select this time frame actively to reflect the construct of interest and intended 
use of the scale. For the new scale, therefore, responses were in a Likert scale format and timed 
to reflect the characteristics of PCOS.  
 
Whilst the PCOSQ does have a suitable response format (in the form of a Likert scale), the 
time frame of responses is contentious. The PCOSQ (Cronin et al., 1998) requires participants 
to recall over a period of two weeks. As PCOS is largely concerned with a woman’s hormonal 
profile and can impact on a woman’s menstrual regularity (Elsenbruch et al., 2013), a two week 
recall period is arguably insufficient to reflect the construct of interest and intended use of the 
scale (DeVellis, 2012). Therefore, a recall period of four weeks was used for the PCOSQOL 
to reflect the average menstrual cycle (NHS, 2014).   
 
2.6.2.3 Have the initial item pool reviewed by experts 
DeVellis (2012) recommends that after items have been generated and a response format 
selected, the initial item pool should be reviewed by individuals knowledgeable in the area, in 
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this case PCOS. DeVellis suggests asking an expert panel to consider: how relevant they think 
each item is, to evaluate the items clarity and conciseness and to identify items that may be 
missing or should be included. This action is related to assessing the content validity of the 
scale and this is discussed later in the section ‘testing for validity’. As such, the initial item 
pool was sent to a panel of experts in the area of PCOS, to be reviewed. 
 
Cronin et al. (1998) report that the initial item pool for the PCOSQ was surveyed by health 
professionals including ‘four endocrinologists, two gynaecologists and two nurse practitioners’ 
(p.1977). Whilst utilising an expert pool demonstrates good practice within scale development 
according to DeVellis (2012), their pool was largely medical and this may mean that the 
psychological aspects of the condition were not adequately reviewed. 
 
2.6.2.4 Administer items to a development sample 
The initial item pool should be administered to a large development sample (Coaley, 2010; 
DeVellis, 2012). A sample size of 300 is suggested to eliminate subject variance (DeVellis, 
2012; Nunally, 1978) and as large samples may be more representative of the target population 
(DeVellis). Therefore in this scale development, the initial item pool was administered to a 
large sample of approximately 300 women with PCOS.  
 
The PCOSQ (Cronin et al., 1998) was also administered to a development sample via phone 
interviews, however, whilst the authors did initially identify a sample of 275 eligible women, 
147 women declined to participate or did not respond to the authors requests to take part, four 
women were identified as ineligible and 24 women withdrew (cancelled or missed 
appointments). Consequently, only 100 patients with PCOS participated in the item reduction 
phase of development and this sample size may not have been large enough to be representative 
of the target population or to eliminate variance, particularly as the inclusion criteria did not 
include two phenotypes of women with PCOS (DeVellis, 2012). 
 
2.6.2.5 Evaluate the items 
Once the initial item pool has been administered to a large sample, to identify appropriate items 
to retain in the scale from the initial large item pool, the items must be analysed (DeVellis, 
2012). This involves analysing the item-scale correlations, item variances, item content and 
item means (DeVellis; Kline, 2000a). However, the principal method to evaluate items is 
through factor analysis (Coaley, 2010; DeVellis, 2012; Kline, 2000; Nunally & Bernstein, 
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1994). Factor analysis, when used for scale development, assesses whether individual items 
relate to a common factor (Coaley, 2010). At this point a coefficient alpha may be calculated 
to assess the items which have been selected from the initial item pool (DeVellis, 2012) (this 
is discussed in more depth in ‘testing for reliability’ below). Therefore, to evaluate the initial 
item pool, items were analysed, a factor analysis was performed and a coefficient alpha was 
calculated.  
 
Whilst the PCOSQ (Cronin et al., 1998) did conduct a form of factor analysis, the authors state 
that they used the factor analysis ‘not to reduce items but…to help place items in domains’ (p. 
1977). Indeed, prior to conducting the factor analysis, Cronin et al. specified the number of 
items per domain and only performed the factor analysis on items endorsed by more than half 
of the sample (minimum 50 participants per item). This suggests that the items were not 
evaluated according to relevant scale development or statistical guidelines (Coaley, 2010; 
DeVellis, 2012; Nunally & Bernstein, 1994). Furthermore, it suggests that the scale items were 
unrepresentative of the intended population and construct as many items which may have had 
an impact on other participants with PCOS, were excluded.  
 
2.6.2.6 Administer and evaluate the revised item pool 
DeVellis (2012) suggests that replicating a factor analysis and its solution on a new population 
sample, may ‘be the best means of demonstrating generalisability’ (p.158). Kline (2000b) 
similarly proposes that it is necessary for scale developers to ensure the factor solution can be 
replicated on a new sample of participants. As such, once appropriate items had been identified 
from the initial item pool, the revised items were sent to a new, large sample of women with 
PCOS in the UK. Item evaluation tests such as factor analysis and calculating coefficient alpha, 
were then performed to evaluate the revised item pool. 
 
The developers of the PCOSQ (Cronin et al., 1998) did not conduct this step, or any of the 
following steps regarding testing for reliability and validity. As such, the scale development 
paper itself has not demonstrated any psychometric properties. The validation of the PCOSQ 
has been completed by other researchers since 1998 (Guyatt et al., 2004; Jones et al., 2004), 
however, these validations face similar criticisms to many of those levied at Cronin et al. (these 
are discussed in more detail in Chapter Five). Indeed, Malik-Aslam et al. (2010) suggest that 




2.6.2.7 Testing for reliability  
Reliability can refer to two factors within scale development: reliability, or stability, of a 
measure over time and the internal consistency of a measure (Kline, 2000a). Test-retest 
reliability refers to whether a measure is consistent over time (Coaley, 2010; DeVellis, 2012), 
this is also known as temporal stability (DeVellis, 2012) which determines whether a test 
measures consistently from one time to another (Aiken & Groth-Marnat, 2006). A good 
measure should have high test-retest reliability (Kline). As such, a test-retest was undertaken 
to test for reliability over time. This involved disseminating the new PCOS scale, to the same 
group of subjects, at two different time points and computing a correlation between the two 
scores (Aiken & Groth-Marnat, 2006; DeVellis, 2012; Kline, 2000a).  
 
Internal consistency reliability refers to the extent to which each item within the measure, is 
measuring the same latent variable (Kline, 2000a), or as DeVellis (2012, p.34) proposes “the 
homogeneity of items within a scale”. To test the internal consistency of a measure, Cronbach’s 
alpha coefficient of reliability (Cronbach, 1951) was calculated (Coaley, 2010; DeVellis, 2012; 
Kline, 2000b).  
 
2.6.2.8 Testing for validity 
Nunally (1994) defines validity as ‘the scientific utility of a measuring instrument, broadly 
state-able in terms of how well it measures what it purports to measure’ (p.83).  More simply, 
validity is whether a scale measures what it intends to measure, in this case the quality of life 
of women with PCOS (Aiken & Groth-Marnat, 2006; Coaley; 2010). There are three 
complimentary forms of validity including content related validity, criterion related validity 
and construct related validity (Coaley; Cronbach, 1990; DeVellis, 2012). However, Cronbach 
(1990) suggests that whilst these forms of validity are treated as separate entities, they should 
all be integrated and are not truly separable. Indeed, Aiken and Groth-Marnat (2006) suggest 
that both content and criterion validity can be used to help further understanding of the 
construct validity of a measure.  
 
Content validity concerns the extent to which a set of items reflect the content domain 
(DeVellis, 2012). Within content validity, face validity is also assessed, this refers to the scales 
physical appearance and whether it looks like it assesses what it intends to (Aiken & Groth-
Marnat, 2006). To assess content validity, Streiner and Norman (2008) recommend that experts 
in the content area, in this case experts in PCOS, give judgement with regards to the content of 
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items. As such, the initial items developed in the new PCOS scale were assessed by area experts 
(see Chapter Five). 
 
Criterion validity refers to correlation of a scale to another ‘gold standard’ measure of the 
construct under study which demonstrates good reliability and validity in the field (DeVellis, 
2012; Streiner & Norman, 2008). It is made up of two types of validity: concurrent (correlate 
the new scale with a criterion measure) and predictive (the criterion is delayed) (Streiner & 
Norman, 2008). Streiner and Norman give the examples of diagnostic tests whereby an 
individual may have to await the outcome of an autopsy to confirm predictions, as an example 
of predictive validity. Concurrent validity, however, may be exampled by correlating a new 
scale with a criterion measure which are given at the same time (Streiner & Norman, 2008). 
As the criterion is not delayed, the new PCOS scale was assessed for concurrent validity. 
However, as the PCOSQ has been critiqued (Malik-Aslam et al., 2010), there is no ‘gold 
standard’ measure in the field of PCOS. As such, DeVellis (2012) recommends using a 
benchmark measure with similar but not identical variables, therefore, criterion validity was 
assessed with similar measures including the WHOQOL-BREF (The WHOQOL Group, 1998). 
 
Construct validity, developed by Cronbach and Meehl (1955), is concerned with the theoretical 
relationship of a variable to other variables (DeVellis, 2012), or, whether the test really 
measures what it claims to measure (Coaley, 2010). Aiken and Groth-Marnat (2006) define 
construct validity as “the extent to which the instrument measures a particularly construct or 
psychological concept” (p.101), in this case quality of life. A method of testing for construct 
validity includes gaining experts judgements on whether the measure reflects the construct of 
interest (Aiken & Groth-Marnat). Another process for testing construct validity is similar to 
that of concurrent validity, in that test scores are correlated with other accepted measures 
(Coaley, 2010). This can be referred to as convergent validity (high correlations with other 
measures of the same construct) or divergent validity (low correlations with measures of 
different constructs) (Aiken & Groth-Marnat).  
 
2.7 Improving Quality of Life 
In order to achieve the overarching aim of this thesis to improve quality of life in women 
with PCOS, an intervention is necessary. Therefore, once an appropriate PCOS quality of life 
measure has been developed, an appropriate intervention can be identified, then tested within 
a population of women with PCOS in the UK. In addition, to aiming to improve quality of 
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life in women with PCOS, an intervention may also provide further validation (construct 
validity) for the new PCOS quality of life measurement through an assessment of its 
sensitivity to change (Streiner & Norman, 2008). That is, assessing whether the measure is 
able to detect clinically meaningful change. Streiner and Norman suggest that to assess this a 
mean score of a control group should be compared with a mean score of a treatment group.  
 
2.7.1 Interventions  
Fayers and Machin (2001) suggest that traditionally interventions have focused on physical 
outcomes, rather than quality of life. Correspondingly, there is a large body of literature which 
explores medical interventions in women with PCOS, however, there is a comparatively small 
number of studies which have investigated the psychological factors of, and interventions for, 
PCOS (Farkas, Rigó & Demetrovics, 2014). Andersen (1992) however, suggests that 
psychological interventions may reduce emotional distress, enhance coping and improve 
adjustment. Moreover, Bennett (2004) suggests that psychological interventions have been 
shown to be strong determinants of quality of life. De Ridder (2004) similarly suggests that 
improving quality of life is a primary goal for psycho-social interventions for individuals with 
long-term illness. As such psychological interventions may be effective for improving quality 
of life in women with PCOS in the UK.  
 
Common medical interventions for women with PCOS include the oral contraceptive pill, 
metformin and clomiphene citrate (CC), commonly known as Clomid. Teede et al. (2006) 
suggest that oral contraceptive pills are the first line of medical therapy for women with PCOS, 
as it is thought to control the hormonal manifestations of PCOS including menstrual irregularity 
and hirsutism (Rosenfield, 2008). In addition, metformin (or glucophage) is the most 
commonly used pharmaceutical drug in clinical use for treatment of PCOS (La Marca, 
Artensio, Stabile & Volpe, 2005). For fertility issues which present as a result of PCOS, women 
with the condition are often prescribed CC which has been used in the United States as the 
mainstay of ovulation induction in women with PCOS since 1967 (Hill, 2003). 
 
In 2009 the Androgen Excess and Polycystic Ovary Syndrome Society (Moran, Pasquali, Teed, 
Hoeger & Norman) suggested that lifestyle management should be used as the primary 
intervention for women with PCOS due to the reported impact on biological symptoms of 
PCOS, such as ovulatory function. Certainly, there are several non-medical interventions which 
have focused on lifestyle factors such as diet and exercise (Ehrmann, 2002; Norman, 2006; 
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Pasquali et al. 2006). Indeed, Wong et al. (2015) explored the impact of a low-glycaemic versus 
a low-fat diet in women with PCOS. Similarly, Mavropoilous, Yancy, Hepburn and Westman 
(2005) investigated the impact of a low carbohydrate diet on women with PCOS. 
 
There remains, however, a need for research which explores the impact of psychological 
interventions on psychological outcomes of PCOS such as quality of life, depression and 
anxiety (Deeks, Gibson-Helm & Teede, 2010). To date, there are few studies which explore 
the impact of lifestyle interventions on quality of life in women with PCOS, or the 
psychological domains associated with the condition including depression and anxiety (Deeks 
et al., 2010). One study which has explored the impact of lifestyle interventions on quality of 
life evaluated changes in quality of life of overweight women with PCOS during a 24-week 
lifestyle modification programme which included diet, exercise and Cognitive Behavioural 
Therapy (Frène et al., 2015). Frène et al. found that quality of life improved significantly for 
the participants. Thomson et al. (2010) similarly found that three groups (diet, diet and aerobic 
exercise, diet and combined aerobic-resistance exercise) in a 20-week lifestyle intervention 
experienced improvements in quality of life. Furthermore, Stener-Victorin, Holm, Janson, 
Gustafson and Waern (2013) investigated the impact of acupuncture or exercise on depression, 
anxiety and quality of life in women with PCOS: they noted an improvement in quality of life 
scores for both those participants in acupuncture and the exercise group.  
 
Other interventions which aim to improve quality of life in women with PCOS have utilised 
both medications and lifestyle management. For example, Harris-Glocker, Davidson, 
Kochman, Guzick and Hoeger (2010) explored the impact of the oral contraceptive pill and 
lifestyle change with and without metformin in women with PCOS. They found that quality of 
life scores improved in all groups, including the placebo group. However, interventions which 
aim to improve quality of life, depression and anxiety in women with PCOS using 
psychological techniques are few. Indeed, Farkas et al. (2014) propose that there are few studies 
which have been carried out regarding the efficacy of psychotherapy in PCOS. Farkas et al. 
detail a study by Rofey et al. (2009) which evaluated the effectiveness of Cognitive 
Behavioural Therapy in adolescent women with PCOS and found a decrease in depressive 
symptoms, however they did not explore the impact on quality of life. More recently, Stefanaki 
et al. (2015) investigated the impact of an eight week mindfulness programme on depression, 
anxiety and quality of life in women with PCOS. They found that the programme reduced 
depression and anxiety symptoms and increased quality of life in women with PCOS.  
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2.7.2 Accessibility to care 
The majority of the intervention studies discussed in this chapter detail medical interventions 
which are made available to women who are, at the time, part of the healthcare system and 
focus on treating biological symptoms, such as weight and menstrual cycles. Indeed, the DOH 
(2008) identify that medication has traditionally been the only treatment available to 
individuals with depression and anxiety. As such, for those women with PCOS who have been 
discharged from the healthcare system there are two issues: lack of access to medical 
interventions and lack of accessible psychological interventions.  
 
According to the NHS (n.d.), individuals with long-term conditions use 50% of all GP 
appointments and their care absorbs 70% of hospital and primary care budgets in England. As 
such, the NHS suggests that individuals with long-term conditions, such as heart disease, 
depression and diabetes (all of which are co-morbidly associated with PCOS), should be 
supported to be as independent and as healthy as they are able to be and to prevent 
hospitalisation. Furthermore, they suggest that addressing the psychological needs of 
individuals with long-term conditions, may help to reduce the impact and costs related to them. 
They example the cost of managing a patient with diabetes and co-morbid depression as being 
four and a half times higher than the cost of managing a patient with diabetes alone. Whilst 
figures are not available for women with PCOS, it can be hazarded that the costs for a woman 
with PCOS may be similar to those for individuals with diabetes due to the similarities in the 
two conditions which include similar medications, similar co-morbid conditions and similar 
symptoms.  
 
The Health and Social Care Act 2012 highlighted the importance of mental health, alongside 
physical health. In addition, in 2008 the UK government launched the Improving Access to 
Psychological Therapies (IAPT) programme which aims to make psychological therapies for 
depression and anxiety, specifically CBT, more widely available in the NHS. However, access 
to psychological therapies is strained with one in 10 people waiting over a year to receive 
treatment (Mind, 2013) and also due to actual costs of the IAPT scheme exceeding their 
estimates (Griffiths & Steen, 2013; Radhakrishnan, Hammond, & Lafortune, 2011; 
Radhakrishnan et al., 2013). Radhakrishnan et al. (2011) suggest that cost-effective, alternative 
intervention methods are needed. Similarly, Bennett (2004) suggests that psychological 
interventions should be developed that require minimal input from a healthcare professional, 
are cost-effect and are brief. Psychological intervention methods that have been identified as 
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being simple, resource light and cost-effective are positive psychology interventions (DuBois, 
Millsetin, Celano & Wexlar, 2015; Lyubomirsky & Layous, 2013). 
 
2.7.3 Positive Psychology  
Michie and Prestwich (2010) suggest that theory-based interventions can aid understanding of 
why interventions are effective or not. Moreover, Michie, Johnston, Francis, Hardeman and 
Eccles (2008) suggest that theory should provide a basis for designing interventions to change 
behaviour. While a psychological intervention is necessary to meet the aim of this thesis and 
improve quality of life in women with PCOS, rather than change a health-related behaviour, it 
is important to first consider the theory upon which the intervention to improve quality of life 
is based. Positive psychology stems from Seligman’s desire for research to focus less on 
pathology, and more on the positive aspects of human existence.  
 
Seligman (2002) argued that after the Second World War, psychology was concerned mainly 
with pathology and repairing damage, rather than on fulfilment as an individual and that a 
change in the direction of psychology from a preoccupation with repairing the worst things in 
life to building the best things in life, was needed. As Seligman states “psychology is not just 
the study of disease, weakness, and damage…Treatment is not just fixing what is wrong: it is 
also building what is right” (p.4.). Seligman urged for a move towards positive health, which 
rather than focusing on the absence of disease, concerned itself with what makes an individual 
thrive after illness (Hefferon, 2013). Gable and Haidt (2005) propose that positive psychology 
is the study of the conditions and processes that contribute to the optimal functioning of 
individuals and groups. Seligman and Csikszentmjhalyi (2000) suggest that positive 
psychology aims to catalyse a change in the focus of psychology from negative aspects to 
positive aspects of life. Indeed, Jørgensen and Nafstad (2005) suggest that mainstream 
psychology gives priority to negative behaviour and various forms of dysfunction, such as 
depression, racism and violence (Gable & Haidt, 2005), whereas positive psychology aims to 
concentrate on positive experiences.  
 
Seligman (2002) suggests that positive psychology, therefore, is aimed towards prevention 
through building of positive human traits. Cohn and Fredrickson (2010) suggest that positive 
emotions predict mental health, successful coping and also physical health and longevity in 
those with long-term conditions. Indeed, Fredrickson (2001) developed the Broaden and Build 
theory which suggests that experiences of positive emotions can broaden an individual’s 
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momentary thought action repertories, which, in turn, builds the individual’s personal 
resources. More simply, positive emotions can broaden attention, cognition and behavioural 
repertoires (Cohn & Fredrickson, 2010). As such, positive emotions can have long lasting 
consequences (Fredrickson, 2001). Certainly, Hefferon (2013) suggests that positive emotions 
have been found to enhance feelings of mental health. Interventions which employ positive 
psychology, therefore, may broaden an individual’s awareness of positive emotion and the 
consequential broadened thought-action repertoires may help the individual to integrate the 
positive psychological behaviour into everyday life (Cohn & Fredrickson, 2010). This reflects 
the regulation of positive emotions, whereby behaviour change experts may encourage 
individuals to increase their positive emotions, in order to better help them change behaviour 
(Michie et al., 2013). Therefore, it is not just those women who are within the healthcare system 
and ‘struggling’ with their PCOS (and potential co-morbid conditions) that could benefit from 
a positive psychology intervention. It is also those women who live with PCOS but do not seek 
medical help, or who have been discharged from the medical system, that could benefit from a 
positive psychology intervention.  
 
2.7.4 Positive Psychology Interventions 
Lyubomirsky and Layous (2013) define positive activities as “simple, intentional and regular 
practices” (p.57) which are intended to mimic the healthy thoughts and behaviours associated 
with naturally happy people; such as counting blessings. This reflects the Broaden and Build 
theory (Fredrickson, 2001) which suggests that positive emotions can broaden an individual’s 
positive resources. Sin and Lyubomirsky (2009) define positive psychology interventions as 
“treatment methods or intentional activities that aim to cultivate positive feelings, behaviours 
or cognitions” (p.468).  
 
Proyer, Wellenzohn, Gander and Ruch (2014) suggest that positive psychology interventions 
are effective in enhancing well-being and ameliorating depression. Moreover, Huffman, 
DuBois, Millsetin, Celano & Wexlar (2015) suggest that positive psychology interventions 
may represent a strategy to increase positive psychological emotions in individuals with long-
term conditions. Huffman et al. state that positive psychology “is a branch of clinical and 
research interventions that uses systematic exercises…to target positive cognitive and 
emotional states” (p.2). In addition, they state that unlike complex health behaviour 
interventions, positive psychology interventions are simple and can be delivered remotely, nor 
do they require participants to have a high level of education or a substantial time commitment 
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to complete them. Similarly, Lyubomirsky and Layous (2013) suggest that positive psychology 
activities, such as counting blessings are brief, can be self-administered and are cost effective.  
 
In 2005 Seligman, Steen, Park and Peterson detailed and tested the effectiveness of five 
positive psychology interventions delivered via the internet, these included: a gratitude visit, 
listing three good things in life, writing about themselves at their best, using signature strengths 
in a new way and identifying signature strengths. Participants in the three good things activity 
demonstrated the most decreased depressive symptoms at the one month, three months and six 
months post intervention, in comparison to the four other intervention activities. Since 
Seligman et al.’s study in 2005, gratitude interventions, such as the three good things 
intervention, have been the most widely used positive psychology intervention in the literature 
(Wood, Froh & Geraghty, 2010). Similarly, Carson, Muir, Clark, Wakely and Chander (2010) 
suggest that gratitude has been incorporated into many positive psychology intervention 
programmes. Hefferon and Boniwell (2011) also propose that gratitude is the underlying 
concept for many positive psychology interventions.  
 
Fredrickson (2004) suggests that gratitude could broaden and build, by inspiring creative 
reciprocity and constructing psychological resources, and this could lead to increases in well-
being. Indeed, Carr (2011) proposes that whilst the psychological study of gratitude is a recent 
development; research suggests individuals who engage in positive activities, such as thinking 
gratefully, become significantly happier (Sin & Lyubomirsky, 2009). Furthermore, 
McCullough et al. (2002) found that grateful people tend to experience less depression and 
anxiety than those individuals who were less grateful. Lyubormisky (2007) also suggests that 
individuals, who are inclined to be grateful, are less likely to be depressed or anxious. 
Moreover, Wood et al. suggest that gratitude interventions are effective in improving well-
being. Gratitude interventions therefore have been found to improve a number of psychological 
outcomes. 
 
It is worth noting that quality of life has not yet been used as an outcome measure within a 
gratitude intervention specifically. However, Park (2015) suggests that gratitude is linked to 
health-related quality of life. It has also been suggested that well-being is incorporated within 
a definition of health-related quality of life (Bowling, 2001; Fayers & Machin, 2007), others 
suggest that quality of life is incorporated within well-being (Dodge, Daly, Huyton & Sanders, 
2012). Whilst it is clear, that quality of life and well-being are both concepts which are often 
61 
 
confused or used interchangeably (Dodge et al., 2012; Galloway, 2005), Park suggests that 
positive psychology may help quality of life researchers to expand their focus to include more 
positive aspects of quality of life.  
 
Wood et al. (2010) suggest that gratitude interventions are often run online and as such, are 
low cost and, therefore, have the potential to increase access to psychological services if 
utilised. As such, in order to provide women with PCOS in the UK with a psychological 
intervention that is easy to access and cost effective, an online positive psychology 
intervention based on the three good things activity was utilised. Participants were asked to 
write down three good things that happened to them each day as part of the positive 
psychology intervention (see Chapter Seven for more details). 
 
2.8 Online Sampling  
As mentioned previously, women with PCOS are often socially isolated (Benson et al., 2009; 
Kitzinger & Willmott, 2002; Moreira & Azevedo, 2006). As such, it is necessary to utilise data 
collection methods which are accessible to them; such as online data collection techniques 
(Lyons, 2015). Indeed, Salmons (2016) suggests that data can be collected via any means that 
individuals use to communicate, such as through computers or mobile devices. Indeed, 
Hewson, Vogel and Laurent (2016) suggest that internet-mediated research methods can 
provide access to diverse sections of the general population. As such, recruitment for all studies 
will use online sampling with recruitment taking place through the online social networking 
website, Facebook and through the PCOS charity website ‘Verity' (for study one).  
 
Coulson (2015) lists several benefits to conducting research online, including: access to 
participants, access to hard-to-reach populations, reduced costs, researcher anonymity, 
flexibility and convenience and access to individuals with stigmatised identities. Similarly, 
Hewson (2003) details the potential to access large samples of specific populations and the 
minimal costs involved in online research, as a benefit of internet mediated research. Coulson 
(2015), however, also identifies several challenges when collecting data online which are 
applicable to the research within this thesis. One such challenge is ‘representativeness’ 
(Coulson, 2015, p.14), that is, that participants recruited online may not be representative of a 
target population due to the lack of equal distribution of the internet across the population. 
Indeed, Hewson (2003) also raises the question of biased samples in online research and 
suggests that online samples are biased but that this may change as the internet grows. Indeed, 
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more recently Hewson et al. (2016) suggest that whilst ‘in the early days of internet mediated 
research…there were widespread concerns about biases inherent in the internet-user 
population’ (p.71) there is no longer bias towards particular groups of users (white, upper 
middle class, well-educated males). Furthermore, in a comparison of data collected online and 
via traditional methods (pen and paper), Gosling, Vazire, Srivastava and John (2004) found 
that their internet findings were consistent with the findings from traditional methods, 
suggesting that the impact of online vs traditional samples on findings may be minimal. 
Moreover, Hewson (2003) suggests that online samples may actually be more representative 
than those that utilise traditional methods.  
 
In 2015, 86% of adults in the UK had used the internet in the preceding 3 months and only 11% 
of adults had never used the internet (ONS, 2015). Furthermore, the social networking website, 
Facebook, reports over one billion daily active users as of September 2015 with 894 million of 
those individuals accessing Facebook through a mobile device (Facebook, 2015). In addition, 
as of 2012, there were approximately 33 million Facebook users in the UK, more than any 
other country in Europe (Internet World Stats, 2014), suggesting that over half the UK 
population (63.7 million) in that year (ONS, 2013) was using Facebook. Considering these 
figures, and the many ways in which individuals can access the internet (computer, mobile 
phone, tablet), they provide support for the ‘increasing diversity and inclusiveness within the 
internet user population’ and samples accessed via the internet (Hewson et al., 2016, p. 77).  
 
Hewson et al. (2016) claim that there is a lack of research on the relationship of different 
recruitment strategies in internet mediated research and how this may influence the sample. 
Although they do suggest that recruiting from a special interest group, such as a group 
dedicated to women with PCOS, will generate a different sample to recruiting in a general 
group (such as group for buying and selling). Indeed, a search conducted in Facebook (2015) 
for the term PCOS, revealed 93 closed groups dedicated to women with PCOS (identified 
through the group name and description); of these, seven groups were specifically dedicated to 
women with PCOS in the UK. Member numbers, at the time of writing, within the 93 PCOS 
groups ranged from 23,793 members to the smallest group with 33 members.   
 
Coulson (2015) also suggests that of those individuals who can access the internet, there may 
be sampling error as not everyone has an equal chance of seeing the recruitment post due 
holidays etc. To combat this, each day, the recruitment post for Chapters Four to Seven, was 
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re-posted, or commented on, to ensure that the post remained at the top of the group Facebook 
‘wall’ and therefore visible to as many members of the group as possible throughout the 
duration of recruitment, in agreement with the group moderators. For the study detailed in 
Chapter Three, as participants were recruited via Verity, the recruitment post remained in the 
same position and visible at all times until after the completion of data collection. 
 
2.9 Summary 
This thesis aims to further understanding of the impact of PCOS on quality of life for women 
in the UK. In addition, it aims to measure this phenomena and increase quality of life for these 
women. This chapter has provided a detailed discussion on the theoretical framework within 
which this research sits, the methods of data collection and generation that were employed and 
also the methods of analysis that were necessary to complete coherent research in order to meet 





Chapter Three -A snapshot of the lives of women with Polycystic Ovary Syndrome 
(PCOS): A photovoice investigation.  
 
This chapter will investigate and identify how women with PCOS in the UK perceive and 
define their quality of life. Furthermore, it will investigate how women with PCOS perceive 
the impact of PCOS on their quality of life, from their perspective. This chapter also restates 
the methods and methodology used to meet these research aims, and also discusses the 
findings and their relationship to previous research.  
 
3. 1 Introduction 
The clinical characteristics of PCOS include hyperandrogenism, chronic anovulation, insulin 
resistance and infertility (Archer & Chang, 2004). These can often manifest as hirsutism, 
obesity (Eggers & Kirchengast, 2001) and acne (Archer & Chang, 2004). PCOS has been 
found to have a greater impact on women’s psychological well-being than illnesses such as 
asthma, epilepsy, back pain and arthritis but a similar or milder physical impact than these 
conditions (Coffey, Bano & Mason, 2006). Consequently, Coffey et al. (2006) argue that 
PCOS affects women psychologically more than physically. Lowenstein (2006) similarly 
proposes that patients with PCOS are often negatively affected by some of the symptoms they 
experience, including acne, hirsutism, alopecia and obesity. 
 
Studies show that women with PCOS have an increased prevalence of psychological 
morbidity (Cipkala-Gaffin, Talbott, Song, Bromberger & Wilson, 2012; Deeks, Gibson-
Helm, Paul & Teede, 2011; McCook et al., 2005) and an impaired quality of life compared to 
women without PCOS (Ching, Burke & Stuckey, 2007; Coffey & Mason, 2003). This 
suggests that PCOS, and its symptoms, can have a considerable negative impact on women 
with the condition. Quantitative studies have demonstrated that PCOS has a negative impact 
on quality of life (Elsenbruch et al., 2003; Upadhya & Trent, 2007), even when compared 
with other long-term conditions such as diabetes and coronary heart disease (Coffey et al., 
2006).  
 
Qualitative studies exploring the impact of PCOS on quality of life, however, are severely 
lacking and often limited to clinical settings (Crete & Adamshick, 2011; Percy, Gibbs, Potter 
& Boardman, 2009; Snyder, 2006). To date the only paper which explores the experience of 
PCOS outside of a clinical setting in the UK was published by Kitzinger & Willmott (2002); 
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they found that the women with the condition felt stigmatised and abnormal. Indeed, Liang et 
al. (2013) claim that understanding the concerns and expectations of women with PCOS is 
important and quantitative methods fail to provide the necessary information. They argue that 
the use of qualitative methods, therefore, become increasingly important to understand the 
meanings experienced by women with PCOS. There is, therefore, a need for qualitative 
research that explores how women with PCOS in the UK define and perceive their quality of 
life; and also how women with PCOS experience this condition and perceive the impact of 
PCOS on their quality of life. 
 
3.2 Photovoice 
Photovoice, developed by Wang and Burris (1994), is a data collection method that is being 
increasingly used in psychological research; particularly to capture an individual’s experience 
of health (Topcu, 2015). It is a process which entrusts cameras in to the hands of people to 
enable them to act as recorders (Wang & Burris, 1997). Photovoice has been employed to 
explore a variety of health conditions including; long-term mental illness (Thompson et al., 
2008), alcohol and drug education (Sharma, 2010), chronic pain (Baker & Wang, 2006), 
Alzheimer’s disease (Wiersma, 2011), food allergy (Valentine & Knibb, 2011) and many 
more (Booth & Booth, 2003; Duffy, 2010; Fitzpatrick et al., 2012; Vaughn, Rojas-Guyler & 
Howell, 2008; Wang & Pies, 2004). It has been suggested that photovoice is able to uncover 
rich descriptive information and can be widely adapted to fit the needs of research (Catalani 
& Minkler, 2010). In the case of this study, photovoice would allow participants to generate 
data free from the researcher’s input, thus enabling them to reflect their perception of quality 
of life, rather than any pre-existing concept.  
 
Wang and Burris (1997) claim that photovoice can be a powerful research method when 
employed with stigmatised or ostracised groups of people and, furthermore, they suggest that 
research participants often have the experience and insight into their condition which 
professionals and outsiders lack. Wang (1999) maintains that photovoice allows people with 
cameras to photograph their perceived health realities. Consequently, Ruby (1991) states that 
photovoice enables health researchers to gain a different perspective of the world. Wang and 
Burris also claim that photovoice enables participants to record things relevant to their life 
such as settings or ideas which health professionals and researchers may not have previously 
had access too. Additionally, Brunsden and Goatcher (2007) suggest visual images allow 
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people to record their experiences and feelings more effectively than words alone allowing 
them to think about their lives in ways not previously considered. 
 
Brunsden and Goatcher (2007) maintain that in any image there is a range of data, both 
observable and interpretable. They state that people inhabit a visual world and experience life 
as visual encounters. Accordingly, photovoice engages participants in the production of new 
images; this puts the participant and the image they create at the centre of the research 
(Brunsden & Goatcher). Moreover, Foster-Fishman, Nowell, Deacon, Niever and McCann 
(2005) propose that photovoice not only allows for participants deep reflection on their lives 
and experiences, but also empowers participants and creates a safe climate for the exploration 
of diverse perspectives.  
 
Photovoice, therefore, may offer new insights into the impact that PCOS can have on an 
individual’s quality of life and allow them to demonstrate how they perceive their quality of 
life to be impacted. It may also help further understanding of the condition by providing a 
snapshot of the day-to-day life of women living with this condition. As such, this study aims 
to utilise a photovoice methodology to enable women with PCOS to illustrate their own 
perceptions of quality of life and what this term means to them, and also to explore the 




Participants were recruited via a post on the website of a popular PCOS charity network 
named Verity (Appendix A). According to Wang (1999) participants recruited for a 
photovoice study may be selected according to a specific sampling criterion. Therefore, the 
inclusion criteria for this study were: Participants aged 18 and over, lived in the UK and 
experienced symptoms of PCOS. The invite to participate specified that participants would be 
excluded if they experienced any other long-term or mental illness which was not related to 
PCOS. Upon contact to the researcher participants were asked to confirm that they met the 
inclusion criteria. Thirty-four participants agreed to participate in the photovoice study and 
were sent a study pack, nine study packs were returned. Of those reported, age ranged from 
20 to 45 years old (Mage = 31.5 years) and length of time since diagnosis ranged from one to 
three years (M= 1.8 years). Current prescribed medications taken by participants included the 
Oral Contraceptive Pill (n=3), Cyproterone, a hormonal treatment (n=1), Metenamic Acid, a 
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pain killer (n=1) and Metformin, an anti-diabetic drug (n=1). Supplemental treatments used 
by the women in this study included Vitamin B (n=1) and Valerian Root tablets (n=1). 
 
3.3.2 Materials 
A study pack which contained a disposable 27 exposure camera, an A7 notebook containing 
plain paper, a consent form (Appendix B) and a letter of instructions (Appendix C) was sent 
to participants. The letter of instructions directed participants to fill out the consent form and 
to return it with their study pack; it also reiterated the contact details of the researcher. An 
envelope and an in depth information sheet (Appendix D) were also sent by first class post to 
participants. The information sheet included information such as: the purpose of the study, 
what taking part involved, how their data would be stored and guidelines on what to 
photograph, for example no inappropriate images. Return postage and a pre-printed return 
address on a sticky label were also included in the study packs.  
 
The majority of previous photovoice research in health has used disposable cameras 
(Aubeeluck & Buchanan, 2006; Baker & Wang, 2006; Moffitt & Vollman, 2004; Thompson 
et al., 2008; Valentine & Knibb, 2011; Wang & Pies, 2004; Wiersma, 2011) due to their ease 
and cost effectiveness. However, the choice of a disposable camera was also guided by the 
researcher’s preference (Wang, 1999) as it allows for images to maintain a consistent size and 
format, and it allowed for ease of use by the participants.   
 
3.3.3 Procedure 
In previous photovoice research after the photographs have been developed, researchers 
conduct an interview with the participants about the images produced. However, as Brunsden 
and Goatcher (2007) state, interviews can follow the researcher’s agenda. Wang (1999) 
suggests that researchers may tailor photovoice, as long as the application of photovoice is 
characterised by a three stage process of selecting, contextualising and codifying.  
 
The present study asked participants to write in notebooks and make diary entries in order to 
limit potential researcher bias. Researcher bias is apparent in traditional qualitative data 
collection methods such as interviewing, as the researcher becomes the instrument through 
which data is collected (Poggenpoel & Myburgh, 2003). Poggenpoel & Myburgh (2003) 
suggest that this can lead to researcher bias particularly if the researcher is a member of the 
population under study. However, the use of notebooks allowed for the data to be 
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contextualised by the participant and allowed the participant to highlight the information they 
felt was important, rather than answering questions at the request of the researcher which 
may have presented a second-hand account of the participant’s reality (Merriam & Tisdell, 
2016). As Wang and Burris (1997) state “what researchers think is important may neglect 
what the community thinks is important” (p.372). Notebooks, therefore, allowed for data 
collection to take place with minimal guidance or interference from the researcher.  
 
Participants were sent study packs via the postal system. Participants were instructed that 
they had one week to take any photograph they wished. This time frame allowed the 
participants to record a detailed account of their daily activities over a short period of time 
(Milligan, Bingley & Gattrell, 2005). Participants were also told that there were no right or 
wrong answers. Participants were not given any instruction on how to use the camera or what 
to take pictures of, besides the research overview to explore impact of PCOS on quality of 
life. Participants were also asked to write a diary entry for each photograph taken in the A7 
notebook. Again, participants were not given any instruction on what to write in the diary 
besides being told that the purpose of the diary was to put the photograph just taken into 
context and to tell the researcher more about it. This allowed for a minimum of interference 
on behalf of the researcher (Catalani & Minkler, 2010). 
 
Participants were informed that should they not use all 27 exposures of the camera within the 
given week then they were to still send the camera back with the study pack. Participants 
were also informed that they should send the consent form back with the disposable camera 
and the A7 notebook. Participants were then required to return the study pack, excluding the 
letter to participants and information sheet. All participants were sent a reminder email to 
send the camera back approximately two months after the first study pack was posted. Upon 




Research complied with The British Psychological Society’s ethical guidelines (2009, 2010) 
and ethical approval was obtained from the Psychology Research Ethics Committee at the 




Participants were required to give informed consent. Participants were asked for consent to 
use verbatim quotes from diary entries and they were aware that they would remain 
anonymous. Participants were also reminded of their right to withdraw from the research at 
any time up to three weeks after taking part, without giving a reason for doing so.  
 
Participants were also informed that, should they wish to take any photographs of people, 
they were to gain fully informed verbal consent first. They were also informed that should 
they take any photographs of people, they would not be republished and would only be used 




The diaries were analysed using an inductive thematic analysis (Braun & Clarke, 2006) and 
followed the six steps recommended by Braun and Clarke (2006): familiarization with the 
data, generation of initial codes, searching for themes, reviewing themes, defining and 
naming themes, and writing the final report. The analysis was primarily undertaken by one 
author. The final themes were reviewed by all authors alongside diary entries and 
photographs to ensure that all were in agreement that the themes were an accurate 




The participants in this study experienced a variety of PCOS symptoms including hirsutism, 
obesity, acne, alopecia, irregular or disrupted menstruation, miscarriage and infertility. The 
number of diary entries participants made were varied as were the length of entries. However, 
despite the length or amount, the data was rich enough to provide an opportunity to explore 
how women with PCOS perceive their condition and how it impacts their quality of life. 
Three major themes emerged from the data: Control, (sub-themes Symptom Management and 
PCOS as Controlling) Perception, (sub-themes Feminine Identity and Positive Outlook) and 
Support, (sub-themes The Health Care System, Education and Relationships). Quotes 
displayed are reproduced as written in the participant’s diaries and accompanied with the 






3.4.1.1 Symptom Management 
The theme Symptom Management was discussed by all of the participants in this study. It was 
also the subject of many photographs. Clark et al. (1991) define self-management as the ‘day 
to day tasks’ that a person must complete to control the impact of their condition (p.5) 
reflecting this theme title and its contents. Certainly, many participants had protocols in place 
to help them control their PCOS symptoms, including: hair management routines to control 
hirsutism, daily skin routines to control acne, specific hair washing routines to control 
alopecia and dietary plans and/or exercise to try and control their weight. These are similar to 
those procedures used by individuals to control ongoing illness outlined by Leventhal et al. 
(2003), including: taking dietary supplements; prescribed medications, and over the counter 
medications.  
 
Crete and Adamshick (2011) also reported a similar theme, ‘Gaining Control’, after 
interviewing women with PCOS. They suggest that the women in their study also sought to 
gain control of their PCOS, including their symptoms. They advise that the primary 
importance for their participants was to gain control of their symptoms, through self-
treatment of symptoms such as hirsutism, acne and through weight control. Castillo (2008) 
also reported the theme ‘Lack of Control over Syndrome and its Symptoms’ in their 
qualitative research. Castillo proposes that the participants in her study experienced feelings 
of losing control over their bodies and their condition. Finally, Snyder (2006) also reported a 
theme of ‘gaining control’ when conducting semi structured interviews with women with 
PCOS.  
 
The quote below reveals how the symptom of hirsutism can impact on women with PCOS 
and their daily lives. In this quote Sandra describes how she spends time using hair removal 
methods, in this case using tweezers to pluck hair, in order to stay in control of her facial hair. 
She further demonstrates how this is a continued process which takes place daily, if not more 
frequently by stating that ‘Its neverending.’ Sandra also discusses how the preoccupation 
with her facial hair continues throughout the day, despite the situation, be it ‘at work, at 
home, with friends’. This preoccupation with facial hair is present throughout her daily 
activities. She furthers this by claiming that if she were to find a hair, she ‘cannot rest until its 
gone’, further demonstrating how facial hair and the need to stay in control of it, can infiltrate 
and impact on every aspect of her day. Similar findings were reported by Lipton, Sherr, 
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Elford, Rustin and Clayton (2006) who found that more than a quarter of the participants in 
their study (n=80), which explored the impact of living with facial hair, stated that their facial 
hair was constantly on their mind and 67% of the participants reported checking for hairs in 
the mirror and by touch. 
 
I’ve now spent a good 10 minutes finding new hairs on my chin. I pluck it every single day – 
probably 10-15 hours a day – really thick stubborn black ones. Its neverending. I spend a lot 
of time feeling my chin – at work, at home, with friends. When I feel one that needs plucked I 
cannot rest until its gone. I get a really stubborn one on my shoulder too. Just the one but it 
bothers me SO much that if I can’t pluck it myself I have to get someone else to do it. [Sandra, 
31] 
 
Similarly to the quote above where Sandra says ‘When I feel one’, Kitzinger and Willmott 
(2002) also found that participants with PCOS who took part in their study often mentioned 
the way hairs felt. Sandra also accompanied the above quote with a photograph (shown 
below) of a pair of tweezers. 
 
 




The daily commitment to removing hair displayed in the quote above by Sandra is also 
shown in the quote below by Linda who says that she has to go through a process of hair 
removal ‘everyday’. Moreover, by using the word ‘have’, Linda demonstrates that this 
routine is something which she is compelled to do. She describes how she uses razors and 
tweezers to remove hairs from not only her face but also the rest of her body. Similarly, 
Snyder (2006) reports that all the participants of their research invested time and money in 
treatments in order to control their hirsutism. This included methods such as waxing, shaving 
and plucking with tweezers. 
 
Lipton et al. (2006) also report that almost 40% of the women with PCOS in their study 
reported using one of more methods of hair removal and over half of the participants reported 
putting a lot of effort into facial hair removal. Moreover, Oláh (2004) states that cosmetic 
procedures play an important role in managing hirsutism. Weiss and Bulmer (2011) also 
report that participants used various methods of hair removal to cope with symptoms. In 
Linda’s diary entry (below) she lists the places on her body where she has to remove hair 
from; interestingly however, she chooses to list the areas of her body in a top to bottom list 
rather than in sentence formation, perhaps to further illustrate the extent of her hair growth.   
 









up my nose. 
I use a razor for women, an electric shaver for women and tweezers, I use on my face, neck, 
tummy. [Linda, 45] 
 
In the photo below Linda (quoted above, as written in diary) shows the different systems of 
hair removal that she uses on a regular basis, including two different types of razor and a pair 





Figure 3.2 A pair of tweezers and two hair removal devices taken by Linda. 
 
Similarly to the quote from Linda, Amy demonstrates (in the quote below) how managing her 
symptoms of hirsutism take up her time and energy. She shows that dealing with facial hair to 
her ‘is like a chore’, suggesting that this is a daily, monotonous routine. Moreover, she claims 
that this is something you ‘HAVE’ to do and is not down to choice or eagerness. This is 
reflective of the theme control and how participants in this research felt that they had to use 
hair removal procedures to control their hirsute symptoms of PCOS.   
 
Having to cope with facial hair is like a chore, something you do not WANT to do, but 
something you HAVE to do! [Amy, AU] 
 
Washington (2005) states that participants in their qualitative study reported removal of their 
unwanted hair through similar processes as the participants in this study, including methods 
such as shaving, plucking and waxing. In the photo below Amy shows herself having her legs 
waxed in order to help manage the PCOS symptom of hirsutism. Her accompanying diary 
entry (below) describes how she allocates time and money to this and how, although she 




Ever since the age of 10, I have been getting my legs waxed. I usually have to consider 
getting them waxed every 2 months or so. Although this is an expensive means of eradicating 
the hair from my legs, I find that it is very much necessary. Since I have been getting them 
waxed my dark, thick hairs have thinned out a lot. [Amy, AU] 
 
 
Figure 3.3 Getting her legs waxed, taken by Amy. 
 
Research has found that women with PCOS who suffer from symptoms of hirsutism may 
experience negative feelings of well-being (Archer & Chang, 2004). Moreover, quantitative 
research by Guyatt, Weaver, Cronin, Dooley and Azziz (2004) proposes that excessive hair 
growth in women with PCOS can have a negative impact on their quality of life. 
Correspondingly, this research has qualitatively demonstrated how suffering from hirsutism 
can impact women with PCOS in a negative way. It has, however, expanded on the 
understanding of what it is like to live with, and experience, the symptoms of hirsutism whilst 
suffering with PCOS. 
 
Janssen, Hahn, Tan, Benson and Elsenbruch reported in 2008 that obesity and hirsutism were 
associated with negative aspects of quality of life. Accordingly, symptom management was 
also discussed by participants in terms of weight maintenance and loss. Participants took 
photographs of food, scales and themselves to demonstrate how PCOS, and the associated 
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weight issues, impacted on their quality of life. They also referred to exercising in their 
diaries, as another means to stay in control of their PCOS. Quantitative research has 
suggested that weight gain has the greatest negative influence on health-related quality of life 
in women with PCOS (Jones, Hall, Balen & Ledger, 2008).  
 
In the quote below Stephanie explains that she invests ‘time and energy’ into controlling her 
eating habits, further suggesting that women with PCOS have to be constantly vigilant with 
their diet and nutrition in order to maintain control over their PCOS and in particular the 
symptoms relating to weight gain and obesity.  
 
I spend so much time and energy trying to control my eating in this sea of demands which 
pull me in different directions. [Stephanie, AU] 
 
Amy photographed the food she eats in order to control her weight (below). She also 
discusses, in the quote below, how she attempted to manage her symptoms through diet and 
exercise. In the quote below she describes how she has improved her diet and how she 
exercises regularly in order to maintain control over her weight. 
 
This has led me to take on a fruit and veg diet and very few carbohydrate type foods. 
Unfortu-nately my diet still consists of rather a lot of carbohydrate because that is my staple 
food. But, I manage to outweight the amount I eat through exercising at least 3 times a 





Figure 3.4 A photograph of food, taken by Amy. 
 
 




Sara also decided to photograph food. In this case she photographed bread loaves (above) and 
made a diary entry about food and how she tries to keep carbohydrates to a minimum in order 
to lose weight, she writes: 
 
This represents carbs in general. I know they are an issue & try to keep them to a minimum 
but it doesn’t help my weight. [Sara, AU] 
 
In the quote below Denise also demonstrates how women with PCOS aim to control their 
PCOS symptoms through weight loss. 
 
A lot of my time and energy goes on thinking about food and diet. [Denise, 30] 
 
Both Stephanie and Denise use the phrase ‘time and energy’, demonstrating the extent that 
trying to control their diet and food consumption can infiltrate their daily lives. Similarly, de 
Ridder (2004) suggests that self-care routines in long-term conditions can be a burden on the 
individual due to the responsibility of performing daily tasks associated with managing their 
condition.  
 
One method participants developed in order to keep track of and control their symptoms, 
especially in relation to diet and food consumption was to create food diaries or diet sheets. 
The picture below shows a diet sheet which Denise had stuck to her fridge. By placing this 
diet sheet on her fridge it shows her daily commitment to controlling her weight through an 





Figure 3.6 Diet sheet, taken by Denise. 
 
Denise also used a notebook to keep track of her menstruation, which she photographed 
(below). In the accompanying diary entry she writes: 
 
Notebook with cycle tracking – while trying to get pregnant I became obsessed with my cycle. 
Every twinge or physical change was noted and analysed. I get annoyed trying to work out if 
I am having a long cycle or if I am pregnant. I do usually get bad PMT (eg moody, hungry, 
tired, lethargic, headaches) so if I don’t have these signs then I get hopeful that I might be 





Figure 3.7 Menstruation diary, taken by Denise. 
 
Similarly, Stephanie writes below about how she keeps track of her symptoms through the 
use of mobile phone applications and personalised tracker documents. She states that keeping 
a record of this helps her feel more in control of her body and her PCOS symptoms.  
 
Keeping track of ..bodily functions (fertility, sleep, eating) using tracker sheets and apps on 
my phone helps me to feel .. less like my body is unpredictable/ out of control. [Stephanie, 
AU] 
 
Another form of managing symptoms mentioned by one participant included a ‘daily skin 
routine’. Jessica described in her diary (the quote below) how she managed her acne 
symptoms through using various face washes and creams, often combined with medications. 
Research suggests that acne is frequently seen in women with PCOS (Hill, 2003) and that in 
some cases, it may be the only clinical manifestation of PCOS (Bunker et al., 1989). 
 
This picture shows my daily skin/morning routine. It starts off in the shower with a face wash 
applied with an exfoliating glove to clean the skin. I don’t use soap only infacare (childrens 
wash) on my skin as its very prone to spots/blackheads and anything scented makes it a bit 
grubby. I then (after drying off) put on a blackhead clenser. I apply Nivea as its quite thick…I 
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then put on “wake me up anti fatigue effect and radiant glow concealer to my biggest 
spots/redest areas that are around the nose, chin and more recently neck. [Jessica, 20] 
 
In the quote above Jessica describes her daily skin routine including what products she uses, 
when she uses them and how she uses them. Similarly, Castillo (2008) found that women 
with PCOS in her study also used cosmetic products to control their acne and hirsutism 
symptoms. The photograph below taken by Jessica shows the products that she uses every 
day in order to maintain some control over her acne. It also shows various medications that 
Jessica takes to control her PCOS. 
 
Figure 3.8 Medications and acne treatments, taken by Jessica. 
 
Other participants also regularly took medication to control their symptoms, Amy writes: 
 
I took an image of the pills I have to take to avoid as many PCOS symptoms as is possible. 
[Amy, AU] 
 
Medications and packets of tablets were common subjects of photographs, with six 
participants out of nine taking photographs (which developed) of them. Snyder (2006) 
similarly found that some of the women in their study took medications to help manage their 
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acne symptoms. Similarly, Leventhal et al. (2003) proposed that in order to control long-term 
illness individuals would take dietary supplements, prescribed medications and over the 
counter medications. Photographs of the medications taken by participants on a daily basis to 
try and control their PCOS symptoms are shown in the photographs below. Interestingly, 
each participant decided to take the photograph in a similar manner, with the tablet packet out 
of the box and placed on a plain surface. Each participant also photographed the tablets with 
space around the packet. 
 
 





Figure 3.10 A photograph of the contraceptive pill, taken by Sara. 
 
 
Figure 3.11 A photograph of the contraceptive pill, taken by Sandra. 
 
Quantitative research by Hahn et al. (2005) suggests that obesity, hirsutism and acne are all 




This qualitative research may expand and add to the understanding of what it is like to live 
with PCOS and how many women try to gain control over their symptoms through a 
combination of self-management methods. Moreover, it demonstrates how, for women with 
PCOS, this daily fight for control over symptoms can be time consuming, expensive and 
often unsatisfactory. De Ridder (2004) suggests that controllability of a condition is a key 
factor which influences how individuals experience their long-term conditions. Indeed, 
Helgeson (1992) suggests that perceived control of a long-term condition is a strong predictor 
of adjustment to the condition. 
 
The self-management routines identified by the women in this study are similar to those 
experienced by individuals with other long-term conditions. De Ridder (2004), as identified 
by some participants in this theme, proposes that self-management routines that individuals 
employ to control their long-term condition can be a burden due to the daily tasks related to 
self-management.  
 
3.4.1.2 PCOS as Controlling 
Another subtheme that emerged from the diary entries was PCOS as Controlling. Castillo 
(2008) also discovered that women with PCOS in their study felt a lack of control of their 
PCOS and its symptoms. Moreover, Castillo’s participants suggested that not being in control 
of their lives was unfair. This is demonstrated in the quote below by Lucy who is discussing 
her diet. She describes how she is unable to eat ready-made food in order to prevent her 
symptoms worsening and pain developing. She also explains that she no longer gets to take 
part in activities she enjoys, in this case baking, because she cannot eat anything she bakes. 
 
Ready made stuff is nono, I can literally feel my ovaries stinging in the hours after I have 
ready made stuff. It sucks. For the record, I was epic at baking before I was diagnosed. Don’t 
get to anymore, really. [Lucy, AU] 
 
Similarly, in the quote below participant Helen explains how because of her condition, and 
her hirsutism symptoms, she keeps other people, particularly men, at a distance. Similarly 
Percy et al. (2009) stated that the women in their qualitative research reported feelings of 
isolation. Washington (2005) also discovered that the women with PCOS in their study 
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avoided interacting with people because of their PCOS symptoms leading them to become 
isolated.  
 
Being a woman, your face is very important to you. It’s the first thing someone sees. I have 
been suffering with PCOS for 5 years (only recently diagnosed) 5 years of excess hair, 5 
years single. Because of this I do not let men or anyone else close to me. [Helen, AU] 
 
Research by Keegan, Liao and Boyle (2003) has similarly suggested that many women with 
PCOS who experienced the symptoms of hirsutism avoided activities. In addition Barth, 
Catalan, Cherry and Day (1993) also found that participants with hirsutism avoided social 
situations. 
 
Snyder (2006) found that the women with PCOS in their study were also concerned with their 
lack of control over their ability to become pregnant. Moreover, their participants described 
how it made them feel out of control. Similarly, in this research Jessica explains how she 
feels under pressure to become pregnant. She writes that becoming pregnant for her is like ‘a 
ticking time bomb’, demonstrating the urgency of becoming pregnant for her and the finality 
she perceives if she does not become pregnant by ‘the age of 25’.  
 
However I also see it as a ticking time bomb. And if I don’t get pregnant from the age of 25. 
THAT IS IT. [Jessica, 20] 
 
The sense of pressure and urgency demonstrated by Jessica may be reflective of the PCOS 
symptom of infertility which many women with PCOS can experience (Balen & Rutherford, 
2007). There may be a number of reasons why women with PCOS feel pressured to conceive. 
Fertility declines with age (Dolan & Rudisill, 2015), and women in the UK are only eligible 
for in vitro fertilisation (IVF) treatment up to the maximum age of 43, dependent on the local 
area (NICE, 2013; NHS, 2016) and after trying to conceive for two years (NICE). Those 
women not eligible for treatment, due to the area or age, may pay for private IVF treatment, 
however this is expensive at £5000 per treatment (NHS, 2016). In addition, a successful 
treatment outcome is reduced in women with a higher BMI (NICE, 2013). As such, women 
with PCOS may feel a sense of pressure to conceive whilst young due to the impact of PCOS 
on their fertility, the difficulty maintaining a low BMI because of their PCOS symptoms 
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(Balen & Rutherford), the time needed for trying to conceive and then subsequent treatments 
and also due to the limited resources available to help women in the UK conceive.  
 
Another way in which PCOS could be seen as controlling is through the life changes women 
with PCOS have to make due to the condition for example, in the quote below Lucy describes 
how she is coming to terms with the condition and how she feels having PCOS may impact 
her life in the future.  
 
I have friends who are getting married soon, and it’s starting to dawn on me that I might 
have to take a path in my adult life different to the family/kids plan the rest of my friends are 
keen on. I was allergic to the birth control that let me have normal sex drive, and for pretty 
obvious reasons I’m not holding out on having kids. I’m scared that in the next few years I’ll 
become pretty isolated as my friends pair up and go through things I can’t relate to. [Lucy, 
AU] 
 
The quote above shows how when a woman is diagnosed with PCOS it can be controlling. 
Not only do women with PCOS have to come to terms with the impact of PCOS on their 
fertility but also how their future plans and life may change due to the condition. This change 
in an individual’s thoughts or future plans has not previously been discussed in the published 
PCOS literature however it is important for health professionals who work with women with 
PCOS to recognise this in order to fully support them.  
 
Lucy (in the quote above) also discusses the impact of PCOS on her friendships and 
expresses concern over becoming socially isolated in the future, similarly to the quote 
displayed earlier by Helen. In the quote below, Stephanie also describes how she has become 
and continues to become isolated from friends. She explains that relationships are 
‘complicated’ to her as the symptoms of PCOS can change the accepted expectations of 
relationships such as having children. 
 
In part that’s because the symptoms of PCOS make me feel undesirable and also because it 
makes all the taken-for-granted expectations of relationships (settling down and having kids 
gets all the more complicated) ….Because relationships seem so complicated to me, spending 
time around couples can make me feel quite jealous. Also as my friends become increasingly 




Once again, we see in the quote above how having PCOS can alienate women from their 
social groups due to their PCOS symptoms, such as infertility and in this way PCOS could be 
seen as controlling for the women who experience it. 
 
3.4.2 PERCEPTION 
3.4.2.1 Feminine Identity 
The theme Feminine Identity has previously been discussed in the published literature. Most 
notably by Kitzinger and Willmott (2002) who explored the experience of PCOS from a 
feminist perspective. One of their main conclusions was that women with PCOS felt 
challenged in their perception of self as feminine. Moreover, they felt that women with PCOS 
perceive themselves as further away from the ‘feminine’ ideal. 
 
In the quote below Linda describes how having symptoms of PCOS such as irregular periods, 
hirsutism and carrying excess weight make her feel like she is ‘not a woman’. She furthers 
this by referring to her weight, and in particular her stomach, as being like a ‘man’s beer 
belly’. Participants in Kitzinger and Willmott’s (2002) research also indicated that they felt 
like they were not a ‘normal’ or ‘proper’ woman. Their participants also often described their 
excess hair symptoms using male terminology. Similarly, in the quote below, Linda uses 
male terminology to describe how they feel about their excess weight. Masculine language or 
references are also used throughout the participant’s diaries either through referring to 
themselves or to their symptoms. For example ‘shaving of the moustache’, ‘I’m rocking the 5 
O’Clock shadow tonight’ and ‘Got a nice bit of stubble going on now’.  
 
Makes me feel im not a woman scribble – no periods – which makes me wonder what is 
happening inside of me – hairy – scribble fat around the middle like a man’s beer belly even 
though I go gym or swimming every week [Linda, 45] 
 
Helen, in the quote below, also compared the excess hair growth she experiences as a result 
of her PCOS to that of a man. 
 
Especially my face. It’s embarrassing, uncomfortable, no woman wants hair on their face 




Similarly to these findings, Snyder (2006) found that women with PCOS in their study 
expressed how symptoms, primarily hirsutism, impacted on their feelings of themselves as 
female, one participant in their study states ‘You’re feeling not as womanly’ (p.388). 
Additionally, research by Keegan et al. (2003) also found that women with PCOS who 
suffered with hirsutism felt unfeminine. Several of the participants in this study also referred 
to their femininity, or lack of it. For example, in the quote below by Amy, she states that she 
feels ‘less female’ because of her hirsutism symptoms. Moreover, she explains how this is a 
regular occurrence for her and it impacts on her mood and self-esteem. 
 
Today, I feel quite self-conscious and less female than usual because of my facial hair 
growth. I often have days like these and it really gets me down [Amy, AU] 
 
Landmark and Wall (2002) suggest that in women who have undergone a mastectomy due to 
cancer, loss of a breast due to cancer could result in a loss of femininity. Similarly, Helms, 
O’Hea and Corso (2008) suggest that as women with breast cancer face weight gain, hair loss 
(both also similar symptoms to PCOS) and loss of a breast(s), they may not meet society’s 
ideals of what a woman should look like, and consequently may not feel feminine after 
treatment. In a study exploring body image in the first months after treatment for breast 
cancer in young women, Fobair et al. (2006) found that women felt less feminine (7%). 
Similarly, the women with PCOS in Kitzinger and Willmott’s study (2002) said that they felt 
unfeminine due to their irregular periods caused by PCOS. This is similar to participants in 
this study who felt less feminine due to their PCOS and its impact on their ability to meet the 
‘typical’ role of a woman. This is demonstrated in the quote below by Jessica who discusses 
the impact of PCOS on her perception of self as a woman in regards to her ability to 
conceive. 
 
When it does I feel like frag-ments of a woman. Like I have the body, the bits but they just 
don’t work. [Jessica, 20] 
 
By using the term ‘frag-ments of a woman’ and also by claiming that her body does not 
‘work’, Jessica compares herself to something that is broken. Similarly, Denise discussed 
how she takes Valerian Root tablets, described to her as a ‘natural sedative’, after recently 
experiencing a miscarriage, to help her sleep, instead of thinking about the impact PCOS has 




 Since I had a miscarriage 2 months ago they have helped me to sleep rather than lie awake 
wondering if my deficient womb will ever carry a child. [Denise, 30] 
 
Similarly to the quote from Jessica, it appears that women with PCOS may perceive 
themselves as being broken or as lacking something. She writes that her womb is ‘deficient’, 
expanding the perception women with PCOS have of themselves being broken or damaged.  
Lucy similarly wrote: 
 
Being able to do reasonably well….makes me feel not as useless. I know that’s a strong word, 
but I’m a girl that doesn’t function as a girl. [Lucy, AU] 
 
In the quote above Lucy also refers to herself as not functioning or working correctly. She 
adds that being able to do well, in this case she is referring to her work at college, makes her 
feel not as ‘useless’, suggesting that the impact of PCOS on the menstrual and reproductive 
system renders her less valuable or suitable. Likewise, Kitzinger and Willmott (2002) found 
that the women in their study experienced their menstrual periods as abnormal and that this 
influenced their sense of self as a woman. 
 
This feeling of being different or abnormal was also mentioned by Amy (in the quote below) 
when she describes how she feels about taking medication to ‘avoid as many PCOS 
symptoms as possible’. 
 
This course of action is unnatural for a woman and it gets me down that my body will never 
naturally produce the right levels of hormones. [Amy, AU] 
 
Once again we see how women with PCOS can perceive themselves as being different from 
other women. In this case, Amy’s perception is distorted by the very act of taking medication 
in order to gain control over her hormones and therefore her PCOS. It is seen as abnormal for 
her to take tablets or medications to achieve what she believes to be natural for a woman to 
experience, in this case to control her symptoms of hirsutism and weight gain. Qualitative 
research has similarly revealed that women with PCOS are aware that taking medications to 
gain control of the menstruation is artificial and as the participant above mentions, unnatural 




3.4.2.2 Positive Outlook 
The theme Positive Outlook featured in four of the nine participant’s photographs or diary 
entries. Many participants perceived their situation in a positive way; they described how 
certain situations or behaviours helped them to develop a more positive outlook. Snyder 
(2006) briefly discusses how a positive outlook was important to some of their participants 
with PCOS. However, whilst Snyder (2006) has touched upon positivity in her research, the 
theme Positive Outlook has not been discussed in depth by any previous qualitative or 
quantitative research.  
 
In the quote below Stephanie explains that keeping a ‘positive’ diary helps her to focus on the 
positive aspects of her life.  
 
The positive diary my (CBT) counseller suggested to me last year helps me focus on the 
positive parts of my life. [Stephanie, AU] 
 
Stephanie also photographed her college card (below) and discussed (in the quote below) 
how doing everyday activities, such as going to college and interacting with others also helps 
her to feel positive. 
 
College – interacting with others during break or group work activities helped me feel more 




Figure 3.12 A college ID taken by Stephanie 
 
Similarly, Amy writes in the quote below that swimming helps her to feel that she is 
‘combating’ her PCOS and in turn this helps her to feel more positive. 
 
Swimming, somehow, makes me feel as though I am combating my PCOS slightly and this 
makes me feel quite positive on my outlook. [Amy, AU] 
 
Hefferon and Boniwell (2011) argue that individuals who develop optimism may engage 
constructive coping such as acceptance and positive reframing. Positive reframing has been 
reported to be a frequently used coping strategy for people with diabetes (Tuncay, Musabak, 
Gok & Kutly, 2008). Additionally, Lutgendorf et al. (2002) found that women with 
gynaecological cancer, who coped using positive reframing, reported better quality of life at 
one year follow-up than those who did not. 
 
Positivity was also discussed by Denise who had recently suffered a miscarriage. In the quote 
below she explains how a story in a newspaper about miscarriage had been upsetting for her 





 Article on miscarriage in today’s metro – upset me this morning on first sight but on 
reflection it is a positive story not to give up hope. [Denise, 30] 
 
 
Figure 3.13 An article on miscarriage in the newspaper, taken by Denise. 
 
Snyder, Lopez and Pedrotti (2011) suggest that for an individual to continue hoping to 
achieve a goal, then there must be sufficient value attached to the goal. They add that hope is 
thought to strengthen goal striving, especially when the goal is at least somewhat in doubt 
and viewed as very important, such as Denise’s desire to conceive with PCOS.  
 
Sara also decided to take a photograph of a baby bottle to represent her ‘joy at being able to 
conceive naturally’, she writes: 
 
Baby Bottle – This represents my daughter & the joy at being able to conceive naturally & 





Figure 3.14 A toy baby bottle, taken by Sara. 
 
3.4.3 SUPPORT 
3.4.3.1 The Health Care System 
Frustration with support, or lack of it, from the health care system was mentioned in the 
diaries by several participants. A number of qualitative studies have previously demonstrated 
that women with PCOS felt frustrated by, and angry about, the lack of information and 
support provided by health care professionals (Crete & Adamshick, 2011; Kitzinger & 
Willmott, 2002; Snyder, 2006; Washington, 2005; Weiss & Bulmer, 2011). The health care 
system and the support it provides was also discussed by Castillo (2008) who reports that 
women with PCOS often felt that they were at the mercy of their health care providers and 
that there was a lack of information available to them at the time of diagnosis.   
 
Snyder (2006) similarly found through an exploration of the lived experience of PCOS that 
women with PCOS felt frustrated during the diagnosis process. Many of the women in their 
study felt that the information given by health professionals was inadequate or that the health 
professionals did not allocate enough time to them at the time of diagnosis. Participants in 
research by Crete and Adamshick (2011) also expressed frustration at having to see several 
health care professionals in order to get a diagnosis. Similarly, in the quote below Jessica 
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describes how she was received by health care professionals when she first approached them 
about her symptoms. She stresses that she had to ‘push’ to get a diagnosis and regularly ‘visit 
the doctor’. She goes on to describe how, even after receiving a referral, it took several years 
for her to get the tests that enabled her to be diagnosed.  
 
The first reaction and advice I got from doctors was that it was probably puberty, the spots 
were puberty, the migraines and so on. I was also told to go on a diet. I had to push and visit 
the doctor regullary before even getting refered, and even then it took over 2 years to get any 
tests other than bloods and iron done. [Jessica, 20] 
 
Crete and Adamshick (2011) also reported that women with PCOS in their research were 
often frustrated with their interactions with health care providers; this then resulted in a lack 
of confidence in the health care system. Additionally, participants commented on the lack of 
attention to them and their symptoms by health care providers and many were exasperated 
that their treatment was symptom based. This aggravation with symptom based treatment was 
also expressed by a participant in this study, Lucy writes: 
 
Doctor only really offers to address 1 symptom at a time – it’s like “You can either not look 
like a monkey under your clothes, or have a greater chance of starting a family later. Pick 
one. [Lucy, AU] 
 
Frustration with the health care system and health service providers has also been reported by 
Washington (2005) who explored the effects of PCOS on the daily activities of women in the 
USA. Washington also found that women with PCOS often expressed frustration with the 
medical community and that participants experienced symptoms for many years before 
receiving a diagnosis. Moreover, participants expressed frustration at the lack of knowledge 
of health care providers, ultimately leading to a lack of trust in the medical community. 
Similarly, in the quote below, Jessica discusses how health care professionals, including 
doctors and counsellors, have been unable to answer her questions about the condition. 
 
I wander in the weight has always been a result of PCOS or if the PCOS was caused by 
sudden weight loss in my early teens. This is something that no one has been able to answer 




Another issue with health care providers, reported by Washington (2005), was the lack of 
cooperation for their participants, from their insurance companies, relating to the costs of 
medications and availability of some treatments. This is reflected in the quote below by Amy 
who describes her concern that she would not be eligible for laser hair removal treatment 
provided by the National Health Service. 
 
Recently I have been considering getting laser hair removal treatment on the NHS but I very 
much doubt that my issues will fit the necessary criteria to get it on the NHS. [Amy, AU] 
 
The findings of this research add to a growing selection of literature which through 
qualitative exploration of the experience of PCOS has found that women with the condition 
are unsatisfied with the care they receive from their health care providers. This discontent 
with the health care system is widespread, impacting on women in different ways and with 
different providers. Moreover, participants in this study expressed concern that the treatments 
they desired, in order to control their symptoms, would not be available to them. Overall this 
theme demonstrates that women with PCOS do not feel that they are supported sufficiently 
by the health care system and because of this, begin to educate themselves. 
 
3.4.3.2 Education 
This lack of support from health care professionals led many of the participants to self-
educate. Several women commented on the ways that they had educated themselves about 
their condition or how to manage their symptoms of PCOS through the use of books and the 
internet. They accompanied these diary entries with pictures of books about PCOS or in one 
case, a picture of the computer and the online site they found useful in helping them educate 
themselves about PCOS.  
 
In the quote below Lucy demonstrates how women with PCOS in this study sought to self-
educate themselves about their condition through the use of books and the internet. She 
shows this by choosing to take a photograph (below) of the books she uses to not only teach 






Some books I got to try help. I learned a lot through these, especially the GI diet book – it 
was recommended I look into it, but it’s kind of tricky to find informations that’s consistent 
sometimes. Doctors were asked about it, and they referred me to Waterstones. Thank you, 
NHS.At a bit of a loss for what to do with my diet. I’m underweight, and looking both online 
and in book like these … [Lucy, AU] 
 
 
Figure 3.15 Books on PCOS, taken by Lucy. 
 
Lucy explains that she has learnt a lot through using the books photographed. However, she 
writes that the information available is not consistent and that this means gaining information 
or an insight, therefore, is difficult. Moreover, she demonstrates how hard it is to find 
educational material by mentioning how even the health professionals who she approached 
about the condition referred her to books available through a national book store. This further 
demonstrates how difficult it is for women with PCOS to find information about the 
condition. Interestingly, the relationship between the health professionals and women with 
PCOS connects with another sub-theme, The Health Care System. 
 
Below is another photograph taken by Jessica featuring a ‘PCOS diet book’. In the 
accompanying diary entry Jessica describes the importance of this educational book to her. 
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She claims it is the ‘bible for PCOS’, indicating how useful and important this book has been 
for her and perhaps even how often she refers to it. Moreover, she explains how she has used 
this book to try and educate her own family about her condition as well as educating herself 
on PCOS. 
 
PCOS Diet book. Do I really need to say much about this. This is the bible for PCOS 
sufferers. Good book with positive information I would definetly recommend it. I made my 
mum read this to try and get her to understand me, my moods and my eating habits a little 
better. [Jessica, 20] 
 
 
Figure 3.16 A book on PCOS, taken by Sandra. 
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Sandra also described how she made use of an educational diet book which she found 
through the recommendation of a magazine she was reading, she writes: 
 
I came across a recommendation for this book in Red magazine and thought I should give it a 
go. I very specific detailed diet to naturally improve symptoms of PCOS. [Sandra, 31] 
 
These findings mirror those of Crete and Adamshick (2011) who found that several of their 
participants with PCOS used online resources or printed materials in order to educate 
themselves about their condition; with more than one participant in their study discussing 
how they had used the internet to gain information. Weiss and Bulmer (2011) also reported 
that participants would seek information on the internet. Moreover, their participants felt that 
self-education helped them gain control of their symptoms. Similarly, Kitzinger and Willmott 
(2002) reported that participants of their qualitative study had conducted their own research 
into the condition as did the participants in this study. 
 
Another way participants educated themselves, which has also not previously been reported 
in the published literature, was through attending ‘PCOS conferences’, as discussed by 
Jessica below. This refers to an annual conference run by the PCOS charity, Verity, where 
women with PCOS are given the opportunity to attend a conference featuring several talks 
about their condition.  
 
I have learnt by attending PCOS conferences that eating is very important, especially eating 
the right things. So I try to allow 1 treat a day. [Jessica, 20] 
 
Lucy discusses in the quote below how she gained information and educated herself about her 
medication through online social networking sites, in this case referring specifically to 
Tumblr, an internet blogging site. The use of online blogs and social networking websites has 
not previously been reported in the published literature for PCOS but the use of dedicated 
online support groups is becoming more popular for a variety of conditions, including PCOS 
and infertility (Holbrey & Coulson, 2013; Malik & Coulson, 2010 ). She also demonstrates 
how women with PCOS can act as educators for other women with the condition. The 





I’ve learned so much on tumblr- way more than through doctors. I’m afraid to take 
Metformin (though I know it’s coming) because it can make you feel so sick, and it was only 
trhough tumblr that I was able to hear about alternatives. Talking to other women with it in 
INVALUABLE. [Lucy, AU] 
 
The quotes and photographs displayed demonstrate how women with PCOS seek to educate 
themselves through the use of books, social networking and media sites and through 
attending conferences in order to improve how they live with their condition, understand it 
and manage their symptoms: all of which aide in improving their quality of life. Similar to 
the women with PCOS in this study, Holman and Lorig (1992) suggest that whilst it is the 
health-care professional’s role to facilitate an individual’s self-management, in long-term 




This use of websites and other media sources also helped one of the women in this study to 
communicate with other women with PCOS. Stephanie demonstrated this by taking a 
photograph (below) of her computer screen and the Verity website. Stephanie accompanied 
this photograph with a diary entry which describes how she feels ‘less isolated’ when using 
websites and when watching television shows which may feature other women with PCOS.  
 
Finding out about other people’s experiences through media like the verity website & 
channel 4’s food hospital, helps me feel less isolated and to realise that there are people who 
suffer more than I do. I also like how the disccusio boards and local groups (verity) mean I 
can talk to other people who actually ‘get it’. Although you do get a few strange looks when 






Figure 3.17 A picture of the verity website on a computer screen, taken by Stephanie. 
 
Women with PCOS often felt that their condition impacted on their relationships with other 
people. The theme of relationships has not previously been explored in any depth by the 
published qualitative literature looking at PCOS. Previous research exploring the impact of 
online support for women with PCOS found that women with PCOS derive benefit from 
using dedicated online support groups and realising that they are not alone (Holbrey & 
Coulson, 2013). Additionally, Holbrey and Coulson suggest that using online support groups 
can also benefit in terms of accessing information and advice which may not be forthcoming 
from health care professionals. Similarly, Weiss and Bulmer (2011) found that women with 
PCOS accessed dedicated online support groups in order to gain information. Chung (2013) 
also argues that individuals who are dissatisfied with the support they receive offline, are 
more likely to prefer social interaction in online support groups. The use of the Verity 
website by participants in this study supports the findings of previous research (Holbrey & 
Coulson) and suggests that future research should explore how women with PCOS make use 




Some of the women in this study took photographs of their partners, and some of their pets, 




Figure 3.18 A photograph of their wedding ring, taken by Sara. 
 
In the quote below Sara describes how she perceives the impact of her PCOS on her husband. 
She explains that because PCOS negatively affects her in terms of her weight and self-
perception, this then passes on to her husband whom she finds it difficult to accept 
compliments from, suggesting that having PCOS causes friction between herself and her 
husband even when her husband is complimentary. Sara accompanied this diary entry with a 
picture of her hand and wedding ring (above). 
 
This represents my husband. My PCOS affects him because my weight affects me & how I 
feel about myself. It’s hard to feel sexy & accept compliments from him when I’m nearly 18 
st. [Sara, AU] 
 
Denise also wrote in her diary about her husband, as shown in the quote below. However, 
slightly differently to Sara, Denise describes how her husband supports her. She explains how 
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her husband supports her through ‘patience and calmness’ and optimism about their chances 
of conceiving and reassuring her of his continued love despite PCOS, also reflecting the 
Positive Outlook theme.  
 
My husband is a wonderful support to me and bears all this PCOS stuff with patience and 
calmness. He remains optimistic about our chances of having a child together. He always 
says he loves me no matter what. I am immensely grateful to him. As for the cat, he is our 
“furry baby” and provides comfort and cuddles! [Denise, 30] 
 
Denise also mentions in the quote above that their cat is their ‘furry baby’, suggesting that 
although Denise may have trouble conceiving due to her PCOS symptoms, her pet acts as a 
potential surrogate child who ‘provides comfort and cuddles’. Linda also took a photograph 
of their pet dog (below) suggesting that having a pet may have an impact on her quality of 
life. The notion of pets acting as a support system for women with PCOS has not previously 
been reported in the published PCOS literature. 
 
 




Previous research suggests that having a pet may be beneficial to an individual’s health 
(Antonacopoulos & Pychyl, 2010; Bonas, McNicholas & Collis, 2000; Jennings, 1997). This 
is supported by Allen, Blascovich and Mendes (2002), who in a study exploring the impact of 
pets on cardiovascular activity, found that people with pets had lower heart rates and blood 
pressure levels. Allen et al. (2002), therefore, propose that individuals perceive their pets as 
important, supportive parts of their lives.  
 
Within long-term condition management, Brooks et al. (2012) explored the impact of pets 
and their role, suggesting that pets provide a specific and significant role in long-term 
condition management, and are not substitutes for human relationships. Pets were deemed to 
provide unconditional support and companionship that was not always apparent in human 
interactions. Ryan and Ziebland (2015) suggest that an individual’s relationships with their 
pet can be downgraded or overlooked in qualitative research, but that pets are important 
agents in the health experiences of some individuals and can offer unequivocal support. 
Moreover, Allen (2003) suggests that individual’s describe their pets as important and 
cherished family members, as can be seen by Denise in the quote above.  
 
In the quote below Jessica describes a situation where someone she considered a friend was 
un-supportive when seeing stretch marks on her stomach which were a result of losing the 
excess weight many women with PCOS gain. This demonstrates how people can lack 
understanding of the condition and its impact and how, in turn, this can be unsupportive to 
women with PCOS. 
 
My lowest point was when a boy I thought was a friend when he saw my stomach went “ew 
oh my god it looks like youve had a kid.” No – ive been fat and lost a lot of weight. [Jessica, 
20] 
 
Radley (2004) suggests that when an individual lives with long-term illness, family and 
friends are likely to offer help. However, individuals with long-term illness may ‘cover up’ or 
conceal their condition from others, also known as ‘passing’ (Charmaz, 1997; Friedman, 
2002). Consequently, they may have to decide who to disclose their condition to, and when to 
do this, in order to maintain these relationships. Similarly, Charmaz (1997) suggests that 
people with long-term illness consider what they should tell other people, and what they need 
103 
 
to tell other people. Indeed, Radley advises that ‘the price of the healthy person’s compassion 
is the concealment of things by the afflicted, things that could be considered abhorrent’ 
(p.158). Moreover, de Ridder (2004) suggests that friends may have problems when 
responding to the altered condition of someone with a long-term illness. This reflects the 
experience of Jessica, detailed above, whose friend was unkind to her upon disclosure of her 
stretch marks. 
 
The quotes and photographs displayed demonstrate how women with PCOS can feel about 
their relationships and the impact of these on their quality of life, or alternatively, how their 
PCOS may impact their relationships. Many aspects of this theme have not previously been 
reported in the published literature and need to be further explored in order to gain a better 
understanding of how women with PCOS experience their relationships.   
 
3.5 Discussion  
This research explored the impact of PCOS on quality of life from the participant’s 
perspective and produced three super ordinate themes: Control, (sub-themes Symptom 
Management and PCOS as Controlling) Perception, (sub-themes Feminine Identity and 
Positive Outlook) and Support, (sub-themes The Health Care System, Education and 
Relationships). These findings shed new light on the perceived positive aspects of living with 
PCOS and the supporting role that pets; online support groups and social networking 
websites play for women with PCOS. 
 
The findings in this study mirror those of previous research in long-term conditions, in that an 
individual’s ability to control their condition can influence how they experience it (De 
Ridder, 2004). The theme of Control particularly reflected previous research which suggests 
that self-management routines are important for individuals to feel in control of their 
condition (De Ridder; Leventhal et al., 2003). In addition, Barlow et al. (2002) suggest that 
an individual’s ability to monitor their condition is necessary to maintain a satisfactory 
quality of life. Moreover, Barlow et al. (2002) suggest that self-management approaches are 
made up of several components including: information, drug and symptom management, 
management of psychological consequences of the long-term condition, life style, social 
support and communication; although these categories are not mutually exclusive. Each one 
of these aspects of self-management was evident in this study from gaining information to 




Barlow et al. (2002) suggest that due to the self-management aspects of a condition, 
responsibility for the management of a long-term condition will gradually change from that 
of the health professional, to the individual. Furthermore, Clark et al. (1991) suggest that for 
an individual to successfully manage their condition, they must have sufficient knowledge of 
the condition and how to manage it. Moreover, Friedman (2002) suggests that when an 
individual with a long-term condition seeks information around their condition, this can be an 
adaptive coping method. However, should the individual insist on information which health 
care professionals cannot provide they can become dissatisfied with the process of 
information seeking, the coping technique then becomes maladaptive. This was reflected in 
the findings of this study through the theme Support and particularly the sub-themes of The 
Health Care Professionals and Education, whereby participants in this study sought to 
educate themselves on their condition in order to manage and control it, often due to 
dissatisfaction with the information provided by their health care professional.  
 
As mentioned, this research highlighted the lack of support the participants received from 
health care professionals, as discussed in previous PCOS literature, (Castillo, 2008; Crete & 
Adamshick, 2011; Holbrey & Coulson, 2013; Kitzinger & Willmott, 2002; Snyder, 2006; 
Washington, 2005). This lack of support often led the participants to educate themselves 
using books and the internet. Whilst this research is the first study within the PCOS literature 
to report that women with PCOS use online blogging websites such as Tumblr to gain 
information and form relationships with other women, the act of searching for information 
and gaining support from others is not new. Certainly, Friedman (2002) suggests that a 
request for reassurance from others is a type of coping technique which can be adaptive, as 
talking to others can be supportive, but also maladaptive should the requests for reassurance 
become excessive. Leventhal et al. (2003), has similarly reported that individuals with long-
term conditions make use of treatment suggestions made by friends or acquaintances over the 
internet. Similarly, Holbrey and Coulson (2013) found women with PCOS use dedicated 
PCOS online support groups to access information and advice, and connect with other 
women with PCOS. However, Moorhead et al. (2013) suggest that whilst social media, such 
as Facebook and blogging websites, bring a ‘new dimension’ to health care, health 
information exchanged on social media ought to be monitored for quality and reliability of 
the health care information being disseminated. The use of social media by participants in 
this study could therefore be problematic for individuals who may receive wrong or 
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inadequate information either from blogging websites such as Tumblr (used by one 
participant in this study) or from other people on social networking sites (such as Facebook).   
 
Due to the risk of patients engaging with inaccurate information on the internet, McMullan 
(2006) suggests that health care professionals should guide patients to reliable and accurate 
health websites and repositories of health information. This provision of information from the 
health care professional to the patient is known as the ‘internet prescription’ (Gerber & Eiser, 
2001). It would be sensible, therefore, to suggest that health care practices and professionals 
introduce websites which would allow their patients to access correct information about their 
PCOS and enable them to access an area in which they could discuss their condition with 
other patients. Moreover, input from a health care professional to this environment would 
enable women with PCOS to feel supported by their health care professional; something 
which the participants in this study felt was inadequate. 
 
This study also found that women with PCOS who experienced the symptoms of hirsutism 
and fertility issues felt like they were not meeting traditional feminine ideals. In the wider 
literature, Hirsch and Hirsch (1989) found that women who experienced infertility perceived 
themselves as more masculine than controls and experienced greater discontent and 
emotional investment over time than their partners. Furthermore, they found that some 
women who experienced infertility may have felt unfeminine and incomplete, as was 
reported by participants in this study and previous PCOS research (Kitzinger & Willmott, 
2002). Callan and Hennessey (1989) explored perceptions of women with infertility issues 
(both explained and unexplained) in comparison to women who were mothers and those who 
were voluntarily childless. They suggest that those women who experience infertility may 
present with a heightened sense of femininity, by which they embody the traditional roles 
associated with being a mother, demonstrating an increased perception of motherhood and its 
relation to being feminine. As a result, Callan and Hennessey suggested that women who are 
experiencing infertility ought to be counselled about their perceptions of a childless lifestyle. 
Similarly, women with PCOS who are experiencing symptoms of infertility and feel that their 
feminine identity is threatened, could receive support from health care professionals with 
regards to their identity without children. 
 
This study also highlighted how women with PCOS retained a positive outlook despite living 
with their condition and its symptoms. It demonstrated how women remained hopeful and 
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optimistic about their future living with PCOS in the face of uncertainty; particularly with 
regards to future fertility. Research has previously suggested that optimism is a significant 
predictor of positive health outcomes (Rasmussen, Scheier & Greenhouse, 2009). Indeed, Litt 
et al. (1992) found that for women undergoing IVF, a fertility procedure often undertaken by 
women with PCOS, the participants who were most optimistic were the least distressed after 
unsuccessful fertilisation. Bleil et al. (2012) similarly report that being pessimistic may be a 
risk factor for IVF treatment failure. This suggests that being optimistic may be advantageous 
for women with PCOS who are suffering with infertility and implies interventions which 
promote hope and optimism may be beneficial. However, the longer term benefits of 
optimism are less clear (Cohen et al., 1999; Segerstrom & Sephton, 2010) and so the long-
term effects of having a positive outlook with no improvement need to be examined. 
 
The number and length of diary entries made by participants varied from one A4 page to 17 
A4 pages (single-side, wide margins). This variety in diary entries is discussed by Braun and 
Clarke (2013), who suggest that this is to be expected when asking participants to keep 
diaries as some participants may provide ‘rich narratives’ and others may provide ‘little 
affective commentary’ (p.151). Elliot (1997) suggests that participants may become more 
confident when making diary entries over time. As such, future research employing a 
researcher-solicited diary should consider extending the data collection period to allow 
participants to become more comfortable with the process of making diary entries.  
 
The use of diaries in this research also allowed the researcher to collect data whilst being 
minimally intrusive (Alaszewski, 2006). Moreover, Alaszewski proposes that diaries allow 
the participants to record what they consider important and relevant, including events, 
activities, interactions and feelings. Bolger, Davis and Rafaeli (2003) similarly suggest that 
diaries allow participants to record their daily lives in a natural context, enabling the 
researcher to explore the participants experience in a way that traditional methods do not 
allow. Using diaries, therefore, enabled an investigation into how women with PCOS in the 
UK perceived and defined their quality of life, with minimal researcher interference.  
 
Several participants created entries in their dairies which referred specifically to photographs 
they had taken; however, upon development of the camera there were no associated 
photographs. It can be assumed that the photographs either were not taken properly or failed 
to develop. This issue, however, does demonstrate the advantage of asking participants to 
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complete diary entries for photographs rather than asking them about photographs at a later 
date which have been developed, as in previous research (Frith & Harcourt, 2005). Moreover, 
Thompson et al. (2008) state that by carrying out photovoice research at two different time 
points (time of photograph and time of interview about photograph), many participants had 
forgotten why they had taken the photo. In this way researcher-solicited diaries allow the 
researcher to see the photographs in an accurate context reducing retrospection and recall bias 
(Alaszewski, 2006; Bolger et al., 2003).   
 
There were limitations with this study; primarily, the attrition rate for this research was high. 
A large sample of participants were recruited and sent study packs (N=34) and only nine 
participants returned their packs, despite reminder emails. A number of participants also 
stated that they had returned completed packs but these never arrived. Although there were a 
small number of participants, this replicates other photovoice research which had similar 
sample sizes (Duffy, 2010; Thompson et al., 2008; Vaughn et al., 2008; Wiersma, 2011) and 
may therefore be related to a methodology which places quite a high burden on the 
participant.  
 
The high attrition rate could also be due to a lack of a personal relationship between the 
participant and researcher, as participants were only in contact with the researcher via email. 
Booth and Booth (2003) suggest that many women in their photovoice study found it difficult 
to use the camera film so put the camera aside and then forgot to go back to it. It is possible, 
therefore, that the women in this study simply forgot to use the camera. Baker and Wang 
(2006) similarly reported issues of high attrition in their photovoice research; they, however, 
suggest that this may be due to the number of steps participants have to take in order to 
complete the research. Indeed, some participants in this research may have completed the 
study but failed to return the study pack. Consequently, the lack of responses may have 
limited the findings of this study and potentially biased the findings to represent those women 
who engaged with the research who may be more able to cope with their PCOS or, indeed, 
those who feel less supported. 
 
A further restriction on the participant sample was that participants were all recruited via a 
post on the website of PCOS charity, Verity and were self-selecting. Therefore, it is 
suggested that all the women in this research were actively seeking support for their condition 
and were engaged with a larger PCOS community. Moreover, there is a possibility that the 
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participants were not clinically diagnosed with PCOS, even though they engaged with these 
communities as participants in this study self-reported their PCOS status. However, the 
included participants presented with a variety of symptoms, including symptoms of: weight, 
acne, hirsutism, infertility and symptoms surrounding blood sugar and hormone control. This 
suggests that they represented the symptom profiles of the four phenotypes of PCOS as 
detailed by the 2003 Rotterdam criteria (2004). 
 
Participants were also informed that they would need to gain verbal informed consent from 
any person they wished to photograph (or the appropriate guardian) which presents another 
limitation for this research. Participants were informed that any pictures they did take of 
people would not be published and their photos would only be used for the purpose of 
analysis. Frith and Harcourt (2005) employed similar ethical guidelines in their photovoice 
study and claimed that this may have influenced or restricted what participants felt able to 
take photographs of. Moreover, they state that the exclusion of using images with people in 
may have resulted in useful data being lost.  
 
To overcome this potential limitation, future photovoice research could require the participant 
to gain written informed consent from the individual being photographed (Wang & 
Redwood-Jones, 2001). Alternatively, participants could use ‘consent vouchers’ (small 
consent forms) to gain consent from individuals they wished to photograph (Hannes & 
Parylo, 2014). However, Hannes and Parylo (2014) found that participants in photovoice 
research often avoided approaching individuals for consent, this was due to either a 
reluctance to approach people or because participants perceived the extra step of gaining 
written consent as an annoyance and unpractical. Consequently, Hannes and Parylo suggest 
that to reduce avoidance of gaining consent; participants should receive practical training on 
how to approach individuals to gain informed consent, thus making the participant more 
comfortable when approaching people for consent. Alternatively, the photographer may 
demonstrate on their consent form that they had received consent from the individual being 
photographed, this could be done through the return of the informed consent form to the 
researcher. However, there is still a potential risk that the participant may not gain approval 
from the individual they wish to photograph. Certainly, Crow and Wiles (2008) suggest that 
to ensure anonymity, as far as possible, visual material should be excluded from research 
projects, or projects should only include visual material that does not feature an individual. 
Moreover, they claim that whilst an individual may give consent for their images to be used, 
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they may later be dissatisfied with how their image is portrayed once reported (Crow & 
Wiles). As such, researchers should avoid the use of photographs of individuals in 
publications without personally receiving their explicit informed consent.  
 
Wang (1999) suggests that the choice of camera in photovoice research should be guided by 
the researcher and any practical considerations. Disposable cameras were chosen as their use 
would ensure that all participants’ images were of the same quality and size and the provision 
of disposable cameras meant that all individuals (who met the inclusion criteria) would be 
able to participate in the research should they wish to, as participation was not dependent on 
access to a camera. Similarly, the majority of previous photovoice research in health has 
utilised disposable cameras (Aubeeluck & Buchanan, 2006; Baker & Wang, 2006; Moffitt & 
Vollman, 2004; Thompson et al., 2008; Valentine & Knibb, 2011; Wang & Pies, 2004; 
Wiersma, 2011). Whilst providing participants with disposable cameras ensures that all 
potential participants could take part in the research, the use of disposable cameras may have 
limited this research as participants may have been unwilling to return cameras if they 
regretted taking a specific photograph, and there were also technical issues with the camera 
itself, such as photographs not printing or being unclear.  
 
Future qualitative research employing photovoice methodology would be useful to further 
explore the impact of PCOS on quality of life from the participant’s perspective, and how 
they live with PCOS on a day-to-day basis. However, there are several ways that this study 
could be improved upon and added to; primarily through the use of smart phones for 
photograph taking. Research into the use of camera phones suggests that individuals have 
camera phones always on hand (Kindberg, Spasojevic, Fleck & Sellen, 2005). Indeed, 
Boulous, Wheeler, Tavares and Jones (2011) suggest that smartphone technology may be 
able to achieve lower attrition rates in health research due to its ease of use. One way of 
achieving this may be through a smartphone application such as the ‘PhotoVoice™’ 
application which allows you take a photograph and then record and attach a sound file to 
that photograph before sending it via email or to social media sites (Kiger, 2016). However, 
there is yet to be research which explores the efficacy of using smartphones for photovoice 
research.  
 
As participants in this study demonstrated a familiarity with social networking websites, 
integrating social media with the taking of photographs could lead not only to lower attrition 
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but an interesting new way of generating data for analysis. Many mobile phones now have 
the capability to not only take photographs but to share them instantly to a variety of social 
networking websites such as Facebook (Wilhelm, Takhteyev, Sarvas, Van House & Davis, 
2004). Indeed, 874 million monthly active users used Facebook mobile products as of 
September 30th 2013 (Facebook, 2014). This suggests that participants would be familiar with 
the actions of taking photographs and uploading them to a social networking website which 
could then be accessed by the researcher and participants: allowing for instant data creation 
and group discussion of the images. This discussion of the photographs could act as an online 
interview or focus group as has been demonstrated in previous offline photovoice research 
(Booth & Booth, 2003; Duffy, 2010; Thompson et al., 2008; Wiersma, 2011). In line with 
this, Strack et al. (2015) recently developed a web-based tool, which will lead individuals 
through the steps and ethics of photovoice, to enhance ‘the reach and impact of photovoice’ 
(p.192). The tool would enable participants to be trained in photovoice and give them a 
dedicated web space to share their photos. As such, this tool could be used by researchers 
who wish to use photovoice in their research. However, to the researcher’s knowledge, there 
is no published photovoice research which utilises an approach using smartphones or an 
online data collection tool.  
 
This study aimed to gain an understanding of how women with PCOS perceived quality of 
life. As such, participants in this study were not given a definition of quality of life before 
taking part. Whilst this may be seen as a limitation to the study, this enabled participants to 
conceptualise what quality of life meant to them. This, therefore, allowed for the research to 
explore the perceptions of quality of life for women with PCOS, rather than the data being 
created according to the researcher’s questions or according to a specified definition that may 
not have fully captured the quality of life of women with PCOS. As such, the data in this 
study represents how participants perceive their quality of life, and the impact PCOS may 
have on it. It is of note, however, that the findings from this study reflect many of the 
domains of quality of life previously reported, such as; physical health, psychological health, 
independence, social relationships, occupational activities, and personal beliefs (Fallowfield, 
1990; WHOQOL Group, 1994). As such, aspects of PCOS identified by the participants 
mirrored the psychological, physical, social, and environmental and level of independence 
factors that are thought to make up the quality of life construct (Fallowfield, 1990; Testa & 




This study revealed how women with PCOS in the UK perceive and define their quality of 
life. The women in this study also captured the impact of PCOS on their quality of life, 
according to their perceptions, this included: relationships, their sense of femininity, the 
physical impact of symptoms, their social activities and the management of their condition. 
These findings reflect the domains of quality of life highlighted by the WHOQOL group 
(1994) including: physical and psychological health, their level of independence, their social 
relationships and their environment. Moreover, aspects of the theme Positive Outlook 
reflected the spiritual/religion/personal beliefs domain reported by the WHOQOL group. By 
capturing their daily experience, this study helped to further understanding of the impact of 
PCOS on quality of life of women in the UK, on a day-to-day basis from their perspective. 
Dissemination of these findings to health professionals may reduce the lack of understanding 
of the daily impact of the condition on quality of life, therefore enabling them to not only 
provide a better health care service to women with PCOS but also allowing women with 







Chapter Four -‘Everything’s from the inside out with PCOS’: Exploring women’s 
experiences of living with Polycystic Ovary Syndrome (PCOS) and co-morbidities 
through Skype™ interviews. 
 
The previous chapter highlighted how women with PCOS engage in self-management 
behaviours in order to control and cope with their condition (De Ridder, 2004). This includes 
hair removal methods, taking medications (both prescribed and supplemental), engaging with 
diet and exercise, and using a variety of skincare routines. Moreover, it demonstrated that 
women with PCOS engage in self-education in order to better manage their condition, often 
resulting from a perceived lack of information and support from health care providers 
(Holroyd & Creer, 1986). The findings also highlighted how women with PCOS sought 
support from relationships, particularly those with other women with PCOS and their family. 
The findings from Chapter Three also demonstrated that the participants often felt unfeminine 
due to their condition and as such, their PCOS had a negative impact on their identity as a 
woman.  Moreover, Chapter Three revealed how women with PCOS perceive and define 
their quality of life. It also furthered understanding of the impact of PCOS on quality of life 
for women with PCOS in the UK, from their perspective. 
 
4.1 Introduction 
Participants in Chapter Three were, however, excluded if they had any other condition 
besides PCOS, in an attempt to provide a greater understanding of the impact of PCOS on 
quality of life, specifically. However, women with PCOS are likely to experience co-morbid 
conditions including cardiovascular disease, diabetes, endometrial cancer, depression and 
anxiety (Benson et al., 2009; Chittenden et al., 2009; Deeks et al., 2011; Marks et al., 2005; 
Navaratnarajah et al., 2008). In addition, during recruitment for the photovoice study, many 
potential participants that contacted the researcher wishing to take part were excluded from 
the study as they experienced, or were diagnosed with, another condition (or conditions) in 
addition to their PCOS. Thus, it is necessary to explore, and gain an understanding of how 
women with PCOS in the UK live with and perceive their condition, and any presenting co-
morbidities on a day-to-day basis. As such, this chapter reports the findings from additional 
qualitative research that aims to explore further how women with PCOS perceive and 
understand their condition on a daily basis, but it does not exclude women with PCOS who 





Many women with PCOS are likely to develop, or experience more than one long-term 
physical and/or mental health condition, including type 2 diabetes, cardiovascular disease 
(Ong, Theodoru & Ledger, 2006; Thomson et al., 2010), irritable bowel syndrome (Mathur, 
Ko, Hwang, Low, Azziz & Pimentel, 2010), thyroid disorders (Janssen, Mehlmauer, Hahn, 
Öffner & Gärtner, 2004; Kachuei, Jafari, Kachuei & Keshteli, 2012; Sinha et al., 2013) and 
eating disorders (Jahanfar, Eden & Nguyent, 1995; McCluskey, Evans, Lacey, Pearce & 
Jacobs, 1991). Studies also suggest that there is a higher prevalence of PCOS in women with 
bipolar disorder (Ragson et al., 2005; Jiang, Kenna & Ragson, 2009). Women with PCOS are 
also more at risk of developing depression (Bhattacharya & Jha, 2010) and anxiety (Laggari 
et al., 2009) disorders. Coffey and Mason (2003) similarly report that women with PCOS 
have higher levels of depression and psychological morbidity than controls. Indeed Cipkala-
Gaffin, Talbott, Song, Bromberger and Wilson (2012) found that women with PCOS have a 
higher prevalence (31%) of mild or moderate depressive symptom levels compared to a 
control group (17%). Deeks et al. (2011) also report that women with PCOS have increased 
anxiety, depression and negative body image compared to women without PCOS. Likewise, 
Ching, Burke and Stuckey (2007) argue that women with PCOS have an impaired quality of 
life and an increased prevalence of psychological morbidity. Of concern, Elsenbruch et al. 
(2006) report that psychiatric illnesses in women with PCOS may go undetected: 22 of 143 
women diagnosed with PCOS but who were un-medicated (three or more months) had a 
possible un-diagnosed psychiatric disorder according to the Symptom Check List 90 (SCL-
90-R; Derogatis, 1977). It is clear therefore that women with PCOS can also experience co-
morbid conditions that may have a negative impact on their quality of life. However, the 
majority of research investigating PCOS and co-morbid conditions has been quantitative or 
clinical in nature. As such, there remains a need for research that not only furthers 
understanding of the impact of PCOS, but also sheds light on the experiences of those women 
who also live with a co-morbid condition. 
 
To date, there are no papers which explore how women with PCOS live with, and manage 
their condition, and any co-morbid conditions they also experience. Certainly, Moreira and 
Azevedo (2006) argue that incorporating qualitative approaches into PCOS studies could 
contribute to our understanding of the psychological impact of the disease. However, only a 
handful of studies have explored PCOS from a qualitative perspective (for example, Crete & 
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Adamshick, 2011; Holbrey & Coulson, 2013; Kitzinger & Willmott, 2002; Percey et al., 
2009; Synder, 2006; Washington, 2008). Moreover, of those studies, all have (or do not 
specify) an exclusion criteria resulting in women with PCOS, who experience co-morbidities, 
being excluded from these studies. Further exploration of this experience would therefore 
aide our understanding of the psychological impact of PCOS, and other conditions, on daily 
life. This study, therefore, aims to explore and gain a further understanding of how women 
with PCOS in the UK live with and perceive their condition, and any presenting co-morbid 
conditions, on a day-to-day basis. It is the first such study to explicitly explore the 
experiences of women with PCOS who experience co-morbid conditions; this is of particular 
importance given the high proportion of co-morbidities discussed earlier in this chapter.  
 
4.2 Online Research Methods 
As discussed in Chapter Two, there is a need for qualitative research to further understanding 
of the impact of PCOS on the day-to-day lives of those women who experience the condition, 
and any co-morbid conditions. However, women with PCOS have also been shown to be 
socially isolated (Kitzinger & Willmott, 2002), this was also demonstrated by participants in 
Chapter Three; therefore, a method of data collection that accounts for this is needed. 
Seymour (2001) suggests that the use of online data collection methods enable the researcher 
to access inaccessible domains, such as hard to reach populations or socially isolated groups. 
Kraut et al. (2004) also argue that online research could make apparent psychological 
phenomena that do not exist in traditional settings. Moreover, Sullivan (2012) proposes that 
there is potential for data collection in social research through the use of technology such as 
Skype™ and Google Hangout. As such, online research may enable access to a socially 
isolated population such as women with PCOS (as discussed in Chapter Two).  
 
Deakin and Wakefield (2013) suggest that online synchronous interviews, such as those 
conducted on Skype™, are a useful replacement of traditional face-to-face interviews for 
qualitative data collection. They describe several advantages of using Skype™ to conduct 
interviews including allowing more flexibility for the researcher and participant, and being 
more cost and time efficient. Janghorban, Roudsari and Taghipour (2014) also argue that 
Skype™ offers a useful alternative to face-to-face interviews and is suitable for conducting 
individual interviews. Previous research using Skype™ has explored online health forums 
(Fan, Lederman, Smith & Chang, 2013) and online psychiatric consultations (Williams et al., 
2014). Williams et al. (2014) found that in their study there was a high acceptability of online 
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consultations via Skype™ amongst their participants. This suggests that Skype™ is a viable 
way to conduct online research. Accordingly, this study explored how women with PCOS 
live with and perceive their condition, and any co-morbid condition(s), on a day-to-day basis 




Participants were recruited via the social networking website, Facebook. A recruitment post 
(Appendix F) was posted to different PCOS support groups available on Facebook. The 
inclusion criteria for this study were women: aged 18 and over, who lived in the UK and 
experienced symptoms of PCOS. Ten participants agreed to participate in the study and were 
interviewed for between 40 and 90 minutes. Of these participants, nine presented with 
symptoms indicative of psychological or physical co-morbid conditions, and as such, only 
nine participants were included in the analysis.  
 
Participants’ ages ranged between 20 to 41 years old (mean age = 31.71 years); two 
participants chose not to disclose their age. Length of diagnosis ranged from one year to 14 
years (mean length of diagnosis = eight years). Four participants reported a clinical diagnosis 
of depression, one participant reported a clinical diagnosis of anxiety. Other co-morbid 
conditions experienced by participants included: irritable bowel syndrome, asthma, eczema, 
Ehlers Danlos syndrome, hypothyroidism, migraines and Fibromyalgia. 
 
4.3.2 Materials 
All potential participants received an information sheet (Appendix G) and a consent form 
(Appendix H). Interviews were conducted using Skype™. Participants were given the option 
to use voice call only or video call; all participants decided to take part via voice call only. 
Skype™ is an online method of making free video or telephone calls; it also allows for 
individuals to send text based messages to one another for free. The interviews were recorded 




After participants had registered their initial interest in taking part in the study via email to 
the main researcher, they were sent an information sheet and a consent form by return email. 
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They were informed that they did not need to fill anything in but were advised to read both 
documents before deciding if they wished to take part in the research, thus ensuring 
participants had sufficient time to consider the implications of taking part in the research 
(NHS HRA, n.d). Participants were able to choose whether to take part in a focus group, or 
an online or face-to-face interview. All participants opted to take part in an online interview. 
Consequently the participants emailed to say they would like to take part arranged an 
interview appointment with the researcher and informed the researcher of their Skype 
username. 
 
At the time of the scheduled interview participants were called through Skype™ (Microsoft, 
UK). The researcher then reminded the participant that the Skype™ call was being recorded. 
Participants were then asked to create a unique identifying code made up of three letters or 
numbers that they would remember and informed that should they wish to withdraw from the 
research then all they need do is contact the researcher with this code (BPS, 2013). After 
participants had created a unique identifying code they were then given the opportunity to ask 
any questions they had. A copy of the statement of informed consent was then sent to the 
participant using the text based message service within Skype™. At this point participants 
were asked to type whether they agreed or disagree to taking part in the research. Finally 
participants were reminded of their right to withdraw from the research up to three weeks 
after participation, and also of their right to stop the interview at any time. Interview 
questions included ‘could you describe a typical day living with PCOS?’, ‘Have you changed 
the way you deal with your PCOS and its symptoms over time?’ and also ‘If you experience 
any other type of illness or disorder, how do you manage this?’(Appendix I). After 
completion of the interview, participants were emailed a study debrief (Appendix J) and 
given the opportunity to ask questions. 
 
4.3.4 Ethics 
Research complied with The British Psychological Society’s ethical guidelines (BPS, 2009) 
and their guidelines for internet-mediated research (BPS, 2013) and ethical approval was 
obtained from the Psychology Research Ethics Committee at the University of Derby (Ethics 







The online interviews were transcribed and then analysed using an inductive thematic 
analysis (Braun & Clarke, 2006). Thematic analysis is a method for identifying and reporting 
themes within the data, which organises and describes the data in detail (Braun & Clarke). 
To analyse the data according to the six steps recommended by Braun and Clarke, the 
transcript was first read and re-read and then initial codes were generated. Next the initial 
codes were sorted into potential themes. The themes were then reviewed, defined and named. 
Finally, the thematic analysis was written up. The final themes were reviewed by two other 
health psychology researchers to ensure all were in agreement and that the themes accurately 
represented the data (Braun & Clarke). 
 
4.4 Findings 
Participants in this study experienced a variety of symptoms including hirsutism, obesity, 
acne and infertility. All participants experienced other conditions, in addition to PCOS. These 
were both physical and psychological, three participants experienced both physical and 
psychology co-morbidities in addition to their PCOS. Four major themes were identified in 
the data: Change (Change to Life Plans and Changing Nature of the Condition), Co-
Morbidities (Living with Other Conditions and Depression and Self-harm), Support (Health 
Care Professionals, Self-support and Relationships) and Self (Feminine Identity and Us and 
Them). All identifying details have been removed from the quotes and participants have been 
referred to by pseudonyms throughout the analysis in order to ensure that they are not 
personally identifiable (BPS, 2010).  
 
4.4.1 CHANGE 
The theme Change permeated the interviews and was discussed by many of the participants, 
in the two sub-themes Change to Life Plans and Changing Nature of the Condition.    
 
4.4.1.1 Change to Life Plans 
Several participants described how PCOS had caused them to change their life plans, 
particularly their plans to start a family. In the quote below Dawn discusses how having a 
large family was the ‘planned thing to do’ and what they (her and her husband) ‘had planned 




I think it did, yeah, I mean I think it might, when me and my husband first got together it was 
you know, my husband’s one of six, I’m one of five, it was the planned thing to do and that’s 
what we had planned to do before we got married erm but it, it, did bother me for a long 
time, a very long time actually, erm but I think the older I’ve gotten and the older we’ve 
gotten the more, I think since I turned 30, it’s become less of an issue, if you like because 
we’ve just, we’ve got used to it. You know, when I turned 30 we’d been dealing with it for 
nearly ten years. So I don’t know if it’s erm, it might have impacted to start off with, but it’s 
not, I don’t, I used to look at children and think yeah I’d love one. [Dawn, 36] 
 
Dawn reflects that over the last ten years, as she has gotten older, she has become ‘used’ to 
the impact PCOS has had on her and her husband’s ability to have children and the family 
they planned. Similarly, Julie (below) states that she had been ‘dreaming’ about having a 
family for almost ‘30 years’. She discusses, in the quote below, how the impact of PCOS on 
her fertility was ‘very hard to grasp’ as it was something she had ‘always wanted’ from a 
young age. The quote illustrates how women with PCOS who plan or want a family may 
have to change the plans they had for their life and adapt to living with PCOS. 
 
I really found it very hard to grasp that the one thing that I’d always wanted right from, well 
from being a little girl and playing with, playing with dollies and that sort of thing. I always 
knew I wanted children, even before I wanted a boyfriend. I knew that malarkey and always 
knew that I wanted a family and so this thing that I’ve been sort of looking forward to and 
dreaming about for nearly the whole of my 30 years was kind of like the, the rug pulled out 
from under my feet kind of thing a little bit and it was erm pretty horrible really. [Julie, 36] 
 
Plans to have children, and how PCOS impacts on these, were also discussed by Kay, in the 
quote below; she described how she was unsure about her future fertility and the fertility 
treatments she was about to start.  
 
I’m about to have a blood test done so all that’s going to be a huge impact erm in my life and 
it’s quite scary really. Well, hopefully it’s going to help but it’s quite scary to think that I’m 
going to have to go through that…and as I say by now in an ideal world I would have had a 
big family. I would have had lots of children erm and we don’t know if we’re going to even be 
able to have one…it’s more the erm you must do it kind of now because you’re running out of 




Marie similarly discussed the impact of PCOS on her plans for a family and how they have 
changed from being a child. She describes how since she was diagnosed (at 14 years old) she 
has tried to become used to the idea that she may not have children. 
 
I’ve sort of become used to the idea of possibly not having children ‘cause when I was 
younger I always thought I wanna get married and I wanna have kids but now I try to think a 
lot more about erm the likelihood of not having children that it’s not gonna be a huge plan 
whether or not to have children as it might not happen [Marie, 20] 
 
Sharon also discussed the impact of PCOS alongside having a bicornuate uterus, an 
abnormality in the uterus, on her plans to have children. 
 
I was having surgery to have that removed [bicornuate uterus] to try and make it viable for 
me to carry pregnancies and erm when I came round from the operation he said it wasn’t 
possible…he said that he was going to tell me he thought it very unlikely that I would have a 
family and that the combination of polycystic ovaries and that abnormality probably made it 
unlikely erm that I would er ever be able to carry a child full term. Erm so obviously that was 
quite upsetting...but I always thought I’ll end up adopting  or something like that erm, as it 
happens, he was very wrong…I did manage to have children [Sharon, 41] 
 
Holly also discusses how she feels pressure to have children; she describes how she feels that 
doctors had pressured her to have children ‘sooner rather than later’ and the consequential 
impact of this on her plans of having a career before having children.   
 
Erm I think erm every doctors tells me that I need to start thinking about having children 
sooner rather than later, that’s quite a change erm ‘cause I’m an army wife so I travel 
around a lot which makes it hard to get jobs and kind of puts your career on the back foot so 
I was hoping to establish a career, a, a settled base and then have children but I’m not sure 
how that’s going to work out for me now. So yeah, I think I probably will have to change my 
plan slightly. [Holly, 25] 
 
Holly, at a later point in the interview, again discusses how she feels a ‘constant pressure’ to 




Erm well like we touched on about the lack of control and the fear of not, of maybe not 
having children and you don’t really know until you start trying and that, that’s how I feel at 
the moment. That I’m, ‘cause I’m not trying I don’t know whether I can or can’t have 
children. I don’t know how hard it’s going to be and it’s erm, it’s that horrible feeling well 
you better get on with it then ‘cause you know it could take years to try and get pregnant. 
There’s that constant pressure, it’s horrible. [Holly, 25] 
 
The impact of PCOS on the ability to conceive for women with PCOS has been highlighted 
previously by Snyder (2006) who demonstrated that women with PCOS felt uncertain about 
their ability to become pregnant. Similarly all the participants (n=10) in Washington’s (2008) 
study expressed concerns surrounding their ability to get pregnant, and also the impact of 
their PCOS on conception. More recently, Sanchez and Jones (2016) explored how digital 
(online) teen and women’s magazines portrayed women with PCOS. They found that PCOS 
was depicted as a barrier to childbearing and starting a family and subsequently, this 
impacted on the role of women with PCOS as wives and mothers (this is discussed further in 
the sub-theme Feminine Identity). Having a child is considered an important life goal for 
many people (Thomson, 2011). This study, however, is the first to discuss the pressure 
women with PCOS feel to have children earlier in life then they may have originally planned 
due to pressure from health care professionals.  
 
The impact of infertility on life plans, whilst not previously being reported in the PCOS 
literature, is similar to experiences of women in other conditions or undergoing treatments 
that can impact on women’s fertility, such as being diagnosed with the BRCA1 gene and the 
impact of cancer treatments on fertility. Some treatments for cancer such as chemotherapy 
and radiotherapy can also have an impact on a woman’s fertility causing them to become 
infertile (Dow, 1995; King et al., 2012; Lamb, 1995; Maltaris et al., 2007; Sonmezer & 
Oktay, 2006). Maltaris et al. suggest that female cancer patients are not adequately advised 
about the impact of treatment on their fertility and suggest that women experiencing this need 
support from psychological specialists due to the additional psychological stress, loss of 
control, grief and depression associated with infertility (Carter et al., 2005). However, 
differently to those women with PCOS progress is being made in fertility preservation during 
cancer treatment in order to give women who have undergone aggressive treatments, a 




Salmela-Aro and Sikkari (2008) suggest that the experience of infertility is an ‘unwelcome 
interruption’ to those individuals who expect to become parents. Loss of control over future 
plans and life goals has also previously been reported as a reaction to infertility (Dunkel-
Schetter & Lobel, 1991). In a review of literature exploring the impact of infertility, Dunkel-
Schetter and Lobel (1991) found that 40% of the studies reported that participants felt that 
they had lost control over their future. Charmaz (1997) suggests that time helps an individual 
to situate themselves and define their self-concept. She argues that it is therefore necessary 
for people with long-term conditions to restructure time and how they perceive their future. 
Moreover, Charmaz states that for individuals with long-term conditions, they may have to 
‘abandon their previous hopes and plans’ (p.21), thus reflecting the experiences of the 
participants in this study. Similarly, Moos and Tsu (1977) suggest that when an individual 
experiences a loss of a function due to a long-term illness, in this case fertility in women with 
PCOS, they need to acknowledge and mourn this loss and then prepare to live with the loss of 
function going forward.  
  
4.4.1.2 Changing Nature of the Condition 
Several participants describe the changing nature of their PCOS symptoms and their inability 
to predict how their condition will change over their lifetime. For example, Julie describes 
how after making the decision to stop trying for a second child she returned to taking the oral 
contraceptive pill, however, it did not work in the same way.  
 
I went back on the pill ‘cause I thought…let’s put it back to bed [trying for a child]…, I 
thought going on the pill would help because I thought it would mask it and control it again. 
Only this time round it made absolutely no difference erm other than it got me back into a 
regular cycle…it made no difference whatsoever. [Julie, 36] 
 
The quote above demonstrates how it can be difficult for women with PCOS to predict how 
their condition, and treating it, will change over time. Crete and Adamshick (2011) have 
similarly reported that women with PCOS were frustrated due to dealing with the 
uncertainties of symptoms and diagnosis. In addition, Castillo (2008) stated that women with 




Similarly, Dawn states in the quote below that her PCOS symptoms have ‘got worse over the 
years’ demonstrating how the symptoms of PCOS are unstable. 
 
It’s definitely just got worse over the years. A lot worse erm I think, I think from the age of 25 
its suddenly started kicking off erm with you know having to start taking care of you know, 
the hair issue and it just, as I said, it just seems to be getting worse. [Dawn, 36] 
 
Participants in Snyder’s (2006) study similarly described how their body was ‘changing’ 
(p.388) as a result of PCOS and that dealing with the ‘uncertainty of the syndrome’ (p.390) 
was frustrating. Similarly, Holly discusses the changing nature of her moods as a result of 
PCOS in the quote below. She describes how she feels she has ‘no control…whatsoever’ and 
how she has taken medication to try and control the symptoms.  
 
Yeah erm I think it’s because it’s, everything’s from the inside out with PCOS. It’s really 
hard to control anything that happens unless, unless you want to go on a contraceptive pill, 
which I don’t. I think that’s probably the only way that you control it. I’ve tried Metformin, 
I’ve tried, well that’s it actually. I’ve tried Metformin and it didn’t work for me and erm 
that’s why, that’s why I feel I’m in no, I have no control over it whatsoever. I can be feeling 
really good and really happy and brilliant and then just get a whole load of spots and think 
and what is that about? It’s really upsetting and I can feel really low and really depressed 
about it and my skin’s looking great and I just don’t understand it at all. It’s horrible.  
[Holly, 25] 
 
Holly was not alone in describing changes she had made to try and control her PCOS. Each 
participant reported trying different medications or symptom management techniques to try 
and control or deal with their symptoms, including hair removal and skin care routines. This 
has been reported by several other studies (Crete & Adamshick, 2011; Kitzinger & Willmott, 
2002; Snyder, 2006; Washington, 2005) and was also described by participants in Chapter 
Three.  
 
Several women reported trying numerous ways to remove excess hair caused by PCOS 
including; shaving, plucking, waxing and epilating the hair. Hirsutism is common in women 
with PCOS; indeed it is the aetiology of approximately 70% of hirsutism in women (Archer 
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& Chang, 2004). Looking for hair and removing it often formed part of the participants’ daily 
routine as described by Kay, Tanya and Marie respectively.  
 
I have to (?) and shave erm my hair…it’s more tweezing and the shaving really, I do that 
almost daily. So that’s quite draining doing it every day… [Kay, AU] 
 
I get up, every day I have to, rather annoyingly, shave my face. [Tanya, 39] 
 
I tend to epilate a lot, erm use hair removal cream, erm but that’s frustrating as well because 
hair removal cream’s really expensive and epilating hurts like hell [Marie, 20] 
 
Similarly, Sharon details the hair removal routine she used to do before having children, 
below. 
 
I think the facial hair was my big, big problem. I hated that and I used to spend an hour a day 
in the, in the bathroom with a pair of tweezers trying to pull it out and I think boyfriends in 
the past, a lot of them didn’t even know I had it…I was just very good at getting rid of it. 
[Sharon, 41] 
 
In the quotes above we can see how participants felt that they needed to manage their 
symptom of hirsutism each day despite it being ‘draining’, annoying or ‘frustrating. 
Similarly, Kitzinger and Willmott (2002) describe how women with PCOS had a daily hair 
removal routine. This was also evidenced by Washington (2008) who found that participants 
shaved or plucked hairs daily. Moreover, Snyder (2006) reports that to control symptoms of 
hirsutism, every participant in their study invested time and money into treatments, including 
similar methods to participants in this study. Crete and Adamshick (2011) also reported the 
importance to their participants of controlling their PCOS symptoms through self-treatment.  
 
Participants had similar routines for other symptoms including their skin care. This included 
checking their skin daily for any blemishes or acne caused by PCOS. Holly described this in 
the quote below; she also stresses how her symptoms are never stable. 
 
So the first thing that always crosses my mind is what does my skin look like today?... I have 
like three weeks of the month where it is just horrendous and then you have a week where it 
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starts to clear up and you think ah (sic) maybe this is it and you think it is getting better now 
and it doesn’t, it just improves for a week or so. [Holly, 25] 
 
Hsu (2013) suggests that women with PCOS may experience changes in their PCOS 
symptoms with age, particularly in adolescence and later life. Consequently, health care 
professionals should be considerate of these changes in presenting symptoms in women with 
PCOS and offer appropriate support and guidance.   
4.4.2 CO-MORBIDITES 
All the participants experienced one or more co-morbid conditions. The physical conditions 
were varied and include migraines, irritable bowel syndrome (IBS), hypermobility syndrome, 
hypothyroidism and adrenal fatigue. Participants also experienced depression and depressive 
symptomology. Holly was also in the process of being diagnosed for endometriosis, in 
addition to her other co-morbidities 
 
4.4.2.1 Living with Other Conditions 
Six of the participants (Holly, Tanya, Kay, Sharon, Emma and Dawn) discussed how they 
lived with other physical conditions as well as their PCOS. In the quotes below Tanya 
describes how she has IBS as well as PCOS. Interestingly, despite experiencing two long-
term health conditions, Tanya states that she and her family ‘don’t really suffer from 
anything’. She goes on to describe how she lives with having two conditions and explains 
that she has to be ‘careful with it’. The quotes below suggest that for Tanya, she identifies as 
being well, rather than ‘poorly’ even with her PCOS and IBS symptoms.  
 
We’ve never really, we’re not really like a poorly family. We don’t really suffer from 
anything. Mmm I do get a lot of colds, I always pick everything up. Oh and I do have a, I’ve 
actually just realised, a touch of IBS. [Tanya, 39] 
 
Yeah, I have a touch of IBS, it’s one of those things that I know what sets it off and I’m just 
careful with it. [Tanya, 39] 
 
To date only one article has explored the prevalence of IBS in women with PCOS. Mathur et 
al. (2010) found that not only were women with PCOS more likely to have IBS than healthy 
controls, but that women with PCOS and IBS symptoms were more likely to have a higher 
BMI and body fat percentage compared to women with PCOS but who did not suffer from 
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IBS. In the current study only Tanya reported experiencing symptoms of IBS; however, this 
finding does demonstrate a need for further research exploring the prevalence, and experience 
of IBS in women with PCOS. 
 
Tanya’s experience and the way she describes her co-morbidities contrasts with Kay who had 
several other conditions in addition to PCOS. In the quotes below Kay discusses how she has 
asthma, eczema and hypermobility (hypermobility is a condition where people experience 
loose or supple joints that can often result in pain). She explains that she has ‘quite a bad time 
with them’, suggesting she finds it difficult living with multiple morbidities. 
 
I have erm asthma, erm I have eczema and I also have hypermobility erm which is basically 
from the double jointedness [sic] erm and I have a lot of problems with my joints, especially 
my knees erm and I have quite a bad time with them. [Kay, AU] 
 
She continues to discuss how she lives with having PCOS and the other conditions explaining 
that you ‘just have to…deal with it’ and ‘get on with it’. Kay also demonstrates a pragmatic 
attitude towards living with her multiple conditions, describing how she makes ‘the best’ out 
of her condition. 
 
Think you just do, you just do, you just have to erm deal with it as it comes erm and get on 
with it. It’s there and there’s not much you can do to change that and you have to make the 
best out of the situation that you’ve been handed I suppose. [Kay, AU] 
 
However, later she adds to this, describing how she can ‘deal’ with the eczema and asthma 
but that she feels her hypermobility impacts on her life. This suggests not only that the 
individual conditions may impact Kay’s life in different ways, but that she perceives her 
ability to cope with the conditions differently as well.   
 
The eczema and the asthma I can deal with that, that’s fine erm it’s, the hypermobility does 
affect your life erm and I’m a full time carer for my partner as well so I have to be careful 
with what I’m doing with that. [Kay, AU] 
 
The quotes above from Kay help to demonstrate how women with PCOS may often be 
struggling to live with not only PCOS but other debilitating disorders as well. Sharon (in the 
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quote below) similarly describes how when living with PCOS and other conditions, in this 
case hypothyroidism, you have to just ‘accept’ it suggesting that women with PCOS and 
other conditions feel they have little control over their conditions and must simply ‘live with 
it’. Sharon describes how she thinks her conditions are linked together, but she has learnt to 
live with them and accept the situation despite the negative physical impact. Sharon also 
states that in order to live effectively with her conditions you must ‘adjust your life’ without 
ruining your life. This suggests that in order to cope with her co-morbidities it is necessary to 
change and find a new balance. This reflects the findings of the previous theme, Changing 
Nature of the Condition.  
  
I think they are linked together to be honest erm I’ve got an underactive thyroid which is 
incredibly common amongst women who’ve got polycystic ovaries erm and I’ve got a couple 
of other medical conditions erm which, which all roll into make me feel tired all the time 
really. Erm but you get to, you get to live with it erm you know, it’s a bit frustrating 
sometimes, you know, sometimes you’d like to have 48 hours in the day to get stuff done but 
you just gotta [sic] accept that you’re gonna be tired and, and that’s the end of it really. You 
just gotta [sic] erm adjust your life to your medical situation without making it ruin your life 
if you see what I mean. [Sharon, 41] 
 
It has been suggested (De Ridder, 2004; Friedman, 2002) that individuals experience two 
phases after diagnosis of a long-term condition; the crisis phase whereby individuals may 
experience depression and anxiety, and the adaption phase where De Ridder suggests that 
individuals make an attempt to adapt to their condition and argues that most individuals will 
adjust to their new situation. This reflects the quote above where Sharon discusses 
‘accepting’ her condition and adjusting her life to living with the condition.  
 
Crisis Theory (Moos & Schaefer, 1984) similarly purposes that physical illness can be 
considered a crisis due to the consequential changes in identity, role, social support, future 
and location. Whilst women with PCOS are unlikely to experience a change in location as a 
direct result of having PCOS, they may experience a change in the other domains such as 
their identity as someone with PCOS (identity), and their future (becoming a mother). In 
order to cope with this crisis, Moos and Schaefer argue that individuals go through three 
processes: cognitive appraisal, adaptive tasks and coping skills. As part of the coping process, 
individuals may need to accept their situation and redefine it in a positive way, as 
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demonstrated in the quote above by Sharon. Charmaz (1997) similarly suggests that there are 
four ways that an individual accepts illness, they may: ignore it, struggle against it, reconcile 
themselves to it or they accept it. The quote above by Sharon is reflective of the latter two 
types of acceptance in that she has decided to ‘live with’ (p.47) her illness by acknowledging 
it and accepting it.  
 
Carr, Gibson and Robinson (2001) suggest that when an individual’s expectations and 
experience are matched, or more simply they accept their condition, then the impact of the 
condition on quality of life is reduced. Moreover, Schüssler (1992) suggests that an 
individual’s ability to control their illness, and acceptance of it, are associated with problem-
related coping rather than emotion-focused coping, which was associated with those 
individuals who did not accept their condition. Acceptance has also been shown to be related 
with coping in women with breast cancer (Lauver, Connolly-Nelson & Vang, 2007). In 
addition, Stanton et al. (2000) found that participants, who accepted their breast cancer, 
reported enhanced quality of life. Women with PCOS who accept their condition may 
therefore be better able to cope with their condition, and increase their quality of life.  
 
Although there has been no research that explores PCOS and hypothyroidism specifically, 
research exploring autoimmune thyroiditis (AIT: the cause of hypothyroidism) suggests that 
there is a threefold higher prevalence of AIT in women with PCOS (Janssen et al., 2004). 
Similarly, Sinha et al. (2013) argue that there is a high prevalence of thyroid disorders in 
women with PCOS. There is a need, therefore, for further research not only into the 
prevalence of thyroid disorders in women with PCOS, but also into the experience of women 
who live with both conditions. 
 
The difficulty managing multiple conditions expressed by Kay was echoed by Emma who 
described how she found it difficult to manage her migraines and PCOS (through taking a 
contraceptive pill) without one interfering with the other. 
 
Well I’ve given up the erm contraceptive pill entirely which is a pain to be honest erm but I 
get migraines as well so it’s a bad combination because I can’t take the combined pill 
because of the migraines and I can’t take the mini pill because they’re progesterone only and 




Like Sharon, Holly (in the quotes below) also felt that her co-morbidities were linked as she 
states that her adrenal glands and PCOS ‘go hand in hand’. She develops this later in the 
interview by stating that she has ‘adrenal fatigue which is linked to PCOS’ and that she also, 
like Sharon, has hyperthyroidism.  However, there has yet to be research exploring adrenal 
fatigue and possible links with PCOS.  
 
I think erm the adrenal glands and the PCOS go hand in hand and because I just feel 
knackered all the time now erm I, I think that the adrenal fatigue, depletion of the adrenal 
gland that usually coincides with PCOS, so yeah. [Holly, 25] 
 
I’m being investigated at the moment for endometriosis erm I also have adrenal fatigue which 
is linked to PCOS and em quite a low thyroid count. I don’t know what you call it, 
hyperthyroidism. [Holly, 25] 
 
Dawn describes below, how she discovered that she had a blocked fallopian tube, when 
attending a general appointment to discuss the possibility of IVF treatment.  
 
Yeah and it was quite a shock because it looks like one of my fallopian tubes stopped working 
as well. So I went into perhaps go and have erm IVF and I went and had a scan with a, well 
they inject a dye into my tubes and erm one of them wouldn’t even go up and it was a hell of a 
shock just to find out well one of your tubes is now not working at all and you’re not 
producing erm the eggs you need and erm all this all down to this, this polycystic ovary 
syndrome…it was very devastating at the time, now I look back on it, it was. [Dawn, 36] 
 
Dawn describes how she feels that the problems with her fallopian tubes were due to PCOS. 
However, there is no research in the area to support or oppose this claim. She adds that it was 
a ‘hell of a shock’ and ‘devastating’ to learn that she had another condition, in addition to her 
PCOS, suggesting that this was a traumatic experience for her. This demonstrates that women 
with PCOS and a co-morbid condition may find it difficult to cope, particularly at the time of 
diagnosis of the additional condition. To date; no research explores the experience of living 
with PCOS, and of being diagnosed with, one or more other conditions. As such, research of 
this nature would aid understanding of how women with PCOS experience living co-morbid 




4.4.2.2 Depression and Self-harm 
Six participants (Dawn, Kay, Julie, Marie, Debbie and Tanya) in this study reported 
experiencing depressive symptoms which for some included self-harm. This has not 
previously been reported in any published qualitative research with regards to the experience 
of PCOS. Quantitative research has shown that women with PCOS report more depressive 
symptoms (Himlein & Thatcher, 2006) and a higher prevalence of depression (Cipkala-
Gaffin et al., 2012; Hollinrake, Abreu, Maifeld, Voorhis & Dokras, 2007) than controls even 
after accounting for BMI and age (Deeks, Gibson-Helm, Paul & Teede, 2011), but findings 
from the present study show that for some women this may be more severe.  
 
The relationship between PCOS and depression was discussed by Kay and Marie in the 
quotes below. Kay suggests that her depression ‘is led from’ her PCOS suggesting that rather 
than her depression being a result of a biological cause, such as polycystic ovaries, Kay sees 
it as a result of living with the symptoms of PCOS. Conversely Marie states that it is her 
PCOS that adds to her depression. 
 
‘cause I don’t, for me polycystic ovaries doesn’t create my depression, my depression is led 
from the aspects of polycystic ovaries [Kay, AU] 
 
I wouldn’t have thought the depression would impact the PCOS really but I suppose it could, 
I haven’t really thought about that but definitely having the PCOS adds to the depression 
because of all the things you hate about yourself makes it diff, harder [Marie, 20] 
 
Julie similarly had trouble defining what PCOS was, and what depression was, when 
discussing getting irritated with her daughter. Julie also touches on how this then impacts her 
relationships with others, in this case her family, demonstrating how having PCOS can also 
have an impact on the individual’s relationships with other, overlapping with the theme of 
Relationships. Julie also speculates on the relationship between her PCOS and depression, 
suggesting that they be intertwined, with one impacting the other and vice-versa. 
 
I don’t know whether that’s the PCOS or whether that’s the depression or whether that’s 
depression ‘cause of PCOS but dealing with that and then the feelings of guilt that come with 




Debbie also discussed her PCOS and her depression in the quote below. Similarly to other 
participants she was unsure about the relationship between the two and whether one affected 
the other or vice versa. This suggests that participants are not receiving adequate information 
regarding their conditions from their health care professional and as such are unable to get the 
appropriate care for them (Percy et al., 2009).  
 
I think I just get on with it really but erm yeah I do sort of prioritise the depression but erm 
yeah I, I really don’t know if that helps though with the PCOS and if it stems from that so it’s 
helping the depression as well. [Debbie, AU] 
 
Two of the participants in this study reported that they had or would self-harm. Currently 
there is no published research reporting the incidence of self-harm in women with PCOS. 
Dawn describes how she will self-harm when she gets ‘hormonal surges’. 
 
I, I think I get an over, an overload of testosterone because my whole attitude changes and 
it’s really unpleasant for my husband and my family when I go through this, I think, a 
hormonal surge…I will self-harm when I get this. [Dawn, 36] 
 
When discussing how she deals with her PCOS Marie also admits that she has a history of 
self-harm. She describes how she still thinks about self-harming and the impact PCOS and 
her depression have on one another; she suggests it is ‘a cycle’ between her depression and 
her thoughts about her PCOS. 
 
Well I don’t think I deal with it very well because erm I have a history of self-harming which 
got quite bad at one point erm I don’t do it anymore but it’s always still in my mind so when I 
have a really bad day I always still think about doing it. Erm and when, if I’m depressed 
about PCOS my thoughts can sort of go round and round and switch between all the different 
things that PCOS is doing and the depression is doing and it’s all just a cycle really as when 
I do get really depressed it’s hard to get back out of it. [Marie, 20] 
 
Tanya (below), also described depressive symptoms, she explains how on ‘really, really blue 
days’ she would begin to think about ‘ending it’ but that thinking of her family and the 
impact it would have on them helps prevent her from following through with these thoughts. 
Similarly, Charmaz (1997) suggests that individuals who are experiencing long-term illness 
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may become immersed in their illness, and that continued immersion in illness may lead 
individuals to contemplate whether they should continue to live at all. 
 
I had suffered some days where I was so depressed and so down I wouldn’t leave the house, 
some days I wouldn’t go out to buy food because I was just so miserable and so fed up and 
there are times that you, not that, you just have these really, really blue days where you just 
think ‘Oh God, I’d love to just end, end it all as in, not, I’m finding it hard to explain it. I 
realise by ending it you would obviously end your life but I feel like if my body just stopped 
working. If I just shut my body down and it will all stop and it will stop doing this and it will 
stop doing that, but then obviously I just think to myself it’s a selfish way of thinking. I’d 
never do that. I’d never go down that route because it’s not fair to bring the stress to your 
family and also again it’s that whole thing of being erm, not trying to be negative about it. 
[Tanya, 39] 
 
Tanya also mentions in the quote how ‘some days’ she ‘wouldn’t leave the house’ or ‘go 
out’. She was not alone in this; Kay and Emma (below) similarly reported isolating 
themselves in this way, demonstrating how these feelings have a substantial impact on their 
behaviour. 
 
You know I don’t go out. I think that erm someone might spot some hair or something then 
I’ll make sure that’s gone first… erm and it just, it kind of feels a lot like erm difficult to go 
out I suppose. It’s just hard to take sometimes. [Kay, AU] 
 
It does inhibit me slightly erm so it, I just, it’ll, I will avoid situations because quite often I 
just feel very, very frumpy with it. [Emma, 25] 
 
Percy et al. (2009) found that women with PCOS in their study also reported feelings of 
social isolation, as did Washington (2008). Kitzinger and Willmott (2002) similarly report 
that women with PCOS in their study would restrict their activities because of their hirsutism 
symptoms. Research suggests that social isolation, or loneliness, may predict changes in 
depressive symptomology (Cacioppo, Hawkley & Thisted, 2010). As such, further research is 
necessary to explore the relationship between social isolation and depressive symptoms in 





4.4.3.1 Health Care Professionals 
Similarly to the findings of Chapter Three, participants in this study described a sense of 
frustration due to lack of support, from their health care professionals. Every participant in 
this study conveyed ‘frustration’ over the support, or lack of support, which they received 
from their health care professionals. Several women expressed having to ‘push’ for tests to 
diagnose their PCOS after they presented at their doctors with symptoms. This is illustrated 
by Dawn in the quote below who presented with symptoms of hirsutism and infertility. 
 
I think I became a right pain in the butt to the, my doctors because I kept going on ‘I think 
something’s not right’, you know, erm and obviously they just, they just kept fobbing (sic) me 
off. You know, ‘you’ll grow out of it’, erm and I think it was, it was because I started getting 
erm like quite a heavy moustache on my top lip….I couldn’t fall pregnant after six months 
that they actually put me through for a scan. Erm so, yeah so then  I reckon yeah it’s when 
they found out that I had the little string of pearls going on [Dawn, 36] 
 
Kitzinger and Willmott (2002) also found that participants in their study felt frustrated about 
delays in diagnosis, perceived health professionals as unwilling to take symptoms seriously, 
and felt that there was a lack of information provided by health professionals. Holly, in the 
quote below, describes a similar experience of having to push her doctors to send her for the 
correct tests to diagnose her PCOS. 
 
Erm I, I think that, thank God I’m not a hypochondriac ‘cause I was really pushing for the 
test and pushing you know I knew there was something wrong, I knew I wasn’t right and erm 
doctors will make you think like, you’ll feel like you’re making it up, like it’s some great big 
mystery of the female reproductive system and er you know all these symptoms are in your 
head. [Holly, 25] 
 
Emma also discusses below how she felt she was not taken seriously by her health 
professional when she sought a diagnosis. She stresses that had she not been ‘strong willed’ 
she may have believed that she did not have PCOS despite experiencing the symptoms. 
 
 Erm I think, well I found it fairly upsetting that she wouldn’t believe me when I knew what 
Helen was and I think if I had not been strong willed the way I am, I could very easily have 
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been convinced it wasn’t true erm so it was a bit frustrating when it was, was very obvious to 
me erm that the doctor didn’t seem to take my, she, she was determined it couldn’t be that 
and sort of you couldn’t get any, couldn’t get her to think any further past that.[Emma, 25] 
 
Holly also describes how her doctors made her feel like her symptoms were not real. She 
discusses how she saw several GPs before she was able to take the tests to diagnose PCOS. 
 
I saw a doctor and he said I’ll treat you as if you have got PCOS but I’m not going to do any 
tests and, and this wasn’t good enough. So I went to another GP and she said ‘no absolutely, 
let’s do your tests’ erm and it just strikes me that doctor’s, GPs especially just don’t really 
know anything about PCOS. It’s really odd to find someone that knows as much as me about 
it which is really disheartening and really frustrating [Holly, 25] 
 
Emma similarly describes how she had to visit more than one healthcare professional to get a 
diagnosis of PCOS. 
 
it’s pot luck who you get because my first doctor, my first GP was absolutely shocking, she 
was a nightmare and then surprisingly I went back the next time, I saw a young male doctor 
and he was completely different [Emma, 25] 
 
This experience of visiting several health care professionals before getting a professional 
diagnosis appears to be a common problem for women with PCOS as Crete and Adamshick 
(2011) also reported that women with PCOS in their study felt frustrated by the need to see 
several health care providers to get a diagnosis of PCOS. Similarly, participants in a study by 
Snyder (2006) expressed frustration over the diagnostic process, with participants reporting 
several changes of health care professional before receiving answers. Washington (2005) also 
reported that participants with PCOS expressed disappointment in the lack of knowledge of 
health care professionals and did not receive a diagnosis for many years.  
 
In the quote below Sharon explains how she believed she had PCOS for ten years before she 
received a diagnosis despite visiting several GPs with symptoms of PCOS.  
 
Erm, I thought I had it for about 10 years before I was diagnosed. I went to a variety of GPs 
with weight gain, menstruation problems, hair in places I didn’t want it erm and I was 
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always pushed away. “Oh your testosterone is OK”, go away, basically. It’s just women’s 
problems. Erm, and then I got myself a really good GP in London and he had a particular 
interest in Polycystic Ovaries and he said that even though my bloods come back normal it 
didn’t mean that I didn’t have it and he sent me off for an ultrasound and sure enough there it 
was. So, erm, I was lucky to be in the right place at the right time really. [Sharon, 41] 
 
Relatedly, Sharon states that she was ‘lucky’ to get a diagnosis, rather than a diagnosis being 
something that she ought to have received after presenting at her local health care 
professional with symptoms of PCOS.  In the quotes below Tanya and Dawn also describe 
how they had both experienced symptoms and visited health care establishments for ‘years’.                                                                                                                                                                                                                                                                                                                                                                                                                                   
 
It’s only recently that someone’s actually said to me it’s going to be PCOS erm based on 
symptoms that I’d gone to the hospital with, for years now. Erm but I think it’s when one of 
the doctors come back to me and said ‘yes, it’s now PCOS’. [Tanya, AU] 
 
Erm it was erm, I think, the doctors first started noticing something was wrong with me when 
I was about 13 and I didn’t get official diagnosis until I was about 22. So yeah, that’s how I 
got to know about it. [Dawn, 36] 
 
Participants continued to feel unsatisfied with their health professionals after receiving a 
diagnosis of PCOS. Several participants described how their doctors or specialists did not 
provide adequate information at the time of diagnosis or thereafter. In the quote below Kay 
describes the time she was diagnosed with PCOS and was left with little information from 
health care professionals.  
 
I was confused, really confused…I’d never heard of it before and I was pretty much just given 
a leaflet and kind of sent on my way…I was just really confused and baffled about what I’d 
got. [Kay, AU] 
 
Previous research has similarly reported that women with PCOS claimed that although 
diagnostic tests may have been provided, health professionals failed to provide any 
information on the development of their PCOS or the condition itself, leaving the women 
with uncertainties over their condition (Crete & Adamshick, 2011). Likewise Snyder (2006) 
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reports women with PCOS in their study felt that not enough information was made available 
to them by their health care professional.  
 
Marie similarly experienced a lack of information at the time of diagnosis, and how due to a 
lack of impact on her life at the time, she did not understand the condition fully. This quote 
also reflects the theme Changing Nature of the Condition, whereby participants PCOS 
symptoms change over time.  
 
I didn’t know what it was so at the time I just sort of, because it didn’t really affect me too 
much at the time, I just sort of thought it was something small 
 
Marie continues to describe how she felt frustrated when she was diagnosed at a young age as 
she did not understand her condition and, therefore, put full trust in the doctors ultimately 
leading to Marie receiving the wrong treatment. Marie states in the quote below “I didn’t 
know what to ask him for”. This suggests that she needed more information and support in 
order to ask the doctor for specific help with her condition.  
 
I was diagnosed earlier but also it’s quite frustrating sometimes cause obviously I was 
growing up and I didn’t understand it much so I was just doing whatever the doctors told me 
and they weren’t very good at all cause I used to go to erm the children’s unit…and the 
doctor I had there was really bad because he put me on the contraceptive pill and then its, 
the next time I went they took me straight off it saying I should never have been put on it 
because I was too overweight but he was the one who put me on it. So that was really 
frustrating, I just didn’t know what to do, I didn’t know how to help myself. I didn’t know 
what to ask him for. [Marie, 20] 
 
Participants in Crete and Adamshick’s (2011) study also stated that they did not know what 
questions to ask their health professional at the time of diagnosis. Moreover, Barry, Bradley, 
Britten, Stevenson and Barber (2000) found that only four of 35 patients in their sample 
discussed everything they wished to with health care professionals in their appointments. 
This, they suggest, leads to patients needs not being addressed appropriately. Morgan (2008) 
also reports that patients are often passive and unquestioning during initial hospital 




Marie later continues to describe how she failed to discuss the ‘list’ of things she would like 
to discuss with her doctor. 
 
I’ve always, whenever I go to the doctors I’ll always sort of prepare a list in my mind of what 
I want to tell them about erm but when I get there I’m not, either I’m too embarrassed to say 
or I just think there’s like too much to talk about and there’s nothing that they’ll be able to do 
and there probably is but I’ll just, won’t say anything erm so I’m very closed off with my 
doctors as well. [Marie, 20] 
 
Ogden (2012) suggests that delays in help-seeking, exampled in the quote above by Marie 
‘I…won’t say anything’, can undermine health care professionals as its make it difficult for 
them to treat the problem. One reason people may delay seeking help from a health care 
professional is due to the cost/benefit analysis of going to the doctor (Ogden). This is 
exampled by Marie in the quote above who did not discuss issues she wished to raise with her 
doctor, as she deemed there to be ‘nothing’ they could do to help. Quill (1989) suggests that 
lack of openness by health care professionals, can have a negative impact on data gathering 
and implementation of treatment in a health care setting. In modern day consultations, Ogden 
(2012) suggests the patient and health care professional are involved in a communication 
process. Furthermore, Bensing and Verhaak (2004) suggest that adequate communication is 
essential for effective ‘doctoring’. However, they also propose that patients are more likely to 
disclose information to health care professionals who show empathy. As such, there is a need 
for health care professionals to encourage patients to express and articulate their needs in 
order to overcome communication barriers (Bensing & Verhaak; Ogden; Quill, 1989).  
 
Holman and Lorig (2004) propose that with the rise of long-term illness both the patient and 
the health care professional have new responsibilities and roles that are not applicable to 
issues associated with acute illness. Specifically, health care professionals take the role of a 
teacher who will enable the patient to develop the skills needed to self-manage their condition 
over time. Therefore, both health care professional and the patient have new responsibilities: 
the patient has a responsibility use medications properly, change behaviour to improve 
symptoms, and interpret their symptoms. Barlow et al. (2002) similarly suggest that health 
care professionals should take time to foster patients’ self-management abilities and ensure 
they are maintained. Jallinoja et al. (2007) similarly found that health care professionals 
working with patients with long-term conditions (diabetes and hypertension) believed that 
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self-care and lifestyle related decisions were the patient’s responsibility. As such, whilst the 
patient should be encouraged to be responsible for their own condition management, the 
health care professional should also provide a supportive environment which gives patients 
the skills to self-manage. Glasgow, Davis, Funnell and Beck (2003) differentiate this as a 
responsibility to the patient and not a responsibility for the patient.  
 
This theme replicates the findings of Chapter Three whereby women with PCOS felt 
unsupported and frustrated by their health care professionals and the lack of information they 
provided. This suggests that health care professionals need to be more supportive of women 
with PCOS and that there is a need for them to recognise the impact of this condition, and co-
morbid conditions, on the individual’s daily life. However, women with PCOS must also 
engage in communication with their health care provide to allow for effective treatments and 
support to be given. Future research exploring these phenomena from a health care provider’s 
perspective may help shed new light on this problem and how this may be improved.  
 
4.4.3.2 Self-Support 
Several participants in this research resorted to supporting themselves through researching 
and educating themselves about their condition due to a lack of information and perceived 
support from their health care professionals; these findings are similar to the findings of the 
Chapter Three theme Education. 
 
Dawn describes below how she feels that when she was diagnosed, she was not given an 
adequate explanation, by health care professionals, about her condition. She also discusses 
how she feels she was just given a label of ‘polycystic ovaries’ and consequently, was left to 
research her condition and educate herself about PCOS.  
 
It’s just like we’ve got this, this label of polycystic ovaries and but there’s not a lot of 
explanation and that was about, oh goodness me, that was about 15 years ago and it was up 
to me to sort of like try and research as much as I could on it. [Dawn, 36] 
 
Marie, as mentioned in the theme Health Care Professionals above, describes how when she 
was diagnosed, at 14 years old, she was unaware of ‘all of the effects’ of PCOS. However, it 
was only through doing ‘loads of research on it’ that she became more aware of PCOS and 
the effects the symptoms may have. She also states that it did not bother her ‘at the time’; this 
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suggests that the impact of PCOS, or relevance of the condition to a person, can change 
throughout an individual’s life. This is similar to the findings of the previous theme, 
Changing Nature of the Condition. 
 
I didn’t know, obviously cause I was only 14, I didn’t know what it was erm, so, at the time I 
just sort of, because it didn’t really affect me too much at that time, I just sort of thought it 
was just something, small, erm, but then I did loads of research on it and found out all of the 
effects it has and its obviously now that I (?) a lot of the symptoms are a lot harder to handle 
now but erm, yeah, at the time it didn’t bother me too much. [Marie, 20] 
 
Holly also proactively researched her condition using books and the internet (blogs) after 
receiving a diagnosis which allowed her to create her ‘own action plan’ in order to be better 
able to manage her condition. She explains that although there is ‘a wealth of information out 
there’ this is not from health care professionals but from women with PCOS who are ‘doing it 
themselves’.  
 
So when I got the diagnosis it made me, you know, I could go out and read the books and 
read the blogs and come up with my own action plan; which I did…So it really does, there’s 
such a wealth of information out there, but unfortunately it’s not from the medical erm 
industry, it’s from people doing it themselves, people who want to cure it naturally. [Holly, 
25] 
 
Later in the interview Holly goes on to discuss that doing her own research and trying new 
ways to manage her symptoms can become ‘exhausting’. She also describes how if new 
methods do not work it can lead her to go ‘back down to that low place’, suggesting that the 
trial and error process which results from self-support methods, like research, can be trying 
on women with PCOS. 
 
I do lots of research and I think oh I’ll try this. I’ll try something new and you kind of rally 
yourself to do new things and then you realise it’s not going to work, it’s not working then 
you go back down to that low place and then you’ve got to rally yourself up again to try 




Similarly to Holly, and to participants in Chapter Three, Tanya discussed how after diagnosis, 
she attended a conference on PCOS held by a UK PCOS charity and this helped her to 
manage her symptoms. 
 
It’s for me to go away now and, and try the creams and take the tablets and beginning to 
research it and go to conferences and things like that. [Tanya, 39] 
 
These findings are similar to those of Snyder (2006) who found that women with PCOS 
actively searched for answers without the help of a health care professional. Similarly, Crete 
and Adamshick (2011) also found that participants in their study discussed formally 
searching for answers through the use of online resources and books, supporting the findings 
of this study which suggest that women with PCOS self-educate. This suggests that women 
with PCOS are not receiving adequate support from their health care professional and are 
instead seeking out health care information independently.  
 
4.4.3.3 Relationships 
Several participants found support and information from other women with PCOS by using 
online support groups available through social networking websites such as Facebook. This is 
reflects the findings of Chapter Three of this thesis.  
 
Holly found support from women with PCOS online, as described in the quote below, 
claiming that they have ‘more knowledge’ than her family, are ‘more understanding’ and ‘so 
supportive’. The quote demonstrates how although Holly’s family were ‘supportive’ they 
were unable to ‘understand’ her condition in a way that other women with PCOS could. This 
suggests that using support groups of this kind can help reduce feelings of loneliness or 
isolation in women with PCOS.  
 
I think erm these women have er more knowledge than my family about it and they’re more 
understanding. My family are supportive but they don’t understand it at all. Even my sister 
whose got PCOS, she has, she hasn’t really got any symptoms other than a bit of excess hair. 
She’s never even researched it because she doesn’t feel she needs to but these women online, 




This concurs with Holbrey and Coulson (2013) who found that participation in an online 
support group for women with PCOS can help women feel empowered as it allows them to 
connect with other women with the condition and enables them to access information and 
advice. Percy et al. (2009) also found that women with PCOS who took part in face-to-face 
support groups valued the opportunity to gain information from the group.  
 
Tanya, as mentioned in the sub-theme Self Support, found support in the form of relationships 
with other women with PCOS through conference attendance. 
 
I went to a conference…there were so many other women there who were in exactly the same 
position as me…It’s very reassuring, as I don’t feel like I’m alone. I feel like there are people 
I can talk to other than my husband and friends and family and like I can actually identify 
with something. [Tanya, 39] 
 
Tanya also described the support she receives from her husband (in the quote below) 
particularly when she does not feel confident or feels paranoid that other people may see her 
symptoms. 
 
My husband, God, loves me more than anything and he is the most understanding thing 
towards this…He’s so wonderful about it…if he knows that losing weight will decrease 
symptoms and make me feel a happy person: he’s all for it, I think he will do anything. 
[Tanya, 39] 
 
Other participants described the support they received through relationships with female 
family members. For example, Emma discussed how through discussions with her mother 
and her cousin who also has PCOS, she decided to visit a healthcare professional. 
 
My mum, ‘cause my cousins got it [PCOS] and my mum independently had a conversation 
with me because we assumed that actually that might be what’s happening…and then my 
cousin saw her, she told my mum separately ‘I think Emma’s got PCOS’ [Emma, 25] 
 
Later in the interview, Emma refers to her cousin’s experience of PCOS and how this helped 
her feel less anxious about being diagnosed, and she also discusses how she will speak to her 
cousin about her PCOS. 
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I knew what it was so I wasn’t anxious about getting the results [Emma, 25] 
 
Every now and again my cousin will have a talk; we’ll chat about it [Emma, 25] 
 
Holly also describes her experiences with her mother and the support she received from her. 
She describes how her mother ‘gets the brunt of it’ partly because of the familial relationship 
and also because her mother is a nurse, and therefore, arguably more knowledgeable about 
PCOS. In contrast, Holly (below) describes how her husband ‘doesn’t understand it in the 
slightest’ but that he ‘bears the brunt’ of her mood swings and complaints about the 
symptoms of PCOS.  
 
Erm yeah I think for me it’s been a long, long road of getting diagnosed, now still I don’t 
particularly feel anywhere near the end of my journey if you like. Like with being happy with 
having PCOS and my mum especially gets the brunt of it because she, well she’s, she was a 
nurse and she’s my mum. She understands and she’s there to listen to me erm but I, I do 
moan to her about it quite a lot and my husband doesn’t understand it in the slightest but he 
bears the brunt of my bad moods and you know if my skin is really hurting one day, he’ll get 
it in the neck for about half an hour while I moan about it. [Holly, 25] 
 
Washington (2008) also reported that participants with PCOS found that their mood swings 
had an impact on their relationships with their spouses and family members.  
 
One participant, Marie, described how in her current relationship her partner was unaware of 
her PCOS and how this had caused ‘problems’ for her and led her to feel ‘insecure’ about her 
body, consequently she would not allow him to touch her ‘in certain places’. However, in her 
past relationships, Marie describes how she was ‘open about’ her PCOS ‘straight away’ and 
this enabled her past partners to ‘understand’. This suggests that for Marie it was difficult to 
talk about her condition to her partner, which may lead to her feeling isolated or withdrawing 
from the physical aspects of their relationship.  
 
Erm, well I’ve only had 3 relationships and the first two it didn’t affect them as I was very 
open about it straight away and I said I’ve got PCOS which is this and they understand but 
the relationship I’m in at the moment it is causing problems for me because I’ve, for some 
reason I haven’t got round to having that conversation of letting him know that I’ve got it so 
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I’m still really switched off and insecure about my body, I won’t take my clothes off in front 
him and I won’t let him touch me in certain places. [Marie, 20] 
 
Friedman (2002) describes this situation, where an individual with a long-term condition 
where the symptoms are not visible to other people chooses not to disclose their condition, as 
‘passing’ (p.197). Charmaz (1997) defines passing as ‘functioning without detection of either 
the illness or its effects’ (p.66). Certainly, Friedman suggests that when a person engages in 
passing, it can cause anxiety when the time comes for the individual to reveal their condition 
to another comes. In addition, Friedman suggests that passing can cause anxiety for the 
individual as it may lead to them questioning whether they will be accepted once they reveal 
their condition, as is demonstrated by Marie in the quote above. This also reflects findings of 
the theme Relationships in Chapter Three. 
 
These findings suggest that women with PCOS may become isolated or withdraw from their 
relationships, although some of the participants in this study were open about their condition 
and felt supported by their families and partners. In this study the women also found support 
from other women with PCOS and deemed this to be a unique level of understanding and 
awareness of their condition. There is a need, therefore, for further research which explores 
the different relationship dynamics women with PCOS may have in order to gain a better 
understanding of how they experience these differing relationships. This is supported by, and 
builds on, the findings of Chapter Two.  
 
4.4.4 IDENTITY 
4.4.4.1 Feminine Identity 
Six participants (Tanya, Dawn, Emma, Julie, Marie and Kay) discussed their PCOS in 
relation to their identity as a woman. Washington (2008) similarly found that for women with 
PCOS the condition could have a negative impact on their self-concept including their self-
image and their femininity. This is also supported by the findings of Chapter Two; many 
women with PCOS perceive themselves as unfeminine.  
 
In the quote below Tanya describes how instead of feeling ‘sexy’ or ‘attractive’, because of 
her PCOS, she feels like a ‘man’. She states that she feels ‘like a freak’ because of her PCOS 
and its symptoms, suggesting she thinks she is abnormal because of her condition. Kitzinger 
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and Willmott (2002) also found that their participants described themselves as a ‘freak’ 
because of the symptoms of their PCOS such as hirsutism. 
 
I think, as a woman, you, you want to feel sexy. You want to feel attractive to the opposite sex. 
I think when you have these problems, you don’t. You feel like a freak. You feel like a man. 
[Tanya, AU] 
 
A number of women talked about having masculine attributes due to symptoms of PCOS, 
threatening their identity as a woman, as demonstrated by Dawn and Emma in the quotes 
below. This is supported by the findings of Chapter Three whereby women with PCOS can 
see themselves as unfeminine, often using male language and terminology to refer to their 
PCOS and its symptoms. 
 
I’ve got a very good sense of humour about it because sometimes I swear I’m just like one 
penis away from turning into a guy. [Dawn, 36] 
 
It’s always at the back of my mind that I’m waiting for the day when one of them is drunk and 
particularly aggressive and mentions it erm and makes some comment along the lines of 
bearded lady or God knows what they’d do. [Emma, 25] 
 
Marie also describes how her PCOS symptoms, in addition to having smaller breasts, make 
her feel ‘less of a woman’.  
 
‘cause of not having periods and hormones being all screwed up, I’ve never really developed 
any breasts. So now at the age of 20 I fell it’s another thing on the list of things that make me 
feel less of a woman because I don’t have breasts and I’m hairy and erm so that’s another 
thing that gets me depressed [Marie, 20] 
 
This impact of PCOS on feminine identity has been identified in the literature a number of 
times. Washington (2008) describes how their participants felt that PCOS negatively 
impacted on all areas they associated with being a woman because of the symptoms of PCOS 
such as obesity, hirsutism, alopecia and infertility problems. Snyder (2006) also found that 
women with PCOS felt that their symptoms impacted on their perception of themselves as 
female. Snyder reported that women with PCOS wanted to be normal and look more 
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feminine. Castillo (2008) also described how women with PCOS in their study did not like 
feeling like less of a woman because of their PCOS. Moreover, Kitzinger and Willmott 
(2002) found that women with PCOS felt challenged in their perception of themselves as 
women because of their symptoms. Several participants in this study also considered 
themselves as not ‘real women’ or as broken due to their PCOS and its symptoms, 
particularly infertility.  
 
Julie felt that she was not ‘a real woman’ because she found it difficult to breast feed her 
baby, which she felt was due to the symptoms of PCOS.  
 
Erm but that, that again, that was something it was like oh well you know a real woman 
would be able to breast feed their baby, I mean that’s what you have babies for is to be able 
to feed the child and I can’t even do that and erm I beat myself up with so many polycystic 
ovaries sticks. [Julie, 36] 
 
Kitzinger and Willmott (2002) similarly describe how women with PCOS in their study 
found their inability to conceive differentiated them from other women. Later in the interview 
Julie (below) again described how she felt like she ‘wasn’t a real woman’ because she 
struggled to conceive due to her PCOS. This led her to self loathe which she believes was 
then ‘exacerbated’ by the difficulty she found in feeding her child. She describes how she felt 
‘utterly inadequate’ and ‘a waste of space’ because she found conceiving and feeding her 
child difficult and felt that ‘everyone else can do it’. This quote demonstrates how women 
with PCOS can compare themselves to other women and perceive themselves as having less 
worth because of their condition and its impact on their life. Negative upward social 
comparison, in this case to women perceived as being ‘normal’, has been shown to be 
negatively related to quality of life and to have a negative impact on adjustment to long-term 
conditions (Dibb & Yardley, 2006).  
 
I just sort of feel like well I obviously wasn’t a real woman because I couldn’t do the children 
bit erm and, yeah, I think there was quite a lot of self-loathing going on really erm and then 
that was, that was sort of exacerbated when I couldn’t feed her myself. Erm, that again it was 
just, just feeling utterly inadequate. I mean inadequate isn’t even a good enough word to 
describe how inadequate I felt. Erm, yeah, I mean literally it was just feeling like just, just a 
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waste really, a waste of space because all these things that mentally you’re saying everyone 
else can do it. [Julie, 36] 
 
For Julie, her difficulty having children led her to see herself as ‘less of a person’ and ‘not a 
real person’, demonstrating the impact that having PCOS can have on an individual’s 
perception of self.  
 
I think Rob probably does, not in, not in the way that I did which was I’m less of a person and 
I’m not a real person cause I can’t have, you know, procreate [Julie, 36] 
 
Dawn similarly did not ‘feel very womanly’ because of her difficulty to conceive. She 
describes how she feels that women are ‘designed’ to have children and ‘look feminine’, and 
how the PCOS symptoms of hirsutism and alopecia do not allow for this.  
 
Well yeah I just don’t function properly do I? You know I, I feel, I try not to think about it too 
much because otherwise you will flump won’t you but I don’t feel very womanly at all, you 
know erm, you know we’re designed as a woman aren’t we to have children, look feminine 
and not have hair sprouting from everywhere apart from the top of your head if you like. 
[Dawn, 36] 
 
Tanya, in the quote below, also felt like there was ‘something wrong’ with her because of her 
PCOS. She describes how having the condition makes her ‘feel like a freak’.   
 
When there’s something wrong with you like this especially, it’s such a socially unacceptable 
thing to have, you do feel like a freak and you think you’re the only person out there.  
[Tanya, 39] 
 
Kay, similarly, feels like she is broken because some ‘things that should come naturally as a 
woman’ don’t. She adds that because of her hirsutism and weight, her ‘self-image’ is low 
and, as a result, she feels like she is ‘broke’. This suggests that PCOS can have a negative 
impact on a woman’s self-image. Indeed, Washington (2008) also found that the participants 




You almost feel like you’re broke erm some of the things that should come naturally as a 
woman, don’t and are never going to and erm so your self-image is quite low erm… weight 
and hair, confidence erm so that’s quite hard at times. Erm yeah, it’s, I was, I always kind of 
feel like you’re broke. That’s how I would explain it. [Kay, AU] 
 
Likewise, Julie described herself as not working when explaining her inability to have 
another child to her daughter.  
 
I just said erm “unfortunately sweetheart mummy’s equipment doesn’t work, so I can’t” we 
always called it cooking; “I can’t cook any more babies I’m afraid. So I’m afraid we won’t, 
you won’t be able to have a brother or a sister”. [Julie, 36] 
 
4.4.4.2 Us and Them 
Several participants discussed how they felt it was ‘unfair’ that they had PCOS or its 
symptoms in comparison to other women without PCOS. As mentioned in the theme above, 
negative social comparison is related to decreased quality of life and can also have a negative 
impact on an individual’s adjustment to a long-term condition (Dibbs & Yardley, 2006).  
 
Certainly, Marie discusses how she will compare herself to her friends without PCOS and 
feel that it is unfair that they do not have symptoms as she does. 
 
I live with my friends and I’m thinking, I’ll look at their bodies and think, why aren’t you 
hairy? How have you got such smooth skin? It’s not fair. [Marie, 20] 
 
Tanya, in the quote below, similarly feels that it is ‘really unfair’ that she suffers from PCOS 
and ‘not’ other ‘people’, questioning ‘why’ she has the condition. Similarly, research 
exploring cancer in women has reported that participants felt it was unfair that they had been 
diagnosed with cancer (Fitch, Godel & Labrecque, 2008) over other people, and questioned 
‘why me’ (Taylor, Outlaw, Bernado & Roy, 1999). Kralik, Brown and Koch (2001) similarly 
found that when women were diagnosed with breast cancer they were initially shocked they 
asked ‘why me?’, however, as they came to terms with their condition and gained more 
information the shock subsided. This suggests that as individuals accept their condition, they 




I do wonder a lot, why me? Why, why did I have to it and not, and not people? I don’t know 
anybody else whose got it er and part of me does feel like my bodies let me down and, and it’s 
really unfair. [Tanya, 39] 
 
Holly also mentions that it is unfair when discussing PCOS in comparison to other women, 
particularly in relation to the fertility symptoms of PCOS. Previous research exploring the 
experience of infertility has also found that participants felt it was unfair that they were not 
able to have children (Cooper, 1993; Redshaw, Hockley & Davisdson, 2007).  
 
It’s just, it feels really unfair. It feels like some women just sneeze and get pregnant…it’s so 
unfair. I just don’t know, understand why PCOS chooses some people and not others. [Holly, 
25] 
 
Holly also questions ‘why’ she has PCOS, as opposed to others, describing it as a ‘horrible’ 
condition. Holly also expresses frustration at the lack of information and ‘explanation’ about 
the causes of PCOS. 
 
Like I said before, I always think why me? I think it’s just such a horrible thing to have erm 
and there’s no real explanation as to why you’ve got it which makes it so frustrating. [Holly, 
25] 
 
It’s just time consuming and frustrating and I wish I could be like normal people who don’t 
have to do this. [Tanya, 39] 
 
I suppose you have to think more about things rather than when other people wouldn’t really 
give, like other women and stuff probably wouldn’t give thoughts to.  [Debbie, AU] 
 
Snyder (2006) found that women with PCOS identified themselves as different to women 
without the condition. Similarly, in the quote above Tanya demonstrates how women with 
PCOS may compare themselves to ‘normal people’ without the condition. Debbie also made 
comparisons to other women without PCOS. In accordance with the theme Feminine Identity, 
the participants made social comparisons that could have a negative impact on the quality of 
life and adjustment to the condition (Dibb & Yardley, 2006). Weiss and Bulmer (2011) 
148 
 
similarly found in their study exploring the experience of PCOS in young women, that 
participants identified themselves as different from women without PCOS.  
 
4.5 Discussion 
This research attempted to explore and gain an understanding of how women with PCOS in 
the UK live with and perceive their condition, and any co-morbid conditions on a day-to-day 
basis. A thematic analysis of the data produced four themes: Change (Change to Life Plans 
and Changing Nature of Condition), Co-morbidities (Living with Other Conditions and 
Depression and Self-harm), Support (Health Care Professionals, Self-Support and 
Relationships) and Identity (Feminine Identity and Us and Them). The themes of Support and 
Identity have been discussed previously in the literature (Kitzinger & Willmott, 2002; 
Snyder, 2006) and in Chapter Three of this thesis. However, this research is the first to 
explicitly explore women’s experiences of living with PCOS and presenting co-morbid 
conditions on a daily basis. 
 
This research is the first to report how women with PCOS perceive their condition as 
impacting on their life plans, for example, having children. Whilst this is the first study to 
discuss this phenomenon in women with PCOS, wider literature surrounding long-term 
conditions suggests long-term illness may jeopardise an individual’s accomplishments of 
goals (De Ridder, 2004). This impact of illness on an individual’s personal goals has been 
suggested to also have an impact on an individual’s perception of their quality of life (De 
Ridder) due to the gap between what an individual hopes to achieve (in this study having 
children at a certain time) and their current situation (Calman, 1984). Furthermore, De Ridder 
suggests that this is due to quality of life involving the individual’s subjective evaluation of 
their goals and their attainment. The impact of PCOS on the participants personal goals may 
therefore, have an impact on their quality of life.  
 
Whilst not discussed previously in the PCOS literature, the impact of long-term conditions on 
future plans has been noted in other women’s health conditions including endometriosis and 
diagnosis of the BRCA gene mutation (Denny, 2009; Moradi, Parker, Sneddon, Lopez & 
Ellwood, 2014; Smith, Ellington, Chan, Coyle & Botkin, 2004). Specifically, research 
suggests that women with endometriosis can be uncertain about their futures and their future 
fertility (Denny, 2009; Moradi et al., 2014). However, Young, Fisher and Kirkman (2014) 
suggest that there is still a paucity of research which explores the experience of infertility for 
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women with endometriosis. Similarly, research exploring the fertility intentions of women 
diagnosed with the BRCA1 Gene mutation found that predictive genetic testing for cancer 
susceptibility affects decision-making with regards to family planning (Fortuny et al., 2009; 
Smith et al., 2004). Prevention and treatments for cancer can also impact a woman’s fertility 
(Werner-Lin, 2008). As such, women diagnosed with the BRCA1/2 gene may experience 
similarities to that of PCOS when considering the impact of the condition on the individual’s 
children related goals.  
 
Participants in this study reflected stages of adaption as proposed by De Ridder (2004): many 
of them discussed feelings in line with the crisis and adaption phases of adjustment to life 
with a long-term condition. That is that participants described being distressed as a result of 
their diagnosis and many of them experienced feelings of depression. However, many of the 
participants detailed how they had begun to adapt to their condition. For example, 
participants in this study engaged with adaptive tasks such as sustaining their relationships 
with family and friends, and preparing for an uncertain future (De Ridder). Whilst adaption to 
a condition is difficult to measure, de Ridder suggests one way that it can be measured is to 
assess quality of life. However, as noted in Chapter Two of this thesis, the existing PCOSQ 
(Cronin et al., 1998) is insufficient for measuring quality of life of women with PCOS and as 
such, Chapter Five will detail the development of a new quality of life measure for women 
with PCOS in the UK.  
 
Many of the participants in this study experienced co-morbid symptoms, both physical 
(migraines, IBS, hypermobility syndrome, hypothyroidism and adrenal fatigue) and 
psychological (depressive symptoms and self-harm). Whilst quantitative research has 
demonstrated the prevalence of depression in women with PCOS (Bhattacharya & Jha, 2010), 
this study is the first to report how women with PCOS experience living with this condition 
and other co-morbidities such as depression. Over half of the participants in this study 
discussed depressive symptoms and self-harm however there is little discussion of self-harm 
in the quantitative literature (Hart & Doherty, 2014; Månsson et al., 2008). Further research is 
needed to explore the prevalence of psychological co-morbidities, including depression in 
women with PCOS in the UK. Furthermore, future research should explore the prevalence of 
self-harm in women with PCOS. In addition, a suitable intervention is needed which aims to 
decrease depressive symptoms in this population. Consequently, this thesis shall explore the 
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prevalence of psychological co-morbidities in women with PCOS in the UK (see Chapter 
Six).  
 
This study highlighted that some of the women with PCOS in this study felt under pressure to 
have children. Holly particularly felt under pressure from her health care professionals, 
whereas Kay discusses the pressure of time on her ability to conceive. Overall, participants 
discussed the negative impact that feeling under pressure to have children had on their life 
plans (Williams et al., 2014). Whilst this has not previously been reported in the PCOS 
literature, Moradi et al. (2014) found that women with endometriosis received 
recommendations by health care professionals to have children at an early age. As research 
suggests that infertile women report poor quality of life compared to controls (Monga, 
Alexandrescu, Katz, Stein & Ganiats, 2004) and that they experience similar psychological 
symptoms to those patients with cancer, hypertension and cardiac rehabilitation (Domar, 
Zuttermeister & Friedman, 1993), infertility can arguably have a large negative impact on the 
women who experience it, without the perceived added pressure to conceive from a health 
care professional that Holly experienced. Thus, research is needed which further explores 
how women with PCOS perceive pressure to conceive, and how they experience 
conversations with their healthcare professional with regards to fertility and family planning. 
Moreover, research is needed which explicitly explores how health care professionals discuss 
pregnancy with women with PCOS and the impact of these conversations.  
 
This study invited women with PCOS to take part in focus groups, and then in a face-to-face 
or online interview. In this way, the focus groups would have enabled further exploration of 
topics raised in the focus groups, in addition to those questions detailed in the interview 
schedule. However, potential participants were given the option of choosing whether to take 
part in both parts of the study, or just one, in the event that recruitment for the focus group 
was not successful. During recruitment potential participants demonstrated a reluctance to 
take part in the focus group aspect of the study, or the face-to-face interviews. As such, all 
participants took part in a one-to-one online interview. In general, participants did not want to 
travel or were unable to travel in order to take part in the focus group. Other participants were 
unable to attend a focus group due to work commitments, and consequently, each participant 
opted to take part in the online interview. To overcome this issue in future studies, 
researchers could consider using online technology which facilitates multi-person calls to 




The use of Skype™ interviews in this study meant participants were easily able to take part, 
and the costs were minimal to both the researcher and participant. The online interviews may 
have allowed participants to feel at home, as evidenced by participant’s behaviours, such 
answering doors or watching their children, demonstrating minimal interference in their day-
to-day lives. Participants in this study also discussed being socially isolated, as such, the 
online interviews allowed them to take part in the interviews (Janghorban et al., 2014). Had 
the interviews been in person or at another location, they may not have wished to take part. 
Whilst using Skype™ was a viable method for data collection for this study, there were 
issues with the technology itself (Saumure & Given, 2010) in the form of noise interference 
on calls which could have had a negative impact on the interviews and resulted in missing 
data. This study also used the audio only call option (the participants preference) available 
through Skype™; as such visual cues were not observed which may have limited the data 
collected in this study (Saumure & Given, 2010). Future research should explore the use of 
other online interview methods such as FaceTime for apple users and Google Hangout; this 
allows up to eight users to take part which could help facilitate online focus groups. 
 
While providing an important account of women’s experiences living with PCOS and co-
morbid conditions as this study recruited participants from Facebook support groups, the 
participants were already seeking support from the online PCOS community. As such, the 
sample may not be representative of women who are not seeking support from other women 
with PCOS, or who are not seeking or utilising support from online sources. It is unclear 
what, if any, support participants received for their co-morbidities from either PCOS groups, 
or indeed other support groups on Facebook. Moreover, as the study recruited participants 
online, a clinical diagnosis of PCOS, or any co-morbid conditions cannot be guaranteed. 
Although previous studies have explored the prevalence of specific co-morbidities (including 
diabetes, hypertension, sleep apnea, anxiety, depression) in a population of women with 
PCOS (Bethea & Nestler, 2008; Sirmans, Parish, Blake & Wang, 2014), there remains a need 
for further research which explores the prevalence of clinically diagnosed co-morbidities in 
women with PCOS in the UK, specifically in relation to psychological co-morbidities such as 
depression and anxiety. As such, the study detailed in Chapter Six will investigate the 




Dissemination of these findings could help increase health care professionals understanding 
of the condition, which was reported to be lacking by participants in this study, and the 
previous of chapter of this thesis. Moreover, dissemination of this study’s findings could 
highlight important new areas of research, including: research into the prevalence of self-
harm in women with PCOS and the prevalence of co-morbidities, exploration of how women 
with PCOS manage their condition with co-morbidities, exploration of the perceived pressure 
to conceive, particularly from health care professionals, and development of an intervention 
which may help reduce depressive symptoms in women with PCOS.  
 
This study aimed to further understanding of how women with PCOS in the UK live with and 
perceive their PCOS, and any co-morbid conditions or symptoms, on a day-to-day basis. The 
findings revealed how women with PCOS may experience negative feelings when faced with 
changing their life plan as a result of their PCOS, particularly with regards to family 
planning. Moreover, the participants described how they found their condition unpredictable, 
meaning they had to regularly change their methods of self-management, including 
medications, daily hair removal and skin treatment routines. It also revealed how women with 
PCOS experienced living with co-morbid conditions, both physical and psychological. 
Similarly to Chapter Three, the findings of this study reflected the domains of quality of life 
as detailed by quality of life researchers (WHOQOL Group, 1994; Testa & Simonson, 1996). 
This included the domains of physical and psychological health, level of independence, social 
relationships and environment (WHOQOL Group). Consequently,  the findings of both 
qualitative studies and how they will be used to inform the development of a new PCOS 





Chapter Five -Development of the PCOSQOL: A quality of life measure for women 
with PCOS. 
 
This thesis aims to assess and find ways to improve quality of life for women with PCOS; it 
is therefore necessary to first ensure that there is a suitable way to measure the construct in a 
UK sample. As such, this chapter describes the development of the PCOSQOL, a quality of 
life measure for women with PCOS in the UK. This chapter also describes the testing of the 
validity and reliability of the PCOSQOL for use with women with PCOS in the UK, 
according to scale development guidelines (DeVellis, 2012; Streiner & Norman, 2008). 
 
The findings of Chapters Three and Four suggested that social relationships were of 
importance to the participants. In both studies, the participants discussed a range of personal 
relationships, social support and sexual activity; mirroring the domain of social relationships 
reported by the WHOQOL Group (1994). Moreover, the participants discussed their 
symptoms and the impact they had on them, including pain, and fatigue; these map on to the 
physical health domain reported by the WHOQOL Group. The domain of independence 
(WHOQOL) was also highlighted within chapter three of this thesis in the theme PCOS as 
Controlling which reflected the participants’ dependence on certain supplements or self-
management routines. Many of the women in the qualitative studies described avoiding social 
activities and becoming socially isolated due to their PCOS, reflecting the environment 
domain. Moreover, in both qualitative chapters, participants discussed their body image and 
negative and positive feelings, reflecting the domain of psychological health (WHOQOL). 
The qualitative findings then suggest that PCOS can have an impact on all areas of quality of 
life. The development of the PCOSQOL therefore, aims to be inclusive of all aspects of 
quality of life that may impact women with PCOS (Malik-Aslam et al., 2010), including the 
physical health, psychological health, level of independence, social relationships and 
environment domains detailed by the WHOQOL group (1994).  
 
As the PCOSQ (Cronin et al., 1998) pertains mostly to physical symptoms, it overlooks many 
of the aspects of quality of life raised by women with PCOS in this thesis, as detailed above. 
In 2012 the Amsterdam ESHRE/ASRM workshop argued that research in the area of quality 
of life in women with PCOS has been hampered by the existence of only one validated 
disease-specific questionnaire, the PCOSQ (Cronin et al., 1998). However, the PCOSQ has 
several problematic characteristics which were detailed in-depth in Chapter Two of this 
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thesis. These issues included development of the PCOSQ using an unrepresentative sample, a 
small sample size and inappropriate methods for item reduction. It was also developed for use 
within a US sample, rather than a UK sample.  
 
5.1 Introduction 
In 1998 Cronin et al. developed the 26-item PCOS questionnaire (PCOSQ) in the USA. 
Whilst Cronin et al. did not validate this questionnaire it was later validated by Guyatt, 
Weaver, Cronin, Dooley and Azziz (2004) and Jones et al. (2004): both Guyatt et al. and 
Jones et al. tested the reliability and discriminative validity of the questionnaire. The PCOSQ 
was the first, and until the development of the current measure, the PCOSQOL, the only 
disease-specific quality of life measure for women with PCOS. However, there are several 
issues with the development of the PCOSQ and its use in the UK. The first issue concerns the 
sample used to develop the items for the scale as the initial interviews were conducted with 
patients of three of the authors of the research, meaning that the patients were already in the 
US health care system and getting professional help. However, the participants in the 
qualitative studies of this thesis (Chapter Three and Four) suggested that they were not 
receiving support from healthcare professionals. For example, Lucy stated that ‘Doctors were 
asked about it [her PCOS], and they referred me to Waterstones’. In addition, Dawn 
described how she would ‘avoid’ visiting a doctor if she could. This suggests that the items 
developed are unlikely to be representative of women who have been discharged from the 
health care system and may not be receiving ongoing support from their health care provider. 
 
In line with this, there is a second issue concerning the participant sample and its recruitment 
from the authors patient pool in that the USA has a different health care system to the UK 
(Ferlie & Shortell, 2001; Schoen et al., 2004); women with PCOS in the UK have differing 
health care experiences from those in the USA and therefore their experiences of the 
condition may have a different impact on quality of life. Schmid, Kirchengast, Vytiska-
Binstorfer and Huber (2004) compared quality of life scores in the domains of infertility and 
menstrual cycle irregularities of Austrian women with Muslim women who had immigrated 
to Austria. They found that in these domains, the mean scores of the Muslim women were 
significantly higher than those of the Austrian women. Schmid et al. suggest that the 
differences may be cultural and due to the stronger social pressure for Muslim women to 
have children. This demonstrates how culture may have an impact on the quality of life of 




In the development of the PCOSQ, Cronin et al. (1998) selected items to be included in the 
scale after interviewing 10 women with PCOS and after a review of the literature. However, 
the questionnaire was developed and consequently published in 1998. At this time, there was 
no other qualitative literature, the first qualitative paper being published in 2002 (Kitzinger & 
Willmott), four years after Cronin et al. published their scale. Whilst the authors did conduct 
interviews with 10 of their patients, the items developed may not fully reflect the experience 
of women with PCOS and the impact the condition has on their quality of life. As the next 
qualitative paper exploring PCOS was not published until 2006 (Snyder, 2006), the same 
critique of lack of qualitative research informing the items could be levied at the later 
validations of the PCOSQ (Guyatt et al., 2004; Jones et al., 2004). Moreover, Cronin et al. 
(1998) focused on reviewing the existent medical literature, and thus may have not included 
all aspects of the psychological impact of PCOS on quality of life. Indeed, many of the 
findings of Chapter Three and Four, particularly the impact of PCOS on the psychological 
and social domains of quality of life experienced by women with PCOS, are not reflected in 
the items of the PCOSQ.  
 
Another issue regarding the generalisability of the PCOSQ concerns Cronin et al.’s (1998) 
inclusion criteria when selecting women to interview, requiring patients to have symptoms of 
hyperandrogenism (elevation of testosterone, facial hirsutism and hair growth on the upper 
chest and back) and menstrual disturbance (such as oligomenorrhea and amenorrhea) only. 
This inclusion criterion excludes women with two phenotypes of PCOS as recognised by the 
Rotterdam 2003 consensus on diagnostic criteria (2004), the recommended diagnostic criteria 
for PCOS according to the NIH (2012). Specifically, women who present with polycystic 
ovaries combined with either oligo or anovulation, or indeed, clinical or biochemical signs of 
hyperandrogenism (Rotterdam, 2004) would have been excluded from the interviews and 
therefore, their perspectives would not have been taken into account when developing items 
for the scale. As such, the scale may be unrepresentative of women with PCOS in the UK on 
two fronts: differing experiences of health care systems (a privatised system versus a 
nationalised system) and differing symptom profiles. 
 
Women with PCOS were also excluded from participating in the scale development process 
(from the interviews for item development to validation) if they presented with any other 
major illness that would influence their quality of life. However, as discussed in the previous 
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chapter, women with PCOS are at a high risk of developing other illnesses, often related to 
their PCOS, including depression (Dokras, Clifton, Futterweit & Wild, 2011), endometrial 
cancer (Balen, 2001), diabetes and heart disease (Harris & Carey, 2000). Patients were also 
excluded from this study if they were trying to conceive. As PCOS impacts on women’s 
menstrual regularity and their ability to conceive this consequently excluded a large 
proportion of women with PCOS from the item development and validation stage of the scale 
development, who may have offered a different account of their lives with PCOS.  
 
As a result of the item development stage, Cronin et al. (1998) had a final pool of 182 items 
which they ‘intuitively categorized’ (p. 1977) into eight domains. However, it is not clear 
how this categorisation was completed. The eight domains included: symptoms (47 items), 
emotions (43 items), social contacts and leisure activities (22 items), marital/partner sexual 
relationship (15 items), dating relationship (12 items), sexual functioning/sexuality (13 
items), vocation/financial issues (15 items), and family/friends relationship (15 items). As 
such, the domains associated with the pool of items prior to item reduction were reflective of 
some domains of quality of life as detailed by the WHOQOL group (1994) including social 
relationships, physical health, environment and psychological health. However, during the 
item reduction stage of scale development, Cronin et al. (1998) detail that they specified that 
each domain on the scale should include four items; suggesting that the authors generated 
their own factor structure. Although the authors did use factor analysis within the item 
reduction phase, their aim was to place scale items in a domain and not to determine scale 
factors. Cronin et al. (1998) also detail the analyses they performed on their data; including a 
factor analysis on all items endorsed by 50% of the respondents. One hundred participants 
were included in the item reduction stage, however, research (Comrey, 1973; Field, 2013; 
Worthington & Whittaker, 2006) suggests that a sample size of 300 should be used for factor 
analysis. As such, of those items developed for the measure, Cronin et al. limited them first 
by pre-deciding the factor structure and then by only using items that were endorsed by half 
of the sample, which was arguably already limited due to the sample being unrepresentative 
of all phenotypes of PCOS. Malik-Aslam et al. (2010) similarly criticise this inclusion criteria 
for items and suggest that due to this cut off, many important issues that can impact on 
quality of life for women with PCOS may have been excluded.  
 
Cronin et al. (1998) also fail to detail the number of participants included in the reduced item 
factor analysis after the initial items were removed, this further suggests that there was an 
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insufficient sample size to run a factor analysis. In addition, the factor analysis used by 
Cronin et al. (1998) is problematic; the authors used a principal components analysis (PCA) 
to analyse their data which assumes that there is no measurement error (Field, 2013). The 
authors also repeated the factor analysis using a varimax rotation suggesting that the items are 
independent and unrelated. However, for any data involving humans or exploring 
psychological constructs, in this case women with PCOS and quality of life, a varimax 
rotation should not be used (Field). Indeed, Field suggests that ‘there are strong grounds to 
believe that orthogonal rotations are complete nonsense for…data involving humans’ (p.644) 
due to the assumption that there is no relationship between the items.  
 
As mentioned, in 2004 Guyatt et al. conducted a study to validate the PCOSQ, finding 
evidence of discriminative and longitudinal validity. However, the methods used by Guyatt et 
al. to validate the scale are also of concern. Primarily, patients involved in the validation of 
the PCOS were principally involved in a randomised controlled trial (RCT) exploring the 
effectiveness of Troglitazone (an anti-diabetic and anti-inflammatory drug) for the treatment 
of PCOS. Participants in this study were, therefore, already participating in research which 
may mean that they felt more supported than those experiencing routine care, or those outside 
of the health care system. The authors do recognise, however, that the PCOSQ may perform 
differently with patients outside of a clinical trial; as such, further validation of the PCOSQ 
with a non-clinical sample would still be required. In addition, as with the development 
sample, the validation sample was recruited from a US patient sample. Moreover, the only 
health related quality of life measure used within the validation was the PCOSQ, so the 
authors were unable to test the construct validity of the PCOSQ.  
 
Guyatt et al. (2004) recognised several limitations with their validation of the PCOSQ, 
including the limited ability to make generalisations due to the lack of demographic 
information collected from participants (including symptom profile). In addition, the authors 
suggested that the scale may be unresponsive to change as it failed to find a difference in 
health-related quality of life in two of the five domains after a treatment intervention. 
Moreover, Guyatt et al. reported weak correlations between the PCOSQ and other measures 
(including measures of hair growth and menstrual cyclicity). As these traits are related this 
suggests that the PCOSQ has poor discriminative validity. Guyatt et al. also recognised that 
there is a need to test the construct validity of the PCOSQ with other health-related quality of 




An additional issue with the later validation (Guyatt et al., 2004) of the PCOSQ was the 
inclusion criteria used; as the authors failed to include women with PCOS who may have 
presented with polycystic ovaries, a recognised symptom of PCOS according to the 2003 
Rotterdam criteria (2004). Patients were also excluded from this study if they were diagnosed 
with other disorders and if they were trying to conceive. Consequently, this excluded a large 
proportion of women with PCOS from the validation study. This suggests that the PCOSQ 
does not accurately represent quality of life for women with PCOS due to the restrictive 
exclusion criteria of the initial scale development and Guyatt et al.’s validation, which 
excluded women presenting with specific phenotypes of PCOS, women with PCOS who 
were trying to conceive and women with PCOS who experienced other disorders. 
 
To confirm the structure of the PCOSQ as developed by Cronin et al. (1998), Guyatt et al. 
(2004) used the same limited development approach, a PCA and a varimax rotation. In 
addition, the factor analysis matrix presented in the Guyatt et al. (2004) paper, demonstrates 
that seven items load onto two factors or more, with one item loading on to three factors. 
Streiner and Norman (2008) advise that items which load on to two or more factors are likely 
to be ‘tapping something other than what the developer intended’ (p.96) and that these items 
should be discarded or rewritten. Guyatt et al. recognise several other issues with their 
validation of the PCOSQ. One example is the weak correlations between the PCOSQ and 
other measures (including measures of hair growth and menstrual cyclicity). Moreover, the 
authors suggest that the scale may be unresponsive to change. In addition, Guyatt et al. 
identify that there is a need to test the construct validity of the PCOSQ with other health-
related quality of life measures. However, this was later partly completed by Jones et al. 
(2004) using the SF-36, a measure designed to survey health status (Ware & Sherbourne, 
1992). 
 
Overall, Jones et al. (2004) concluded that the PCOSQ was a reliable measure for health-
related quality of life in women with PCOS with Cronbach’s alphas ranging from 0.7-0.97 for 
all scales on the PCOSQ. The PCOSQ total score also correlated well with the SF-36 total 
score (r=0.49); though Jones et al. stated that the validity of the questionnaire needed to be 
improved by including a dimension of acne into the instrument. Similarly to Cronin et al. 
(1998) and Guyatt et al. (2004), Jones et al. excluded women with PCOS from their 
validation study if they experienced any other conditions. Moreover, participants were 
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recruited from a gynaecology clinic which the authors recognise may bias the participant 
sample towards women presenting with menstrual disturbances and infertility. As such, Jones 
et al. also failed to validate the PCOSQ with a representative sample of women with PCOS, 
including women with co-morbidities and those women who do not experience symptoms of 
menstrual disturbance or infertility.  
 
Jones et al. (2004) did, however, attempt to gain reliability data in the form of a test-retest, 
asking participants to take part in a retest in order to look at the reliability of the scale over 
time. However, the retest occurred only three to six days after participants had completed the 
baseline measures. The time allowed in the retest was criticised by Malik-Aslam et al. (2010) 
who suggest that the time between the first and second administration of the PCOSQ was 
unusually short, questioning the length of the retest period, particularly as the recall period 
for the PCOSQ is over the last two weeks; meaning that the period of time considered by 
participants at baseline and at re-test overlapped. Although a three to six day retest period is 
adequate for scale development (Streiner & Norman, 2008) it could be considered 
inappropriate for a PCOS specific measure as women with this condition often experience 
irregular or absent menstrual periods (Elsenbruch et al., 2003); therefore a three to six day 
retest would not be considerate of participant’s menstrual cycles.   
 
Jones et al. (2004) also attempted to assess face validity of the PCOSQ by interviewing 
participants. One concern raised by participants was that the PCOSQ implied that PCOS was 
a short term condition. Although Jones et al. provide no further detail of this participant 
feedback, it may be that this is due to the length of the recall period (the last two weeks) that 
participants are asked to consider in relation to their PCOS when answering items in the 
PCOSQ. Similarly to Cronin et al. (1998) and Guyatt et al. (2004); Jones et al. also attempted 
to verify the factor structure of the PCOSQ using a PCA and varimax rotation. In addition, 
they performed these tests with a small sample size of only 82 participants. Coaley (2010) 
suggests that when using a small sample size in validity testing, there is a risk of a larger 
amount of error. Whilst the authors recognise the limitation of a small sample size, the issues 
of using a PCA, varimax rotation and a sample size of less than 300 for scale development, 
which have been discussed previously in this chapter, remain.  
 
Further criticism of the PCOSQ comes from Malik-Aslam et al. (2010) who carried out a 
systematic review of nine published papers (including the three discussed in this introduction) 
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which aimed to identify PCOS specific quality of life measures and establish whether their 
development history and measurement properties supported their use in clinical trials. At this 
time there was only one PCOS specific quality of life measure, the PCOSQ. They state that 
there is a lack of evidence to attest to the suitability of the PCOSQ in terms of overall face 
and content validity. The convergent validity was found to be satisfactory, although this was 
only explored in two of the nine papers and responsiveness to change was only examined in 
one of the nine papers (Guyatt et al. 2004). Crucially, Malik-Aslam et al. claim that the 
PCOSQ is inadequate to assess the impact of PCOS on quality of life (Speight & McCann as 
cited in Malik-Aslam et al.), based on their own research. Indeed, they suggest that the 
PCOSQ would be better conceptualised as a measure of symptom bother and psychological 
well-being rather than a measure of quality of life.  
 
The WHOQOL group (1994) propose that there are six domains of quality of life: physical 
health, psychological health, level of independence, social relationships, and environment and 
spirituality/religion/personal beliefs. Previous quality of life measures by the WHOQOL 
group have included psychological, physical, social, environmental and independence 
domains (WHOQOL Group, 1994; 2004). Fayers and Machin (2001), similarly, suggest that 
when developing a health status instrument there should be at least physical, emotional and 
social domains. The PCOSQ (Cronin et al. 1998) includes five subscales: emotions, body 
hair, infertility, weight and menstrual problems. Jones et al. also suggested in 2004 that an 
additional acne domain should be added to the questionnaire. However, even with the 
addition of an acne domain, the PCOSQ is overwhelmingly focused on the physical impact of 
the condition with four domains (body hair, infertility, weight and menstrual problems) on 
the impact of symptoms, falling within a largely physical domain of quality of life (Fayers & 
Machin, 2001; Testa & Simonson, 1996; WHOQOL Group, 1994).  
 
The items in the PCOSQ (Cronin et al., 1998) subscale of emotions are less focused on 
physical symptoms than the other domains, mapping more clearly onto the emotional domain 
put forward by Fayers and Machin (2001), and arguably the domain of psychological health 
specified by the WHOQOL Group (1994). However, Guyatt et al. (2004) demonstrated that 
five of the seven items in the emotions domain also load onto at least one, if not two, other 
factors. This suggests that these items may represent a domain other than psychological 
health or emotions. In addition, as the items in this domain are vague, for example: 
‘depressed’, ‘tired easily’, ‘worried’, ‘moody’, ‘low self-esteem’ and ‘being self-conscious’, 
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they may not fully represent the impact of PCOS on quality of life but may tap onto other 
factors outside of PCOS. For example, if a participant has recently been through a traumatic 
life event, they may also feel depressed, worried and moody. The PCOSQ, therefore, does not 
represent all the domains of quality of life, particularly the psychological, social and 
environmental domains, which may be impacted by the condition. 
 
McGee (2004) suggested that when developing disease-specific measures, they should focus 
on the most important aspects of quality of life for the individuals with the specific health 
condition. In this case, PCOS-specific quality of life measures should represent the most 
important areas of quality of life for women with PCOS. The findings from Chapter Three 
and Four of this thesis also suggest that the PCOSQ may not fully represent all domains of 
quality of life that are important for women with PCOS including the impact of PCOS on 
social and psychological aspects of quality of life. Malik-Aslam et al. (2010) similarly 
suggest that a comprehensive measure of the impact of PCOS on quality of life needs to 
include all the relevant elements of life that can be affected by PCOS and that such a measure 
should be informed by interviews with women with PCOS (as in Chapter Four of this thesis). 
 
It is clear that the PCOSQ is inadequate to measure quality of life for women in the UK due 
to the issues with its development, detailed in this chapter. Moreover, the PCOSQ overlooks 
areas of quality of life that are deemed important by women with PCOS in the UK, including 
psychological, social and environmental issues. As this thesis aims to further understanding 
and improve quality of life in women with PCOS in the UK, a new instrument should be 
developed to measure quality of life (DeVellis, 2012; Streiner & Norman, 2008). There is a 
need, therefore, for a PCOS specific quality of life measure which encompasses relevant 
areas of life that can be impacted by the condition as defined by women with PCOS.  
 
5.1.1 Participant Feedback 
As part of the interviews detailed in Chapter Four, participants were asked to provide 
feedback on the PCOSQ (Cronin et al., 1998). They were not given any further direction but 
were asked to provide any initial thoughts they may have on the scale. Overall participants 
commented positively on the scale items and stated that the items seemed like ‘quite valid 
statements’ or stated that they would agree to them all. However, several participants 
reported issues with the PCOSQ; for example, Debbie discussed how the scale did not 
discuss the impact of PCOS on their ‘jobs and relationships’. Holly discussed concerns over 
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the focus of questions on the PCOSQ towards physical symptoms rather than psychological 
or emotional symptoms: ‘a lot of the questions are about the physicality’s of PCOS like the 
hair and the weight. Erm for me it’s more mental’. Similarly, Julie referred to the lack of 
questions on infertility: ‘there’s a lot of, a lot of questions about weight and hair...there’s only 
a couple of questions about, about infertility or lack of fertility’. Compatible with these 
comments, Malik-Aslam et al. (2010) state that the PCOSQ mainly pertains to symptoms and 
that a quality of life measure for PCOS needs to consider the impact of the condition on all 
aspects of an individual’s life.  
 
Another area of concern surrounded the recall period of the PCOSQ: Sharon questioned the 
recall period (the last two weeks) stating, ‘I mean ‘cause you pinpoint it down to two weeks, I 
wonder whether it would be different to be over a longer period. Two weeks is such a short 
space of time’. She goes on to recommend a ‘two month period’ which could encompass all 
the aspects of symptom management she experiences such as waxing excess hair growth and 
its regrowth. Emma had similar trepidations over the wording of the item ‘In relation to your 
last menstruation, how much were the following issues a problem for you’: she suggested that 
she had difficulty answering this item because she could not ‘remember’ her ‘last one’, 
referring to her menstrual cycle, in order to answer the question. This feedback suggests that 
the recall period, and the phrasing of questions, need to be improved in order to make the 
scale applicable for women with PCOS.  
 
The need for a new disease-specific quality of life scale for use in clinical and research 
settings is evidenced by the limitations of the reliability and validity of the PCOSQ and by 
the criticisms from women with PCOS outlined above. This need is also supported by Malik-
Aslam et al. (2010) who claim that there is a need for a PCOS specific quality of life measure 
that incorporates all the elements of life that can be impacted by PCOS. Consequently, this 
chapter details the development and testing of a psychometric quality of life scale, 
particularly for use with women with PCOS in the UK. 
 
5.2 Methods and Results 
5.2.1 Ethics 
This study complied with The British Psychological Society’s ethical guidelines (BPS, 2009, 
2010) and also complied with their guidelines for internet mediated research (2013). Ethical 
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approval was obtained from the Psychology Research Ethics Committee (Appendix K) at the 
University of Derby (06012-SWSW). All participants provided online consent to take part.  
 
This scale development took place over four phases, using distinct participant samples: item 
generation (n=18), scale reduction and reliability (n=298), scale validity and re-test reliability 
(n=308) and further validation (n=108). All participants were required to read an information 
sheet (Appendix O) and give informed consent (Appendix P) before participating; and all 
participants were debriefed after participation (Appendix Q). 
 
5.2.2 Phase I: Item generation 
5.2.1.1 Participants and Procedure 
Items were developed as a result of in-depth interviews with 10 women with PCOS (Chapter 
Four) and also through qualitative exploration of the impact of PCOS on quality of life 
(Chapter Three) that utilised photovoice methodology (see Williams, Sheffield & Knibb, 
2014). All data was analysed using Thematic Analysis (Braun & Clarke, 2006): findings 
relating to identified themes were written as statements and formed the scale items (Kelly, 
Jenkinson & Ziebland, 2013). A literature review was also performed to help develop items 
for inclusion. The initial item pool reflected all the domains of quality of life reported by the 
WHOQOL group (1994), this included items pertaining to: physical health, psychological 
health, level of independence, social relationships and environment. There were also some 
items which discussed hope and optimism, reflecting the spirituality/religion/personal belief 
domain of quality of life (WHOQOL SRPB Group, 2006). 
 
Once the initial item pool was developed this was reviewed by an expert panel (DeVellis, 
2012). The expert panel comprised five persons with experience and knowledge of PCOS 
including consultant practitioners and academics with expertise in gynaecology, obstetrics, 
endocrinology, nutrition, long-term conditions and scale development. The panel was asked 
to provide feedback on the relevance of each item (high, moderate or low) and were afforded 
the opportunity to provide any additional comments. The panel were also asked to provide 
any feedback they may have on the structure of the scale and the language used. Overall, the 
scale feedback was positive, ‘the questionnaire is detailed and relevant’, resulting in all items 
being retained. As a result, the prototype Polycystic Ovary Syndrome Quality of Life 
(PCOSQOL) scale consisted of 62-items using a 7-point Likert scale ranging from ‘Does Not 
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Apply’ to ‘Usually’ (Appendix M). Participants were asked to respond to the statements by 
selecting the option that most reflected how they felt, they were advised there were no right 
or wrong answers and they were asked to consider the statements when reflecting on the past 
four weeks. Example items include: ‘Felt under pressure to have a child’, ‘Felt like you 
weren’t a real woman because of your PCOS’ and ‘Felt depressed about how PCOS has 
impacted your life’.  
 
5.2.3 Phase II: Scale reduction and reliability 
5.2.3.1 Statistical Analysis 
Data analyses were conducted using SPSS version 22. First, the factor structure was tested 
using exploratory factor analysis. Then the internal consistency of the scale was assessed 
using Cronbach’s alpha. Next, Spearman’s correlations were conducted between scale scores 
to assess construct validity. Spearman’s correlations were also performed to assess the 
discriminative validity of the PCOSQOL by comparing demographic data and condition 
characteristics. Confirmatory factor analysis was also used to test the structural validity of the 
scale. 
 
5.2.3.2 Participants and Procedure 
In order to reduce items in the prototype scale and assess the reliability, a large sample 
(n=298) of women with PCOS were recruited through the social networking website, 
Facebook (Appendix N). Groups included ‘PCOS Cysterhood UK’ and ‘PCOS Awareness 
UK’. Inclusion criteria for the study were that the participants were: 18 years old and over, 
lived in the UK, had English as a first language and suffered from the symptoms of PCOS. 
Participants were not excluded if they suffered from other conditions in addition to their 
PCOS.  Participants completed the prototype questionnaire anonymously. Two hundred and 
ninety eight participants completed the prototype PCOSQOL scale. Participants age ranged 
from 18 to 51 years old (Mage=29.54; SD=6.26).  
 
5.2.3.3 Demographic Questions 
All participants at each phase of the scale development process; scale reduction and 
reliability, scale validity and reliability and further validation, completed a questionnaire 
designed to gather demographic information from the participants. Questions were based on 
the findings of qualitative studies (Chapter Three and Four), and published literature. 
Information collected included the type of symptoms participants experienced, whether they 
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had received a diagnosis from a healthcare professional, length of diagnosis, medication and 
history of depression and anxiety, if any. Characteristics of participants can be found in Table 
5.1. 
 
5.2.3.4 Item Reduction 
Item Analysis 
Items in the prototype scale were analysed for frequency, means and correlations. Items with 
endorsement frequency rates (the proportion of people who give each response to alternative 
choices of an item) between 0.2 and 0.8 were retained (Streiner & Norman, 2008) which 
resulted in all items being retained. Analysis of item means too near to the extreme were 
removed resulting in the removal of five items with item means below 2 (1.78 to 1.92; 
DeVellis, 2012). Two of the removed items related to weight, ‘Felt under pressure to lose 
weight’ and ‘Had negative thoughts about your weight’.  One item related to the symptom of 
acne, ‘Felt depressed because of the spots on your face’ was also removed.  All items 
significantly correlated with at least one other item; significant correlations ranged from 0.14 
to 0.79.   
 
An exploratory factor analysis was run on the data collected from participants at phase II 
(n=298). Principal axis factoring was employed using a direct oblimin rotation (Field, 2013). 
Initially, using eigenvalues above 1 as criteria for factor extraction, 12 factors were extracted. 
However, the scree plot (Figure 5.1) was ambiguous and showed inflexions that would justify 
retaining either 2 or 4 factors. Four factors had eigenvalues over 2; therefore, the analysis was 
rerun specifying the extraction of four factors. Coefficients below 0.45 were suppressed 
according to Comrey and Lee (1992). Of the 57 items, 35 had factor loadings of at least 0.45 
and all of these items loaded onto one factor only. As a result 35 items were retained. After 
inspection of items loading onto each factor, subscales were labelled: Impact of PCOS, 










Table 5.1  
Characteristics of participants who completed the scale at all stages (n=/%). 
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- Irregular Periods 
- Excess Weight 
- Skin Discolouration 
- Excess Hair 
- Acne 
- Alopecia 
- Skin Tags 



































Cronbach’s alpha for the overall scale was excellent (α = .95) as were the alphas for the four 
subscales: Impact of PCOS, Infertility, Hisutism and Mood; α = .95, α = .93, α =.96 & α= .85, 
respectively. The closer Cronbach’s alpha coefficient is to 1.0, the greater the internal 
consistency of the items in the scale (George & Mallery, 2003; Gliem & Gliem, 2003). 
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Nunally (1978) also recommends that α should be at least .8, and should be at least .9 for a 
clinical instrument. Moreover, Ponterotto and Ruckdeschel (2007) state that for a scale with 
more than 11 items and a sample size of over 300, α would need to be .9 to be considered 
‘good’. Whilst some research may suggest that alpha’s should not be over .9 as this indicates 
some redundancy in the scale (Streiner & Norman, 2008), the Cronbach’s alphas for this 
scale are similar to those reported in previous scale development research (Burckhardt & 
Anderson, 2003; Hunt, Clark-Carter & Sheffield, 2011; Vaughan, Crooks, Locke, Veigas, 




























Overall Scale α=.948 Factor Loadings 
IMPACT OF PCOS (α=.95), Eigenvalue = 17.21, % of variance = 30.20 1 2 3 4 
Felt like you weren’t a real woman because of your PCOS .818    
Felt abnormal because of your PCOS .800    
Felt that it is unfair that you have PCOS .727    
Felt angry that you have PCOS .716    
Felt like you don’t know what to do to control your PCOS .705    
Been envious of women without PCOS .678    
Felt embarrassed about the way you look .666    
Felt like you don’t know what to do to help yourself  .662    
Felt embarrassed about having PCOS .653    
Felt like less of a woman because of having PCOS .638    
Felt like your PCOS is in control of your life .638    
Struggled to cope with your PCOS and your other condition(s) .634    
Felt like you hated yourself .613    
Felt depressed about how PCOS has impacted your life .539    
Wanted to do something but haven’t because of your PCOS .503    
Wanted to take part in a social activity but haven’t because of your 
PCOS 
.499    
INFERTILITY (α=.95), Eigenvalue = 4.99, % of variance = 8.76  
Felt depressed over your struggle to have children  .940   
Felt depressed over difficulties conceiving a child  .917   
Felt depressed because of your infertility  .893   
Felt like a failure because of your trouble conceiving   .866   
Felt anxious about conceiving a child  .842   
Felt under pressure to have a child  .734   
Been scared that you may not have children  .723   
HIRSUTISM (α=.97), Eigenvalue = 4.11, % of variance = 7.22  
Felt embarrassed by your facial hair   .937  
Felt depressed because of your facial hair   .926  
Been worried about other people seeing your facial hair   .919  
Spent a lot of time and energy removing excess hair   .883  
Felt moody because of your excess hair   .876  
Felt depressed because of your hirsutism   .797  
MOOD (α=.89), Eigenvalue =  2.24 , % of variance = 3.92  
Felt guilty for being overly aggressive towards a friend of family 
member 
   .715 
Over reacted to a day to day occurrence because of your PCOS    .711 
Had a short temper with your close friends and/or family    .664 
Felt overwhelmed by your PCOS and depression    .595 
Felt depressed    .482 
Felt like crying for no reason    .459 
Table 5.2  






Figure 5.1 A scree plot as a result of a principal axis factor analysis (Phase II) 
 
5.2.4 Phase III: Scale validity and re-test reliability 
5.2.4.1 Participants and Procedure 
To assess the construct and discriminative validity, and reliability of the reduced item 
PCOSQOL, a second large sample (n=308) of women with PCOS were recruited through the 
groups on the social networking website, Facebook. Inclusion criteria for the study were the 
same, in that the participants were: 18 years old and over, lived in the UK, had English as a 
first language and suffered from the symptoms of PCOS. Participants were not excluded if 
they suffered from other conditions in addition to their PCOS. Participants completed the 
PCOSQOL anonymously; however, participants were asked if they would like to take part in 
a test-retest to provide their consent and email address to this aspect of the study. The 
characteristics of the participants can be found in Table 5.1. Participants were also asked to 
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complete the Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) alongside the 
reduced item PCOSQOL. Age ranged between 18 and 57 years old (Mage= 29.88; SD=6.90) 
and was normally distributed. Participants completed the questionnaires anonymously but 
were asked to provide their email address if they were happy to complete some of the 
questionnaire again three weeks later in order to check consistency of the PCOSQOL over 
time. A total of 90 participants completed the re-test of the PCOSQOL from this sample. 
Scores for the PCOSQOL in phase III were normally distributed as demonstrated by the 
Histograms (Figure 5.2). 
 








5.2.4.2 Cross-sectional Validation Measures 
Hospital Anxiety and Depression Scale (HADS) 
Three hundred and eight participants completed the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983) and the PCOSQOL. HADS is a 14-item scale with seven 
items for each subscale (Depression and Anxiety) and each item is scored from zero to three. 
Items include ‘I get sudden feelings of panic’ and ‘I feel cheerful’. The subscales for HADS 
have demonstrated good internal consistency, with Cronbach’s alpha of 0.80 for the anxiety 
subscale and 0.76 for the depression subscale (Mykletun, Stordal & Dahl, 2001). The 
subscales for HADS also demonstrated internal consistency with this Phase III sample, with 
Cronbach’s alpha of 0.72 for the anxiety subscale and 0.78 for the depression subscale. The 
results of the validity testing are detailed in Phase IIII. 
 
5.2.4.3 Structural Validity 
Confirmatory Factor Analysis  
In order to test the factorial validity of the PCOSQOL scale, a confirmatory factor analysis 
was conducted in Analysis of Moment Structures (AMOS 17) to examine the four 
dimensional model identified in the exploratory factor analysis at phase II. The CFA revealed 
a large and highly significant chi squared; χ² (554) =1925.720, p<.001. However, this was 
expected as confirmatory factor analysis’ Chi square is sensitive to large sample sizes 
(Hooper, Coughlan & Mullen, 2008; Kline, 1994).  
 
Other goodness of fit measures were also taken including the comparative fit index (CFI) 
=.86 and the root mean square error of approximation (RMSEA) =.09. MacCallum, Browne 
and Sugawara (1996) suggest that RMSEA values in the range of 0.08 to 0.10 indicate a 
mediocre fit. However, Hu and Bentler (1999) suggest an RMSEA value close to .06 is 
needed before it can be concluded that there is a good fit between the model and the data. 
Indeed, Hooper et al. (2008) state that the RMSEA, in a well-fitting model, should be 
between 0 and 0.08. As such the RMSEA was greater than the cut off for a good fit, as was 
the CFI value of .86 since a value of 0.95 or above is considered a good fit (Hu & Bentler, 
1999).  
 
Saucier and Goldberg (1996), however, suggest that exploratory factor analysis provides a 
more rigorous replication test than confirmatory analysis and that an exploratory factor 
analysis may be preferred to a confirmatory analysis. DeVellis (2012) states that if data from 
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different samples of individuals on different occasions produce essentially identical factor 
analysis results using exploratory approaches, then the likelihood of those results being a 
‘quirk’ is quite small. As such, a second exploratory factor analysis was run on the data 
collected from participants at phase III (n=308). Principal axis factoring was again employed 
using a direct oblimin rotation. Kaiser-Meyer-Olkin measure (KMO= .934) indicated that 
sampling adequacy was met. Factor analysis was conducted excluding for missing values 
pairwise. The scree plot supported a four factor structure (Figure 5.3). Coefficients below 
0.45 were suppressed (Comrey & Lee, 1992). The factor analysis showed that all 35 items 
loaded onto the same factors as the exploratory factor analysis conducted in Phase II. 
Cronbach’s alphas were checked again and found to be excellent for the overall scale (α = 
.948) (George & Mallery, 2003), as well as for the four subscales; Impact of PCOS, 
Infertility, Hirsutism and Mood (α = .95, α = .95, α =.97 and α= .89). 
 
5.2.4.4 Reliability and Consistency over Time 
Ninety participants from Phase III (29%) completed a re-test of the PCOSQOL after three 
weeks. Correlation analyses were used to examine the relationship between the reduced item 
PCOSQOL and the test re-test data. Results indicated a strong, positive relationship between 
the total scores of the reduced item PCOSQOL and the test-retest data (missing data excluded 
pairwise), which was statistically significant (rs[57]=.902, p<.001 BCa CI [.817, .948]). 
Mean scores were 105.67 (SD=37.315) for the PCOSQOL and 112.44 (SD=38.41) for the 
retest. This difference suggests that quality of life was improved for the participants at the re-
test point. This was confirmed by a paired samples t-test which revealed a significant 
difference between scores of quality of life at Phase III and the re-test, t(57)=-2.098, p<0.05. 
This may be attributable to being part of the research. Cronbach’s alpha for the re-test, for the 
overall scale was excellent (α = .949) (George & Mallery, 2003), as well as for the four 






Figure 5.3 A scree plot as a result of principal axis factor analysis (Phase III). 
 
5.2.5 Phase IIII: Further validation 
Due to a loss of data during Phase III (occurring as a result of a software error), an additional 
108 participants were recruited to complete the reduced item PCOSQOL and a further two 
cross-sectional validation measures including The WHOQOL-BREF and the PCOSQ 
(participant characteristics can be seen in Table 5.1). Participants were recruited through the 
same Facebook groups as detailed in previous phases, and using the same inclusion/exclusion 









5.2.5.1 Construct Validity 
Cross-sectional Validation Measures 
 
WHOQOL BREF  
The WHOQOL-BREF (The WHOQOL Group, 1998) has 22-items and uses a 5-point Likert 
scale. It contains four subscales, including: Physical Health, Psychological, Environment and 
Social Relationships. Questions include issues regarding negative feelings, ability to perform 
daily activities, capacity to work and personal relationships. Cronbach’s alpha for the scale 
has been found to be good for three domains; Physical (α=0.82), Psychological (α=0.81) and 
Environment (α=0.80) but marginal (α=0.68) for Social Relationships (Skevington, Lofty, 
O’Connell & the WHOQOL group, 2004). Cronbach’s alpha for the participants in Phase IIII 
on the WHOQOL BREF domains were similar: Physical (α=0.86), Psychological (α=0.85) 
and Environment (α=0.78), and Social Relationships (α=.70). 
 
POLYCYSTIC OVARY SYNDROME QUESTIONNAIRE 
The PCOSQ (Cronin et al., 1998) is the only other disease-specific quality of life measure for 
women with PCOS to date. It has 26 items and uses a 7-point Likert scale. Questions focus 
on issues concerning growth of visible hair, infertility problems and feelings of depression. 
The PCOSQ has five domains: Emotions (eight items), Body Hair (five items), Weight (five 
items), Infertility problems (four items) and Menstrual problems (four items). Cronbach’s 
alpha was above 0.7 when the PCOSQ was validated by Jones et al. (2004); however this 
must be treated with caution as the validation paper used different definitions of PCOS.  
 
5.2.5.2 Cross-Sectional Correlation Analyses 
Tests of normality revealed that the data were not normally disturbed and therefore the non-
parametric Spearman’s correlation analysis was employed for all correlations including: the 
PCOSQOL and HADS, the PCOSQOL and the PCOSQ and the PCOSQOL and the 
WHOQOL-BREF. For correlation analyses all missing data was deleted pairwise to ensure 
consistency, and to retain as much data as possible.  
 
PCOSQOL and HADS 
Spearman’s correlation was run to determine the relationship between the PCOSQOL, and its 
subscales, and the HADS subscales. Results are displayed in Table 5.3. This indicated that 
women with greater anxiety and depression had poorer PCOS quality of life. 
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Table 5.3  
Spearman’s correlation exploring the relationship between the PCOSQOL, its subscales and 
HADS. 
 HADS Depression HADS Anxiety 
Impact of PCOS -.615** -.521** 
Infertility -.187** -.240** 
Hirsutism -.357** -.285** 
Mood -.563** -.588** 
PCOSQOL Total -.532** -.493** 
* p<.05; ** p<.01 
 
PCOSQOL and PCOSQ 
Spearman’s correlation analyses were used to examine the relationship between the 
PCOSQOL total score and the PCOSQ total score (Cronin et al., 1998). Results indicated a 
strong, positive relationship between the total scores of the PCOSQOL and the PCOSQ, 
which was statistically significant (rs[60]=.754, p<.001). 
 
PCOSQOL and WHOQOL-BREF 
Spearman’s correlation analyses were also used to examine the relationship between the 
subscales of the WHOQOL-BREF (Physical Health, Psychological Health, Social 
Relationships and Environment) and the PCOSQOL (Impact of PCOS, Infertility, Hirsutism 
and Mood), as demonstrated in Table 5.4 (n=87).  
 
Correlation analyses revealed positive significant relationships between the PCOS subscales 
of Impact of PCOS and Mood and all the WHOQOL subscales. The PCOSQOL subscale, 
Hirsutism had positive weak to moderate correlations with three of the WHOQOL subscales: 
Psychological, Social Relationships and Environment domains. The PCOSQOL subscale 
Infertility demonstrated a significant weak, positive relationship with the WHOQOL 








Spearman’s Correlations between the WHOQOL subscales and the PCOSQOL total scores 
and subscales (n=87). 
    * p<.05; ** p<.01 
 
5.2.5.3 Discriminative Validity of PCOSQOL 
Independent t-tests revealed a significant difference in scores of quality of life between those 
participants who experience symptoms of infertility (t(213)=1.220, p<0.001), excess hair 
(t(213)=5.099, p<.001), excess weight (t(213)=3.665, p<.001), alopecia (t(213)=2.598, 
p<.05), skin tags (t(213)=3.445, p<.001), mood swings (t(213)=5.531, p<.001):  or had 
received a clinical diagnosis of depression (t(205)=-2.137,p<.05) compared to women who 
had not. This suggests that for women with PCOS, experiencing these symptoms can have a 
negative impact on overall quality of life. There was also a significant difference in scores of 
quality of life for those women who were trying to conceive compared to those who were not 











































PCOSQOL Total .282** .518** .251* .449** 
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Table 5.5  
Mean (SD) quality of life scores for those women who did experience symptoms of PCOS, 
and have a diagnosis of depression, and those who did not. 
 
 Quality of Life Scores (M,SD) 
 Did experience the 
characteristic 
Did not experience the 
characteristic 
Infertility 95.63, 36.80 120.99, 37.73 
Excess Hair 98.34, 37.77 127.85, 34.77 
Excess Weight 98.34, 37.77 127.85, 34.77 
Alopecia 93.92, 29.58 109.80, 41.15 
Skin Tags 96.36, 33.83 114.33, 41.65 
Mood Swings 98.07, 35.62 130.38, 39.86 
Diagnosis of Depression 99.37, 41.09 110.94, 36.68 
Trying to Conceive  88.11, 30.57 120.56, 38.45 
 
5.3 Discussion 
This study aimed to develop a scale which will enable measurement of quality of life, as 
defined by women with PCOS in the UK, which is inclusive of all aspects of quality of life, 
which may be impacted by PCOS. In addition, this chapter details the reliability and validity 
testing of the disease-specific quality of life measure, the PCOSQOL, according to current 
scale development guidelines (DeVellis, 2012; Streiner & Norman, 2008).  
 
The PCOSQOL was developed as a measure of quality of life for women with PCOS that was 
applicable for women with PCOS who also suffer from co-morbidities. Of the original 62 
items in the prototype scale, 35 items were retained. Four subscales: Impact of PCOS, 
Infertility, Hirsutism and Mood, were generated using exploratory factor analysis; 
Cronbach’s alpha for the overall scale and for each sub-scale was excellent and it also 
demonstrated good test re-test reliability and construct and discriminative validity.  
 
Items for the PCOSQOL were developed from the qualitative findings of Chapter Three and 
Four of this thesis, expert opinion, and from a comprehensive literature review of both 
qualitative and quantitative data, as suggested by Malik-Aslam et al. (2010). The PCOSQOL 
was also developed (n=298) and validated (n=308) using a large sample of women with 
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PCOS, as recommended for factor analysis (Field, 2013). The PCOSQOL, therefore, was 
developed with a suitable sample size for factor analysis. In addition, the factor analysis 
utilised a direct oblimin rotation which assumes that the underlying psychological constructs 
are related (Field) and therefore overcomes the limitations levied at the PCOSQ and its later 
validations described earlier in this chapter (Cronin et al., 1998; Guyatt et al., 2004, Jones et 
al., 2004). The PCOSQOL also demonstrates sensitivity to co-morbidities, as demonstrated 
by the different PCOSQOL scores in women with and without diagnosis of depression, as 
well as the impact of symptoms on the participant (see Chapter Six for more detail).  
 
The PCOSQOL includes items that were missing in the PCOSQ which reflected the social, 
psychological and environmental domains of quality of life. For example, the PCOSQOL 
included items such as; ‘Felt overwhelmed by your PCOS and depression’, ‘Wanted to do 
something but haven’t because of your PCOS’ and ‘Felt depressed about how PCOS has 
impacted your life’. The PCOSQOL also includes items which assess the impact of PCOS on 
feminine identity, the negative impact of PCOS on family and friends, feeling under pressure 
to have children and comparison to women without PCOS, all of which were not included in 
the PCOSQ. As such, the PCOSQOL includes items which are reflective of the 
psychological, social and environment domains which are important for a quality of life 
measure (Fayers & Machin, 2001; WHOQOL Group, 1994) and that were not included in the 
PCOSQ. However, items pertaining to the spirituality/religion/personal belief domain 
(WHOQOL Group, 1994) were not endorsed by participants in the item reduction phase and 
therefore were not included in the final PCOSQOL.  
 
Whilst the PCOSQOL does not capture every aspect of quality of life as defined by the 
WHOQOL Group (1994), the items included are reflective of those aspects of quality of life 
which are deemed most important to women with PCOS in the UK. Thus the PCOSQOL 
focuses on issues of particular concern for women with PCOS (Fayers & Machin, 2007) and 
those areas perceived to be important to them (Osborne et al. 2014). The PCOSQOL, 
therefore, begins to address issues raised by Malik-Aslam et al. (2010) who suggest that a 
comprehensive measure of the impact of PCOS on quality of life needs to include all the 
relevant elements of life that can be affected by PCOS as detailed by women with PCOS 




The development of the PCOSQOL does have some limitations which need to be recognised. 
The scale was developed completely online, with recruitment via Facebook, email and data 
was collected using online questionnaire software. There were limitations to developing the 
scale online including lack of control over the participant population, specifically, whether 
they lived in the UK.  The PCOSQOL was developed and tested for a UK sample; however, 
participants were not required to enter a postcode or state which region they lived in. Indeed, 
one participant (not based in the UK) did report that they had filled in the scale online, only 
to realise after completion that it was intended for a UK sample. As such, whilst this study 
cannot guarantee that the scale was developed with only a UK sample, the Facebook groups 
used for recruitment were intended for UK women with PCOS only. The scale development 
could have been improved, therefore, by asking participants to state where they were from 
and excluding those participants who were not based in the UK.  
 
As participant recruitment for this study was completed via Facebook support groups, the 
participant sample may be unrepresentative of the general population as these women were 
already seeking support for their PCOS. There is also no way of verifying that the women 
who participated in this study had received a clinical diagnosis of PCOS, despite stating that 
they had. Moreover, it is also unclear what diagnostic criteria the women were diagnosed 
with, for example the Rotterdam criteria (2004) or the NIH (1991) criteria. Consequently, the 
PCOSQOL needs validating within a clinical population so that diagnosis of PCOS can be 
assured. Whilst this is a limitation of the development of the PCOSQOL, the demographic 
information provided by participants with regards to the symptoms they experienced suggests 
that participants represented all phenotypes of PCOS as detailed in the Rotterdam criteria 
(2004) including women who were diagnosed with polycystic ovaries. As such, the sample 
for this scale development is more inclusive than those used in the development and 
validation of the PCOSQ (Cronin et al., 1998; Guyatt et al., 2004; Jones et al., 2004) and, 
therefore, more representative of the different phenotypes of women with PCOS. 
 
The ‘Mood’ subscale on the PCOSQOL contains six items, of these only two directly refer to 
PCOS. It is therefore possible that this subscale could measure effects of mood that are 
unrelated to PCOS; however, participants are advised to consider the questions in the 
PCOSQOL in relation to their PCOS. Future research should therefore explore how the 
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wording of these items may affect the measurement of quality of life for women with PCOS; 
this may lead to the alteration of items to directly refer to mood in relation to PCOS. 
 
A further limitation of conducting this study was the lack of control over when participants 
completed the questionnaires in the test-retest aspect of the scale development. As 
participants were sent the link to complete the re-test measures via email it is possible that 
participants may not have completed the questionnaires on the day the email was sent. As 
such the test-retest period for this study, for some participants, may have been greater than 
the three weeks intended. This could have been overcome had participants been required to 
enter the date they completed the re-test on, so as to gather further information on the re-test 
period. However, as the retest period would have been extended rather than shortened, this 
suggests that the PCOSQOL may have demonstrated validity over a longer period of time 
than three weeks. Future validation studies of the PCOSQOL should, therefore, seek to 
complete further test-retests. 
 
Completing the scale development online gave rise to online questionnaire software errors 
that resulted in lost data (two items from WHOQOL-BREF). As a consequence of this an 
additional 108 participants were recruited to complete the PCOSQOL and the WHOQOL-
BREF. Similarly, a software error resulted in the loss of the demographic question 
concerning length of diagnosis throughout data collection. Therefore, it is suggested that if 
online software is used in data collection, investigators should pilot the software prior to data 
collection and check recording of data during data collection. Due to the loss of this data, 
future studies should aim to further validate the PCOSQOL in women with PCOS with 
differing lengths of diagnosis to ensure that it is applicable to those women who are newly 
diagnosed and as well as those who have been diagnosed for many years. 
 
Analysis of the demographic data in this study revealed that women with PCOS are likely to 
have a diagnosis of depression and/or anxiety (see Chapter Six). However, this study did not 
explore the prevalence of any further co-morbid conditions that the participants may have 
experienced. Accordingly, future research should aim to validate the PCOSQOL for women 
with PCOS who suffer from a range of co-morbidities, inclusive of those discussed in 
Chapter Four of this thesis. In addition, the high prevalence of anxiety and depression in 
women with PCOS in this sample suggest the need for an intervention to improve quality of 
life and decrease levels of depression and anxiety. The sensitivity of the PCOSQOL to 
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change after an intervention will therefore be assessed in Chapter Seven of this thesis; so that 
further information with regards to the validity of the PCOSQOL as a measure of quality of 
life for women with PCOS in the UK can be gathered.  
 
The PCOSQOL is the first UK disease-specific quality of life measure for women with PCOS 
which explores the impact of PCOS on all aspects of life, including psychological and social 
domains (Fayers & Machin, 2001; The WHOQOL Group, 1994) as recommended by Malik-
Aslam et al. (2010). Moreover, the PCOSQOL improves on areas of the PCOSQ and its 
development, such as: an improved recall period, demonstrative construct and discriminative 
validity and development based on a representative sample of the population.  
 
Streiner and Norman (2008) suggest that upon development of a new scale which measures a 
construct such as quality of life, then validation is not only necessary at the point of 
development but as an ongoing task. Streiner and Norman suggest, in accordance with 
Nunally (1994), that when validating a measure, the researcher is not simply validating the 
scale but how the scale is used, therefore a test may be valid for one purpose but not another. 
Furthermore, Nunally (1994) suggests that validation is ‘an unending process’ (p. 84), 
whereby psychological measures need to be consistently evaluated and re-evaluated. As such, 
in order to gain further information with regards to the validity and reliability of the 
PCOSQOL, the PCOSQOL shall be utilised within the next two chapters of this thesis 
(Chapter Six and Chapter Seven). Within Chapter Six the PCOSQOL shall be used to explore 
associations of quality of life with PCOS symptoms experienced by women with PCOS in the 
UK and within Chapter Seven it shall be used to measure the impact of an online positive 
psychology intervention on quality of life for women with, therefore, gaining further 
information about the validity of the PCOSQOL and how it can be used in different quality of 










Chapter Six -Identifying and exploring the prevalence of PCOS symptoms and 
psychological co-morbid conditions and their association with quality of life. 
 
The previous chapter and Chapter Two discuss in detail why the PCOSQ (Cronin et al., 1998) 
is not suitable to meet the overarching aims of this thesis (DeVellis, 2012). Consequently, 
Chapter Five detailed the development, and initial reliability and validity testing of a new 
disease-specific quality of life measure, the PCOSQOL. Studies which have not used the 
PCOSQ have utilised other generic quality of life measures such as the SF-36 (Ware & 
Sherbourne, 1992), which has been used by six studies that explore quality of life in women 
with PCOS (Açmaz et al., 2013; Ching, Burke & Stuckey, 2007; Coffey, Bano & Mason, 
2006; Elsenbruch et al., 2003; Hahn et al., 2005; Jones et al., 2010), or the WHOQOL-BREF 
(Kumarapeli, Seneviratne & Wijeyaratne, 2011). As such, whilst the SF-36 and WHOQOL-
BREF are considered reliable measures, they are not disease-specific and therefore provide 
an indication of overall health status or health-related quality of life and not quality of life as 
specifically associated with PCOS.   
 
This thesis aims to further understanding, and improve quality of life in women with PCOS. 
Moreover, Chapter Four identified that two thirds of the sample of women with PCOS 
experienced depressive symptoms; as such this chapter also aims to investigate the 
prevalence of psychological co-morbid conditions in women with PCOS and their impact on 
quality of life. In addition, this chapter seeks to identify symptoms experience by women 
with PCOS and their prevalence. Once symptoms and psychological co-morbidities 
experienced by women with PCOS have been identified, and their prevalence assessed, this 
study will explore their association with quality of life in order to gain an understanding of 
the impact of PCOS on quality of life for women with PCOS in the UK. 
 
6.1 Introduction 
PCOS is characterised by many symptoms including: hirsutism, excess weight, acne, 
alopecia, and aconthosis nigricans (Lowenstein, 2006). However, to date there is only a small 
body of research which explores the associations of the symptoms experienced by women 
with PCOS and quality of life (Bazarganipour et al., 2013; Benetti-Pinto et al., 2014; Hahn et 
al., 2005; Khomami et al., 2015; Riddhi & Prajakta, 2015). The first study to explore the 
relationship of PCOS symptoms and quality of life was conducted by Hahn et al. in a 2005 
study with participants from Germany. Hahn et al. reported that symptoms which had an 
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impact on an individual’s outer appearance, including obesity and hirsutism, but not acne, 
were associated with lower quality of life scores (as measured by the SF-36). In addition, 
they found that BMI, hirsutism, acne, hyperandrogenism, menstrual irregularities and 
infertility were contributors to psychological problems in women with PCOS.  
 
Jones et al. (2008) later explored the impact of PCOS symptoms on quality of life through a 
systematic review of the literature; this included studies which were methodological in focus, 
such as those related to the development and validation of the PCOSQ, and studies 
comparing quality of life in women with PCOS with other populations (including health 
conditions, cultures and normative population data). Overall, they found that the symptoms of 
acne, hirsutism, irregular menses, obesity and subfertility had a negative impact on quality of 
life.  
 
Recently, a body of research from Iran has emerged which explores associations between 
clinical manifestations of PCOS and quality of life in Iranian women with PCOS. 
Bazarganipour et al. (2013) found (using the MPCOSQ) that Iranian women with PCOS 
reported menstruation as their greatest concern and it had the most negative influence on 
quality of life. Symptoms of infertility were the second highest concern for the participants. 
However, Bazarganipour et al. note that these findings may have been impacted by the 
pressure on Iranian women to have children. In contrast, later research exploring the impact 
of symptoms on quality of life (using the PCOSQ) in Iranian women with PCOS found that 
hirsutism was reported as having the strongest impact on quality of life, followed by BMI, 
irregular menstruation and then infertility (Khomami et al., 2015). These studies demonstrate 
that for women in Iran, symptoms of infertility and irregular menstruation were of importance 
to both samples of women. However, there is some disagreement over the symptom of 
hirsutism and its impact on quality of life for women in Iran. 
 
Research has also emerged from other countries: in an Indian study (Riddhi & Prajakta, 
2015) the symptoms of body weight, followed by infertility, had the most impact on quality 
of life in women with PCOS (as measured by the PCOSQ). Similarly, in Brazilian women 
with PCOS (Benetti-Pinto, Ferreira, Antunes Jr. & Yela, 2014), body weight was found to be 
associated with worse quality of life (as measured by the WHOQOL-BREF) in comparison to 
a control group. The studies discussed here (Bazanganipour et al., 2013; Benetti-Pinto et al., 
2014; Khomami et al., 2015; Riddhi & Prajakta, 2015), however, have gathered data from 
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women with PCOS in Asia and South America and as such, may not be applicable to the 
experiences of women with PCOS in the UK due to cultural differences and differences in 
healthcare systems. To date, there is little research which explores the impact and association 
of PCOS symptoms on quality of life for women in the UK, or the prevalence of those 
symptoms. 
 
There is also limited research on the prevalence of some PCOS symptoms, particularly 
acanthosis nigricans (AN) which is a medical term for symptoms of skin discolouration and 
skin tags (NHS, 2013). Whilst previous research has demonstrated that there is a relationship 
between AN and insulin resistance (Barbato et al., 2012; Napolitano, Megna & Nofrecola, 
2015) the relationship between AN and PCOS is unclear. Previous research explored the 
prevalence of AN in women with hyperandrogenism and found that in a sample of 300 
women with clinically significant hyperandrogenism, 5% of women had AN (Flier, Eastman, 
Minaker, Matteson & Rowe, 1985). Later, Dunaif, Graf, Mandeli, Laumas and Dobrjansky 
(1987) found that AN was present in 29% of a sample of 62 hyperandrogenic women. 
However, a literature review revealed that, to date, no study has explored the prevalence of 
AN specifically in a population of women with PCOS. There is a need, therefore, to explore 
the prevalence of this symptom in women with PCOS in the UK.  
 
Women with PCOS are likely to experience co-morbid conditions, as demonstrated in 
Chapter Four, particularly psychological conditions such as depression and anxiety (Cipkala-
Gaffin, Talbott, Song, Bromberger & Wilson, 2012; Deeks, Gibson-Helm, Paul & Teede, 
2011; McCook et al., 2005). In line with this, women with PCOS are more likely to 
experience the symptoms associated with anxiety and depression (Benson et al., 2009; Cinar 
et al., 2011; Deeks, Gibson-Helm & Teede, 2010; Dokras, Clifton, Futterweit & Wild, 2012).  
McCook, Bailey, Williams, Anand and Reame (2015) found that the menstrual problems 
experienced by women with PCOS, in a clinical sample of US women, were a strong 
predictor of psychological problems, as measured with the Brief Symptom Inventory 
(Derogatis, 1993). Furthermore, they found that symptoms of hirsutism and obesity also had a 
negative impact on psychological symptoms in women with PCOS in comparison to data 
from normative samples. However, there has yet to be research which explores the 
relationship of symptoms of PCOS and their association with psychological co-morbidities in 




In relation to anxiety specifically, previous research has suggested that women with PCOS 
are likely to experience an increased prevalence of generalised anxiety symptoms (Dokras et 
al., 2012). However, Dokras (2012) states that there is insufficient data examining the risk of 
other anxiety disorders such as social phobia, obsessive compulsive disorder and panic 
disorder. In addition, Dokras et al. (2011) suggest that only a few studies report other types of 
anxiety in addition to generalised anxiety disorder, detailing three studies which explore the 
prevalence of social phobia (Jedel et al., 2010; Mänsson et al., 2008; Soyupek et al., 2008), 
two which explore obsessive compulsive disorder (Mänsson et al.; Soyupek et al.) and two 
which explore panic disorders (Jedel et al.; Mänsson et al.). Whilst, it is clear that women 
with PCOS are at an increased risk of experiencing anxiety disorders (Benson et al., 2009; 
Dokras et al., 2012) little is known about the relationship between PCOS symptoms and 
anxiety. Certainly, McCook et al. (2015) conclude that additional research is needed to 
explore the relationship of PCOS symptoms and psychological morbidity. 
 
As mentioned, research suggests that there is a higher incidence of depression in women with 
PCOS (Mänsson et al., 2008). Of concern, the findings of Chapter Four of this thesis revealed 
that some participants with PCOS who self-reported experiencing depressive symptoms, also 
discussed self-harm. To date, no study has explored the prevalence of self-harm in women 
with PCOS or its association with the condition and/or co-morbid psychological conditions. It 
is necessary, therefore, to further explore this phenomena, in relation to its prevalence and 
quality of life in a large sample of women with PCOS.   
 
This study, therefore, aims: to investigate the prevalence of symptoms experienced by women 
with PCOS in the UK; to investigate the prevalence of psychological co-morbid conditions 
experienced by women with PCOS in the UK; and finally, to explore the association of PCOS 
symptoms and psychological co-morbid conditions with quality of life in women with PCOS 




Participants were recruited through a post to PCOS support groups held on Facebook. 
Participants were included if they were aged 18 or over, lived in the UK and experienced the 
symptoms of PCOS. In total 714 participants completed the demographic questionnaires; 689 
reported that they had received a diagnosis of PCOS from a health care professional. 
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Participants age ranged from 18 to 57 years old (Mage=29.84, SD=6.53). Further details 
regarding demographic information are included in Table 6.1. 
 
Table 6.1  
A table to show the demographics details of women with PCOS participants. 
 Number and 
(%) of 
participants 





- Civil Partnership 
- Divorced 
- Single 

























     225 (31.51) 
 
Children: 
- Had children 
- Were pregnant 








The procedure for data collection was identical to that of Chapter Five. Participants were 
recruited through Facebook groups with the permission of the group administrator. 
Participants were able to select a web link in the post where they could view the information 
sheet, consent form and fill in their demographic data. After completion in the study 
participants were debriefed and thanked for taking part.  
 
6.2.3 Materials 
Demographic data was collected online through questionnaire survey software LimeSurvey.  
Participants completed demographic data (Appendix U) and the PCOSQOL. Materials also 






Ethical approval has been granted by the University of Derby Psychology Research Ethics 
Committee (PREC; Reference 086-13-SW). This study complies with the ethical guidelines 
of The British Psychological Society (BPS, 2009; 2010) and the BPS guidelines for internet 
mediated research (BPS, 2013). 
 
6.2.5 Analytic Strategy 
The variables were tested for normality using their histograms, the Kolmogorov-Smirnov and 
Shapiro-Wilk test. Data was analysed for frequency, and associations between categorical 
variables were analysed using Chi-Squared tests. Differences between variables were 
explored using independent t-tests. Due to the large sample size, missing data were excluded 
listwise. Data were analysed using frequency analyses; associations between categorical data 
were explored using Chi-Square tests. Shapiro Wilk tests revealed that data were not 
normally distributed and therefore Mann Whitney U tests were used to explore differences in 
scores of quality of life, and scores of the quality of life subscales between groups. A Monte 
Carlo method was used, as recommended for large samples (Field, 2013). Missing data were 
treated listwise. All tests were two-tailed.  
 
6.3 Results 
6.3.1 Participant Characteristics 
Frequency analyses were conducted to explore the prevalence of symptoms experienced in 
the sample; findings are shown in Table 6.2. The symptom most experienced by participants 
was excess weight, followed by irregular periods, mood swings, hirsutism and infertility. 













Table 6.2  
Frequency of symptoms experienced by women in the demographic analysis sample. 
Symptom N experienced % of sample 
Excess Weight 616 86.27 
Irregular Periods 597 83.61 
Mood Swings 554 77.59 
Hirsutism 545 76.33 
Infertility 431 60.36 
Acne 326 45.66 
Skin Tags 320 44.82 
Alopecia 195 27.31 
Skin Discolouration 188 26.33 
 
Frequency analysis (detailed in Table 6.3) revealed that almost 45% of the population had 
received a clinical diagnosis of depression and almost a third of the sample had received a 
clinical diagnosis of anxiety. Moreover, almost a third of the sample had self-harmed at some 
point in their life.  
 
Table 6.3  
Frequency analysis of psychological co-morbidities, including: Depression, Anxiety, Self-
Harm and Eating Disorders. 
 N experienced % of sample 
Diagnosis of Depression 320 44.82 
Diagnosis of Anxiety 225 31.52 
History of Self Harm 





Diagnosis of an Eating Disorder 29 4.06 
Diagnosis of Depression and Anxiety 178 24.93 
 
Of those women who had a diagnosis of anxiety (n=162) 72% had generalised anxiety 
disorder (GAD), 35% had social anxiety disorder (SAD), 33% had panic disorder (PD), 14% 
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Chi-square tests were run to determine the associations between a history of self-harm, 
diagnosis of depression, diagnosis of anxiety and symptoms of PCOS. Significant findings 
are displayed in Table 6.4. Chi-square tests also revealed a significant association between a 
diagnosis of depression and a history of self-harm (χ²=30.61, p<.001). 
 
Further Chi square tests were run to explore the associations between symptoms and types of 
anxiety disorder; results can be found in Table 6.5. Results demonstrated that all visible 
symptoms, except the symptom of acne, correlated with social anxiety disorder. The four 
symptoms of acne, alopecia, skin discolouration and skin tags identified above as correlating 
with a diagnosis of anxiety, also correlated with panic disorder.  
 
Table 6.4  
Results of Chi-Square analyses exploring associations between symptoms experienced and a 
diagnosis of depression, anxiety and a history of self-harm. 
Symptom Depression Anxiety Self-harm 
Infertility .226 .001 .010 
Irregular Periods 2.46 2.28 .041 
Hirsutism 2.82 .443 1.47 
Acne 4.51* 4.21* 2.52 
Weight 6.54* 3.15 2.05 
Alopecia 4.66* 6.32* .441 
Skin Discolouration 4.60* 9.22* 1.26 
Skin Tags 9.50* 13.06** .056 
Mood Swings 16.40** 4.27* 8.61* 
*significant at the 0.05 level ** significant at the 0.01 level 
 
A Mann Whitney U test revealed that women with PCOS had significantly different scores on 
quality of life if they experienced the symptom of infertility (U=20952.50, p<.001, r=), 
hirsutism (U=14311.00, p<.001, r=), acne (U=30984.50, p<.05, r=), excess weight 
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(U=9710.50, p<.001, r=), alopecia (22296.00, p<.05, r=), skin discolouration (U=22001.50, 
p<.05, r=), skin tags (U=28033.00, p<.001, r=) and mood swings (U=1419.00, p<.001, r=). 
Descriptive statistics can be found in Table 6.6. 
 
A Mann Whitney U test found that women with PCOS who had also received a diagnosis of 
depression had significantly lower scores (Mdn=83.00) of quality of life than those women 
with PCOS without a diagnosis of depression (Mdn=108.00), U=21651, p<.001, r=-0.28.  A 
Mann Whitney U test also found that women with PCOS who had a history of self-harm had 
significantly lower scores of quality of life (Mdn=83.00) than those women who did not have 
a history of self-harm (Mdn=104.00), U=20080.50, p<.001, r=-0.22. 
 
Table 6.5  
Results of a Chi Square test to explore associations between anxiety disorders and symptoms 
experienced. 
Symptom GAD OCD PTSD SAD PD 
Infertility  .163 3.865* .568 .511 .277 
Irregular Periods .139 .737 .351 .333 .032 
Hirsutism 1.26 .368 .274 5.71* .322 
Acne 2.08 1.52 .000 2.37 6.30* 
Weight 5.75* .042 2.00 5.47* 1.46 
Alopecia 5.56* .011 2.99 5.48* 13.01** 
Skin Discolouration 3.59 .418 1.20 9.75* 10.91** 
Skin Tags 4.96* .935 1.33 5.87* 4.76* 
Mood Swings 5.87* .887 .123 0.09* 12.26** 











Table 6.6  
Median scores of quality of life (PCOSQOL) for those women who did and did not experience 
symptoms. 
 
 Quality of Life Scores [Mdn] 
 Did experience the symptom Did not experience the 
symptom 
Infertility** 86.00 114.50 
Irregular Periods 92.50 96.00 
Hirsutism** 89.00 121.00 
Acne* 93.00 98.50 
Excess Weight** 92.50 131.00 
Alopecia* 88.00 99.00 
Skin Discolouration* 89.00 98.50 
Skin Tags** 88.00 100.00 
Mood Swings** 89.00 123.00 
*Significant at the .05 level *significant at the .001 level  
 
Mann Whitney U tests also found that women with PCOS who had a diagnosis of anxiety had 
significantly lower quality of life scores (Mdn=88.00) than those women without a diagnosis 
of anxiety (Mdn=100.00), U=22563.50, p<.001, r=-0.14. Moreover, scores of quality of life 
were significantly lower (Mdn=88.00) for women with a diagnosis of generalised anxiety 
disorder than those without (Mdn=98.00), U=20959.50, p<.05, r=-0.12. Scores were also 
significantly lower (Mdn=79.00) for women with a diagnosis of social anxiety disorder than 
those without (Mdn=98.00), U=9324, p<.001, r=-0.18 and scores were significantly lower 
(Mdn=83.00) for those women with panic disorder than those without (Mdn=98.00), 
U=10371.50, p<.05, r=-0.12.  
 
Mann Whitney U tests were also run to explore differences between the four subscales of the 
PCOSQOL (Impact of PCOS, Infertility, Hirsutism and Mood) and a diagnosis of depression, 
anxiety and a history of self-harm. Results can be found in Table 6.7. Results indicated that 
the scores on the subscales Impact of PCOS, Hirsutism and Mood correlated with depression, 





Table 6.7  
Results of Mann Whitney U tests exploring the differences between the PCOSQOL subscales 
and receiving a diagnosis of anxiety or depression and a history of self-harm. 
 
PCOS Subscale Depression Anxiety Self-Harm 
Impact of PCOS 21313.50** 20737.50** 19757.00** 
Infertility 29968.50 26880.00 24261.50* 
Hirsutism 23896.50** 24305.00* 24010.00* 
Mood 18246.50** 19500.00** 19423.00** 
*U value is significant at the 0.05 level ** U Value is significant at the 0.01 level  
 
Mann Whitney U tests were also used to explore the differences between the PCOSQOL 
subscales (Impact of PCOS, Infertility, Hirsutism and Mood) and the types of anxiety 
disorder (GAD, OCD, PTSD, SAD and PD). Results, displayed in Table 6.8, demonstrate that 
the subscale Hirsutism only correlated with Social Anxiety Disorder.  
 
Table 6.8  
Results of Mann Whitney U analyses exploring the differences between PCOSQOL subscales 
and type of anxiety disorder. 
 
PCOS Subscale GAD OCD PTSD SAD PD 
Impact of PCOS 19292.50** 3859.50** 3758.50 8409.50** 8510.50** 
Infertility 23478.00 5750.00 4714.50 12777.50 12862.5 
Hirsutism 22436.00 5891.50 4641.00 9882.00** 11948.00 
Mood  18261.00** 3626.50** 3066.50* 8207.50** 8513.00** 
*U value is significant at the 0.05 level ** U value is significant at the 0.01 level  
 
6.4 Discussion  
This study aimed to identify the symptoms experienced by women with PCOS in the UK. It 
also aimed to identify co-morbid psychological conditions that women with PCOS in the UK 
may experience. Moreover, this study aimed to explore the association of symptoms 
experienced by women with PCOS, and any presenting co-morbid conditions, with quality of 
life. The symptom and co-morbidities of a large sample of women with PCOS (n=714) were 
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investigated in this study. The results highlighted that women with PCOS experience a range 
of symptoms including infertility, hirsutism, excess weight, alopecia, skin discolouration, 
skin tags and also mood swings. In addition, those women with PCOS who experienced the 
symptoms of infertility, hirsutism, weight, alopecia, skin discolouration, skin tags and mood 
swings had significantly lower scores of overall quality of life than those women with PCOS 
who did not experience the symptoms. The women in this study also reported clinical 
diagnoses of co-morbid psychological conditions of depression and anxiety. Furthermore, the 
results demonstrated that those women with PCOS who had previously received a diagnosis 
of depression or anxiety had lower quality of life than those women with PCOS without 
depression or anxiety. 
 
Women who experienced the symptoms of infertility, hirsutism, weight, alopecia, skin 
discolouration, skin tags and mood swings had significantly lower scores of quality of life 
than those women who did not experience the symptoms. This suggests that as participants’ 
symptoms decrease, quality of life increases. Previous research has detailed how hirsutism 
(Hahn et al., 2005) and excess weight (Barnard et al., 2007; Jones, Hall, Balen & Ledger, 
2008) can impact quality of life. Similarly, Khomami et al. (2015), Riddhi and Prajakta 
(2015) and Benetti-Pinto et al. (2015) report that weight and hirsutism had the biggest impact 
on quality of life in women with PCOS, in their samples. Bazarganipour et al. (2013a) and 
Jones et al. (2008) also found that infertility had a negative impact on quality of life. 
However, to date, there is no other literature which explores the associations or relationships 
of skin discolouration and skin tags with quality of life. 
 
As mentioned, infertility has been shown to negatively impact quality of life in women with 
PCOS (Elsenbruch et al., 2003; McCook et al., 2005). Interestingly, 60% of this sample 
experienced the symptom of infertility and of these participants almost a third had children. 
This suggests that women with PCOS classify themselves as experiencing the symptom of 
infertility even after childbirth, evidencing the continued negative impact of infertility on 
quality of life. Another explanation may be that of the participants that had children, 71 
(32%) were trying to conceive for another child, suggesting that participants were still 
experiencing symptoms of infertility. This is defined as ‘secondary infertility – where a 
person has had one or more pregnancies in the past, but is having difficulty conceiving again’ 
as opposed to ‘primary infertility – where someone has never conceived a child in the past 
has difficult conceiving’ (NHS, 2014, para.7). Moreover, McCook et al. (2005) found that 
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women with PCOS who had never conceived, and women who had only experienced 
pregnancy losses, had significantly lower quality of life scores for the infertility subscale of 
the PCOSQ (Cronin et al., 1998). This study is limited, therefore, as it did not explore history 
of past fertility such as previous miscarriages which may have had an impact on participant’s 
quality of life, and their perceptions of fertility. This suggests that women with PCOS are 
experiencing distinct phenotypes of infertility and as such, future research should aim to 
explore the experience of women with PCOS with both primary and secondary infertility. 
Accordingly, future studies exploring infertility in women with PCOS should also ensure that 
they specify which type of infertility their participants are experiencing, in order to gain 
further understanding of the two types of infertility in PCOS. 
 
Almost 45% of participants experienced skin tags, as opposed to the lesser 26% who 
experienced skin discolouration. This suggests that women with PCOS may be more likely to 
experience the skin tags associated with AN than the skin discolouration. This is in contrast 
to Lowenstein (2006) who stated that skin tags, which are frequently observed with AN, had 
not been reported to be associated with PCOS. The symptom of skin tags was significantly 
associated with a diagnosis of depression. This further highlights the need for future research 
which aims to explore the prevalence of AN and the specific symptom profile (skin 
discolouration, skin tags) in women with PCOS and also explores the possible pathogenesis 
behind the association of skin tags and a diagnosis of depression. Moreover, the symptoms of 
acne, alopecia, skin discolouration and skin tags all had significant associations with a 
diagnosis of anxiety.  
 
Previous research has suggested that the symptoms of hirsutism and obesity may be the 
trigger for social anxiety in women with PCOS (Mänsson et al., 2008). This is supported by 
Chi square analyses that revealed that the symptoms of hirsutism and excess weight had 
significant associations with social anxiety disorder. Indeed, the women with social anxiety 
disorder had significantly lower scores on the Hirsutism subscale of the PCOSQOL, but there 
were no differences for any other type of anxiety. Research has also suggested that anxiety is 
elevated in women with PCOS with acne (Benson et al., 2009). However, in this study the 
symptoms of alopecia, skin discolouration and skin tags, but not acne, had significant 
associations with social anxiety disorder. Moreover, symptoms of alopecia, acne, skin 
discolouration and skin tags all had significant associations with panic disorder. As such 
future research should explore the prevalence of social anxiety disorder and panic disorder in 
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women with PCOS who suffer from anxiety. Moreover, the physical manifestations of PCOS 
that cannot be changed, such as skin tags, alopecia and skin discolouration, and their 
associations with social anxiety disorder and panic disorder should be investigated.  
 
The analysis of demographic data revealed that of those women who had a diagnosis of 
anxiety (n=225), over 70% self-reported having Generalised Anxiety Disorder and over a 
third reported experiencing Social Anxiety Disorder and Panic Disorder. Consequently, this 
is the first study to explore the prevalence of each type of anxiety disorder but, it is limited by 
the omission of a comparator group from a population of women without PCOS. Future 
research should aim to explore the prevalence of anxiety disorders in women with PCOS, 
inclusive of Generalised Anxiety Disorder, Social Anxiety Disorder and Panic Disorder in 
comparison to a ‘healthy’ population of women. Moreover, as anxiety in this study was self-
reported, future research should aim to explore the prevalence of clinically diagnosed anxiety 
disorders in women with PCOS. 
 
Analysis revealed significant deflated quality of life scores for those women with a diagnosis 
of anxiety. Moreover, Mann Whitney U tests found significant differences in quality of life 
scores and generalised anxiety disorder, social anxiety disorder and panic disorder but not 
obsessive compulsive disorder or post-traumatic stress disorder suggesting that women with 
PCOS who also have an anxiety disorder (particularly generalised anxiety disorder, social 
anxiety disorder or panic disorder) may experience reduced quality of life. This finding 
supports the earlier analysis that revealed that symptoms of PCOS were significantly 
correlated with social anxiety disorder and panic disorder. This study is the first to highlight 
the relationship between the PCOS symptoms of alopecia, skin discolouration and skin tags 
and a diagnosis of anxiety. Interestingly, these symptoms are all concerned with aspects of 
body image that cannot be changed or managed as is possible with hirsutism (through 
waxing, shaving or plucking) and obesity (through diet and exercise). As such, future 
research should aim to explore the relationship between these PCOS symptoms and diagnoses 
of anxiety, particularly in relation to social anxiety disorder and panic disorder. 
 
Infertility was significantly associated with a diagnosis of obsessive compulsive disorder but 
no other anxiety condition. Elsenbruch et al. (2003) similarly found that women with PCOS 
revealed significantly higher scores on the dimensions of obsessive-compulsive when 
measured with the SCL-90-R in comparison to healthy controls who scored within the normal 
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range. This was supported by Tan et al. (2008) who also found that women with PCOS had 
significantly increased scores on the domain of obsessive-compulsive on the SCL-90-R in 
comparison to population norms. It may be speculated that the obsessive behaviour present in 
women with PCOS is related to infertility, in particular, trying to conceive. Whilst not 
detailed in the chapter (Four), one participant (Julie) in the Skype™ study discussed how 
trying for a baby, including monitoring diet and exercise, was an ‘unhealthy obsession’ 
stating ‘it became an obsession…to an unhealthy level’. 
 
In Britain, 88 per 1000 cases (9%) of people experienced co-occurring mixed anxiety and 
depressive disorders (Singleton, Bumpstead, O’Brien, Lee & Meltzer, 2000). However, in 
this sample 25% of the participants (178 out of 714) had been diagnosed with both depression 
and an anxiety disorder at some point in their lives. Indeed, almost half the participants (45%) 
in this sample reported receiving a diagnosis of depression from a health care professional. 
Moreover, when participants were asked ‘have you ever self-harmed?’ almost a third (32%) 
of the participants reported having previously self-harmed. Horrocks and House (2002) 
suggest that rates of self-harm in the UK are amongst the highest in Europe at 0.4% (400 per 
100,000 cases per year). Interestingly, in this sample, rates of self-harm within the last three 
months were 10 times this amount (over 4% of the sample). Chi-square analyses revealed a 
significant association between a history of self-harm and a diagnosis of depression: 60.4% of 
women with PCOS who had a diagnosis of depression also had a history of self-harm, 
compared to 39.6% of women who had a history of self-harm without a diagnosis of 
depression.  
 
Haw, Hawton, Houston and Townsend (2001) state that psychiatric disorders are common in 
deliberate self-harm patients; finding in a sample of 150 deliberate self-harm patients, that 
138 (92%) had psychiatric disorders. Similarly, Horrocks and House (2002) suggest that up 
to three quarters of individuals suffer from depression at the time of self-harming. However, 
in this study only 136 (59%) of those participants with a history of self-harm had also 
received a diagnosis of depression. This suggests that many women with PCOS may be 
undiagnosed for depression; or, that women with PCOS have self-harmed (often referred to 
as self-injury) for other reasons, such as a coping mechanism (Laye-Gindhu & Schonert-
Reichl, 2005). Consequently, further research is needed to explore the prevalence of self-
harm in women with PCOS in comparison to ‘healthy’ women without PCOS, and the 




The prevalence of depression in women with PCOS has been well reported in the literature 
(Bhattacharya & Jha, 2009; Cinar et al., 2011; Rassi et al., 2010; Rasgon et al., 2003), 
however this is the first study to detail the high levels of a history of self-harm in the 
population. Klonsky and Olino (2008) distinguished between four different types of non-
suicidal self-injurers (NSSI) including: experimental NSSI, mild NSSI, multiple 
functions/anxious group and an automatic functions/suicidal group. Similarly, Rodham, 
Hawton and Evans (2004) found that those students, who took overdoses, often had an 
intention to die, whereas those students who cut themselves reported this behaviour as self-
punishment. This suggests that there are a variety of self-harm which can be undertaken for 
different reasons by different people.  
 
Infertility subscale scores were significantly different for those women who had a history of 
self-harm, but not for those women with a diagnosis of depression. Interestingly, this further 
suggests that women with PCOS may experience self-harm independently to a psychiatric 
condition. Claes and Vandereycken (2007) state that self-harm could be considered as a way 
of coping with distress. Previous research has also suggested that individuals who 
deliberately harmed themselves were characterised by a propensity to use maladaptive, rather 
than adaptive, coping strategies (Mikolajaczak, Petrides & Hurry, 2009). Indeed, the Affect-
Regulation Model proposed by Suyemoto (1998) suggests that an individual’s self-harm 
stems from a need to express anxiety or pain that cannot be expressed verbally or through 
other means; it is a method to gain control over emotions that would otherwise impact their 
sense of self. This is supported by Klonsky (2007) who suggest that individuals who self-
harm may do so as they may be better able to cope with physical injuries, than emotional 
injuries. Certainly, as the research discussed here suggests (Klonsky, 2007; Klonsky & Olino, 
2008; Rodham et al. 2004; Suyemoto, 1998), self-harm can have different meanings to 
different people, take different forms, and the intention when completing the self-harm 
behavior can be different for different people. As participants in this study were only asked if 
they had ‘ever self-harmed’, caution interpreting the findings regarding self-harm in this 
study is warranted. Future research, therefore, could explore how women with PCOS define 





Previous research has suggested that women with PCOS may experience disordered eating 
patterns (Jahanfar, Eden & Nguyent, 1995; Mänsson et al., 2008; McCluskey, Evans, Lacey, 
Pearce & Jacobs, 1991). More recently, however, Larsson et al. (2015) found that there was 
no difference in current or previous symptoms of bulimia nervosa in women with PCOS, 
compared to controls. Indeed, in this sample less than 5% of participants reported receiving a 
diagnosis of an eating disorder, supporting the findings of Larsson et al. However, as 
participants were not asked if they experienced disordered eating behaviours, but only if they 
had a clinical diagnosis of an eating disorder, women with PCOS who did experience these 
behaviours may have been excluded from the analysis. Thus, there is still a lack of research 
exploring the prevalence of disordered eating in women with PCOS; therefore, future 
research should explore disordered eating in an undiagnosed sample of women with PCOS.  
 
Previous studies have explored quality of life overall in women with PCOS previously 
(Barnard et al., 2007; Barzangipour et al., 2013b, 2014; Ching et al., 2007; Coffey et al., 
2006; Elsenbruch et al., 2003; Jones et al., 2010; Kumarapeli et al., 2011). In addition, while 
there is also a growing body of research that explores the impact of individual PCOS 
symptoms on quality of life for women with PCOS across the globe (Açmaz et al., 2013; 
Bazarganipour et al., 2013a; Benetti-Pinto et al., 2015; Hahn et al., 2005; Khomami et al., 
2015; McCook et al., 2005), this is the first study to explore associations of PCOS symptoms 
and quality of life in the UK. This study is limited however, as the participants in this study 
self-reported a diagnosis of PCOS and as such, their diagnosis is uncertain. Moreover, as the 
women in this study were recruited online from Facebook support groups, it could be argued 
that these women were already seeking support for their condition and may therefore not 
represent the larger population of women with PCOS in the UK. As such, future research 
should be carried out which explores the associations of symptoms of PCOS with quality of 
life in a clinical sample.  
 
Through utilisation of the PCOSQOL, this study was able to provide further validation 
information of the scale as a disease-specific quality of life measure (Nunally, 1994; Streiner 
& Norman, 2008). In accordance with Streiner and Norman and Nunally, this study helped 
evaluate the use of the scale in studies which seek to explore the associations of quality of life 
with PCOS and its symptoms, thus providing further validation for the PCOSQOL. Use of 
the PCOSQOL in the next chapter (Chapter Seven) will also provide more information about 
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the efficacy of the PCOSQOL for use within an intervention which aims to improve quality 
of life in women with PCOS in the UK.  
 
This study revealed the prevalence of symptoms, and psychological co-morbid conditions, in 
a large sample of women with PCOS in the UK. This study also reported the association of 
symptoms of PCOS with quality life, including infertility, hirsutism, weight, alopecia, skin 
discolouration, skin tags and mood swings being associated with lower quality of life than 
women who did not experience those symptoms. In addition, key areas for future research 
were identified: including an investigation of the prevalence and relationship of individual 
anxiety disorders in women with PCOS, and also an exploration of the prevalence of AN, in 
particular the symptom of skin tags, in women with PCOS in the UK. Overall, this study 
helped further understanding of the impact of PCOS, and its symptoms, on quality of life for 


























Chapter Seven -The impact of an online positive psychology intervention on quality of 
life for women with PCOS: A pilot study 
 
The findings detailed in the previous chapters of this thesis demonstrate that women with 
PCOS in the UK experience a reduced quality of life, supporting previous research (Cinar et 
al., 2011; Coffey et al., 2006; Hahn et al., 2005). Moreover, the findings from Chapter Four 
and Chapter Six highlight that women with PCOS in the UK are likely to experience a 
psychological co-morbidity of depression and/or anxiety. In order to meet the latter half of 
the overall objective of this thesis, ‘to improve quality of life in women with PCOS’ it is 
necessary to identify, develop and test a pilot intervention which can increase quality of life 
in women with PCOS, who may also present with anxiety and depression. In addition, as 
detailed by Streiner and Norman (2008) and Nunally (1994) validation of a psychometric 
measure is an on-going task, and measures should be validated for different uses. As such, the 
PCOSQOL shall be used in this study in order to develop more evidence of the reliability and 
validity of the PCOSQOL as a disease-specific quality of life measure.  
 
In 2013 the National Institute of Health (NIH) Office of Disease Prevention claimed that the 
cost to the US health care system to identify and manage PCOS was approximately $4 billion 
annually (figures for the UK are unavailable). The panel also called for the establishment of 
programmes which aim to improve management of the syndrome for the women who have 
the condition. An intervention which can improve quality of life in women with PCOS, 
therefore, would not only help women with PCOS to manage their condition as 
recommended, but may also help to reduce costs to the health care system whilst improving 
the lives of women with PCOS. This chapter, therefore, aims to identify, develop and test the 
impact of an intervention for women with PCOS in the UK who may also experience 
symptoms of depression and anxiety. 
 
7.1 Introduction 
Research suggests that women with PCOS have higher levels of psychological distress 
including anxiety and depression than healthy women (Cinar et al., 2011; Deeks, Gibson-
Helm & Teede, 2010; Dokras, Clifton, Futterweit & Wild, 2012; Mänsson et al., 2008). 
Indeed, Lipton, Sherr, Elford, Rustin and Clayton (2006) found that in a sample of women 
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with PCOS over 74% had clinical levels of anxiety, over 30 % had clinical levels of 
depression and over 29% of women had clinical levels of both depression and anxiety. 
Additionally, Lipton et al. found that those women with higher levels of depression and 
anxiety reported poorer quality of life. Rassi et al. (2010) similarly reported that in a sample 
of 72 patients with PCOS, over half (57%) presented with at least one psychiatric diagnosis. 
Cipkala-Gaffin et al. (2012) similarly suggest that depressive symptoms are a significant 
psychological concern in women with PCOS. These studies demonstrate the extent that 
women with PCOS are at risk of developing and suffering from a mental health disorder, 
particularly anxiety and depression, and the impact this may have on their quality of life. This 
highlights the need for an intervention which may help women with PCOS to reduce their 
anxiety and depressive symptoms and improve their quality of life.  
 
Interventions for women with PCOS to date have been largely based on lifestyle change and 
medical treatments, for example, Harris-Glocker et al. (2010) explored the effect of 
metformin combined with an oral contraceptive and lifestyle change on quality of life. 
Similarly, Hoeger et al. (2004) explored the impact lifestyle modification and metformin on 
ovulation and androgen concentrations in obese women with PCOS. Lass, Kleber, Winkel, 
Wunsch and Reinehr (2011) also explored the impact of lifestyle intervention, including 
nutrition education and exercise training, on biological symptoms such as menstrual 
irregularities and hyperandrogenemia in adolescents with PCOS. Moreover, Stamets et al. 
(2004) explored the impact of a dietary intervention on weight loss in obese women with 
PCOS. There have been few studies which explore the impact of interventions on 
psychological aspects of PCOS; indeed, Farrell and Antoni (2011) suggest that medical 
management of PCOS would benefit from the inclusion of psychological approaches.  
 
One lifestyle intervention that has been found to have an impact on depression in women 
with PCOS was run by Galletly et al. (2007) who explored the psychological effects of a high 
protein, low carbohydrate diet in obese women with the condition. They found that that this 
diet was associated with a significant reduction in depression. Similarly, Thomson et al. 
(2010) explored the impact of lifestyle change on depression and quality of life. Participants 
were randomised into three groups: diet; diet and aerobic exercise; and diet and aerobic-
resistance exercise. At the end of the 20-week intervention they found that all women had 
improvements in quality of life and in scores of depression. Consequently, it appears that 
lifestyle interventions can have a positive impact on quality of life and depression. Other 
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interventions have explored the impact of Cognitive Behavioural Therapy (CBT: Correa, 
Sperry & Darkes, 2015; Rofey et al., 2009). Rofey et al. (2009) explored the impact of CBT 
(over an eight week period) on depressive symptoms in adolescents with PCOS, and found 
that it reduced depressive symptoms and improved health-related quality of life. As such, 
lifestyle and CBT interventions have demonstrated some efficacy in reducing levels of 
depression and improving quality of life in women with PCOS, however, these interventions 
are resource and time heavy. It is clear therefore that there is a need for a psychological 
intervention which aims to improve quality of life, and symptoms of depression and anxiety, 
in women with PCOS which addresses these resource and time cost issues.  
 
Psychological interventions have been shown to have a large impact on quality of life 
(Bennett, 2004). However, Bennett suggests that the challenge is to utilise psychological 
interventions in a wider healthcare setting than traditional interventions through the use of 
brief, cost-effective interventions that require minimal professional input. Moreover, Bennett 
proposes that interventions should be employed which require minimum input, but with the 
most benefit to a wide population. One group of psychological interventions gaining 
increasing focus, and demonstrating a growing evidence base of effectiveness, are positive 
psychology interventions (Donaldson, Dollwett & Rao, 2015). Specifically, positive 
psychology interventions have been shown to help improve depressive symptoms and well-
being in a variety of populations (Bolier et al., 2013; Seligman, Steen, Park & Peterson, 2005; 
Sin & Lyumbomirsky, 2009).  
 
Positive psychology has been described as the science of well-being and optimal functioning 
(Hefferon & Boniwell, 2011). It developed as an opposing force to the predominant focus of 
psychology on negative aspects of life, rather than the positive (Seligman, 2002; Seligman & 
Csikszentmjhalyi, 2000). It is therefore concerned with optimal functioning (Gable & Haidt, 
2005) and building positive traits (Seligman, 2002), rather than dysfunction as has arguably 
been the focus of psychology previously (Jørgensen & Natstad, 2005). Seligman called for 
psychology researchers to focus more on the positive aspects of human existence and less on 
pathology (Donaldson et al., 2015). Positive psychology, therefore, is aimed more towards 
prevention than treatment (Seligman, 2002). In line with this, Hefferon (2013) suggests that it 
is focused on enabling individuals from both clinical and non-clinical populations to be at 
their best. As such, positive psychology interventions may benefit all women with PCOS, 




Within the field of positive psychology, the Broaden-and-Build theory of positive emotions 
(Fredrickson, 2001) theorises ‘that experiences of positive emotions broaden people’s 
momentary thought-action repertoires, which in turn serves to build their enduring personal 
resources, ranging from physical and intellectual resources to social and psychological 
resources’ (p. 218). Positive emotions, such as love and gratitude, therefore broaden habitual 
ways of thinking and/or acting (Fredrickson). Fredrickson (2004) proposes that gratitude 
broadens people’s modes of thinking and habitual habits, by building their skills of showing 
appreciation. Fredrickson and Cohn (2010) suggest that people are willing to learn methods 
which enable them to generate positive emotions, including methods or positive psychology 
interventions built on gratitude. One type of positive psychology intervention based in 
gratitude are those where individual’s count their blessings, these interventions are normally 
reflective and self-focused (Fredrickson & Cohn, 2011). Through utilisation of positive 
psychology interventions, individuals are able to become more healthy and resilient. 
(Fredrickson, 2004). 
 
Gratitude is the underlying concept for many positive psychology interventions (Hefferon, 
2013) and the most widely used positive psychology interventions focus on gratitude (Park, 
2014). Indeed, Lyubomisky (2007) suggests that gratitude is causally linked to improvements 
in mental health, and that expressing gratitude during long-term illness can help an 
individual’s adjustment. Gratitude interventions have demonstrated an ability to decrease 
depression and increase well-being (Donaldson et al., 2015). Moreover, gratitude has been 
linked with improvements in health-related quality of life (Park, 2014). Gratitude 
interventions utilised by Seligman (2005), detailed below, included exercises such as writing 
down three good things, also known as counting blessings (Lyubomirsky, 2007) and making 
a gratitude visit (Seligman, 2005).  
 
In 2005 Seligman et al. conducted a study exploring the impact of five online positive 
psychology interventions, activities included: a gratitude visit (write and deliver a letter of 
gratitude in person to someone who has been especially kind), listing three good things in life 
(list three things each day), you at your best (write about a time when you were at your best 
and reflect on personal strengths displayed), using signature strengths in a new way (use one 
of your top strengths in a new and different way) and identifying signature strengths (note 
five highest strengths and use them more often). For the signature strength exercises 
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participants were asked to complete a questionnaire to identify their character strengths, they 
were provided with feedback about their top five and then either asked to use one of the 
strengths in a new way every day for a week (using signature strengths in a new way) or to 
use any of the five more often during a week (identifying signature strengths). The control 
group were given an exercise called early memories whereby participants were asked to write 
about their early memories every night for one week. Participants were asked to complete 
measures at baseline and at five follow up points: immediate post-test, one week post-test, 
one month post-test, three months post-test and six months post-test. Seligman et al. (2005) 
found that two of the positive psychology exercises, using signature strengths in a new way 
and three good things (whereby participants were asked to write down three things that went 
well each day and their causes) both increased happiness and decreased depressive symptoms 
for six months. Participants in the three good things exercise were happier and less depressed 
than they had been at baseline and this effect was maintained at one month, three month and 
six months following the intervention. Although using signature strengths in a new way also 
showed long-term improvements for participants the immediate effects were less pronounced 
than for the participants in the three good things condition.  
 
Later, Mitchell et al. (2009) used an online positive psychology intervention where 
participants were given three weeks to complete an intervention. Seligman et al. (2005) ran 
their positive psychology intervention for one week however later claimed that this was not 
enough time for participants in the three good things condition to gain enough skill. 
Manicavasagar et al. (2014) ran an online positive psychology intervention for adolescents 
(12 to 18 years old) for six consecutive weeks. Moreover, Sin and Lyubomirsky (2009) state 
that longer positive psychology interventions were also more like to produce greater gains in 
well- being and that the longer duration gives participants a chance to convert the positive 
psychology practices into habits. Online positive psychology interventions should therefore 
allow participants enough time to build the skills which will enable them to convert practice 
into habit. 
 
As positive psychology interventions aim to cultivate positive feelings and behaviours (Sin & 
Lyumbomirsky, 2009), they may be of benefit to all women with PCOS and not just those 
who are experiencing depressive symptoms. A non-invasive trial offering an online positive 
psychology intervention to women with PCOS may, therefore see improvements in quality of 
life and depressive symptoms in all women with PCOS. As such, a three good things 
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condition (Seligman, 2005) whereby participants write down three things that they are 
grateful for each day will be used as the intervention. This study aims to explore the benefits 
of an online positive psychology intervention for women with PCOS over a four week period, 
using quality of life as an endpoint and a two-week follow up, is proposed. This will be the 
first study to investigate whether an online intervention utilising positive psychology 
techniques can improve the quality of life of women with PCOS. 
 
It is hypothesised that those participants completing the three goods things activity as part of 
the intervention group will experience a significant decrease in depression and anxiety scores 
when compared to the control group over the three study time points; baseline, post 
intervention and follow up. In addition, participants in the intervention group will experience 
a significant positive increase in quality of life scores overall and in particular within the 
subscales of Impact of PCOS and Mood, as these subscales contain items which pertain to 
depressive symptomology, when compared to participants in the control group over the three 
time points.  
 
7.2 Methods 
7.2.1 Online Positive Psychology Interventions 
Positive psychology interventions are often delivered online (Mitchell, Vella-Brodrick & 
Klein, 2010; Seligman et al. 2005). The internet offers the potential to disseminate positive 
psychology interventions to a broad audience in an accessible and sustainable manner 
(Mitchell et al. 2009). The internet also offers easy access whilst maintaining anonymity, and 
it can be accessed at a person’s own convenience, without the need for human interaction 
(Mitchell et al. 2010). Mitchell et al. concluded that well-being interventions could be 
effectively delivered via the internet; this is beneficial for women with PCOS as studies 
suggest that they can be socially isolated (Percy et al., 2009; Washington, 2005). 
 
7.2.2 Design 
A 2x3 independent measures design was employed to explore the impact of an online positive 
psychology intervention on quality of life, depression and anxiety. Measures were captured 
between groups (control and intervention group) at three time points (pre-intervention, post-






Participants who experienced the symptoms of PCOS were recruited through Facebook 
groups intended to be used by women with PCOS. Inclusion criteria for the study were that 
participants were: aged 18 and over, lived in the UK, had access to the internet and suffered 
from the symptoms of PCOS. Exclusion criteria included participants who self-reported a 
mental incapacity who were unable to give informed consent and participants who were 
unable to understand verbal and written information in English. The participants’ ages ranged 
from 21 to 49 years old with a mean age of 30.2 (SD=6.18) years. Participant figures at each 
stage of the intervention can be seen in Figure 7.1. Of the 76 participants, most classified 
themselves as White (n=57) and/or British (n=54), and the majority of participants were 
married (n=37). Four of the participants were currently pregnant, but all reported being more 
than 10 weeks away from their due date at the time of filling in their demographic 
questionnaire, 29 participants were trying to conceive.  
 
The participants experienced a variety of symptoms including: infertility (n=44), hirsutism 
(n=58), excess weight (n=60), mood swings (n=58), insulin resistance (n=33), skin tags 
(n=32), acne (n=32) and male patterned hair loss (n=21). Of the 76 participants who 
completed demographic data and were randomised, 75 self-reported receiving an official 
diagnosis of PCOS. Thirty eight had received a clinical diagnosis of depression and 19 had 
received a clinical diagnosis of anxiety; 14 participants had received a clinical diagnosis of 
both. Moreover, 17 participants had a history of self-harm and seven participants had a 
diagnosis of an eating disorder. 
 
7.2.4 Materials 
The primary study endpoint for this research was quality of life. Quality of life was measured 
using the PCOSQOL Scale (developed and validated in Chapters Five and Six) and the 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). Psychometric 
properties for each of these measures can be found in Chapter Five. Materials also included 
an information sheet, consent form, demographic questions, online intervention instructions 
and debrief (Appendix V to AA). Participants were also sent evaluation questions which 
included Likert scale and open text box questions, such as; ‘please tell us about your 







Participants were recruited through a post on Facebook. The post detailed the inclusion 
criteria and information regarding withdrawal and confidentiality of data. Also included was 
a link to the information sheet and demographic questionnaires. Upon clicking this link 
participants were directed to a website where they could read the information sheet, fill in the 
consent form and complete their demographic information. Once complete, participants were 
blindly randomised by a member of the research team (Dr. H Sowter) using randomisation 
software from Randomization.com as reviewed by Saghaei (2011) and Suresh (2011). This 
software is also listed on the ‘directory of randomisation software and services’ website 
(Bland, 2014).All participants in the control group were offered the intervention after the 
follow-up period. Randomisation software is available here: 
http://www.jerrydallal.com/random/random_block_size_r.htm.  
 
Participants in the intervention group were directed to Qualtrics; an online survey website 
(via email) and asked to complete the baseline measures. Once they had completed these 
measures, participants were emailed and directed to Qualtrics to complete their positive 
psychology exercise, three good things, for 28 days by typing them in the boxes provided. 
Participants were sent daily reminders to the email address they provided. Participants in the 
control group were not asked to complete any exercise for the duration of the study nor were 
they contacted during the 28 days. Intervention participants were asked to complete their 
three good things exercise daily towards the end of each day. If participants were unable to 
get online for whatever reason they were advised to write their three good things by any other 
method (on paper, on their mobile phone) and then to send these to the researcher at the next 
opportunity, or to follow the web link for that day. Participants were informed in the study 
instructions that if they could not think of three good things to write, to write as many as they 


































Figure 7.1 A CONSORT diagram to show progress through the five stages of the 
intervention: Recruitment, randomisation, baseline measures, post intervention measures and 
follow up measures. 
 
Participants in both arms of the study were asked to complete the PCOSQOL scale and the 
Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) questionnaires at baseline, 
on completion of the intervention (or four weeks after completing baseline measures for the 
control arm) and at a two week follow up. Participants were directed to an online website to 
complete these; all questionnaires were held online. All questionnaire data was retained with 
Participants are assessed 
for eligibility (n=99) 
Allocated to control group (n=36) 
Randomised (n=76) 
Excluded (n=23)  
- Withdrew from the study by non-      
completion (BPS, 2013). 
Allocated to intervention (n=40) 
ALLOCATION 
 
Completed baseline measures (n=27)  
Completed baseline measures (n=28)  
PRE-INTERVENTION 
 
Completed post intervention measures (n=14) Completed post intervention measures (n=8)  
- Withdrawn (n=1) 
POST-INTERVENTION 
Completed follow up measures (n=9) Completed follow up measures (n=12) 
FOLLOW UP 
ENROLLMENT 








a unique identifying code: follow up emails and reminders were sent to the participants’ 
email addresses.  
 
Once data collection for the study was complete; participants were sent an email containing a 
link to evaluation questions to assess the feasibility and impact of the online positive 
psychology intervention. All participants who completed the baseline data (n=55) were asked 
to complete an anonymous, brief evaluation questionnaire on; how much they enjoyed the 
intervention, ease of use, their experience of the intervention and an opportunity to give any 
other comments.. Questions included; ‘How easy did you find it to complete the 
intervention…” whereby participants were asked to rate on a scale of one to seven where one 
is ‘Very Difficult’ and seven is ‘Very Easy’ how easy they found the intervention to 
complete: and the open question, “Please tell us about your experience on the positive 
psychology intervention…”.   
 
7.2.6 Ethics  
Ethical approval was granted by the University of Derby Psychology Research Ethics 
Committee (PREC; Reference 086-13-SW). This study complies with the ethical guidelines 
of The British Psychological Society (BPS, 2009) and the BPS guidelines for internet 
mediated research (BPS, 2013). 
 
7.2.7 Analytic Strategy 
Data was analysed using SPSS version 22. The continuous variables were tested for 
normality using their histograms, the Kolmogorov-Smirnov and Shapiro-Wilk test. To 
explore the differences in scores of quality of life, anxiety and depression between those 
participants in the intervention and control group, at pre and post intervention and follow up; 
a 2x3 mixed model ANOVA was employed. To explore the differences between scores on 
the subscales on the PCOSQOL (Impact of PCOS, Infertility, Hirsutism and Mood); a 2x3 
mixed model ANOVA was also employed. All tests were two-tailed.  
 
7.3 Results 
In total, 55 participants completed baseline measures. Of these, 14 participants completed 
measures at all time points (pre-intervention, post intervention and follow-up). Chi-square 
analysis revealed that there was a significant difference between those participants who 
completed baseline measures (or more) after randomization and those who did not, and the 
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symptom of mood swings ( χ² (1)=4.099, N=76, p<0.05). Of those participants who did not 
take part in the study after randomisation, 91.3% experienced the symptom of mood swings 
compared to 69.8% who took part in the study. There were no other significant differences 
between those participants who took part after randomisation and those who did not.  
 
7.3.1 Quality of Life 
Mauchly’s Test of Sphericity indicated that the assumption of sphericity had been violated, 
X²(2)=8.107, p<.05, and therefore, a Greenhouse-Geisser correction was used. A mixed 
design ANOVA found a significant main effect of the time point that participants completed 
the quality of life measures (pre, post and follow up), F(1.286,14.144)=5.438, p<.05, r=0.53, 
seen in Figure 7.2. Contrasts revealed that quality of life scores were significantly higher at 
follow-up than at baseline, F(1,11)=6.971, p<.05, r=0.6. However, there was no significant 
effect for quality of life scores post intervention and at follow-up, F(1,11)=.098, p=.76, 
r=0.09. There was no significant effect of group, indicating that quality of life scores from the 
intervention and control group were similar, F(1,11)=.159, p=.70, r=0.11. There was also no 
significant interaction effect between the time point the quality of life measures were 








































Descriptive statistics shown in Table 7.1 suggest that being part of a study had a positive 
impact on participants’ quality of life, regardless of the condition. However, this impact was 
not maintained at follow-up for participants in the control group.  
 
For the Hirsutism subscale, a 2x3 mixed design ANOVA did not find a significant main 
effect of the time point that participants completed the PCOSQOL subscale of ‘Hirsutism’ 
(pre, post and follow up), F(2,24)=1.542, p=.23, r=0.25. There was also no significant 
interaction effect between the time the quality of life measures were completed and the group 
(control or intervention) F(2,24)=1.667. p=21, r=0.25. There was no significant effect of 
group, indicating that Hirsutism scores from the intervention and control group were similar, 
F(1,12)=3.553, p=.08, r=0.48.  
 
Table 7.1  
Means and Standard deviations for all measures at all-time points for the Control (C) and 
Intervention (I) conditions.  
 
 Baseline 





Quality of Life C 119.40, 51.81 144.40, 49.10  140.40, 49.07  
I 114.50, 33.43 125.63, 54.46 131.75, 55.12 
Impact of PCOS C 49.80, 27.63  62.60, 27.74  59.00, 28.11  
I 49.63, 18.28 55.00, 27.16 57.50, 28.24 
Infertility C 19.00, 15.07  24.40, 12.60  24.20, 13.31  
I 24.75, 14.45 26.88, 13.16 28.38, 13.52 
Hirsutism C 31.80, 8.87  33.20, 6.14  35.20, 6.69  
I 21.22, 13.37 19.89, 14.42 21.00, 14.48 
Mood C 24.40, 13.65  24.20, 13.85  22.00, 13.58  
I 18.78, 7.40 20.89, 8.82 21.22, 9.54 
Depression C 5.20, 4.82  5.80, 4.09  4.00, 4.30  
I 6.38, 5.66 6.13, 4.42 5.38, 3.54 
Anxiety C 9.80, 8.14  9.20, 5.92  8.20, 7.92  
I 10.25, 6.14 9.25, 5.92 9,75, 6.07 




For the Impact of PCOS subscale, a 2x3 mixed design ANOVA found a significant main 
effect of the time point that participants completed the PCOSQOL subscale of ‘Impact of 
PCOS’ (pre, post and follow up), F(2,22)=4.642, p<.05, r=0.42. Contrasts revealed that there 
was a significant effect for Impact of PCOS scores at pre intervention and follow up, 
F(1,11)=.046, p<.05, r=0.06 (see Figure 7.3). However, Impact of PCOS scores were not 
significantly higher at follow-up than at the end of study measures, F(1,11)=.066, p=.80, 
r=0.08. There was also no significant interaction effect between the time point the quality of 
life measures were completed and the group (control or intervention) F(2,22)=.701 p=.51, 
r=0.18. There was no significant effect of group, indicating that Impact of PCOS scores from 
the intervention and control group were similar, F(1,11)=.047, p=.83, r=0.07.  
 
 
Figure 7.3 PCOSQOL Impact of PCOS subscale scores across all three time points. 
 
For the Mood subscale, Mauchly’s Test of Sphericity indicated that the assumption of 
sphericity had been violated, X²(2)=9.368, p<.05, and therefore a Greenhouse-Geisser 
correction was used. A 2x3 mixed design ANOVA found no significant main effect of the 
time point that participants completed the PCOSQOL subscale of ‘Mood’ (pre, post and 
follow up), F(1.271,15.255)=1.556, p=.24, r=0.30. There was also no significant interaction 
effect between the time point the Mood subscale was completed and the group (control or 
































indicating that Impact of PCOS scores from the intervention and control group were similar, 
F(1,12)=.155, p=.70, r=0.11.  
 
For the Infertility subscale, Mauchly’s Test of Sphericity also indicated that the assumption 
of sphericity had been violated, X²(2)=9.342, p<.05, and therefore a Greenhouse-Geisser 
correction was used. A 2x3 mixed design ANOVA found no significant main effect of the 
time point that participants completed the PCOSQOL subscale of ‘Infertility’ (pre, post and 
follow up), F(1.244, 13.689)=3.099, p=.09, r=0.43. However, scores on the Infertility 
subscale were significantly higher at follow up than at baseline, F(1, 11)=5.648, p<.05, 
r=0.58 (Figure 7). There was also no significant interaction effect between the time point the 
Infertility subscale was completed and the group (control or intervention) F(1.244, 
13.689)=.366 p=.60, r=0.47. There was no significant effect of group, indicating that 
Infertility subscale scores from the intervention and control group were similar, 




Figure 7.4 PCOSQOL Infertility subscale scores across all three time points. 
 
In summary, analyses revealed that there was no interaction effect between condition and the 
time (pre and post intervention and follow up) that participants completed the PCOSQOL 




























7.3.2 HADS  
A mixed design ANOVA found no significant main effect of the time point that participants 
completed the HADS depression measure (pre, post and follow up), F(2,22)=1.541, p=.24, 
r=0.23. There was no significant effect of group, indicating that depression scores from the 
intervention and control group were similar, F(1,11)=.16, p=.701, r=0.12. There was also no 
significant interaction effect between the time point the HADS depression measures were 
completed and the group (control or intervention) F(2,22)=.251, p=.78, r=0.11.   
 
There was also no significant main effect of the time point that participants completed the 
HADS anxiety measure (pre, post and follow up), F(2,22)=.705, p=.51, r=0.18. There was no 
significant effect of group, indicating that anxiety scores from the intervention and control 
group were similar, F(1,11)=.033, p=.86, r=0.05. There was also no significant interaction 
effect between the time point the HADS anxiety measures were completed and the group 
(control or intervention) F(2,22)=.354, p=.71, r=0.13.   
 
7.4 Evaluation 
Twenty participants provided evaluative feedback of the study from both the control (n=9) 
and the intervention (n=11) group. Participants have been identified by a letter in the quotes 
below and the condition (intervention or control) they belonged to highlighted. 
 
Of the participants in the intervention group who took part in the activity (n=29) only two 
participants completed the daily three good things activity each day for the duration of the 
intervention. Moreover, only 12 of those women who took part completed 50% or more of 
the three good things intervention and 10 women completed less than 25% of the of the three 
good things intervention over the four week period. 
 
The majority of participants (n=7) found the intervention ‘Very Easy’ to complete (control 
n=3, intervention n=4). Two participants found the intervention ‘Very Difficult’ to complete; 
both of these participants were in the control condition. Of the participants who found the 
study ‘Very Difficult’ both also stated that ‘No I didn’t enjoy it’ when asked if they had 




“I didn’t even receive questionnaires or interventions through! I think I was asked to 
complete one initial questionnaire and that was it to my recollection. I’ve checked my inbox 
and also my junkmail folder and nothing came in that I can see.”  
[Participant A, Control] 
 
“Maybe actually ensuring questionnaires/intervention tasks have been sent would help in 
your research!” [Participant A, Control] 
 
This participant raises an important issue in online research as there is no way for researchers 
to ensure that emails are successfully delivered to participants in online based interventions. 
Participant B, similarly states: 
 
“The emails didn’t always arrive” [Participant B, Control] 
 
They highlight the need for researchers to check successful delivery of emails; this may be 
done by requiring that the participants confirms that they have the read the email either 
voluntarily or through ‘a delivery receipt’ which informs the sender of the email that it has 
been delivered. However, this latter suggestion is ethically problematic as it breaches the 
participant’s privacy, whereas the former suggestion requires the participants to complete 
extra activities which could contribute to them withdrawing from the study due to the impact 
on ease of use. It is also worth noting that this participant appears confused about their role as 
a member of the control condition; she states that she did not receive ‘interventions’, however 
as a member of the control group she would not have had any. Therefore, in future 
interventions participants should be advised to contact the research team if they have not 
heard anything at the data collection time points.  
 
Largely, participants reported a positive experience of taking part in the intervention: 
 
It helped to inforce positive feelings about myself… [Participant C, Intervention] 
 
it was nice to sit down at the end of the day and think of good things that happened that day. 




it made me aware of my own positivity and the importance of considering my activities, and 
the effect these will have on my physical health and wellbeing [Participant E, Intervention] 
 
Consciously thinking about positive rings really helped me appreciate things, even on days 
where I felt completely hopeless [Participant F, Intervention] 
 
The participants above demonstrate the direct impact of taking part in the three good things 
activity, despite the lack of significant findings in this study. Moreover, two participants in 
the control group (from n=4) had a positive experience in taking part in the study:  
 
 It made me think that there is more to life then worrying about PCOS. [Participant G, 
Control] 
 
Made you think of only good things [Participant H, Control] 
 
This supports the statistical finding that simply being part of the online positive psychology 
intervention, regardless of condition, can have a positive impact of participants who take part. 
In contrast, Participant I found it more difficult to complete the daily three good things 
activity, even though they enjoyed aspects of the intervention. Participant L also found it 
difficult to think of three good things each day, they state: 
 
On my “down” days I found it very difficult to find a positive about my day. As I am trying to 
live with infertility but am desperate for a child, nothing seems to be a help. I did reflect on 
my day when filling out my daily positive and thought about how many people I am greatful 
to have in my life. [Participant I, Intervention] 
 
Sometimes it was hard finding 3 things each day… [Participant L, Intervention] 
 
Eight participants in the intervention group had incomplete entries for their three good things 
activity, often only stating one good thing or writing ‘nothing’, ‘none’ or ‘cant think of 
anything’. This suggests that other participants may have found it difficult to think of three 
good things each day of the intervention. As Participant I states that this occurred for her on 
her ‘down days’, it may be that the participants depressive symptoms make it difficult for her 
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positive aspects of her day. She suggests that future interventions should allow participants to 
describe their emotions for each day: 
 
Possibly the next survey could have a box for emotion for the individual to express how they 
feel each particular day along with their 3 positive outcomes [Participant I, Intervention] 
 
This would allow the research team to further understand of how, and if, participants’ mood 
and emotions impact their completion of the three good things activity.  
 
One participant who found it difficult to think of three good things each day discontinued 
their participation in the three good things activity as it made her ‘unhappy’, she states:  
 
I found it difficult in my current situation (unemployed, astranged from family) to come up 
with any sort of substantial positive. Those that I did think of remained constant day to day, 
and reminding myself of that only served to make me feel more aware that my situation was 
not changing. I discontinued the study because it made me unhappy. [Participant M, 
Intervention] 
 
The quote above suggests that participants may have voluntarily discontinued their 
participation in the three good things activity; this may account for the lack of completion of 
the daily activity across the intervention condition. Other reasons for non-completion may 
include the length of time the intervention required to complete, both for the completion of 
questionnaire measures and the three good things activity, and also the difficulty in 
remembering to take part in the activity. This is demonstrated by the participants below: 
 
…the only problem I found was remembering to fit it in my normal routine! [Participant C, 
Intervention] 
 
it made me think of positives in my life which was very good for me but some questions were 
very repetitive on the longer questionnaires [Participant J, Intervention] 
 
It was easy enough to do just took a bit of time logging in etc. was thought provoking trying 
to think of positive aspects of my day. Don’t really feel it made a difference to my life or how 




…sometimes I forgot as the email came through quite early in the day and by the time I had 3 
things it was the evening and I forgot to fill the form in [Participant L, Intervention] 
 
It was hard to keep up [Participant B, Control] 
 
Participants discussed how the intervention took ‘time’, was ‘hard to keep up’ and one lady 
described how she ‘forgot’ as she received the email reminders early in the day.  
 
 It was difficult to keep up with, remembering to do it! Some sort of text alert would have 
helped – equally, with hindsight, I could have set a reminder” [Participant E, Intervention] 
 
7.5 Discussion  
This study aimed to explore the impact of an online positive psychology intervention on 
quality of life and levels of depression and anxiety. Analyses of the data for all measures 
revealed that there was a significant main effect of the time point that participants completed 
measures, specifically from baseline to follow up for overall quality of life scores and scores 
on the PCOSQOL subscales, Impact of PCOS and Infertility. However, the intervention 
activity had no impact on quality of life scores or depression and anxiety scores. These 
results, in combination with an analysis of descriptive statistics suggests that being part of the 
study may have had an impact on participants scores of quality of life and depression 
regardless of taking part in the three good things intervention.  
 
The descriptive statistics suggest that the mean scores of depression decreased from baseline 
to follow up; however, no significant difference was found. Interestingly, the mean scores of 
anxiety for the HADS subscale ranged from 8 to 10 across the three measurement times: 
according to Snaith (2003), this is suggestive of the presence of anxiety. A mixed model 2x3 
ANOVA, however, found no differences in anxiety scores between groups, and across time 
points. This suggests that a positive psychology intervention whilst being effect in reducing 
scores of depression (Seligman et al., 2005) may not be effective in reducing symptoms of 
anxiety. Participants scores on the HADS depression subscale, however, were considered 
normal, with all mean scores for both control and the intervention group, at each time point, 
being below 7 (Snaith, 2003). This is similar to the findings of Sin and Lyubomirsky (2009) 
who suggested that there may be a ‘floor-effect’; participants with low levels of depression 
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do not experience much improvement in levels of depression and so larger or more selective 
samples may afford better tests of positive psychology interventions in women with PCOS.  
 
There was a low retention rate in this study; this is similar to Manicavasagar et al. (2014) who 
also experienced difficulties maintaining high levels of adherence and low levels of attrition. 
Chi square analyses suggest that there is an association between participants who experienced 
the symptom mood swing or not, and participants who did not take part in the study after 
randomisation. To improve this, future research should employ text messaging or mobile 
phone applications to run the intervention, as discussed by participants in the Evaluation 
section of this chapter. The low retention rate for this study led to a small sample size which 
was a limitation for this intervention. However, post-hoc power analyses conducted in 
G*Power revealed that for the sample size of 14 for a 2x3 ANOVA and an effect size (ƒ) of 
0.53 and an non-sphericity Epsilon value of .643, a power of 0.69 was achieved; this suggests 
the study was underpowered. A priori power analyses revealed, with the same effect size (ƒ) 
of 0.53 and a non-sphericity correction of .643, to gain a power of 0.9, a sample size of 24 
would be needed. Given a retention rate of 18%, future studies should there aim to recruit at 
least 135 participants to achieve a power of 0.9. 
 
Several participants in this study only entered items on the three good things activity that 
related to their symptoms. It is feasible, therefore, to assume that participants may not have 
understood that they were able to write about any three good things that happened to them 
that day, and not just those good things which were related to PCOS. This may have meant 
that participants felt limited in what they could enter for the activity and therefore, they may 
have not completed the three good things activity each day. Whilst participants were given 
examples of good things they could choose which were outside of their condition, future 
research should ensure that participants are reminded of this throughout the intervention. 
Similarly, Evaluation revealed that some participants found it difficult to think of three good 
things. Indeed, several participants entered ‘none’, ‘nothing’ or did not complete the three 
entries for the daily activity. As such, not all participants in the intervention group 
consistently entered ‘good things’ in their three good things activity. Futures studies should 
seek to complete analysis of the items entered in the three good things activity using a text 
analysis method such as Linguistic Inquiry and Word Count (Pennebaker, Booth & Francis, 
2007); this would afford  examination of what participants write about, and if what they write 




Evaluation feedback suggested that participants should be able to enter their mood when 
filling in the three good things activity. As such, future research employing a three good 
things activity should allow participants to describe what type of mood they are in, or what 
emotions they are experience that day, to further understand the participants experience of the 
online positive psychology intervention. Moreover, it is evident from the evaluation feedback 
that the method of intervention delivery could be improved. One way this could be achieved 
is through the use of mobile technology (mhealth), which are increasingly being used in 
health psychology research (Arora, Peters, Agy & Menchine, 2012; Akter & Ray, 2010; 
Cafazzo, Casselman, Hamming, Katzman & Palmert, 2012). Indeed, Rosser and Eccleston 
(2011) noted that smartphone applications are becoming increasingly popular. Consequently, 
future research exploring the use of online positive psychology should assess the efficacy of 
delivering the intervention through a mobile phone application. Similarly, Participant E also 
suggested that the intervention was ‘difficult to keep up with’, however they suggest that they 
could have set an alert on their mobile phone to remind them. Moreover, they suggest that a 
text alert from the research team would have helped to remind here to take part in the study. 
 
The use of text message reminders in health behaviour change research is increasingly 
common (Armstrong et al., 2009; Sims et al., 2012; Zurovac et al., 2011). Indeed, Pop-
Eleches et al. (2011) suggest that text message reminders improve adherence to treatment in 
individuals with HIV. Similarly, Petrie, Perry, Broadbent and Weignman (2011) concluded 
that targeted text messages increased adherence to use of an asthma preventer inhaler. 
Further, Cole-Lewis and Kershaw (2010) state that text messaging may improve existing 
practices and interventions and may be an important took in providing more effective disease 
management support. As such, future research should aim to explore the impact of using text 
message reminders, over email reminders, for participants in an online positive psychology 
intervention. Future research should, therefore, explore the use of a text message based 
service where participants receive reminders and text in their three good things each day to 
the research team.  
 
Patrick et al. (2009) found that the use of text messages in a weight loss intervention, 
whereby participants were sent a text message and a response was required to that message, 
was received well by the participants. This approach, therefore, could also help to overcome 
some of the limitations of this study, as highlighted by the participants, such as ensuring that 
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reminders are received (by requiring a response) and by encouraging participation in the 
study through text message reminders. Therefore, future research exploring the impact of a 
positive psychology intervention on quality of life in women with PCOS should aim to assess 
the efficacy of delivering reminders via text message.  
 
One other limitation of this study is that participants were not asked about any life events that 
may have happened during the study which may have caused participant’s to discontinue the 
study or which may have impacted on participant’s quality of life scores and depression 
scores. Indeed, one participant withdrew from the study when they received an email asking 
them to complete measures citing difficulties in their personal life which made them feel 
unable to take part any longer.  
 
As recruitment for this study took place online, participants self-reported whether they met 
the inclusion criteria which specified that those with mental incapacity or those unable to give 
informed consent would be excluded from taking part in the research. As such, it was not 
possible to guarantee that those participants who took part in the study did or did not meet the 
inclusion criteria. Future research is therefore necessary using a clinical sample in order to 
have more control of the participant sample.  
 
During recruitment for this study it became evident that one of the Facebook groups had 
begun to run their own weekly, three good things activity (possibly as a result of hearing 
about this study). Members of the group would ‘comment’ on a post by the administrator, and 
list three good things that had happened to them that week. Whilst it is unclear exactly 
whether participants in this research took part in the Facebook activity, it is possible that 
participants in this study may have taken part in the weekly activity as well. This is 
particularly important when considering the impact this may have had on members of the 
control group and the analyses of descriptive statistics that revealed improved quality of life 
of scores for participants in the control group and the intervention group at baseline to end of 
study. Future studies should ensure they expressly advise participants not to take part in any 
similar gratitude activities whilst completing the study to avoid this. Alternatively, 
participants in the control group could complete a placebo activity. 
 
Within this study participants in the control group were not given an activity to complete, but 
were asked to fill in the relevant measures at each time point. In perhaps the most notable 
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three good things intervention, Seligman et al. (2005) asked participants in the control group 
to write about their early memories. Writing about early memories as an activity for the 
control group has since been used by other researchers utilising the three good things activity 
(Gander, Proyer, Ruch & Wyss, 2012; Mongrain & Anselmo-Matthews, 2012). Other control 
activities used in gratitude interventions within the positive psychology literature include 
writing about daily life events (Emmons & Mccullough, 2003) whereby participants write 
about things that they have done that week. However, this was later replicated by Martinez-
Marti, Avia and Hernádez-Lloreda (2010) who suggested that this was not a suitable control 
group as participants wrote about more positive things than neutral ones, thus potentially 
mimicking a positive writing intervention. Other research, similarly to the study reported in 
this chapter, have not provided any alternative activity for the control group during the trial 
(Schueller & Parks, 2012) and simply taken measures from participants at the appropriate 
time. As such, development of this pilot trial should consider using a neutral but similar task 
to the three good things activity, such as writing down three daily events (Emmons & 
Mccullough).  
 
This pilot RCT was also limited as it was an open trial, meaning that all participants were 
given information about the intervention activity (Schulz & Grimes, 2002). Schulz and 
Grimes suggest that knowledge of an intervention and perceptions of it can have an impact on 
the psychological responses of participants. As such, the results of this study need to be 
interpreted with caution, as it is possible, as detailed above, that a participant in the control 
group could have undertaken the three good things activity during the study. Previous 
positive psychology interventions have previously implemented blinding of subjects to the 
condition they have been assigned (Emmons, 2006; Lyubomirsky, 2011; Seligman, 2005; 
Sheldon, 2002, 2006). Future research should, therefore, employ a minimum of a single-
blinded randomised controlled trial which ensures that the participants do not know which 
group they belong too (Karanicolas, Farrokhyar & Handari, 2010; Schulz & Grimes). By 
including a placebo activity, as discussed above, participants can be told that they will be 
asked to write each day but no detail with regards to whether they are writing three good 
things, or writing for a placebo activity needs to be given, this may mean that any findings 
are due to the intervention.  
 
Whilst this pilot study did not find an effect of utilising a three good things activity, a study 
with a larger sample may find improvements in quality of life in women with PCOS. Future 
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research should assess the effectiveness of this intervention in a larger sample of women with 
PCOS. Moreover, future research should explore the utility of using text-message, or mobile 
phone applications, in positive psychology interventions; particularly with the three good 




Chapter Eight -General Discussion 
 
This thesis aimed to further understanding of, and improve quality of life, of women with 
PCOS, including those who live with co-morbid conditions. To achieve this, it aimed to 
investigate and identify how women with PCOS in the UK perceive and define their quality 
of life; to further understanding of the impact of PCOS on quality of life from their 
perspective; to explore and gain an understanding of how women with PCOS in the UK live 
with and perceive their condition and any co-morbid conditions on a daily basis; to develop 
and test a disease-specific quality of life scale for women with PCOS in the UK; to identify 
and investigate the prevalence of PCOS symptoms and co-morbid conditions in women with 
PCOS and their association with quality of life; and finally, to identify, develop and test a 
pilot intervention aimed at increasing quality of life in women with PCOS who may present 
with symptoms of depression and/or anxiety.  
 
This chapter will build on the discussions of the previous chapters and provide an overall 
discussion of the thesis. It will begin with a summary of the main findings, and it shall then 
discuss the contribution of this thesis to wider knowledge with regards to coping in long-term 
conditions and quality of life. Moreover, this chapter will discuss the methods used for 
recruitment and data generation. It shall continue with a discussion of the strengths and 
limitations of this thesis, recommendations for individuals working in clinical practice and 
future directions. Finally, reflections of this PhD and the overall conclusion shall be 
discussed.  
 
8.1 Summary of Main Findings 
This thesis began with an exploration of the impact of PCOS on quality of life, from the 
participant’s perspective and utilised a photovoice methodology (chapter three). This chapter 
identified three main themes: Control (Symptom Management and PCOS as Controlling), 
Perception (Feminine Identity and Positive Outlook) and Support (The Health Care System, 
Education and Relationships). Some of the themes detailed in this chapter have been 
discussed in previous research including the theme Symptom Management (Crete & 
Adamshick, 2011) which discusses the methods used by women with PCOS to manage their 
symptoms. This can include diet, exercise, medication and hair removal techniques. Another 
theme which has previously been discussed in the literature is the theme Feminine Identity. 
This theme concerns the way women with PCOS feel that the condition and its symptoms, 
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impact on their identity as a women. In particular, this relates to the symptoms of infertility 
(feeling they are not a real woman due to their inability to conceive) and hirsutism (feeling 
they are more masculine than feminine due to their hirsutism symptoms).  
 
Another theme that has been touched upon by previous literature, although not explicitly 
discussed, is the theme PCOS as Controlling (Percy et al., 2009; Snyder, 2006). The theme 
demonstrated how women with PCOS felt like they had a lack of control over their condition, 
and its symptoms, which often lead to participants becoming socially isolated. There were, 
however, several original findings within this chapter; this includes the theme of Positive 
Outlook which pertains to the way in which women with PCOS retained an optimistic 
outlook despite living with their condition and its symptoms. In particular, it revealed how 
women with PCOS remained optimistic about their condition, particularly their future 
fertility.  
 
The overarching theme of Support has been discussed in the previous literature (Holbrey & 
Coulson, 2013; Percy et al., 2009). Within this theme, the sub-theme Health Care 
Professionals discussed the lack of support women with PCOS felt they received from their 
health care professionals (Crete & Adamshick, 2011; Kitzinger & Willmott, 2002; Snyder, 
2006). This was the first study to discuss how women with PCOS used online support groups 
held on social networking websites such as Facebook, and online blogging websites such as 
Tumblr, to gain support from other women with PCOS and to find information about their 
condition, particularly when this information was not forthcoming from their health care 
professional. Moreover, whilst the role of pets and support has been discussed in the wider 
literature (Allen, 2003; Allen et al., 2002; Antonacopoulos & Psychyl, 2010); the study 
within this thesis was the first to reveal the supportive role pets played for women with PCOS 
with one participant referring to their cat as their ‘furry baby’.  
 
The Skype™ interview study detailed in chapter four found four major themes: Change (To 
Life Plans and Changing Nature of the Condition), Co-Morbidities (Living with Other 
Conditions and Depression and Self-harm), Support (Health Care Professionals, Self-support 
and Relationships) and Self (Feminine Identity and Us and Them). Women in this study, 
within the theme Support, also felt that they did not get enough support from their health care 
professionals and, as detailed in Chapter Four, they found themselves searching for the 
information and described gaining support from women in online social networks such as 
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Facebook. In addition, this study found a theme of Feminine Identity (similar to chapter 
three). Findings in the interview study supported those of the photovoice study in Chapter 
Three, however, the impact of PCOS on the participant’s identity did not pertain just to their 
feminine identity but also to their perception of themselves as broken.  
 
In the interview study in Chapter Four two themes that held original findings were detailed: 
Change and Co-Morbidities. The theme Change discussed the impact the condition had on 
the participants’ life plans, often resulting in women having to change their life goals, to 
focus on family planning, or from their plan of having a family to not being able to. 
Moreover, some participants reported that they felt under pressure to conceive, with one 
participant specifying that this pressure came from their health care professional. This is the 
first time that pressure to conceive, and pressure from a health care professional to conceive, 
for women with PCOS has been reported. 
 
Another theme reported in this chapter is that of Co-morbidities. Within this chapter, six 
participants reported experiencing at least one co-morbid condition to their PCOS including 
thyroid disorders, hypermobility and IBS. Whilst these conditions have been explored in 
relation to PCOS in the medical literature (Janssen, Mehlmauer, Hahn, Öffner & Gärtner, 
2004; Mathur et al., 2009; Sinha et al., 2013), this is the first study to explore how women 
with PCOS who also have a co-morbid condition, experience living with more than one long-
term condition on a day-to-day basis. In addition, two thirds of the participants reported 
experiencing psychological co-morbidities, or depressive symptoms, including self-harm. 
The prevalence of depression in women with PCOS has been previously documented (Deeks, 
Gibson-Helm & Teede, 2010; Månsson et al., 2008; Rassi et al., 2010). However, the study 
described in Chapter Four of this thesis is the first to discuss how women with PCOS 
experience living with their condition and psychological co-morbidities, such as depression. 
Furthermore, this chapter also demonstrated that women with PCOS seek support online from 
social networking websites such as Facebook where they gain not only support from other 
women with PCOS but also information. Chapter four, therefore, furthers understanding of 
the experience of living with PCOS and co-morbid conditions, on a day-to-day basis. 
 
The findings of Chapter Three and Four also aided in the development of items for a disease-
specific quality of life measure, the PCOSQOL, detailed in Chapter Five. Example items of 
the PCOSQOL include: ‘Felt under pressure to have a child’, ‘Felt like you weren’t a real 
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woman because of your PCOS’, ‘Felt like you don’t know what to do to control your PCOS’ 
and ‘Struggled to cope with your PCOS and other condition(s)’. The items included in the 
development process pertained to all domains of quality of life as detailed by the WHOQOL 
group (1994), including: social, environment, level of independence, physical health and 
psychological health. The initial 62-item prototype scale was reduced to a 35-item scale after 
item reduction, the scale was then subject to validity and reliability testing (as detailed in 
chapter five). The final PCOSQOL is made up of 35-items and four subscales: Impact of 
PCOS, Infertility, Hirsutism and Mood. This scale was developed on and for a UK 
population, overcame some of the criticisms of the PCOSQ and had excellent reliability and 
good construct validity. Information about the validity of the PCOSQOL was also sought and 
tested as part of Chapters Six and Seven (Nunally, 1994; Streiner & Norman, 2008) 
 
This thesis also aimed to investigate the prevalence of symptoms and co-morbid conditions, 
in women with PCOS in the UK. As two thirds of the women in chapter four discussed their 
psychological co-morbidities, particular focus was placed on the prevalence of psychological 
co-morbidities over physical. This thesis then also aimed to explore the association of these 
symptoms with overall quality of life. As such, data was gathered from women with PCOS 
during the scale development study, which included their quality of life scores from the 
PCOSQOL. Many of the demographic questions were based upon the findings of the studies 
in chapter three and four: this included questions around participants’ past clinical diagnoses 
of depression and anxiety, and symptoms they experienced. Analyses, detailed in chapter six, 
revealed that women with PCOS who experienced the symptoms of infertility, hirsutism, 
weight, alopecia, skin discolouration, skin tags and mood swings had significantly lower 
quality of life scores than those women who did not experience the symptoms. These findings 
suggest that quality of life for women with PCOS may be mediated by the symptoms they 
experience. This analysis also helped provide information with regards to the validity of the 
PCOSQOL as the measure was able to identify differences in quality of life within the sample 
of women with PCOS.  
 
There were key findings in chapter six: primarily, analysis of the data revealed that the 
symptom of skin tags may be a more prevalent symptom of PCOS than previously reported 
(Lowenstein, 2006). Indeed, the symptoms which impact physical appearance including 
alopecia, skin discolouration and skin tags, were all significantly associated with a self-
reported clinical diagnosis of Social Anxiety Disorder. Moreover, there were the high levels 
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of depression and anxiety reported by women with PCOS in the UK, supporting previous 
research (Bhattacharya & Jha, 2010; Dokras, 2012). These findings further highlighted the 
need for an intervention to improve quality of life in women with PCOS and also to reduce 
levels of depression and anxiety.  
 
To improve quality of life for women with PCOS in the UK, regardless of their health care 
status, a cost-effective, accessible intervention which required minimum input from a health 
care professional was needed (Bennet, 2004). A positive psychology intervention was 
identified as having the potential to benefit the most people, with the minimum input 
(Bennet). As such, a positive psychology intervention would be suitable for those women 
with PCOS who no longer engage with the wider health care system. A pilot randomised 
controlled open trial utilising an online positive psychology intervention was therefore 
developed to explore the impact on quality of life, depression and anxiety in women with 
PCOS (Chapter Seven).  
 
The open randomised controlled trial consisted of participants in the intervention condition 
completing the three good things activity (Seligman, Steen, Park & Peterson, 2005) where 
participants write down thee good things that happen to them each day for 28 days. Whilst 
the study did not find an effect of the three good things activity on quality of life, depression 
or anxiety; it did find an overall effect of time, meaning that participants (regardless of 
condition) had significantly increased scores of quality of life from pre intervention to follow 
up. These results, and analysis of descriptive statistics, suggest that being part of a study may 
have had an impact on participant’s quality of life scores regardless of the condition they 
were randomised to. No interaction or time effect was found for scores of anxiety and 
depression.  
 
8.2 Quality of Life 
The overarching objective of this thesis was to further understanding and improve quality of 
life in women with PCOS which includes those who live with co-morbid conditions. 
Specifically, this thesis also aimed to explore how women with PCOS in the UK perceived 
and defined their quality of life (Chapter Three). With regards to quality of life for women 
with PCOS in the UK, the qualitative studies of this thesis demonstrated that women with 
PCOS perceived their quality of life to be made up of aspects relating to their physical health 
(e.g., the experience of symptoms) and psychological health (e.g., negative feelings and 
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bodily image), social concerns (e.g., relationships and social support), their environment 
(e.g., participation in recreation and financial resources) and their independence (e.g., 
activities of daily living and their dependence on medications/treatments). These concerns 
reflect those domains of quality of life reported by the WHOQOL Group (1994). In addition, 
the women in the qualitative studies maintained a positive outlook, particularly demonstrated 
by Denise who found a story in the newspaper about a successful pregnancy after many 
miscarriages, gave her hope. Through this positive outlook, the women in these studies also 
demonstrated aspects of optimism and hope which reflect the spirituality, religion and 
personal beliefs domain of quality of life (WHOQOL Group, 1994).  
 
The findings of this thesis demonstrate that quality of life, for the women with PCOS in this 
research reflect those of the WHOQOL Group (1994). However, although items pertaining to 
all these areas of quality of life were included in the prototype 62-item scale, many of them 
were discarded though the scale development process of item reduction. This suggests that 
those domains most represented by items included in the final PCOSQOL best reflect the 
areas of quality of life deemed important to women with PCOS in the UK. That is the 
physical, psychological and social domains of health. As such, quality of life as defined by 
women with PCOS in the UK would reflect those domains of quality of life identified by 
previous research (Fallowfield, 1990; Fayers & Machin, 2007; Testa & Simonson, 1996).  
 
In addition to furthering understanding of how women with PCOS in the UK perceive and 
define their quality of life, and the day-to-day to experience of living with PCOS, the findings 
of this thesis demonstrate that PCOS can have a negative impact on quality of life for women 
with PCOS in the UK. Moreover, it found that women with PCOS who experience the 
symptoms of infertility, hirsutism, weight, alopecia, skin discolouration, skin tags and mood 
swings had a lower quality of life than women who did not experience these symptoms. This 
suggests that effective management and/or treatment of these symptoms may improve quality 
of life for the women who experience them.  
 
8.3 The Feminine Role 
For the participants of this research, PCOS permeated all the levels of their life (Radley, 
2004). However, the impact of PCOS on the participants’ perception of themselves as a 
woman, and on their ability to have children, was discussed in each qualitative study and was 
of notable importance in the scale development study through the inclusion of items ‘Felt like 
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less of a woman because of having PCOS’ and ‘Felt like you weren’t a real woman because 
of your PCOS’ in the PCOSQOL, demonstrating their importance to quality of life for 
women with PCOS.  
 
8.3.1 Feminine Identity 
Within the qualitative chapters of this thesis it became evident that PCOS has a negative 
impact on the participant’s sense of identity as a woman. In both the qualitative chapters, 
participants discussed how the symptoms of hirsutism, and the symptoms relating to 
menstrual regularity and fertility, impacted their identity as a woman. In addition, items 
pertaining to feminine identity in the scale development chapter were endorsed by many of 
the participants, and were included in the final PCOSQOL. This suggests that PCOS 
symptoms which impact a woman’s feminine identity are related to their quality of life, 
however, the exact nature of this relationship is unclear.  
 
Farkas et al. (2014) suggest that women with PCOS perceive themselves as unable to 
conform to the traditional feminine social norm due to the impact of PCOS on their 
appearance. Farkas et al. specify the symptoms of hirsutism, menstrual cycle abnormalities 
and infertility as impacting on their sense of femininity. Similarly, Kitzinger and Willmott 
(2002) were the first to describe the impact of PCOS on a woman’s sense of femininity. They 
detail how their participants referred to themselves as ‘freakish’ and not ‘proper’ women (p. 
349). Snyder (2006) and Keegan et al. (2003) also reported that women with PCOS could feel 
less like a woman due to the impact of their hirsutism. Amiri et al. (2014) found that women 
with PCOS perceived themselves as less feminine due to their hirsutism, menstrual 
irregularities and infertility. It is probable that these feelings in turn affect the quality of life 
ratings given by these women.  
 
The impact of infertility on feminine identity is not unique to PCOS and has been observed in 
women who experience endometriosis and women being treated for cancer (Komatsu et al., 
2014; Moradi, Parker, Sneddon, Lopez & Ellwood, 2014), both of which can lead to 
difficulties conceiving. Moradi et al. (2014) found that women with endometriosis also felt 
like their condition had a negative impact on their identity as a woman, due to their 
symptoms of infertility and difficulties having sexual relationships. Similarly, women being 
treated for cervical cancer, where there is a risk to their fertility, felt that their feminine 




Ireland (1993) suggests that within society there is an assumption that motherhood is intrinsic 
to adult female identity, as such, women who are unable to become mothers may feel, and be 
perceived, as missing something. Certainly, Amiri et al. (2014) suggest that health care 
professionals should initiate management of PCOS which is aimed at reconstructing their 
womanhood. Furthermore, whilst the impact of PCOS on feminine identity has been 
discussed in previous research (for example, Keegan et al., 2003; Kitzinger & Willmott, 
2002; Snyder, 2006), there has yet to be research which explores this impact of PCOS in any 
depth, or its relationship to quality of life. As such, future research should seek to explore the 
impact of PCOS on feminine identity and on quality of life.  
 
8.3.2 Goal Attainment 
As mentioned above, women with PCOS can experience difficulties conceiving and having 
children: as such, their goal to have children can be unfulfilled, as was demonstrated by 
participants in this thesis. In line with this, Thompson, Woodward and Stanton (2011) 
propose that individuals with long-term conditions often face challenges to their life-goals. 
Alongside optimism (discussed in Section 8.3.1 of this chapter), goal adjustment can 
influence quality of life (Wrosch & Scheier, 2003). Personal goals have been shown to be 
important factors to an individual’s perceived quality of life (DeRidder, 2004). Similarly, 
Kuijer and de Ridder (2003) suggest that an individual’s ability to fulfil a goal is related to 
their overall well-being. Emmons (2003) also suggests that goal attainment is important for 
the experience of well-being. This reflects the findings of chapter four whereby the 
participants, as a result of PCOS, had changed their life plans with regards to having children. 
Indeed, Kuijer and de Ridder (2003) suggest that when a goal is of high importance to a 
person, but is not easy to attain, then there may be a negative impact on well-being. They 
example personal goals in long-term illness, proposing that personal goals related to family 
may be threatened.  
 
Wrosch and Scheier (2003) suggest that if a relevant goal proves unattainable and there is no 
possible alternative means to attain the goal, then people should be able to identify an 
alternative goal, commit to the new goal and initiate activities towards goal attainment. This 
re-engagement with a goal may contribute to quality of life (Wrosch & Scheier). Salmela-Aro 
and Suikkari (2008) explored adjustment in women with PCOS with regards to their child-
related goals during infertility treatment. They found that goal attainability decreased among 
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individuals with unsuccessful infertility treatment. Moreover, they report that unsuccessful 
child-related goal adjustment among individuals with unsuccessful treatment was related to 
higher levels of depressive symptoms. Therefore, women with PCOS who are unable to fulfil 
their goals of having children may be at risk of depressive symptomology.  
 
Kraaij, Garnefski and Schroevers (2009) suggest that those people who are involuntarily 
childless, are in need of help to learn how to cope with their childlessness. Similarly to 
Salmela-Aro and Suikkari (2008), Kraaij et al. suggest that goal adjustment is necessary to 
cope with definitive infertility. In addition, Thompson et al. (2011) propose that goal 
disengagement is adaptive. Health care professionals should, therefore, encourage women 
with PCOS who are unable to achieve their goal of having children biologically, to come to 
terms with their goal being unattainable, and commit to a new goal. Moreover, careful 
attention should be paid to any presenting depressive symptoms in women with PCOS as they 
adjust their goals.  
 
8.4 Coping in Long-term Conditions 
Research suggests that long-term illness has the potential to induce changes in a person’s life 
which can consequently have a negative impact on quality of life (de Ridder, Geenan, Kuijer 
& van Middendorp, 2008). Similarly, Radley (2004) suggests that when an individual has a 
long-term condition, then all areas of their life including the physical, social and medical 
aspects must adapt to the condition. Moreover, Radley proposes that when an individual is 
coping with their condition, it can become a ‘way of life’ (p.152). Certainly De Ridder et al. 
(2008) suggest that performance of adaptive tasks is an element of successful adaption to 
long-term illness. Moreover, Kolahi et al. (2015) suggest that inefficient coping strategies 
negatively impact quality of life of women with PCOS. It is clear, therefore, that coping and 
adaption in long-term conditions is related to quality of life.  
 
8.4.1 Optimism 
Findings from the first qualitative study suggested that some women with PCOS attempt to 
keep a Positive Outlook (Chapter Three, Section 3.4.2.2). Rasmussen et al. (2009) suggests 
that keeping a positive outlook, or, being optimistic is a significant predictor of positive 
health outcomes. De Ridder (2004) suggests that optimists maintain an active coping style 
which is characterised by problem-focused coping and seeking social support. This was 
similarly reported by Carver, Scheier and Segerstrom (2010) who report that optimism 
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predicted active attempts to both change and accommodate to stressful circumstances. De 
Ridder et al. (2008) propose that a positive mood can positively impact self-management. 
Similarly de Ridder, Fournier and Bensing (2004) suggest that optimism may promote self-
care behaviour. However, Friedman (2002) suggests that it is not clear how optimism relates 
to a person’s degree of psychological adjustment. Research, therefore, suggests that optimism 
is related to positive health outcomes and active coping styles, although the exact nature of 
the role is unclear. 
 
There has yet to be research which explores the role of optimism in women with PCOS, 
however, research into the impact and role of optimism has been undertaken in other long-
term conditions (Carver et al., 2005; Deimling, Bowman, Sterns, Wagner & Kahana, 2006). 
Certainly, initial optimism has been found to predict long-term adjustment in women with 
breast cancer (Carver et al., 2005). Similarly, research has reported that optimists reported 
fewer cancer-related health worries than pessimists (Deimling et al., 2006). Moreover, 
research exploring the contribution of optimism to adaption with long-term illness found that 
those with long-term illness, including type 1 diabetes, rheumatoid arthritis and multiple 
sclerosis, who were optimistic about their health outcomes, showed improvements in mental 
health over time (Fournier, de Ridder, Bensing, 2002). Future research, should therefore, 
explore the role of optimism with regards to coping and adjustment in women with PCOS.  
 
8.4.2 Self-Management 
Marks et al. (2005) report that individuals with long-term conditions engage with self-
regulation, whereby they actively monitor and adjust their medication. Similarly, the 
participants in the qualitative studies in this thesis described their self-management routines, 
including: taking medication and supplements to control both internal and external 
symptoms, hair removal of excess body hair, hair washing routines to protect against 
alopecia, skin routines to control acne, taking part in exercise and eating a specific diet as a 
burden. The burden of self-management routines was also highlighted through the inclusion 
of the item “Spent a lot of time and energy removing excess hair” in the final version of the 
PCOSQOL, representing the impact of this item on quality of life. This item and the previous 
qualitative findings support suggestions by de Ridder (2004) and de Ridder et al. (2008) that 




Self-management routines enable individuals to feel in control of their condition (de Ridder, 
2004; Leventhal et al., 2003). Indeed, Clark et al. (1991) defined self-management as the 
daily tasks that an individual must complete to control the impact of their condition, 
reflecting those tasks undertaken by participants in this study. Additionally, De Ridder (2004) 
suggests that when a person with a long-term condition develops self-care routines in order to 
control their condition, it can increase their perceived control of the condition. These self-
care routines involve undertaking tasks in order to manage the condition, which could include 
taking medication, exercising, controlling body weight, eating a specific diet (de Ridder, 
2004). Certainly, many women in this study completed adaptive tasks such as performing 
self-management routines (Moos & Schaefer, 1984). Furthermore, Kuijer and de Ridder 
(2003) suggest that adaptive tasks (Moos & Schaefer, 1984) may be labelled as illness-related 
goals (relating to Goal Attainment in Section 8.2.2 of this chapter).  
 
Women with PCOS, therefore, engage with adaptive tasks through performance of self-
management routines. For the participants in this study this included taking prescribed 
medications, taking supplements, controlling the symptom of hirsutism through methods such 
as shaving and waxing, performing daily skin routines to control acne and also exercising and 
maintaining a suitable diet. However, there is little research which explores coping in women 
with PCOS, therefore, future research should explore the methods women with PCOS use to 
cope and adapt to their condition. 
 
8.4.3 Support 
Support was discussed by the participants in this thesis in both the qualitative studies, and its 
importance was also demonstrated in the scale development study through the final inclusion 
of support items in the PCOSQOL. This includes items such as ‘wanted to do something but 
haven’t because of your PCOS’ and also ‘wanted to take part in a social activity but haven’t 
because of your PCOS’. The qualitative findings of this thesis suggest that women with 
PCOS may become isolated due to their perception of how other people may react to them 
(Radley, 2004). 
 
De Ridder (2004) suggests that perceived social support is a better predictor of adjustment 
than actual support. Moreover, De Ridder (2004) proposes that social support in long-term 
illness can come in different forms, including: information (what could be done to alleviate 
the stressor/symptoms), assistance (provision of services), and emotional support 
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(reassurance and acceptance). Certainly, in this thesis, each of these forms of support were 
discussed (Chapter Three, Section 3.4.3 and Chapter Four, Section 4.4.3). Of particular note 
in this thesis was the use of online social media such as Facebook, and attendance at PCOS 
conferences, to gain support from other women with PCOS.  
 
Social support has been discussed previously in the PCOS literature. Specifically, Percy et al. 
(2009) suggested that social support was a key factor in mediating the impact of PCOS, and 
that social support may help women with PCOS to improve their self-management. In 
addition, Holbrey and Coulson (2013) found that there were many positive benefits for 
women with PCOS when participating in dedicated online discussion board groups, including 
a realisation that they were not alone, and facilitating access to advice and information; 
reflecting the types of support detailed by de Ridder (2004). One additional method of 
gaining support raised in this thesis was that of gaining emotional support from pets (Chapter 
Three, Section 3.4.3.3). Within Chapter Three, two participants detailed their pets as having 
an impact on their quality of life, with one participant referring to her cat as her ‘furry baby’. 
This is in line with research by Allen (2003) who proposed that pets can be important family 
members to individuals. Indeed, whilst this is the first study exploring PCOS to report the 
supporting nature of pets, previous research has detailed how pets can act as support in health 
experiences (Allen et al., 2002; Ryan & Ziebland, 2015). 
 
Mousiolis, Michala and Antsaklis (2012) report, use of the internet and social media has now 
largely replaced the health care professional as the main source of information for individuals 
with PCOS. Avery and Braunack-Mayar (2007) similarly suggest that for women with PCOS 
the internet was the most versatile and beneficial source of information. Moreover, Dowdy 
(2012) reported that many teenagers with PCOS used the internet for guidance and support, 
when they found their health care professional lacking. This suggests that women gain 
informational support as well as emotional support, from other women with PCOS and the 
internet. There remains a need therefore, for more research which explores the role of social 
support for women with PCOS, particularly in relation to how they make use of the internet 
and social media support groups. 
 
8.5 Psychological Co-morbidities  
This thesis aimed to further understanding and improve quality of life for women with PCOS. 
However, many of the participants reported experiencing co-morbid conditions in addition to 
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their PCOS. Specifically, within Chapter Four, of the nine participants with PCOS who took 
part six participants experienced a physical co-morbidity, these included: migraines (n=1), 
IBS (n=1), hypermobility (n=1), hypothyroidism (n=1) and adrenal fatigue (n=1). Of note, 
however, six participants reported experiencing symptoms of depression. Of these 
participants three experienced both a physical co-morbidity and a psychological co-morbidity 
(Dawn, Kay and Tanya).  
 
Previous research has suggested that individuals with long-term conditions are likely to 
experience depression and anxiety (Marks et al., 2015). For women with PCOS, this is also 
shown to be true as women with PCOS are more likely to experience increased levels of 
anxiety and depression in comparison to women without PCOS (Benson et al., 2009; 
Cipkala-Gaffin et al., 2012; Deeks et al., 2011; McCook et al., 2005). Certainly, Coffey et al. 
(2006) suggest that PCOS can impact women more psychologically than physically. This was 
reflected by participants in this thesis and the initial 62-item prototype scale, which included 
items regarding the experience of living with co-morbidities and psychological co-
morbidities. Whilst not all of these items remained after the item reduction procedures, the 
item ‘felt overwhelmed by your PCOS and depression’ and ‘struggled to cope with your 
PCOS and your other condition(s)’ did remain. This suggests that living with PCOS and 
depression or other co-morbid conditions, is a key aspect of quality of life for women with 
PCOS in the UK.  
 
De Ridder et al. (2008) suggest that symptoms of depression and anxiety can interfere with 
self-management routines. De Ridder et al. also report that absence of psychological 
disorders is an element of successful adjustment to a long-term condition (in addition to 
performance of adaptive tasks). However, as many of the participants in this thesis presented 
with psychological disorders of depression and anxiety and it suggests that a number of 
women with PCOS in the UK may not have successfully adjusted to their PCOS. Benson et 
al. (2010) report that in women with PCOS, maladaptive coping is associated with anxiety 
and depressive symptoms and also reduced quality of life. As such, further research is needed 
which explores the impact and role of psychological co-morbidities such as depression and 






There were several little-used methods used in this thesis, including online research methods 
to recruit participants and collect data and also photovoice as a data generation method.  
 
8.6.1 Online Research  
The majority of research for this thesis was conducted online, including recruitment, data 
generation and data collection: in the photovoice study, participants were recruited via a post 
on the PCOS charity Verity, and communicated with via email; in the Skype™ study 
participants were interviewed online and in the third and fourth study, participants’ data were 
collected entirely through online questionnaire software (LimeSurvey and Qualtrics). With 
the exception of Chapter Three, whereby participants were recruited via a post on the Verity 
website, participants were recruited entirely online through online social networking website 
Facebook using PCOS support groups in the UK. Verity were unable to facilitate recruitment 
for the latter three studies detailed in this thesis.  
 
Each of the Facebook support groups had several hundred women with PCOS as members 
and at least one, if not more, administrators of the group. The administrators were responsible 
for maintaining order within the group, including deleting sales posts which were trying to 
sell products and deleting comments, or closing ‘threads’ where members of the group had 
begun to argue. Each of the administrators was a volunteer and used their own time to help 
provide a supportive area for the women in their group, and they were crucial for this 
research, as without their permission, recruitment would not have been possible. However, 
these women, and often the members of the groups, went above and beyond to help support 
this research; often ‘pinning’ recruitment posts to the top of the group or ‘bumping’ 
recruitment posts to ensure that they stayed visible to members of the group. Participants who 
had or were taking part in the research would also recommend the research to other women in 
the group and encourage them to take part. This is demonstrated in the quote below regarding 
the online positive psychology intervention (Chapter Seven), from a member of one of the 
Facebook groups: 
 
If anyone’s thought about taking part in Sophie’s research, I’d recommend it. I’ve been 
struggling recently to stay positive and this helps me focus on recognising positive things 




This feedback demonstrated direct impact of taking part in the study to participants. This is 
reflected in the quotes below, written in response to the recruitment post for the scale 
development study (Chapter Five): 
 
I already have done it, and thinking about the answers made me realise how much it is 
actually affecting me emotionally! So it gave me the push to go back to the doctors and admit 
that they was right, I am depressed, and taking it out on other people closest to me, so Thank 
you!  [Participant B] 
 
I completed the survey and I must say that the questions were really well thought out. Some of 
them made me realise that I can’t be the only one feeling like I am. I just hope one day that 
doctors will have a better understanding of this condition so that they can better support 
women. It isn’t just an isolated symptom, it impacts on ever area of your life. I am so happy 
that something is being done! [Participant C] 
 
Completed it for you now Sophie, I was so happy to be being asked those questions because 
no medical professional has ever asked me those questions yet the answers to those questions 
are a huge part of PCOS – it’s so sad that health care professionals do not indulge 
themselves with PCOS when the facts are that 1in10 women have PCOS – so frustrating!  
…… [Participant D] 
 
When participants posted comments as above, they were asked if it would be okay for the 
quote to be used (anonymously) in this thesis. Every participant said yes, and some added 
more, for example:  
 
Sure I would love that because I feel very strongly about this research being right and 
coming into fruition I have been trying to conceive for 9 and half years and been pushed from 
pillar to post if I can help prevent that happening to someone else then be my guest  x 
[Participant D] 
 
This visible, positive impact of the research on participants helped reaffirm the need for, and 
importance of, this research. Moreover, over the course of the research, recruiting participants 
from Facebook became easier as group administrators began to recognise the researcher’s 
name and became familiar with the research. Indeed, as the research progressed and studies 
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were completed, the Facebook groups and those individuals who participated were updated 
on the research and any subsequent publications or conference presentations. Upon 
completion of all the studies, a summary of the research findings was posted to the groups 
that had allowed recruitment to take place. In this way, the participants have been involved 
‘full-circle’ with this research and its findings. These posts received many ‘likes’ and also 
several comments. One member of the groups said: 
 
Well done Sophie and thank you so much for your work to bring better understanding of what 
it’s like to live with PCOS. 
 
Its good to hear that research is being done for awareness. 
 
Other aspects of this research were also carried out online, including data collection; the 
interviews in Chapter Four were carried out on Skype™ and in Chapter Five, Six and Seven 
data were collected using online survey software, including LimeSurvey and Qualtrics. 
Whilst completing data collection online had many benefits including being cost and time 
effective, it did lead to several problems with data retention, particularly in the scale 
development study detailed in Chapter Five.  
 
Whilst software errors may be frustrating, there will always be an element of human error to 
online research. The responsibility to check each day that there are no errors with the 
software lies with the researcher. Certainly, one of the biggest lessons learnt whilst 
completing this research was how one small software error could have a large impact on the 
research. Therefore, when conducting online data collection, researchers should be aware of 
the possibility of errors in the data collection software. However, due to these events, it is has 
since been possible to advise other students on potential problems they may encounter in 
online research, and how to prepare for them. For example, giving advice to a student on 
possible issues they may encounter when conducting Skype™ interviews and how to prepare 
for them.   
 
8.6.2 Photovoice 
In addition to Facebook, participants also communicated through other means such as taking 
photographs and keeping diaries. One participant included a ‘Thank you’ note in the diary 
they completed as part of the photovoice study. The thank you note was not the only 
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interesting, and unexpected, way that participants used their diaries. In the photovoice study, 
two of the nine participants used their diaries to draw diagrams that represented various 
aspects of themselves; one was a diagram of the participant’s changing sexuality and the 




Figure 8.1 Example of Diagrams from participant’s diaries detailed in Chapter Three 
 
Whilst diagrams have been previously used for data collection (Umoquit, Tso, Burchett & 
Dobrow, 2011; Umoquit, Tso, Varga-Atkins, O’Brien & Wheeldon, 2013), a literature review 
revealed that the spontaneous use of diaries to draw diagrams/figures by participants in 
photovoice research had not previously been reported. Interestingly, at the Midlands Health 
Psychology Network Conference (2014), Carmel Capewell presented her photovoice research 
and found that many of her participants, rather than taking their own photos, had used the 
internet to search for images.  
 
Another participant, allowed her friend to write a diary entry in her diary. Within this post 
they detailed how the participant had overcome obstacles placed in their way by PCOS. For 




‘Since I have known about PCOS I have seen a change in her. She knows exactly what she 
needs to do to jump over this hurdle. I am so proud of her because, I’ve heard of other cases 
and how them individuals cope. [They] have taken all the negatives, of this case and turned 
them into possible positives…It seems like yesterday that she told me, but it’s been four years. 
Glad to say she has accepted the condition, but shes also ready to do something about it.’ 
 
It is evident then, that photovoice is still a ‘new’ method and future research should allow 
participants more creative freedom within the method, which could help to uncover original 
research findings. Photovoice could also be expanded to include family members and friends 
in order to explore their perceptions of the participant and their PCOS, or other phenomena. 
 
8.7 Strengths and Limitations 
There are a number of strengths and limitations to the research detailed in this thesis. Many 
of these are discussed at length within each chapter. However, there were also a number of 
strengths and limitations across the thesis including the use of online research methods.  
 
There were several benefits to utilising online research methods; the most evident was the 
ability to recruit a large sample of participants from a disease-specific population (this is most 
evident in Chapter Five and Six). An additional benefit was the ability to recruit participants 
who were located throughout the UK rather than in a specific area (such as Derby or 
Derbyshire). Moreover, utilising online methods resulted in time and cost savings: reaching a 
sample size of 714 would have been unlikely if participants had been required to complete 
measures in a face-to-face scenario. This was similarly evidenced in Chapter Four as 
participants were unable to take part in face-to-face interviews or focus groups, opting instead 
to take part online. 
 
It could also be considered a strength that the lead researcher was female as many of the 
PCOS groups on Facebook that were used for recruitment did not allow male members, even 
if that person had joined the group in order to support a loved one such as a wife or daughter. 
Often members of the group would express discomfort at the thought of a man being a 
member of the group and participating, or viewing, discussions between the female members 
of the group with PCOS. In addition, the lead researcher also had PCOS and so it is possible 
that being diagnosed with the condition, and sharing this information with participants when 
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asked, may have made the researcher more approachable and allowed the participants to feel 
more comfortable sharing, often emotive, information with them. 
 
This self-disclosure, defined as ‘the act of revealing personal information to others’ (Archer, 
1980, p.183), may have helped form a closer relationship with participants. Certainly, 
research suggests that when conducting email interviews, the researcher should introduce and 
provide information about themselves, as this may help the participants engage in self-
disclosure (Meho, 2006; Moon, 2000). Joinson (2001) similarly found that participants were 
more open in their responses to internet based surveys when the researcher engaged in self-
disclosure. Moon (2000) details the principal of self-disclosure reciprocity whereby a person 
is more likely to engage with self-disclosure, if the previous speaker has engaged in self-
disclosure as well. Similarly, Derlaga and Berg (2013) suggest if a person self-discloses, the 
receiver is also likely to self-disclose. They also propose that self-disclosure may result in 
increased liking by the recipient for the self-discloser. In addition, Dindia and Allen (1992) 
found through a meta-analysis of 205 studies, that women were more likely to self-disclose to 
other women. This would support the above discussion that being a woman with PCOS made 
the researcher more approachable and encouraged participants to share their experiences. 
However, there is yet to be research which explores the impact of researcher gender on 
recruitment in Facebook groups or on possible negative consequences of self-disclosure in 
this setting. Future research is needed to explore the impact of the researcher’s gender on 
recruitment in predominantly female Facebook groups and the possible consequences for 
recruitment and the nature of the data collected due to self-disclosure on the part of the 
researcher.  
 
Recruiting participants from Facebook support groups, however, may have meant that the 
population sample was biased as participants were already seeking support and therefore the 
findings of this thesis may not be applicable to those women with PCOS who are not seeking 
support online. Trepte and Reinecke (2013) suggest that individuals who use social 
networking sites like Facebook are more likely to engage in self-disclosure. As recruitment 
took place online for all studies, participants could only be excluded if they self-reported that 
they did not meet the inclusion criteria. For example, in Chapter Three (the photovoice study) 
participants were asked to confirm that they met the inclusion criteria and therefore did not 
experience any other long-term or psychological illness which was not related to the PCOS 
(Chapter Three, Section 3.3). Whilst most potential participants were open about whether 
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they met the criteria or not, it is possible that participants could have experienced other 
conditions, not disclosed this and consequently have taken part in the study.  
 
Another strength of this thesis is the mixed-methods approach utilised (see Chapter Two for 
more detail). Use of a mixed-methods approach allowed for the participants’ experiences to 
be explored and consequently enabled the quantitative studies to be derived from the 
experiences of women living with PCOS in the UK. Studies derived from previous literature, 
or from the researchers own assumptions, may not have adequately reflected the experience 
of women with PCOS. Moreover, the findings of the quantitative chapters led to other 
research questions which should be explored qualitatively in order to gain a deeper 
understanding of the phenomena. For example, in Chapter Four, self-harm was spontaneously 
discussed by participants. Consequently, in the quantitative studies participants were asked 
about their self-harm history, revealing high levels of a history of self-harm in the population. 
This resulted in the identification of the need for further qualitative research which explores 
how women with PCOS experience self-harm, continuing the research development process.  
 
Creswell (2003) describes this process as sequential, whereby the researcher expands on 
findings of one method, with another method; an example being, beginning with qualitative 
methods for exploratory purposes and following up with quantitative methods to generalise 
results to a population. Furthermore, Creswell suggests that a mixed-methods approach 
employs strategies that involve collecting data sequentially to best understand research 
problems. Similarly, Denscombe (2008) suggests that mixed methods approaches have been 
previously used to allow for a more complete picture of the data to be produced and as a way 
of developing analysis and building on initial findings. Suggested future qualitative research 
derived from the quantitative aspects of this thesis; include an exploration of the impact of 




8.8 Recommendations for Clinical Practice 
The findings from this thesis have a number of implications for clinical practice. One of the 
most important is for health care professionals to be aware that women with PCOS are likely 
to experience depression and anxiety and be prepared to offer appropriate support to these 
women. Moreover, this thesis revealed that women with PCOS may be unable to meet child-
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related goals. As such, health care professionals working with women with PCOS who have 
been trying, but are unable to have children, should provide appropriate support to help them 
adjust their goals. 
 
Findings from Chapter Three demonstrated that PCOS can be a changing condition which 
makes it difficult for women with PCOS to manage their symptoms over time. In addition, 
according to whether the woman wishes to try for children or not, the treatments they receive 
will also change. As such, health care professionals should be considerate that symptoms of 
PCOS, and the necessary treatments, will change over the lifespan. Women with PCOS 
should therefore be required to follow up with their health care professional on a regular basis 
in order to help them maintain control over their condition, or indeed, to change treatments 
when necessary.  
 
In Chapters Three and Four participants discussed how they seek information and support 
from online sources including blogs such as Tumblr and social networking websites. Health 
care professionals should be aware of this and ensure that correct and up-to-date information 
regarding PCOS is available online from a recognised and trusted source, such as a GP 
practice or hospital website. Furthermore, online message boards which are moderated by a 
qualified health care professional could enable women with PCOS to feel more supported by 
the health care system, and ensure that these women have access to appropriate advice and 
information. One possibility is that a lay member of the public is employed as a moderator 
who would be able to guide group members to appropriate sources of information and advice 
made available through the relevant health care professionals, similar to Facebook group 
administrators. Greene et al. (2010) also suggest that policymakers should consider that 
patients may seek social networking websites developed and patrolled by health care 
professionals to promote accurate and unbiased information exchange.   
 
Finally, Chapter Six identified that women with PCOS may be more likely to experience the 
symptom of skin tags than previously reported. As this symptom is part of Aconthosis 
Nigricans, a condition that can be an early sign of diabetes (NHS, 2013), health care 
professionals should carefully screen women that present with skin tags and skin 





8.9 Future Directions 
There have been many recommendations for future research throughout this thesis. This 
section shall summarise the recommendations detailed within Chapters Three to Seven.  
 
This thesis has provided some insight into the experience of women with PCOS but further 
qualitative research is necessary as there still remains a need for research which describes and 
interprets the personal experiences of women with PCOS (Smith, 2015). Qualitative research 
will facilitate rich descriptions and explanations of their world and how they make sense of 
their lives (Coyle, 2016). Specifically, there is a need for further qualitative research which 
utilises methods such as photovoice in order to explore the day-to-day experiences of women 
with PCOS in more depth, as defined by them and not at the request of the researcher. The 
use of this method in this thesis allowed participants to use photographs and diaries in novel 
ways which could be further explored in future research in order to help the researcher 
understand how women with PCOS make sense of their condition and the impact it has on 
their lives.  
 
This thesis highlighted that women with PCOS use social media websites such as Tumblr and 
social networking websites like Facebook to gain information and support about their PCOS. 
As such, there is also a need for future research which explores how women with PCOS 
utilise online media to educate themselves about their condition and how they make use of 
online support from social networks such as Facebook and the impact this may have on them, 
both negative and positive. Qualitative methods would allow women with PCOS to share 
their experiences of using online media and social networking websites to gain information 
about their condition. Moreover, through using qualitative methods a further understanding of 
the role of social networking websites in social support could be gained. This would also 
further understanding of how women with PCOS gain knowledge about their condition, how 
they form relationships with other women with PCOS online, and also provide a deeper 
understanding of the role of support in these environments.  
 
This thesis identified that women with PCOS felt under pressure to conceive (Chapter Three 
and Four). As such, further qualitative research would enable an in-depth exploration of this 
perceived pressure as experienced by women with PCOS. Moreover, qualitative research 
could investigate why women with PCOS perceive pressure to conceive, and where this 
pressure is perceived to be from. In addition, research should explore the impact of advice to 
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conceive earlier rather than later from health care professionals on women with PCOS and 
the impact this advice and/or pressure may have on younger women with PCOS who may not 
be in an appropriate position to have children (financial instability etc.). How health care 
professionals communicate with their patients with regards to family planning and the way 
this is understood by those patients should also be explored with both women with PCOS and 
the health care professionals who advise and communicate with them.  
 
Women with PCOS can experience several physical and psychological co-morbid conditions 
in addition to their PCOS, as demonstrated in Chapter Four and Six. There is, therefore, a 
need for research which explores the prevalence of co-morbid conditions in women with 
PCOS and how these women experience and manage multiple conditions. Participants in 
Chapter Four also spontaneously discussed their experiences of self-harm and Chapter Six 
revealed that women with PCOS had high rates of self-harm when asked if they had a 
‘history of self-harm’. However, how the participant perceived and defined self-harm is not 
clear in this context. As such, further research is needed that explores the prevalence of self-
harm in women with PCOS, how women with PCOS define self-harm, and their experiences 
with regards to self-harm. 
 
Future research is also necessary to further validate the PCOSQOL in a clinical population 
and in women with PCOS who have differing lengths of diagnosis. Moreover, the PCOSQOL 
should be validated with participants in countries outside of the UK. This will enable the 
PCOSQOL to be used in clinical practice as a measure of quality of life in different countries.  
Further research exploring the associations between PCOS and symptoms experienced is 
necessary. In addition, future research should explore associations between PCOS and types 
of anxiety experienced by women with PCOS, particularly Social Anxiety Disorder and Panic 
Disorder. Research is also needed to explore the prevalence of Skin Tags in women with 
PCOS. Methods of coping used by women with PCOS would be useful to investigate, 
particularly the role of optimism in coping and adjustment in women with PCOS and coping 
strategies used by women who are presently involved in the health care system and those who 
have been discharged.  
 
Finally, this thesis revealed that being a part of a positive psychology intervention may have a 
positive impact on quality of life for women with PCOS regardless of the condition they are 
assigned to (intervention/control). However, this intervention was underpowered; therefore, 
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future research should explore the impact of a positive psychology intervention in a large 
sample of women in order to ensure that the study is appropriately powered. Future research 
utilising a positive psychology intervention should seek to complete a minimum of a single-
blinded randomised controlled trial, and also provide participants in the control group with a 
placebo activity.  
 
8.10 Reflection 
This section discusses some personal reflections on this thesis and the journey completing it. 
Jasper (2005) states that reflective writing “acknowledges at the outset that what is presented 
is that relating and purporting to the experiences and perceptions of the author” (p.250). As 
such, this section will be written in first person.  
 
As detailed in Chapter Two of this thesis, I had previously been diagnosed with PCOS. As 
has been stated several times in this thesis, PCOS can impact each individual differently and 
my experience of PCOS is at the mild end of the spectrum, with a symptom profile that 
pertains mostly to insulin resistance. It was my early diagnosis that led me to complete a 
qualitative analysis of discussion boards used by women with PCOS for my undergraduate 
dissertation: this study later formed the basis of my PhD proposal.  
 
During recruitment for these studies I did not disclose my diagnosis to participants. However, 
if participants asked why I was doing the research I explained that my interest had developed 
from earlier personal experiences, this seemed to help develop my rapport with potential 
participants and members of the Facebook support groups. In addition to participants asking 
about my interest, I have also been asked by other academics and researchers; why did you 
chose this topic? And, does this have an impact on your research? Consequently, I have had 
time to reflect on my position and whilst I do believe that my position has allowed me to be 
empathetic to my participants, as my experiences differ from those of my participants, my 
analyses were able to remain grounded in the data and not my personal experiences. 
Moreover, I attempted to ensure that my analyses represented the data by discussing it with 
my supervisory team, particularly in the qualitative studies (Chapter Three and Four) when 
discussing themes (Yardley, 2015).  
 
Whilst there were aspects of completing my PhD that were difficult; these pertained to the 
emotive nature of the research, rather than my own experiences. Certainly, the most 
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surprising finding to me was the voluntary discussion of self-harm in Chapter Four, and the 
subsequent figures of ‘a history of self-harm’ and diagnoses of depression and anxiety in 
Chapter Six. However, whilst these findings were emotive, I was able to discuss them within 
my supervision team, and in my wider support network.  
 
Another emotive aspect of this research came though recruitment: the only ‘down-side’ of 
recruiting through the Facebook groups was receiving a constant stream of posts on my own 
personal Facebook, as a result of belonging to the group. These were often highly negative 
and/or highly emotive posts: the worst of which included photos of miscarried foetuses and 
babies. Other posts were often labelled as TMI (too much information) and included 
photographs of menstruation or other bodily fluids. At times I did find these posts rather 
distressing and I found that the negativity of the posts was beginning to have an impact on 
my own mood. So, after recruiting for the scale development study I removed myself from 
many of these groups and attempted to limit the posts I could see from the ones I stayed in, 
re-joining only to recruit for the intervention study. In this way, online recruitment and data 
collection differs from face-to-face scenarios. In a face-to-face situation you would recruit 
your participant, generate and collect data, and then you would then no longer be a part of 
that participant’s personal life: you play the role of researcher and participant. When 
recruiting on Facebook, by using a personal Facebook profile, the (potential) participants’ 
lives become embedded within the researcher’s, so your personal time becomes saturated 
with the personal lives and troubles of the population, and it becomes difficult to remove 
oneself from the scenario.  
 
Chapters Three and Four demonstrated that women with PCOS were seeking support from 
online social networking sites such as Facebook. It may be, therefore, that this overload of 
negativity may have a similar impact on the women in the groups, particularly as they were 
often members of several Facebook groups. Indeed, Weiss and Bulmer (2011) reported that 
participants in their study did not find satisfaction in using dedicated PCOS support groups. 
Furthermore, Malik and Coulson (2010) report that of 295 women using dedicated online 
support forums for infertility over 57% reported disadvantages to online support including 
reading about negative experiences. In addition, Holbrey and Coulson (2013) found that 
women with PCOS reported negative aspects of using dedicated online support forums, 
including reading about the negative experiences of other members. It remains, however, that 
dedicated online support groups are often held on external websites outside of the 
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individual’s personal Facebook page. Future research should, therefore, explore the function 
of Facebook support groups for the women who are part of them.  
 
At the 12th Annual Psychology, Health and Medicine conference in Belfast, Northern Ireland 
(2015), Trish Niland described a study which explored how young adults airbrushed drinking 
practices on Facebook. In their study participants accessed their Facebook pages and 
discussed their profiles with the researcher to explore how young adults made use of 
Facebook. Bender, Jimenez-Marroquin and Jadad (2011) conducted a content analysis on 
Facebook support groups for women with breast cancer. They suggest that Facebook groups 
are a popular tool for support-seeking and raising awareness, but that further research is 
necessary to explore the implications of social networking sites as a health resource. In 
addition, Greene, Choudhry, Kilabuk and Shrank (2010) conducted a qualitative analysis of 
Diabetes management groups on Facebook. They found that Facebook provided a forum for 
reporting personal experiences, and gaining feedback from individuals living with diabetes. 
Therefore future research is needed that explores how women with PCOS use Facebook and 
other online media to gain support and the role it plays for them.  
 
8.11 Conclusion 
In 2012 the Amsterdam ESHRE/ASRM- sponsored 3rd PCOS consensus workshop group 
summarised current knowledge regarding PCOS and published their recommendations for 
future research to fill the various knowledge gaps regarding women’s health in PCOS. With 
regards to quality of life, the workshop group recognised that there is a need for the 
prevalence of psychological disorders in women with PCOS to be determined, and that there 
is a need for appropriate interventions to be developed. Moreover, the workshop group 
claimed that studies in the area of quality of life were hampered by the existence of only one 
disease specific quality of life questionnaire for women with PCOS (The PCOSQ: Cronin et 
al. 1998). As such, this PhD has addressed many of the concerns and recommendations of the 
workshop group through: development and validation of a UK disease specific quality of life 
scale (PCOSQOL), exploration of the prevalence of anxiety and depression in a large sample 
of women with PCOS and the development and piloting of an online positive psychology 
intervention.  
 
The findings of this thesis suggest that PCOS has a negative impact on quality of life: they 
demonstrate that quality of life for women with PCOS is reflective of psychological, 
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physical, social, environmental, independence and spiritual/religion/personal belief domains 
as previously reported by the WHOQOL Group (1994). However, the findings of this thesis 
suggest that for women with PCOS the majority of quality of life concerns fall within the 
psychological, physical and social domains of quality of life (Fayers & Machin, 2007; Testa 
& Simonson, 1996). The findings also suggest that quality of life for women with PCOS is 
associated with the experience of specific symptoms, including: infertility, obesity, alopecia, 
skin discolouration, skin tags and mood swings. In addition, living with co-morbidities, 
particularly psychological co-morbidities, may be important aspects of quality of life for 
women with PCOS. Whilst this thesis has furthered understanding of the impact of PCOS on 
quality of life for women with the condition in the UK, and attempted to improve quality of 
life; there remains a need for research which explores further the quality of life in women 
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Appendix A: Photovoice study – invite to participate 
 
PCOS and the impact on quality of life 
If you are over 18, live in the UK and suffer from PCOS and you would like to take part in a 
PhD study researching the impact of PCOS on quality of life then please email 
S.Williams3@derby.ac.uk. The study has been granted ethical approval from the University 
of Derby and will abide by the British Psychological Society's ethical guidelines. You will 
remain anonymous and all information will be confidential. All you would need to do for the 
study is take photographs (camera provided) and write diary entries (notepad provided) for 
one week of anything you which you feel relates to your quality of life and PCOS. There are 
no right or wrong answers. If you are interested please just email me on the address above 




Appendix B: Photovoice study – consent form 
Polycystic Ovary Syndrome on quality of life through the use of a photovoice methodology.  
Researcher – s.williams3@derby.ac.uk 
Director of Studies – r.c.knibb@derby.ac.uk 
University of Derby 
 
Thank you for your interest in taking part in this research. This research is being undertaken 
as part of a postgraduate research degree. This research has been granted ethical approval by 
the University of Derby Psychology Research Ethics Committee. This research will require 
you to take photographs on a disposable camera and to make a diary entry in the notebook 
provided explaining each photograph you take. 
 
Anonymous verbatim quotes from the diary entries will be used as part of the research 
findings in the final written report and possibly in publications, I guarantee that all 
identifying details will remain anonymous, being seen only by the researcher and research 
supervisors of this study. There will be no reference to names or any identifying details of the 
participants. Your decision to participate is completely voluntary and you may withdraw 
from this research at any point up to three weeks after participation, you do not need to give a 
reason or explanation for doing so.  
 
You will also be required to create a unique participant code. This is a code made up of three 
items of any combination, of letters or numbers. This code must be easy for you to remember 
as it will enable you to withdraw your research easily if you so chose too. If you have any 
questions about the research, please feel free to ask the researcher before you decide whether 
you want to take part.  
 
Participants Statement of Informed Consent 
 I understand that I have agreed to participate in a photovoice study which will require 
me to take photographs and make diary entries for a period of one week. 
 I understand that if, at any time, up to three weeks, I decide I no longer wish to take 
part in this project, I can notify the researcher involved and withdraw immediately. 
 I agree that the research project named above has been explained to me to my 
satisfaction and I have had the opportunity to ask the researcher any questions. 
 I understand that anonymous verbatim quotes may be used in the final report and may 
be published. 
 I understand that anonymity will be maintained and it will not be possible to identify 
me.  
 I understand that any photographs containing people, without their verbal consent, 
shall be destroyed and shall not be republished. 
 




Appendix C: Photovoice study – letter of instructions 
 Sophie Williams 
Centre for Psychological Research 
Faculty of Education, Health and Sciences 








I would like to thank you for your interest and participation in this research study. Please be 
reminded that to take part in this study you need to be a woman with PCOS, aged 18 years 
and above and have no other chronic or mental illness (which is not related to PCOS). 
Everything you need should be found inside the envelope you received along with this letter. 
This includes a disposable camera, a notepad, an information pack, a consent form and a 
return envelope with a pre addressed sticker. If you do not have any of those things please 
contact me and I will get them to you straight away. Also, the information sheet is yours to 
keep should you have any questions during or after participation in this research. 
 
In your study pack you should find a consent form as mentioned before. It is important that 
you read the information sheet (contacting me or the research team with any questions – 
details found in the information sheet) and then sign the consent form and return it with your 
camera and notepad once you have finished taking part in the study. If we do not receive a 
signed consent form then we cannot use your data in the research. 
 
To take part in this study all you need to do is take photographs of anything which you feel is 
related to your PCOS and has an impact on your quality of life. This could be something that 
enhances your quality of life or makes it worse (there are no good or bad photographs). For 
each photograph you take please make a diary entry in the notepad about the photograph, for 
example, what it is of (if it is unclear) or why you decided to take it. Again, there are no right 
or wrong ‘answers’ here.  
 
You are asked to do this (take photos and make diary entries) over a period of one week. 
Should you use all your camera exposures before the week is over please feel free to return 
the study pack early (excluding your information sheet). Don’t worry if a week finishes and 
you have not used all your exposures, just send the camera and notepad back with whatever 
you have done.  
 
To send your camera, notepad and consent form back just place the pre addressed sticker on 
the front of the envelope you received and post it back to us.  
 
We also ask that, should you wish to take photographs of any people, that you gain their 
consent first (more information about this is available in the information sheet). We also ask 
that you do not take any inappropriate images for example, featuring nudity. 
 
If you have any questions please feel free to contact myself or the research team on the 















Appendix D: Photovoice study – information sheet 
 
Sophie Williams 
Centre for Psychological Research 
Faculty of Education, Health and Sciences 





Director of Studies 
Dr Rebecca Knibb 
r.c.knibb@derby.ac.uk                                    
 
 




My name is Sophie Williams and I am a postgraduate research student at the University of 
Derby. I am currently researching Polycystic Ovary Syndrome and its impact on quality of 
life. I am inviting you to take part in a study which will form one part of my PhD. 
 
Before you decide if you would like to take part, it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following 
information carefully.  If anything is not clear and you would like some more information 
you can get in touch with me on the above number or email address. Please take your time to 
decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
The purpose of the study: 
 
To date there has been no research exploring the impact of PCOS on quality of life using 
visual data (photographs or drawings etc). This research hopes to fill this gap in the academic 
literature and therefore, further understanding of the experience of PCOS and its impact upon 
an individual’s quality of life. 
 
Why have I been chosen to take part? 
 
You will have been selected to take part if you are a woman with PCOS, who has no other 
chronic or mental illness not related to PCOS and who is over 18 years of age. 
 
Do I have to take part? 
 
No, it is up to you to decide whether or not to take part.  If you decide to take part you will be 
asked to keep this information sheet and to sign a consent form, which says you are happy to 
take part. If you decide to take part you are free to withdraw (stop taking part in the study) at 
any time up to three weeks after taking part and without giving a reason.  If you do take part 
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in the study and you change your mind afterwards, you can just contact us and we will 
destroy all the information and photographs you gave us.   
 
To do this you will need to have a unique participant code which is a code made up of three 
items (numbers or letters) which you create. Make sure you keep a copy of this code (we 
suggest writing it on the information sheet which you will keep). Please write the code clearly 




What does taking part involve? 
 
You will be asked to take photographs on a provided disposable camera for one week which 
relate to the impact of PCOS on your quality of life. These may be photographs of something 
which enhances your quality of life or makes it worse (there are no good or bad photographs). 
For each photograph you take please make a diary entry in the notepad provided about the 
photograph, for example, what it is of (if it is unclear) or why you decided to take it or even 
how you were feeling at the time. Again there is no right or wrong ‘answer’ here. 
 
When the week is up, or when you have used all of your camera exposures you will then be 
asked to put the camera and the notepad along with your consent form in an envelope and to 
mail it back to the researcher and research team.  
 
If you decide to take part in this study a study pack (containing a copy of the information 
sheet, a consent form, instructions for participant, a disposable camera, notebook and pen) 
will be sent to you.  
 
 
What should I take photographs of? 
 
You can take photographs of absolutely anything you feel impacts on your quality of life, be 
it positively or negatively. There is no limit to this and no right or wrong answer. 
 
We only ask that should you wish to take photographs of people you gain their consent. 
Although photographs of people will not be published or used for any other purpose than the 
psychological analysis for this study and my PhD thesis; it is still necessary that the person 
you wish to photograph is aware that it will be seen by me and the research team. It is also 
important that the individual understands the photograph is being taken for a PhD study. 
Therefore fully informed verbal consent should be gained from anyone you may wish to 
photograph. 
 
We also ask that you refrain from taking any inappropriate images, for example photos 
containing nudity.  
 
What are the benefits of taking part? 
 
By taking part you will be helping to further understanding of PCOS. 
 
 




There are no disadvantages to taking part in this study. 
 
What if there is a problem? 
 
If you have any concerns or complaints about anything to do with this study, please speak to 
the researcher or research team and we will do our best to answer your questions.  You can 
email Sophie Williams (email address is at the top of this information sheet) or Dr Rebecca 
Knibb (email address and phone number at top of this information sheet).  If you are still 
unhappy and want to complain formally, you can do this through the University of Derby’s 




Will the information I give in this study be kept confidential? 
 
Yes, all information collected from you for this study will be kept strictly confidential.  That 
means that no one outside of the research team will see any of the information you give us. 
Each person taking part in the study will be given a unique participant code that we will use 
when looking at what you have written in the notebooks and the photographs you have taken.  
 
Anonymised verbatim quotes from the diary entries will be used as part of the research 
findings in the final written report.  Information will be kept in a locked filing cabinet and on 




What will happen to the results of the study? 
      
The information you give us will be analysed  by Sophie Williams and the research team. The 
finding of this study will be written up into a report; this will form part of the PhD and may 
be published and presented at conferences etc.  We can send you a copy of the report if you 
would like it.  Your name will not be included in the report nor will any photographs of 
people be published in any publications. 
  
 
Who has reviewed the study? 
 
This study has been looked by the Ethics Committee at the University of Derby and is in 
accordance with the ethical guidelines of the British Psychological Society. These are a 
professional body of psychologists in the UK who check research to make sure that it protects 
the safety, rights, wellbeing and dignity of anyone who takes part. 
 
 
Can I get more information? 
 
If you are interested in taking part in this study but would like some more information before 
you decide, please talk to Sophie Williams or contact Dr Rebecca Knibb (contact details 
provided above). If you would like to talk to someone about research in Psychology at the 
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University please contact the Head of the Centre for Psychological Research, Professor James 
Elander, on j.elander@derby.ac.uk. 
 
 
If I decide to take part what do I do now? 
 


















Appendix E: Photovoice study – PREC approval letter (050-11-SW) 
 
Approval Letter: Psychology Research Ethics Committee 
 
University of Derby 
 
6th February 2012 
James Elander  





Ethics Ref No: 050-11-SW: A qualitative exploration of the impact of Polycystic Ovary 
Syndrome on quality of life. 
 
Thank you for submitting this revised application to the Psychology Research Ethics 
Committee.   
 
The reviewers of your original application have now reviewed the revised documents you 
sent following the feedback you received on your initial application, and are all satisfied that 
all of the issues raised have been dealt with. The application can now therefore be approved. 
 
 The following documents have now been reviewed: 
 
1. Revised ethics application form 
2. Revised letters to participants 
3. Revised participant information forms 
4. Revised consent form 
5. Debriefing information 
  
If any changes to the study described in the application or supporting documentation is 
necessary, you must notify the committee and may be required to make a resubmission of the 
application.  
 











Appendix F: Skype study – invite to participate 
 
 
Participants required to take part in research concerning “The impact of PCOS on quality of 
life”; a study being run by a PhD student at the University of Derby, UK.  Your participation 
will remain confidential and anonymous and is completely voluntary. You may also 
withdraw from the research after participation. 
There are two parts to this study: you can choose to take part in either: 
(1) (a) Participation will involve you taking part in a focus group with up to 6 other women 
with         PCOS and may last up to two hours. The focus group will take place at the 
University of Derby.  
 
(b) If you have taken part in the focus group you will also be invited to participate in a 
face to face or online interview which may last between one and two hours. The 
interview will take place at the University of Derby, UK or an alternative safe 
location may be arranged.  
 
(2) Participation will involve you reviewing a document of statements related to PCOS. This 
may be via the postal system (all postage costs will be provided) or via email. 
To take part you must meet the following criteria: have a diagnosis of PCOS, be 18 or over, 
live in England and have English as a first language. Participants must not suffer from any 
other condition which is unrelated to PCOS. 
 
If you are interested in either study please contact S.Williams3@derby.ac.uk or call 





Appendix G: Skype study – information sheet 
Sophie Williams 
Centre for Psychological Research 
Faculty of Education, Health and Sciences 





Director of Studies 
Dr Rebecca Knibb 
r.c.knibb@derby.ac.uk                                    
 




My name is Sophie Williams and I am a postgraduate research student at the University of 
Derby. I am currently researching Polycystic Ovary Syndrome and its impact on quality of 
life. I am inviting you to take part in a study which will form one part of my PhD. 
 
Before you decide if you would like to take part, it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following 
information carefully.  If anything is not clear and you would like some more information 
you can get in touch with me on the above number or email address. Please take your time to 
decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
The purpose of the study: 
 
 
Why have I been chosen to take part? 
 
You will have been selected to take part if you are a woman with PCOS, who has no other 
chronic or mental illness not related to PCOS and who is over 18 years of age, who also lives 
in England and has English as a first language. 
 
Do I have to take part? 
 
No, it is up to you to decide whether or not to take part.  If you decide to take part you will be 
asked to keep this information sheet and to sign a consent form, which says you are happy to 
take part. If you decide to take part you are free to withdraw (stop taking part in the study) at 
any time up to three weeks after taking part and without giving a reason.  If you do take part 
in the study and you change your mind afterwards, you can just contact us and we will 
destroy all the information you gave us and your data. 
 
To do this you will need to have a unique participant code which is a code made up of three 
items (numbers or letters) which you create. Make sure you keep a copy of this code (we 
suggest writing it on the information sheet which you will keep). You will be asked to 
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provide the code either during the online interview or you will be asked to write it on a 




What does taking part involve? 
 
There are three parts to this study: you can choose to take part in all or just one part: 
 
(3) Participation will involve you taking part in a focus group with up to 6 other women with 
PCOS and may last up to two hours. The focus group will take place at the University of 
Derby.  
 
(4) If you have taken part in the focus group you will also be invited to participate in a face to 
face or online interview which may last between one and two hours. The interview will 
take place at the University of Derby, UK or an alternative safe location may be arranged.  
 
(5) Participation will involve you reviewing a document of statements related to PCOS. This 




What are the benefits of taking part? 
 
By taking part you will be helping to further understanding of PCOS. 
 
 
What are the disadvantages of taking part? 
 
There are no disadvantages to taking part in this study. 
 
What if there is a problem? 
 
If you have any concerns or complaints about anything to do with this study, please speak to 
the researcher or research team and we will do our best to answer your questions.  You can 
email me (Sophie Williams, my email address is at the top of this information sheet) or Dr 
Rebecca Knibb (email address and phone number at top of this information sheet).  If you are 
still unhappy and want to complain formally, you can do this through the University of 




Will the information I give in this study be kept confidential? 
 
Yes, all information collected from you for this study will be kept strictly confidential.  That 
means that no one outside of the research team will see any of the information you give us. 
Each person taking part in the study will be given a unique participant code that we will use 




Anonymised verbatim quotes from the interview or focus group will be used as part of the 
research findings in the final written report and may be published. Information will be kept in 
a locked filing cabinet and on a password protected computer at the University of Derby for 
up to 7 years and then it will be destroyed.  
 
 
What will happen to the results of the study? 
      
The information you give us will be analysed  by Sophie Williams and the research team. The 
finding of this study will be written up into a report; this will form part of the PhD and may 
be published and presented at conferences etc.  We can send you a copy of the report if you 
would like it.  Your name will not be included in the report nor will it be published. 
  
 
Who has reviewed the study? 
 
This study has been looked by the Ethics Committee at the University of Derby and is in 
accordance with the ethical guidelines of the British Psychological Society. These are a 
professional body of psychologists in the UK who check research to make sure that it protects 
the safety, rights, wellbeing and dignity of anyone who takes part. 
 
 
Can I get more information? 
 
If you are interested in taking part in this study but would like some more information before 
you decide, please talk to me (Sophie Williams) or contact Dr Rebecca Knibb (contact details 
provided above). If you would like to talk to someone about research in Psychology at the 
University please contact the Head of the Centre for Psychological Research, Professor James 
Elander, on j.elander@derby.ac.uk. 
 
 
If I decide to take part what do I do now? 
 
If you do decide to take part in this study, thank you very much. All you need to do is let me 
(Sophie Williams) know you wish to take part and I will guide you through the rest of the 

















Appendix H: Skype study – consent form  
The Impact of Polycystic Ovary Syndrome on Quality of Life  
Researcher – s.williams3@derby.ac.uk 
Director of Studies – r.c.knibb@derby.ac.uk 
University of Derby 
 
Thank you for your interest in taking part in this research. This research is being undertaken 
as part of a postgraduate research degree. This research has been granted ethical approval by 
the University of Derby Psychology Research Ethics Committee. This research will require 
you to take part in a face to face or online interview with the primary researcher on in a focus 
group 
 
Anonymous verbatim quotes from the interviews and focus groups will be used as part of the 
research findings in the final written report and possibly in publications, I guarantee that all 
identifying details will remain anonymous, being seen only by the researcher and research 
supervisors of this study. There will be no reference to names or any identifying details of the 
participants. Your decision to participate is completely voluntary and you may withdraw 
from this research at any point up to three weeks after participation, you do not need to give a 
reason or explanation for doing so.  
 
You will also be required to create a unique participant code. This is a code made up of three 
items of any combination, of letters or numbers. This code must be easy for you to remember 
as it will enable you to withdraw your research easily if you so chose too. If you have any 
questions about the research, please feel free to ask the researcher before you decide whether 
you want to take part.  
 
You will also be asked to provide your contact details. This is so the researcher can contact 
you with any vital information (for example, informing you of changes to interview or focus 
group times) or to give you reminders (for example, about an upcoming interview). 
 
Participants Statement of Informed Consent 
 I understand that I have agreed to participate in a face to face or online interview or in 
a focus group. 
 I understand that if; at any time up to three weeks, I decide I no longer wish to take 
part in this project, I can notify the researcher involved and withdraw immediately. 
 I agree that the research project named above has been explained to me to my 
satisfaction and I have had the opportunity to ask the researcher any questions. 
 I understand that anonymous verbatim quotes may be used in the final report and may 
be published. 
 I understand that anonymity will be maintained and it will not be possible to identify 
me.  
 I understand that the researcher may contact me via email or telephone when 










Appendix I: Skype study – interview schedule 
 
Please could you tell me how you first became aware of your PCOS? 
- What did you think about it? 
- How did you feel about it? 
- Can you tell me more about that? 
- Do you have any examples? 
Could you describe a typical day for you living with PCOS? 
- How did you/do you feel about that? 
- Can you tell me more about that? 
- Do you have any examples? 
Do you think PCOS has changed the pattern of your life at all? 
- Did/do you make any major changes? 
- How did/do you feel about this? 
- What did/do you think about this? 
Have you changed the way you deal with your PCOS and its symptoms over time? 
- In what ways? 
- Does anything, any situation make it better? 
- Does anything, any situation make it worse? 
- How do you feel about these changes? 
Can you describe how having PCOS effects your relationships with others? 
- Family and friends 
- Doctor 
- University Lecturers/Collegues 
Has having PCOS changed the way you think or feel about yourself? 
- Do you see yourself differently now than before being diagnosed with PCOS? 
- Do you think others see you differently? 
If you suffer from any other type of illness or disorder, how do you manage this? 
- In what ways? 
- Does anything, any situation make it better? 
- Does anything, any situation make it worse? 
Could you please look at this questionnaire and tell me your thoughts on it? This 
questionnaire refers to the PCOSQ (Cronin et al., 1998).  
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Appendix J: Skype study – debrief 
Sophie Williams 
Centre for Psychological Research 
Faculty of Education, Health and Sciences 








Thank you very much for taking part in this research study. Your decision to participate is 
completely voluntary. Should you wish to withdraw from the research you may do so at any 
point, up to three weeks after participation. You will not need to give any reason or 
explanation for doing so. To withdraw your data simply contact the researcher or research 
team with your unique participant code (the three item code made up of numbers or letters). 
Should you have any questions about the research please feel free to contact me on the above 
details.  If you have lost your participant information sheet and would like another one please 
let me know and I will send you one. 
If you would like more information about PCOS or have any worries about PCOS please 









Appendix K: Skype study – PREC approval letter (06012-SW) 
 
Approval Letter: Psychology Research Ethics Committee 
 
University of Derby 
 
2nd October 2012 
James Elander  





Ethics Ref No:  06012-SW: Exploring the impact of PCOS 
 
Thank you for submitting this revised application to the Psychology Research Ethics 
Committee.   
 
I have now reviewed the revised documents you sent following the feedback you received on 
your initial application, and I am satisfied that all of the issues raised have been dealt with. 
The application can now therefore be approved. 
 
 The following revised documents have now been reviewed: 
 
1. Revised ethics application form 
2. Revised invitation letters 
3. Consent form 
  
If any changes to the study described in the application or supporting documentation is 
necessary, you must notify the committee and may be required to make a resubmission of the 
application.  
 










Appendix L: Scale development – The Polycystic Ovary Syndrome Questionnaire 
(PCOSQ) 
 
Presented are sample items from the PCOSQ 
Extract of Instructions: 
For each question, you have seven rating options. Option 1 represents the greatest possible 
impairment, while Option 7 represents the least impairment. Choose only one option for each 
question. There is no right or wrong answer. Just choose the option that is closest to how you 
feel. 
 
How much of the time during the last two weeks did you: 
















the time  
Feel like 













       
 
 
During the past two weeks, how much of the time have you felt: 
 
















the time  
Concerned 
with 






a result of 
having 
PCOS 




Appendix M:  The PCOS QOL Prototype 
The Polycystic Ovary Syndrome Quality of Life Scale (PCOS QOL) 
Instructions 
This scale has been specifically designed to measure quality of life for women with 
Polycystic Ovary Syndrome (PCOS). Throughout this scale Polycystic Ovary Syndrome will 
be referred to as PCOS. The questions in this scale are concerned with your PCOS, your 
health and health related issues. Please respond to every question by selecting/highlighting 
the option that reflects how you feel the most. There are no right or wrong answers, just 
choose the answer that shows you feel best.  Please choose only one answer for each 
question.  
 
After reading each statement please circle the answer which you feel most applies to 
you. Please only circle one.  
 
During the last four weeks 




























































































Felt guilty for being overly 
aggressive towards a friend 
























Over reacted to day to day 

























Felt like you weren’t a real 

























Been unsatisfied with the 
support you receive from 





















































Felt overwhelmed by your PCOS 



















































Felt depressed about how PCOS 
























Had negative thoughts about 

























Been worried about other people 









































































Felt depressed over difficulties 


























Felt like you were broken 


























Felt a lack of intimacy in your 










































































Felt like less of a woman because 


















































Had a short temper with my close 
































































































































































































































Felt like I don’t know what to do 
























Felt like I don’t know what to do 

























Felt frustrated with the health care 

















































Felt like my PCOS is in control 





















































Had problems in my relationships 



















































Felt depressed because of the 





































































































Found it hard to cope with my 

























Spent a lot of time and energy 
























Felt depressed over my struggle 

































































































































Felt like a failure because of my 


























































































































Struggled to cope with my PCOS 
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Been worried about how your 























Self harmed because I felt 































I am looking for Participants to take part in some research to develop a quality of life 
questionnaire for women with Polycystic Ovary Syndrome (PCOS). This research will help 
form part of my PhD at the University of Derby. My PhD explores the impact of PCOS on 
quality of life. All you would have to do is answer some questions about your PCOS and 
some other questions to check if the new questionnaire works. Your participation will remain 
confidential and anonymous and is completely voluntary. You may also withdraw from the 
research after participation. 
To take part you must meet the following criteria: have a diagnosis of PCOS, be 18 or over, 
live in the UK and have English as a first language. To read more information about the study 
just click on the link below, if you then decide you want to take part just continue on to the 
questionnaires.  
PLEASE NOTE: Only take part in this study if you have not previously taken part in it – 
thank you.  
 
This study has been granted ethical approval by the University of Derby Psychology Ethics 
Committee. If you have any questions please contact S.Williams3@derby.ac.uk or call 
01332592898 for more information. There is no obligation to participate but we are grateful 




Appendix O: Scale development – information sheet 
Testing a Quality of Life Scale 
 
Participant Information Sheet 
 
Introduction 
You are invited to take part in a research study to help develop and test a scale to measure 
quality of life for women with PCOS.  
 
Who is doing this research? 
The research is being undertaken by a team from The University of Derby and will form part 
of a PhD thesis. The research team includes Sophie Williams, a PhD student at the University 
of Derby; Professor David Sheffield, Assistant head of Psychological Centre for Research, Dr 
Rebecca Knibb, Senior Lecturer in Health Psychology at Aston University and Dr Heidi 
Sowter, Senior Lecturer in Biology at the University of Derby. 
 
Why have you been invited to participate? 
You have been invited to take part in this research as you have PCOS, live in the UK, can 
understand and read English and are over the age of 18.   
 
What does taking part in this research involve? 
The aim of the research is to develop and test a scale which will measure the quality of life in 
women with PCOS.  
 
If you decided to participate all you will need to do is click the website link which will take 
you to a website where you can give consent to take part in this research. At this point you 
will be asked if you would be willing to participate in what we call a re-test, meaning that 
you would complete the questionnaires again at a later date. 
 
Once you have given consent you will be asked to fill out some general information such as 
age and diagnostic information. You will then be able to complete the questions on the 
quality of life scale as well as some other questions taken from other psychological scales 
(we use the other scales to help check the new one is right). If you decide not to take part in 
the re-test you will not be required to do anything else. You will then see, on the website, 
what we call a debrief which summaries the study you have just taken part in. If you do 
decide to take part in the re-test you will be contacted again a few weeks later by the lead 
researcher (Sophie). 
 
What if I want to take part in the re-test? 
 
If you want to take part in the re-test aspect of this research, (where you complete the same 
questionnaires again but a later date) you will be asked to provide an email address when you 
give consent to take part in the study. The lead researcher (Sophie) will then use this to 
contact you to give you all the information you need to complete the questionnaires again 3 
weeks later. Once you have completed the questionnaires for the second time you will be 
given another debrief (on the website) which again summarises the research you have just 
taken part in.  
 
How long will it take? 
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Completing the questionnaires will take around 30 minutes, although it may be longer or 
shorter as filling in the questionnaires is very individual. If you wish to take time with it then 
by all means, take as much time as you want. There is no race to complete them.  
 
 
What if I can’t get online or the website doesn’t work for me? 
If for whatever reason you are unable to get online or you have any problems with the website 
just email the main researcher (Sophie) on s.williams3@derby.ac.uk and let her know the 
problem and a postal address. She will then post you a paper copy with return postage. 
 
 
What are the possible disadvantages or side effects of taking part? 
Currently, there are no known side effects of completing a quality of life scale. To take part 




What are the possible benefits of taking part? 
We are trying to develop a tool which may help health professionals understand the impact of 
PCOS on your quality of life. This scale may also help researchers to measure the impact of 
PCOS on quality of life. We cannot promise that this study will help you, but the information 
we get from this study could help to improve the care of PCOS patients. 
 
What if there is a problem? 
We do not believe that participation in this study will harm you in any way. In the unlikely 
event that you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s negligence, however, then 
you may have grounds for legal action which you may have to pay for.  
 
If you have a concern or complaint about any aspect of this study, you should speak to the 
research team and we will do our best to address your concerns (tel: 01332 592898). If you 
have a concern which you would like to take up with someone other than the research team, 
you can contact James Elander (tel: 01332 593048) who is the Head of the Centre for 
Psychological Research at The University of Derby. 
 
Who is organising and funding the research? 
The research is funded by Sophie Williams and is part of her PhD thesis. 
 
Who has reviewed the study? 
This study has been reviewed and given favourable opinion by the University of Derby Ethics 
Committee. If you have any questions or concerns about this study, you should discuss them 
with the research team (contact details below). 
 
What do I do if I am interested in taking part in the research? 
If you would like to take part in the research all you need to do is click on the website link (or 
continue on this page) and fill out the information and answer the questions. Alternatively, you 
can contact one of the research team by telephone or email (you can find these at the bottom 
of this sheet). At this point we will be able to explain the study in more detail and answer any 




What happens if you change your mind? 
Although your input to this research will be extremely valuable, participation is entirely 
voluntary and should you decide you no longer want to take part you are free to withdraw from 
the study at any time, before, during or up to two weeks after you have participated. If you 
have taken part in the re-test aspect of this research, you are still able to withdraw from the 
study at any time, before, during or after for up to two weeks after completing the re-test 
questionnaires. 
 
What happens if you decide not to take part? 
It is your choice whether you take part in the research or not. Participation is entirely voluntary. 
If you decide that you do not want to take part and have already participated all you would 
need to do is email the main researcher (Sophie) and provide your unique participant code. She 
can then withdraw any data attached to this code. 
 
Will I be anonymous? 
If you want to take part in this research you will remain anonymous and all identifying details 
shall be anonymised. You will be asked to provide a unique participant code which will attach 
to your information, in that way if you wish to withdraw, we will use to withdraw your data.  
 
If you choose to take part in the re-test the main researcher and the research team will have 
access to your name and details however these will not be shared with anyone outside of the 
research team. Your data (the answers to the questions and information about your age etc) 
shall remain anonymous and shall be recognised by the unique participant code. 
 
What will happen to the information that you give? 
The information will be stored securely at the University of Derby for 10 years and only the 
research team will have access to it. All of your data will be anonymised. A summary of the 
data and the overall findings will be used in research papers and be submitted to the University 
of Derby as part of a PhD thesis. Results from the study will also feed into the development of 
health care services if appropriate. You will not be identified in any report or publication. 
 
 
Where can I get more information about this research? 
If you would like more information about this research please contact one of the research team 
on the details below. 
 












Dr Rebecca Knibb 
r.knibb@aston.ac.uk 
0121 204 3402 
 
 





Appendix P: Scale development – consent form 
 
Quality of Life Scale 
 
Statement of Informed Consent 
 
I understand that I have agreed to participate in a research study to develop and test a quality of 
life scale for women Polycystic Ovary Syndrome. 
 
I have seen and read a copy of the project information sheet and have been given an opportunity 
to ask any questions about the study. 
 
I understand that my participation in the study is voluntary, and that if I wish to withdraw from 
the study at any time I may do so up to two weeks after completing the questionnaires and up to 
two weeks after the re-test. I understand that I do not have to give any reasons or explanations 
for doing so. I have been provided with details of who I should contact if I wish to withdraw. 
 
I understand that if I wish to take part in the re-test aspect of this study the research team will 
have access to my name and email address however all questionnaire data shall be recognised by 
a unique identifying code. 
 
I understand that my personal data will be kept confidential and that all information collected for 
the research will be stored securely at the University of Derby on a password protected database. 
Only the research team have access to this. 
 
I understand that these results may be disseminated through conferences and/or published 
articles. I understand that my data will remain anonymous at all times. I understand that the 
results of this research study will be written up as part of a PhD thesis and submitted to the 
University of Derby.  
 
I agree to and understand the above statements (participants are only able to select one) 
 
Yes  No 
 
If you wish to take part in the re-test please provide your email address below (this will 





I consent to taking part in the re-test (participants are only able to select one) 
 




Appendix Q: Scale development – debrief 
 
The impact of PCOS on Quality of Life Scale Development 
Participant Debrief 
 
Thank you very much for taking part in this research study. 
Your decision to participate is completely voluntary. Should you wish to withdraw from the 
research you may do so at any point, up to two weeks after participation. You will not need to 
give any reason or explanation for doing so. To withdraw your data simply contact the 
researcher or research team on the details below with your unique participant code (the three 
item code made up of numbers or letters). 
Should you have any questions about the research please feel free to contact myself or the 
research team on the provided details.  If you have lost your participant information sheet and 
would like another one please let me know and I will send you one. 
If you would like more information about PCOS or have any worries about PCOS please 










Dr Rebecca Knibb 
r.knibb@aston.ac.uk 
0121 204 3402 
 





Appendix R: Scale development – The PCOS QOL 
The PCOS QOL 
 
This scale has been specifically designed to measure quality of life for women with 
Polycystic Ovary Syndrome (PCOS). The questions in this scale are concerned with your 
PCOS, your health and health related issues. Please read and respond to every statement by 
selecting the option that reflects how you feel the most. There are no right or wrong answers, 
just choose the answer that shows how you feel best. If you feel a question does not apply to 
you, please select ‘Does not apply’. 
 
During the last four weeks how often have you: 
 





Felt under pressure to 
have a child 
1 2 3 4 5 6 7 
Felt guilty for being 
overly aggressive 
towards a friend or 
family member 
1 2 3 4 5 6 7 
Over reacted to a day 
to day occurrence 
because of PCOS 
1 2 3 4 5 6 7 
Felt like you weren’t a 
real woman because 
of your PCOS 
1 2 3 4 5 6 7 
Felt overwhelmed by 
your PCOS and 
depression 
1 2 3 4 5 6 7 
Felt depressed about 
how PCOS has 
impacted your life 
1 2 3 4 5 6 7 
Been worried about 
other people seeing 
your facial hair 
1 2 3 4 5 6 7 
Felt anxious about 
conceiving a child 
1 2 3 4 5 6 7 
 
Felt depressed over 
difficulties conceiving 
a child 
1 2 3 4 5 6 7 
Felt like less of a 
woman because of 
having PCOS 
1 2 3 4 5 6 7 
Had a short tempter 
with your close 
friends and/or family 
1 2 3 4 5 6 7 
Felt like crying for no 
reason 
1 2 3 4 5 6 7 
Wanted to do 
something but haven’t 
because of your PCOS 
1 2 3 4 5 6 7 
Felt depressed 1 2 3 4 5 6 7 
 
Felt abnormal because 
of your PCOS 
1 2 3 4 5 6 7 
Felt like you don’t 
know what to do to 
help yourself 
1 2 3 4 5 6 7 
Felt like you don’t 
know what to do to 
control your PCOS 
1 2 3 4 5 6 7 
Felt like you hated 
yourself 
1 2 3 4 5 6 7 
Felt like your PCOS is 
in control of your life 
1 2 3 4 5 6 7 
Felt embarrassed 
about the way you 
look 
1 2 3 4 5 6 7 
Felt moody because of 
your excess hair 
1 2 3 4 5 6 7 
 
Felt depressed 
because of your 
hirsutism 
1 2 3 4 5 6 7 
Felt depressed 
because of your 
infertility 
1 2 3 4 5 6 7 
Spent a lot of time and 
energy removing 
excess hair 
1 2 3 4 5 6 7 
Felt depressed over 
your struggle to have 
children 
1 2 3 4 5 6 7 
Felt depressed 
because of your facial 
hair 
1 2 3 4 5 6 7 
Felt angry that you 
have PCOS 
1 2 3 4 5 6 7 
Been envious of 
women without PCOS 
1 2 3 4 5 6 7 
Felt embarrassed 
about having PCOS 
1 2 3 4 5 6 7 
Felt embarrassed by 
your facial hair 
1 2 3 4 5 6 7 
Felt like a failure 
because of your 
trouble concieving 
1 2 3 4 5 6 7 
Felt that it is unfair 
that you have PCOS 
1 2 3 4 5 6 7 
Struggled to cope with 
your PCOS and your 
other condition(s) 
1 2 3 4 5 6 7 
Been scared that you 
may not have children 
1 2 3 4 5 6 7 
Wanted to take part in 
a social activity but 
1 2 3 4 5 6 7 
 




Appendix S: Scale development – Hospital Anxiety and Depression Scale 
Presented are sample items from the depression and anxiety subscales of the HADS.  
 
I feel tense or ‘wound up’:  A  
Most of the time  3  
A lot of the time  2  
Time to time, occasionally  1  
Not at all  0  
I still enjoy the things I used to enjoy:  D  
Definitely as much  0  
Not quite so much  1  
Only a little  2  
Not at all  3  
  
I get sudden feelings of panic:  A  
Very often indeed  3  
Quite often  2  
Not very often  1  
Not at all  0  
I can enjoy a good book or radio or TV programme:  D  
Often  0  
Sometimes  1  
Not often  2  




Appendix T: Scale development – The WHOQOL-BREF UK 
Presented are samples of items from The WHOQOL-BREF UK 
 
 Very Poor Poor Neither poor 
Nor Good 
Good Very Good 
How would 
you rate your 
quality of 
life? 

















 Very Poor Poor Neither poor 
Nor Good 
Good Very Good 
How well are 
you able to 
get around? 














1 2 3 4 5 
 
Appendix U: Scale development – demographic questionnaire 
 
In the box provided please provide a unique identyfing code. This should be 4 units made up of 
numbers and/or letters that you will easily be able to remember. Please keep a record of this, should 
you want to withdraw your data, this is the code you will need.  
Please write your answer here: 
  
Age  
Please write your answer here: 
What is your marital status?  
Please choose all that apply: 
 Married  
 Civil Partnership  
 Divorced  
 Single  
 Living with Partner  
 Long term relationship  
 Other:  
  
Do you have any children?  
Please choose only one of the following: 
 Yes  
 No  
If yes, how many children do you have?  
Please write your answer here: 
   
And if you answered Yes, how old are your children?  
Please choose all that apply: 
 0-2 years  
 3-5 years  
 6-8 years  
 9-11 years  
 12-15 years  
 15-17 years  
 18-20 years  
 
 21 and above  
Have you adopted any of your children?  
Please choose only one of the following: 
 Yes  
 No  
If yes, how many?  
Please write your answer here: 
  
Are you pregnant now?  
Please choose only one of the following: 
 Yes  
 No  
If you answered yes, how many weeks are left until your due date?  
Please write your answer here: 
   
If no, are you currently trying to conceive?   
Please choose only one of the following: 
 Yes  
 No  
Have you received a diagnosis of PCOS from a doctor, specialist or other relevant health care 
professional?  
Please choose only one of the following: 
 Yes  
 No  
If yes, what tests did you have to get a diagnosis?  
Please choose all that apply: 
 Vaginal Ultrasound  
 Abdominal Ultrasound  
 
 Blood Test (this may be checking your androgen hormone levels or your glucose 
levels)  
 Physical Exam (this may be checking your BMI, your waist measurement or signs 
of excess hair)  
 Other:  
What are the main PCOS symptoms you experience?  
Please choose all that apply: 
 Infertility  
 Irregular Periods  
 Hirsutism (Excess hair on the body)  
 Acne  
 Excess Weight  
 Male Patterned Baldness or Thinning Hair  
 Patches of Skin Discolouration  
 Skin Tags  
 Mood Swings  
 Other:   
What treatments/medications, if any, are you currently taking?  
Please write your answer here: 
What treatments/medications, if any, have you had or taken in the past?  
Please write your answer here: 
Have you received a clinical diagnosis (from a doctor or health professional) of Depression?  
Please choose only one of the following: 
 Yes  
 No  
If Yes, When?  
Please write your answer here: 
 If Yes, have you received any treatment or medications for your depression? Please 
detail any medications or treatments you may have taken or received.   
Please write your answer here: 
  
Have you ever self harmed?  
Please choose only one of the following: 
 
 Yes  
 No  
If yes, have you self harmed recently (in the last 3 months)?  
Please choose only one of the following: 
 Yes  
 No  
Have you received a clinical diagnosis (from a doctor or health professional) of Anxiety?  
Please choose only one of the following: 
 Yes  
 No  
If Yes, When?  
Please write your answer here: 
If yes, what type of anxiety disorer have you been diagnosed with?  
Please choose all that apply: 
 Generalised Anxiety Disorder  
 Obsessive Compulsive Disorder  
 Post Traumatic Stress Disorder  
 Social Anxiety Disorder  
 Panic Disorder  
 Other:   
If Yes, have you received any treatment or medications for your anxiety?  
Please write your answer here: 
Have you ever been diagnosed with an eating disorder?  
Please choose only one of the following: 
 Yes  
 No  
If yes, when were you diagnosed?  
Please write your answer here: 
  
 
Appendix V: Intervention study- Invite to participate 
 
Would you like to participate in a clinical trial to see if completing a positive psychology 
activity has an impact on quality of life for women with Polycystic Ovary Syndrome 
(PCOS)? 
Positive psychology is described as the science of well-being and optimal functioning and 
previous research has shown that positive psychology activities, such as writing down three 
good things that happen to you in a day, can have beneficial effects on quality of life.  
So, this intervention will use the three good things activity, where you write down three good 
things that have happened to you each day, for four weeks. This is to see if doing a positive 
psychology activity can have an impact on your quality of life. It will be run completely 
online and so having access to the internet is important but it also means that you can take 
part in the comfort of your own home. The research team will also contact you via email but 
you are free to call/email/write to them at any time if you have any questions or queries. This 
study has received ethical approval from University of Derby Psychology Ethics Committee. 
The study also follows the British Psychological Society requirements regarding ethics and 
also conforms to the regulations outlined in The Data Protection Act (1998).   
To find more information or to take part please click here [link to website with info 
sheet/consent/demographics] 
If you have any questions then all you need to do is contact Sophie Williams at 
s.williams3@derby.ac.uk or 01332592898.  
  
 
Appendix W: Intervention study – information sheet 
This will be printed on headed paper and available online. 
 
Positive Psychology and Quality of Life Study 
 
Participant Information Sheet 
 
Introduction 
You are invited to take part in an online research study to explore the use of positive psychology 
activities as a complimentary therapy for patients with Polycystic Ovary Syndrome (PCOS) 
and the impact practicing positive psychology activities can have on quality of life. 
 
Several studies have shown that positive psychology activities, such as writing down three 
good things that happen to you in a day, can have beneficial effects on quality of life. This 
research will try to find out if a positive psychology activity has positive effects on quality of 
life in women with PCOS. If this study shows any benefits for participants we can then 
recommend this type of intervention for future patients or individuals who could benefit from 
an improved care service. 
 
Who is doing this research? 
The research is being undertaken by a multi disciplinary team from the NHS and the University 
of Derby. The research team includes Sophie Williams, a PhD student at the University of 
Derby; Professor David Sheffield, Assistant Head of Psychology Research Centre, Dr Rebecca 
Knibb, Senior Lecturer in Psychology at Aston University and Dr Heidi Sowter, Reader in 
Oncology at the University of Derby. It also includes Mr. Saad Amer, a Consultant 
Gynaecologist who runs the weekly PCOS clinic at the Royal Derby Hospital.  
 
Why have you been invited to participate? 
You have been invited to participate as you experience PCOS symptoms, are over 18 and live 
in the UK. 
 
What does taking part in this research involve? 
The aim of the research is to compare a group of participants who are taking part in a four week 
online course of a positive psychology activity (intervention group) and a group who don’t take 
part in the positive psychology activity (comparison group). Agreeing to take part in this 
research would mean that you are prepared to be in either group (but don’t worry, the 
intervention will be offered to all comparison group participants at the end of this study but we 
can’t guarantee there will be any benefit from taking part in this study to you).  
 
You should have also seen a post which will have on it a website address, if you go to the 
website you will be able to consent to taking part by ticking a box saying that you either ‘Agree’ 
or ‘Disagree’ to taking part. This will act as an online signature. After consenting to take part 
in this research you will then be asked straight away to fill in some information about yourself. 
Once you’ve done that you will be randomly placed by the research team in either the 
intervention group or the comparison group. The whole study will take place using the internet.  
 
Those in the intervention group will then be invited to take part in a four week course of a 
positive psychology activity, where you will first be asked to complete some questionnaires. 
You will then be asked to write down three good things which have happened to you each day 
for four weeks. If you can, complete the task towards the end of your day, but if you can’t do 
 
it then, any time will be fine. You will be able to complete this on a website which will be 
provided for you.  
 
When the four weeks is up participants in the intervention group will be asked to complete 
another set of questionnaires. Participants in the comparison group will just be asked to fill in 
the questionnaires at the start of the study and again 4 weeks after they initially consent to take 
part. If you are in this group you will NOT be asked to write about three good things every day. 
All participants will be contacted 6 weeks after the start of the study to gather further follow 
up information. At this point you will be asked to complete the questionnaire pack for a final 
time. 
 
What if I can’t get online? 
This is an online study and so you will need to be able to access the internet to take part. If you 
are in the intervention group and one day are unable to get online to fill in your three good 
things you can write it down (on paper, on your phone, in a notebook etc) and email it to the 
researcher as soon as you are able to, stating which day the entry is for. 
 
What if I forgot to do my three good things activity? 
If you forget to do your three good things activity that’s fine, just continue to do the three good 
things activity everyday as normal for the remainder of the intervention. 
 
What if I cannot think of three good things? 
Don’t worry if you can’t think of three good things, just do what you can. There are no rules 
on what a ‘good’ thing is; this may be as simple and small as a nice meal or the sun is shining; 
or as big as a promotion at work. It’s completely up to you but if you can’t think of three try 
for two or just one. If you cannot think of any, just say so in the area where you would normally 
write a good thing. 
 
What is the procedure that is being tested? 
We are trying to find out if practicing positive psychology activities can improve the quality of 
life women with PCOS. We are not anticipating any other therapeutic benefits such as an 
improved diagnosis. 
 
What are the possible disadvantages or side effects of taking part? 
Currently, there are no known side effects of taking part in a positive psychology activity. The 
positive psychology activity you will be asked to complete has been used previously in other 
psychology research. To take part you will need access to a computer and the internet however 
the activity should not take long to complete. 
 
What are the possible benefits of taking part? 
We are trying to find out if a positive psychology activity can benefit women with PCOS by 
helping them to manage symptoms of the condition, such as depression or anxiety symptoms 
and in turn to see if there is an impact on quality of life. We cannot promise that this study will 
help you, but the information we get from this study could help to improve the care of PCOS 
patients. 
 
What if there is a problem? 
We do not believe that participation in this study will harm you in any way. In the unlikely 
event that you are harmed by taking part in this research project, there are no special 
 
compensation arrangements. If you are harmed due to someone’s negligence, however, then 
you may have grounds for legal action which you may have to pay for.  
 
If you have a concern or complaint about any aspect of this study, you should speak to the 
research team and we will do our best to address your concerns (tel: 01332 592898). If you 
have a concern which you would like to take up with someone other than the research team, 
you can contact the Head of Psychological Research, Professor James Elander (email: 
j.elander@derby.ac.uk, tel: 01332593048) 
 
Who is organising and funding the research? 
The research is funded by the University of Derby and Sophie Williams. This research is part 
of Sophie William’s PhD thesis. 
 
Who has reviewed the study? 
This study has been reviewed and given favourable opinion by the University of Derby 
Psychology Research Ethics Committee, and has undergone external peer review. If you have 
any questions or concerns about this study, you should discuss them with the hospital doctor 
involved with the study.  
 
What happens if you change your mind? 
Although your input to this research will be extremely valuable, participation is entirely 
voluntary and should you decide you no longer want to take part you are free to withdraw from 
the study at any time, before, during or up to two weeks after you have finished your positive 
psychology activity. You just need to email one of the research team to let them know and all 
your details will be removed from the study. 
 
What happens if you decide not to take part? 
It is your choice whether you take part in the research or not. Participation is entirely voluntary.  
 
What will happen to the information that you give? 
The information will be stored securely at the University of Derby for 10 years and only the 
researchers will have access to it. Although the research team will have access to your email 
address (only the research team will have access to this) all of your data will be stored under a 
participant identification code that you create. A summary of the data, the overall findings and 
any entries you make during the study may be used in research papers and be submitted to the 
University of Derby as part of a PhD thesis. Results from the study will also feed into the 
development of health care services if appropriate. You will not be identified, nor will any 
identifying details be used, in any report or publication. Information entered online whilst 
participating in the study will be stored online within the computer software and shall be 
accessible only by the research team and will be password protected. 
 
Where can I get more information about this research? 
If you would like more information about this research please contact one of the research team 
on the following details. 
 
 









Dr Rebecca Knibb 
r.knibb@aston.ac.uk 
0121 204 3402 
 




What do I do if I want to take part? 
If you want to take part all you need to do is contact Sophie Williams on the details above. Or, 
alternatively you can go directly to the study website here (enter website address), read more 
information and begin to take part. 
 
Will I get a summary of the results? 
Yes when the study is completed the research team will email you a summary of the results. 
 
Can I get advice from the research team about my PCOS? 
Unfortunately the research team is unable to offer you any advice on PCOS. If you do need 
any advice or help we would recommend you contact your doctor or relevant health 
professional.  
 
What if I become distressed during the study? 
It is not anticipated that there will be any reason for you to become distressed during this study 
but if you do please contact your GP or relevant health professional. Alternatively, you can get 
support from the UK PCOS charity, Verity.  
 
 
Appendix X: Intervention study – consent form 
 
Positive Psychology and Quality of Life in PCOS 
 
Statement of Informed Consent 
 
 
I understand that I have agreed to participate in a research study exploring the impact of positive 
psychology on the quality of life of women with Polycystic Ovary Syndrome. 
 
I have received a copy of the project information sheet (dated x) and have been given an 
opportunity to ask any questions about the study. 
 
I understand that my participation in the study is voluntary, and that if I wish to withdraw from the 
study at any time I may do so up to two weeks after participation, and that I do not have to give 
any reasons or explanations for doing so. I have been provided with details of who I should contact 
if I wish to withdraw. 
 
I understand that my personal data will be kept confidential and that all information collected for 
the research will be stored securely at the University of Derby on a password protected database 
or a locked filing cabinet. Only the research team have access to this.  
 
I understand that the research team will have access to my email address  
however all my details will remain anonymous and no identifying information  
shall be published.  
 
I understand that verbatim quotes from my entries into the three good things  
activity may be published. However these will remain anonymous and all  
identifying details will be removed. 
 
I understand that these results may be disseminated through conferences and/or published articles. 
I understand that my data will remain anonymous at all times. I understand that the results of this 
research study will be written up as part of a PhD thesis and submitted to the University of Derby.   
 
I am happy to take part in the study and acknowledge that I may be randomly allocated to either 
the positive psychology intervention condition or the control condition (no positive psychology 
intervention). 
 
I have read and understood all the information above and agree to take part in this study. 
 






Appendix Y: Intervention study – debrief 
Positive Psychology and Quality of Life Study 
Participant Debrief 
 
Thank you very much for taking part in this research study. 
Your decision to participate is completely voluntary. Should you wish to withdraw from the 
research you may do so at any point, up to two weeks after participation. You will not need to 
give any reason or explanation for doing so. To withdraw your data simply contact the researcher 
or research team on the details below with your unique participant code (the four item code made 
up of numbers and/or letters). 
Should you have any questions about the research please feel free to contact myself or the 
research team on the provided details.  If you have lost your participant information sheet and 
would like another one please let me know and I will send you one. 
If you were a member of the control group and would like to access the intervention please 
contact Sophie Williams on the details below who will give you all the information you need. 
If you would like more information about PCOS or have any worries about PCOS please contact 










Dr Rebecca Knibb 
r.knibb@aston.ac.uk 
0121 204 3402 







Appendix Z: Intervention study – evaluation questions 
Evaluation 
The following questions aim to provide the research team with more information about the 
positive psychology study so they can understand how it may be improved. Please answer the 
questions considering your experiences with the positive psychology intervention.  





Did you find the positive psychology intervention study enjoyable? 
Likert scale 1 – 7  
1 = no I didn’t enjoy it  
7 – I enjoyed it very much  
 
How easy did you find it to complete the intervention (including the positive psychology 
activity and/or any questionnaires you completed)? 
Liker scale 1 – 7 
1 = very difficult 
7 = very easy  
 
Please tell us about your experience on the positive psychology intervention.  Please consider 
what was good and what was bad? [open text] 
 







Appendix AA: Intervention study – PREC approval letter (87-13-SW) 
Approval Letter: Psychology Research Ethics Committee 
 
University of Derby 
 
Date: 21st August 2013 
 
Dr Frances A. Maratos  





Ethics Ref No:  087-13-SW 
 
Thank you for submitting this revised application to the Psychology Research Ethics 
Committee.   
 
I have now reviewed the revised documents you sent following the feedback you 
received on your initial application, and I am satisfied that all of the issues raised 
have been dealt with. The application can now therefore be approved. 
 
If any changes to the study described in the application or supporting documentation 
is necessary, you must notify the committee and may be required to make a 
resubmission of the application.  
 




F. A .Maratos 
 
Frances A. Maratos 
 
 
 
 
 
 
 
 
 
 
